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Summary 
Innate immune sensing of cytosolic nuclear acids is executed by pattern recognition receptors and is a 
powerful tool to counteract viral and bacterial infection. Nucleic acids with their essential function as 
genetic information carriers serve as a very general pathogen-derived pattern and therefore trigger a 
powerful immune response. The innate immune system evolved to distinguish between pathogen-specific 
patterns such as secondary structures or modifications of RNA and host nucleic acids. In case of DNA, 
however, such strategies as DNA compartmentalization are used to prevent self-DNA recognition. 
Indeed, cellular DNA normally present in nuclei and mitochondria is immunosilent, whereas 
accumulation of cytosolic DNA triggers an inflammatory response. Such DNA can emerge due to viral 
infection, mitochondrial and nuclear stress or due to dysfunction of key proteins responsible for 
elimination of excessive DNA amounts in the cytosol and lysosomes. 
cGAS is a central sensor of cytosolic DNA expressed in almost all cell types. cGAS recognizes cytosolic 
dsDNA in a broad sequence-indiscriminatory manner and synthesizes the second messenger cyclic GMP-
AMP (pG(2’-5’)pA(3’-5’), 2’3’-cGAMP) from ATP and GTP. Unlike bacterial cyclic dinucleotides 
(CDNs) with canonical 3’-5’ linkages, 2’3’-cGAMP is a unique metazoan CDN that comprises both 3’-5’ 
and a non-canonical 2’-5’ phosphodiester linkages connecting adenosine with guanosine and guanosine 
with adenosine, respectively. 2’3’-cGAMP produced upon infection binds and activates the downstream 
adaptor stimulator of interferon genes (STING). Residing on the endoplasmic reticulum, STING binds 
cGAS-generated cGAMP or bacterial CDNs and undergoes trafficking to the Golgi complex in 
perinuclear space where it recruits TANK-binding kinase 1 (TBK1) and transcription factor interferon 
regulatory factor 3 (IRF3). As a result of the pathway activation IRF3 gets phosphorylated, dimerizes and 
translocates into the nucleus resulting in type I interferons (IFNs) production. 
A range of cGAS structures and biochemical studies revealed activation and catalytic mechanisms of 
cGAS. cGAS was discovered to dimerize upon DNA binding in a way that two DNA molecules are 
sandwiched between two cGAS protomers and such dimerization was shown to be necessary for cGAS 
activation. The nature and physiological function of cGAS dimerization, however, remains elusive, since 
such conformation was not found for functionally and structurally similar 2'-5'-oligoadenylate synthetases 
(OAS) or other proteins suggesting it to be a unique feature of cGAS. Moreover, the proposed 
dimerization does not explain why short DNA constructs of 14-20 base pairs (bp) used for crystallization 
fail to fully activate cGAS in vivo, though they are capable of inducing all conformational changes known 
for cGAS activation in the crystal. Furthermore, the composition of such cGAS dimers would lead to 
steric clashes between two bound DNA molecules, if the length of DNA strands exceeds 18 bp present in 
the structure. The instability of such dimeric cGAS conformation is another enigma to be clarified, since 
cGAS2:DNA2 species could only be observed in non-physiological high concentrations of cGAS and 
DNA.  
In this work a mechanism of cGAS activation by biologically relevant ligands was studied. Furthermore, 
a model for cooperative sensing of long DNA by cGAS was established. Mab-21 domain of cGAS was 
found to have an intrinsic capability to measure DNA length, since its activity dramatically increased with 
DNA length by the same number of cGAS binding sites in vitro and in cell-based experiments. In order to 
investigate cGAS activity, a novel high-throughput fluorescence-based assay was developed. The first 
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crystal structure of cGAS in complex with stimulatory DNA of 39 bp presented in this thesis provided an 
insight into cGAS activation by fibril formation. Such cGAS oligomers were found to make protein-DNA 
ladders with two nearly parallel DNA strands as “ladder sides” and cGAS dimers as “rungs” holding them 
together. cGAS-DNA oligomers, first observed in crystal packing, were confirmed by isothermal titration 
calorimetry (ITC) and by size exclusion chromatography coupled to right-angle light scattering (SEC-
RALS). These methods revealed the stoichiometry and molecular weights of cGAS complexes with 
different DNA species that together determined an exact complex composition and confirmed the 
presence of (cGAS2)n:DNA2 complexes in solution. According to our model, the formation of the first 
dimer is highly unfavorable resulting in an unstable complex, however, it parallelizes two DNA strands 
and enables an effective binding of the subsequent cGAS dimer. This results in cooperative binding of 
cGAS on long stimulatory DNA with cooperativity emerging already from cGAS-DNA interactions. 
cGAS dimers are mutually stabilized within a fibril resulting in higher cGAS activity. Furthermore, 
potential cGAS co-factors were proposed. Based on similarities in DNA conformations and a recent 
research revealing mitochondrial DNA to be a cGAS activator, mitochondrial transcription factor A 
(TFAM), as well as high-mobility group box 1 (HMGB1) and bacterial nucleoid HU proteins were 
discovered to enhance cGAS activity. According to our hypothesis, TFAM and other DNA-bending 
proteins introduce a U-turn in long DNA, prearrange DNA in a manner favorable for cGAS dimerization 
and thus serve as nucleation points for cGAS-DNA ladder formation. 
Another part of this thesis was dedicated to discover other physiological nucleic acid ligands of cGAS. 
Cell line experiments with different synthetic constructs revealed RNA:DNA hybrids to be potent cGAS 
activators. Furthermore, ssDNA hairpins formed by HIV-1 reverse-transcribed ssDNA were found to 
stimulate cGAS during HIV-1 infection. Substitution of guanines flanking the double-stranded hairpin 
regions abolished cGAS activity and specific short Y-shaped DNA with G-overhangs (YSD) were found 
to be potent cGAS ligands. Intriguingly, such YSDs were capable of cGAS activation despite their short 
length (< 20 bp) leaving the question open, whether the cGAS-DNA ladder model is applicable in this 
case. 
Taken together, this work presents a range of cGAS activators that include RNA:DNA hybrids, HIV-1 
ssDNA hairpins and partly unfolded mitochondrial and bacterial nucleoids rather than naked dsDNA as 
specific cGAS ligands. The oligomerization mechanism of cGAS described in this thesis provides a link 
between a peculiar cGAS dimerization, on the one hand, and high stimulatory activity of long dsDNA in 
vivo, on the other hand. Proposed cGAS co-factors further clarify the complexity of DNA recognition by 
cGAS in the living cell suggesting that analogically to RNA sensing by RIG-I, cGAS recognizes specific 
structures of dsDNA rather than just mislocalized DNA fragments. However, further studies are needed to 
evaluate the relevance of the oligomerization mechanism for cGAS sensing of other ligands and to 
discover other cellular co-factors facilitating cGAS activity in vivo.  
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Introduction 
1. Immunity and innate immune system 
Recognizing and fighting invading pathogens and foreign molecules are the key mechanisms of organism 
survival. Through the whole tree of life organisms developed mechanisms aimed to response to invading 
pathogens that are called immune system [2]. For example, bacteria possess a set of inducible nucleases to 
eliminate phage DNA [3]. The innate immune system is an evolutionary conserved part of the immune 
system, developed early in multicellular organisms. It recognizes the invading pathogens through 
pathogen-associated molecular patterns (PAMPs), the presence of altered self through damage-associated 
molecular patterns (DAMPs) or the absence of self, like in case of MHC class I recognition by natural 
killer cells [4, 5]. The innate immune system is represented by a limited number of genes and can be 
characterized by its precision in pattern recognition, immediate activation and recognition of evolutionary 
conserved molecular patterns [6]. Vertebrates are the only phylum that together with innate immunity 
developed an adaptive immune system that allows a much higher variability of receptors and sensed 
patterns and immunological memory of invading pathogens. Though the adaptive immune system is more 
flexible and pathogen-specific in comparison to the innate immune system, it is also slower and more 
prone to allergic and autoimmune reactions[6]. Both the innate and adaptive immune systems create a 
strong defense against pathogen invasion: innate immunity is the first line of defense, initiating 
inflammatory response upon binding to pathogen-specific proteins, nucleic acids and lipids, whereas 
adaptive immune response fine-tunes the pathogen recognition by adding adjustable antigen-specific 
receptors [7]. However, the presence of innate immune responses are crucial for adaptive immunity: 
activation of the innate immune system, represented by macrophages, dendritic cells and NK-cells, results 
in production of proinflammatory cytokines, chemokines and type I and II interferons that recruit and 
activate T and B lymphocytes of the adaptive immune system [8-10]. Moreover, activation of innate 
immune system is a crucial step for antigen-presentation to T-lymphocytes by dendritic cells [11].  
Dysregulation of the innate immune system is associated with various autoimmune diseases, such as 
rheumatoid arthritis, Crohn’s disease (CD), systemic lupus erythematosus (SLE), Acardi Goutières 
syndrome (AGS), and Sjogren’s syndrome [12]. Dysfunction of the innate immune system, on the other 
hand, can result in higher susceptibility to viral and bacterial infections. Thus, deep understanding of 
precise mechanisms of innate immune responses, their regulation and inhibition by invading pathogens is 
absolutely necessary for developing of new vaccines and therapies against the huge range of diseases of 
bacterial, viral or autoimmune origin.  
2. Pattern recognition receptors 
The main targets of innate immune recognition are pathogen- and damage-associated molecular patterns 
(PAMPs and DAMPs), such as lypopolysaccharides, lipopeptides, flagellin, cyclic dinucleotides (CDNs) 
or various nucleic acids emerging from bacterial and viral replication or from the damaged self. Such 
molecular patterns have several features in common: they are produced only by pathogen or in damaged 
host and not by healthy host organism; they are essential for pathogen viability, so that pathogens can not 
lose them through evolution; the same type of PAMPs or DAMPs are usually introduced by several 
groups of pathogens and stress signals, so that the innate immune system can use the same tools for 
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multiple kinds of invasions; and PAMPs are chosen to carry information about the type of infection in 
order to trigger the best suitable immune response [4]. These PAMPs and DAMPs are sensed by the 
innate immune system using a range of evolutionally conserved pattern recognition receptors (PRRs).  
Major PRR families include Toll-like receptors, recognizing a variety of bacterial and fungous structural 
elements, as well as nucleic acids; C-type lectin receptors (CLRs) sensing mannose, fucose and glucan 
carbohydrate structures present in bacterial cell walls; absent in melanoma 2 (AIM2)-like and nucleotide-
binding and oligomerization domain (NOD)-like receptors involved in inflammasome formation and 
caspase-1 activation; retinoic acid inducible gene I (RIG-I)-like receptors (RLRs) sensing various 
cytosolic RNA species; and cGAS-STING pathway responsible for cytosolic DNA sensing. Activation of 
these receptors leads to signal transduction through different adaptor proteins resulting in activation of 
various transcription factors, such as NF-κB, interferon regulatory factor 3 (IRF3) and 7 (IRF7) [13-15]. 
These cascades of interactions result in transcription activation and production of IFN-β, cytokines and 
chemokines that in turn activate the neighboring cells. IFN-β is produced in early stages of infection, 
binds to IFN-α/β receptor (IFNAR) and induces transcription of IFN-stimulated genes (ISGs) through the 
JAK-STAT pathway, thus increasing the anti-viral defense of the neighboring cells, activating natural 
killer (NK) cells and macrophages and increasing antigen presentation [16-19].  
Though the main function of the majority of PRRs is inducing inflammation, their activation can be 
associated with various types of cell death in order to eliminate the pathogens and to trigger a potent 
immune response. Activation of ALRs or NLRs resulting in inflammasome formation and activation of 
caspase-1 leads to IL-1β and IL-18 maturation on the one side, but also to highly inflammatory pyroptotic 
cell death [20-22]. TLR2, 3 and 4 were shown to be involved in apoptosis by association of their adaptor 
Toll/IL-1R domain-containing adapter inducing IFN-β (TRIF) with Fas-associated death domain (FADD) 
and caspase-8-dependent apoptotic pathway [23-27]. The cytosolic DNA sensor DNA-dependent 
activator of interferon regulatory factors (DAI) is able to directly interact with receptor interacting protein 
kinase 3 (RIP3) and thus to mediate necroptosis in response to viral infection [28]. Additionally, 
activation of stimulator of interferon genes (STING) was recently shown to induce lysosomal cell death 
and to additionally activate inflammasome pathway resulting in high inflammatory response [29]. 
PRRs are present in different cell compartments. Toll-like and C-type lectin receptors are membrane-
associated PRRs and are localized in the cell or endosome membranes. RLRs, ALRs, NLRs and cGAS 
are cytosolic PRRs. Some PRRs like mannan-binding protein or C-reactive protein are secreted into the 
blood stream where they participate in microorganism opsonisation and activation of the complement 
system, inflammation and phagocytosis [30].  
The cooperative action and regulation of PRRs on the cell an organism levels provide a diverse and 
specific platform for pathogen and damage recognition serving as the first line of defense against the 
changes in organism homeostasis. 
3. Nucleic acids sensors 
Though recognition of bacterial structural elements by surface PRRs is extremely important for the rapid 
response to pathogens, sensing of intracellular pathogens is far more challenging for the innate immune 
system, since the exact discrimination between self and non-self is required. The most common group of 
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DAMPs occurring in all intracellular pathogens is represented by nucleic acids arising from bacterial and 
viral genomes and their replication products. Invertebrates recognize such nucleic acids mostly using 
RNA interference (RNAi). For example, in Drosophila the mutations in Dicer-2 or Argonaute-2 proteins 
result in higher susceptibility to viral infections [31, 32]. In contrast, vertebrates mostly use sequence-
unspecific type I IFNs-dependent immune response. Surprisingly, the RNAi is even down-regulated in 
mammals upon viral infection, while it inhibits the excessive expression of interferon-stimulated genes 
(ISGs) in the absence of immunogenic stimuli [33]. The innate immune system of vertebrates recognizes 
nucleic acids as foreign according to their local concentration, specific localization, such as in cytosol or 
lysosomes and specific structural elements and chemical groups usually absent in the host, such as 
cytosolic double-stranded RNA or RNA with 5’-triphosphates at the RNA end  [34].  
Nucleic acid receptors can be divided into two groups: receptors with a direct antiviral activity and PRRs 
that activate the downstream signaling cascade and transcription factors resulting in the synthesis of 
effector proteins and cytokines. The expression level of the nucleic acid sensors depends of the cell type. 
For example, Toll-like receptors are largely expressed in specialized immune cells like dendritic cells, 
monocytes, macrophages and T- and B-lymphocytes. Epithelial cells of skin and lungs are equipped with 
high levels of cytosolic DNA and RNA sensors. Some PRRs, like cGAS, are expressed in almost all cell 
types. Recent studies showed that the same PRRs can be activated in presence of self-DNA, if it appears 
in unusual compartment. For example, mitochondrial and nuclear stresses can result in a leakage of 
cellular DNA into the cytosol where it is recognized by the same PRRs that usually detect pathogenic 
genomes. Specific groups of PRRs involved in nucleic acid sensing will be discussed in detail below.    
3.1. Toll-like receptors 
Toll-like receptors are an evolutionary conserved and one of the most studied groups of PRRs. The first 
Toll-like receptor was discovered in Drosophila and was found to be crucial for dorsal-ventral polarity 
establishment in embryogenesis [35]. Except for its function during development, this receptor was 
shown to be involved in Drosophila’s defense against fungal infection [36]. Homologous proteins were 
soon found in vertebrata that now correspond to one of the largest families of PRRs – toll-like and IL-1 
receptor (TLR/IL-1R) family. 
TLRs are expressed in epithelial cells and fibroblasts, as well as in immune cells like macrophages, 
dendritic cells and B- and T- cells [37]. In humans the TLR family comprises 10 members. Extracellular 
TLRs 1, 2, 4, 5 and 6 recognize structural components of bacteria, such as lipopeptides, peptidoglicans, 
lipopolysaccharides and flagellin. Other TLRs monitor the lumen of lysosomes for the presence of foreign 
nucleic acids. TLR3 is activated upon binding of synthetic and viral dsRNA, TLR 7 and 8 are responsible 
for GU-rich ssRNA emerging form viruses and bacteria [38-40]. TLR9 recognizes unmethylated CpG 
motifs of bacterial and viral DNA [41]. IL-1R family receptors are direct binders of proinflammatory 
cytokines like IL-1β, IL-18, IL-33 that regulate innate and adaptive immune responses [42, 43]. A couple 
of TLRs absent in humans were recently discovered in mice. TLR11 and 12 were shown to recognize 
profilin and flagellin emerging from apicomplexan parasites and bacteria [44-46]. Mouse TLR13, also 
absent in humans, specifically senses bacterial 23S rRNA of Gram-positive and Gram-negative bacteria 
[47].   
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TLRs are membrane-bound receptors that consist of a common cytoplasmic signaling domain – Toll-IL-
1R (TIR) homology domain, transmembrane part and different ectodomains containing leucine-rich 
repeats that are responsible for PAMP sensing [48]. Upon ligand binding the TLRs form homo- or 
heterodimers that lead to TIR conformational changes and adaptor recruitment. For example, TLR2 forms 
a heterodimer with TLR6 or TLR1 for effective sensing of Gram-positive bacteria by recognizing 
peptidoglycan and di- or triacylopeptides, respectively [49]. TLR3, 4, 5 and 9 are known to form 
homodimers [50-53]. Such cooperative interactions between TLRs not only enhances the recognition of 
pathogens by combining several PAMPs recognition, but also plays important role in regulation of TLRs. 
TLR8 dimerization with TLR7 or TLR9 was shown to antagonize activation of these receptors, whereas 
TLR9 inhibits TLR7, indicating the complexity of TLRs activation and cross-talk [54].  
Following the ligand binding, TLRs 
recruit adaptor proteins myeloid 
differentiation primary-response 
protein 88 (MYD88) or TIR domain-
containing adaptor protein inducing 
IFNβ (TRIF) that lead to nuclear 
factor kappa light-chain enhancer of 
activated B cells (NF-κB) activation 
and proinflammatory cytokine 
production or type I IFN response, 
respectively (Figure 1). Most of TLRs 
use MYD88 which forms a complex 
with IL-1R-associated kinases 
(IRAKs) via its death domain forming 
a complex called Myddosome [55]. 
Myddosome initiates a kinase cascade 
leading to phosphorylation of NF-κB 
inhibitory protein IκBa and NF-κB 
translocation into the nucleus [56]. In 
addition to NF-κB pathway, TLR7 
and TLR9 induce type I IFN 
production in MYD88-dependent 
manner by phosphorylating 
transcription factors IRF1 or IRF7 
that lead to IFN-β activation [57]. In 
contrast to other TLRs, TLR3 (and 
internalized TLR4), a sensor of 
endosomal dsRNA, binds adaptor 
TRIF that associates with kinases 
TANK-binding kinase 1 (TBK1) and 
IKK-i which in turn phosphorylate 
and activate transcription factor IRF3 and IRF7 resulting in IFN-β induction and expression of IFN-
inducible genes [58-60]. TLR signaling pathways are summarized in Figure 1. 
Figure 1 Toll-like receptor signaling pathways.  
Upon ligand binding TLRs form homo- or heterodimers and recruit 
adaptors MyD88 (myeloid differentiation primary-response protein 88) 
or TRIF (TIR domain-containing adaptor protein inducing IFNβ) for 
downstream signaling resulting in production of proimflammatory 
cytokines and type I IFNs. Adopted from Du B., et al., 2016 [1]. 
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3.2. AIM2- and NOD-like receptors 
Another group of PRRs sensing a broad range of pathogen associated molecules consists of absence in 
melanoma 2 (AIM2)-like receptors (ALRs) and nucleotide oligomerization domain (NOD)-like receptors 
(NLRs) [61]. ALRs and NLRs are known to form multi-protein signaling complexes called 
inflammasomes and to activate inflammatory caspases, leading to IL-1β and IL-18 secretion and cell 
death. Unlike TLRs, ALRs and NLRs are cytosolic receptors and are ubiquitously expressed in all cell 
types, however, different NLRs and ALRs are not equally distributed and can be preferentially expressed 
in particular tissue [62]. Invertebrates and plants have proteins similar to NLRs in domain architecture, 
like Arabadopsis resistance (R) proteins or NLR-proteins in corals, however the NLR homologues are 
missing in nematodes and Drosophila [61, 63, 64]. 
In humans ALRs and NLRs family counts 24 members that all possess a ligand binding domain and at 
least one signaling domain of death domain superfamily (Figure 2). AIM-2 family members consist of N-
terminal effector pyrin domain (PYD) and one or two C-terminal hemopoietic expression, interferon-
inducibility, nuclear localization (HIN) domains responsible for dsDNA binding [65-68]. NLRs comprise 
N-terminal effector domain followed by central nucleotide oligomerization domain (NOD) and C-
terminal leucine-rich repeats (LRR) responsible for PAMP recognition. N-terminal effector domain is 
represented by PYD domain in NLRP subfamily, CARD in NLRCs or baculoviral inhibitory repeat 
(BIR)-like domains in NLR family-apoptosis inhibitory proteins (NAIPs). NLRs respond to a variety of 
PAMPs of bacterial and viral origins, as well as to cellular damage signals. NLRP1 senses a protease 
from Bacillus anthracis, NLRC4 in complex with NAIP is responsible for flagellin and bacterial type III 
secretion system (T3SS) recognition [69]. NLRP3 ligands include pathogen derived toxins, such as Syk 
kinase of Candida albicans, pore-forming toxins of S. aureus or L. monocytogenes and alpha-toxin of S. 
aureus, or host-derived molecules indicating cellular stress like extracellular ATP, ion influx, amyloid-β 
peptide, uric acid crystals or elevated level of extracellular glucose [70-75]. 
Some ALRs and NLRs are reported to retain their autoinhibited state in the absence of signal by 
interaction between ligand-binding and signaling or NOD domains [76-78]. Ligand binding results in 
oligomerization of the receptors. AIM2 and IFI16 create fibrils along dsDNA stretches. Whereas IFI16 
oligomerization is driven by clustering of pyrin domains, DNA-binding HIN-domains of AIM2 are 
sufficient for filament formation [79, 80]. Though no high-resolution structure is available so far, based 
on homology with apoptosome and electron microscopy studies of NLRP1 NLRs are believed to 
assemble into a ring-like structure via CARD-domain association [81-83]. ALRs and NLRs 
oligomerization results in PYD or CARD-domain aggregation that recruits adaptor protein apoptosis- 
associated speck-like protein containing a CARD (ASC) via PYD-PYD or CARD-CARD domains 
interactions, respectively (Figure 2) [83-85]. Interaction of ASC with PYD-containing ALRs or NLRs 
nucleates ASCPYD filament formation that brings its CARD domains in close proximity and thus creates a 
platform for caspase-1 recruitment and activation [86-89]. NLRs containing a CARD domain can directly 
bind and activate caspase-1, however, the presence of ASC as mediator of inflammasome formation 
results in more efficient signaling (Figure 2) [78, 85, 90]. Several oligomerization steps of inflammasome 
formation result in a star-shaped protein assembly with ALR/NLR-ASC complex attached to long 
caspase-1 filaments [87]. Activated caspase-1 processes IL-1β and IL-18 and cleaves gasdermin D, which 
induces pyroptosis by forming membrane pores (Figure 2) [84, 91-93]. 
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Figure 2 Inflammasome signaling pathways.  
NLRP1 (NLRP1b in mice), NLRP3, NLRC4/NAIP and AIM-2 recruit adaptor ASC via PYD-PYD interactions. 
CARD domains of ASC assemble pro-caspase-1 filaments via CARD-CARD interaction leading to caspase-1 
activation and cleavage of pro-IL-1β and gasdermin D followed by gasdermin D-mediated pore formation, 
pyroptotic cell death and IL-1β release. Depicted domains include CARD (caspase activation and recruitment 
domain), PYD (pyrin domain), NOD (nucleotide oligomerization domain), LRR (leucin-rich repeats), BIR 
(baculoviral inhibitory repeat), caspase, FIIND (function-to-find domain), NR100 (amino-terminal domain of rodent 
NLRP1 of about 100 amino acids), HIN (hemopoietic expression, interferon-inducibility, nuclear localization). A 
schematic representation of domains is shown in figure. Adopted from Man S.M. and Kanneganti T.-D., 2016 [94]. 
 
Except for PAMP sensing and pyroptosis, inflammasomes are described to be involved in physiological 
processes unrelated to inflammation. For example, NLRP1 or NAIP/NLRC4 inflammasomes activation is 
associated with caspase-1 mediated activation of phospholipase A2 and eicosanoid synthesis [95]. NLRP3 
inflammasome supports phagosome maturation and antigen cross-presentation in macrophages [96]. 
NLRC4 induced activation of caspase-1 was reported to impair autophagy through TRIF cleavage, as well 
as to cleave glycolysis-related enzymes [97, 98]. ALRs and NLRs can also function inflammasome-
independently. For instance, AIM2 is involved in colorectal cancer suppression, NLPR3 influences 
transcription program in T helper cells by directly engaging with nuclear transcription factors, NLRP6 
negatively regulates NF- κB activation by Toll-like receptors, but stimulates type I IFN response upon 
EMCV infection [99-102]. 
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3.3. RIG-I-like receptors 
Unlike Toll-like receptors and AIM-2/NOD-like receptors RIG-I-like receptors (RLRs) are specialized in 
foreign RNA recognition. RLRs trigger innate immune response counteracting broad range of RNA 
viruses like influenza A virus, Newcastle disease virus, Sendai virus, vesicular stomatitis virus, hepatitis 
C virus and picornaviruses by detecting their genomes or replication products [103]. DNA viruses such as 
herpes simplex virus-1, adenovirus, Epstein-Barr virus, vaccinia virus and hepatitis B virus were also 
reported to trigger an immune response through RLRs [104, 105]. RLRs are expressed in most tissues, 
enabling immune sensing in all cell types.  
RLR family consists of three receptors: retinoic acid-inducible gene I (RIG-I), melanoma differentiation-
associated gene 5 (MDA5) and laboratory of genetics and physiology 2 (LGP2) [106]. Though cellular 
RNAs like mRNA, tRNA, rRNA and miRNA are also present in the cytosol, their length, structure and 
modifications restrict their recognition by RLRs. RIG-I specifically recognizes dsRNA >19 bp with 5’-tri 
or di-phosphates, though short fragments of poly(I:C) and very long dsRNA molecules were reported to 
be bound by RIG-I independently of 5’-phosphates [107-110]. Interestingly, even nucleoprotein-
encapsidated dsRNAs with 5’-triphosphate are recognized by RIG-I [111]. RIG-I is also indirectly 
involved in poly(dA:dT) DNA sensing through its RNA intermediate transcribed by RNA polymerase III 
[112]. MDA5 is known for recognition of long > 1kbp dsRNA, poly(I:C) and AU-rich viral mRNAs 
originating from measles virus [113-115]. RIG-I and MDA5 are also suggested to have direct antiviral 
activity and to interfere with viral polymerases by binding to the replicating viral genomic RNA [105, 
116]. LGP2, the only RLR lacking downstream signaling domains, preferentially binds dsRNA ends and 
was first described as negative regulator of RIG-I and MDA5 signaling [106, 117, 118]. However, more 
recent studies revealed LGP2 to assist in MDA5-RNA interaction and enhance MDA5 RNA recognition 
of EMCV virus [119, 120]. 
RLRs comprise of an SF2 ATPase domain and a C-terminal domain (CTD) that are responsible for RNA 
binding and ATP binding and hydrolysis (Figure 3). RIG-I and MDA5 additionally have an N-terminal 
tandem caspase recruitment domain (2CARD) for signal transduction. The CTD is responsible for 
substrate specificity: in RIG-I it specifically binds 5’-triphosphate, in LGP2 – dsRNA termini, and in 
MDA5 – dsRNA stem [121-124]. ATPase activity of RLRs is supposed to weaken dsRNA binding and 
thus support discrimination between self and non-self dsRNAs. ATP hydrolysis is reported to disassemble 
MDA5 fibrils formed on short dsRNAs thereby driving MDA5 filament formation only to long virus-
derived RNAs [125]. Mutations in the RIG-I ATPase domain trapping the protein in its ATP-bound state 
were described to result in a constitutive activation of RIG-I due to its association with self-RNA and 
elevated IFN response in the absence of infection [126, 127]. 
Inactive RIG-I is present in an autoinhibited state with CARDs bound to the ATPase domain. Upon RNA 
and ATP binding the ATPase domain together with CTD forms a ring around dsRNA, and CARD 
domains of RIG-I are released to enable downstream signaling [128, 129]. CARD domains of RIG-I then 
assemble into a helical tetramer that is additionally stabilized by ubiquitin chains thus forming a scaffold 
for interaction with the adaptor MAVS (Figure 3) [130-132]. Unlike RIG-I, CARD domains of MDA5 are 
not inhibited by protein conformation [133]. MDA5 forms a ring-like structure on long dsRNA similar to 
RIG-I and undergoes further oligomerization through interactions between ATPase domains thus bringing  
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Figure 3 RIG-I and MDA5 RNA-sensing pathways.  
RIG-I and MDA5 recognize 5’-PP/PPP and long dsRNA, respectively, that emerge from viruses or reverse 
transcribed by RNA polymerase II (RNA pol III) AT-rich dsDNA and form oligomers. 2CARD signaling domains 
assemble into tetramers stabilized by ubiquitin (Ub) and initiate oligomerization of CARD domains of MAVS. 
Further recruitment of TRAFs results in activation of IKK and TBK1 kinases resulting in phosphorylation of 
transcription factors and synthesis of type I IFNs and proinflammatory cytokines. Adopted from Yoneyama M., et al, 
2015 [134]. 
 
CARD domains in close proximity and facilitating their interaction (Figure 3) [125, 135, 136]. According 
to structural studies, LGP2 also assembles into filaments similar to MDA5 proposing filament nucleation 
to be a mechanism for its MDA5 signaling enhancement [137]. In presence of ATP RIG-I also can form 
active filaments along dsRNA, similar to those formed by MDA5 [138]. Taken together, dsRNA-driven 
oligomerization of RIG-I and MDA5 represents a general mechanism of cooperative dsRNA sensing by 
RLRs.    
Activated RIG-I and MDA5 recruit adaptor mitochondrial antiviral signaling (MAVS) through CARD 
domains interaction (Figure 3) [139]. CARD-filaments originating from RIG-I and MDA5 are believed to 
serve as nucleation point for MAVS prion-like fibrils formation on mitochondrial surface [140, 141]. 
Tumor necrosis factor Receptor-Associated Factor (TRAF) binding motifs (TBMs) of MAVS oligomers 
bind TRAF proteins that activate IKK and TBK-1 kinases resulting in NF-κB or IRF3 activation and IFN 
response [142-147]. RLRs key features and pathways are summarized in Figure 3. 
-11- 
 
3.4. OAS proteins 
Another class of RNA-sensing PRRs is represented by 2’-5’ oligoadenylate synthase (OAS) proteins. 
OAS/RNase L pathway is one of first discovered innate immune pathways leading to IFN production and 
counteracting viral infection. OASs are template-independent nucleotidyltransferases that recognize 
intracellular dsRNA and produce 2′-5′-linked oligoadenylate (2-5A) second messenger  [148, 149]. This 
second messenger binds and activates a downstream effector – endoribonuclease L (RNase L) that 
degrades viral and host RNA preventing protein synthesis and causes apoptosis of the infected cell 
(Figure 4) [150-152]. OAS proteins are widely expressed in different cell types and their expression is 
enhanced in the presence of type I IFN [148, 149, 153]. OAS/RNaseL axis detects dsRNA emerging from 
viral genomes or during the viral replication and is involved in antiviral defense against picornaviruses, 
such as encephalomyocarditis virus (EMCV), vaccinia virus, hepatitis C virus (HCV) and HIV [154-158].     
OAS/RNaseL homologs can be found in most tetrapods, however, OAS-like proteins exist throughout 
metazoans and can be found even in sponges, indicating an ancient origin of 2’-5’-specific catalysis [159-
161]. The human OAS family consists of 4 members – OAS1, OAS2, OAS3 containing one, two or three 
basal OAS units, respectively, and OAS-like protein (OASL) comprised of one OAS unit and a C-
terminal ubiquitin-like domain  [162-166]. OAS1 and OAS2 both exist as two splice variants with 
different C-terminal parts, whereas only one isoform of OAS3 was detected [167-169]. Different OAS 
proteins and their isoforms are characterized by different expression level, localization and biological 
functions [170]. For example, OAS3 was demonstrated to be localized with ribosomal RNA, whereas 
OAS2 was reported to be associated with nuclear envelope and rough endoplasmic reticulum and OAS1 
localizes to the nucleus and cytoplasm or can have antiviral functions in the extracellular space [162, 171-
174]. OAS proteins are expressed during different stages of viral infection and combine their functions for 
an optimal antiviral activity [175-177].  
OAS proteins are nucleotidyltransferases and one OAS unit consists of a two lobes characteristic for this 
family of enzymes (Figure 4) [178, 179]. OAS1-3 bind dsRNA with a positively charged “spine” between 
two lobes that results in active site rearrangement and show preferential binding to long dsRNAs [178-
180]. Other OAS ligands include ssRNA with defined secondary structure, such as a stem-loop of HIV 
mRNA in 5’-untranslated region [181]. Activated OAS binds two Mg2+ ions and two ATP and catalyzes a 
nucleophilic attack by the 2’OH of the acceptor ATP or polyadenylate to triphosphate of donor ATP – the 
reaction mechanism proposed for the whole class of nucleotidyltransferases [179, 182, 183]. 2’-5’ bond 
specificity emerges from the positioning of an acceptor ATP in the active site: in contrast to 3’-5’ specific 
nucleotidyltransferases such as poly(A)-polymerase, OAS1 structure revealed the absence of bulky 
residues in proximity to the acceptor binding site, thus enabling the rotation of the acceptor ATP and 
positioning of 2’-OH at the reactive center [179, 184]. The base of the donor ATP is coordinated with 
unspecific hydrophobic interactions that explain the possibility of other OAS substrates. OAS can 
catalyze pppA(pA)n(2’-5’)pG  and pppG(2’-5’)pG formation, as well as elongate an RpA molecule like 
NAD+, Ap4A or tRNA [185-188]. Unlike OAS1-3, OASL has mutations in catalytic residues responsible 
for triphosphate recognition and therefore lacks enzymatic activity [164, 165]. 
The activity of OAS 1 and OAS2 depends on an intact tripeptide motif (CFK) that is necessary for their  
tetramerization and dimerization, respectively [170, 189]. OAS3 and OASL lack the conservation in 
tripeptide motif resulting in monomeric form of these proteins [170]. The oligomerization of OAS 
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correlates with the enzyme processivity: tetrameric OAS1 and dimeric OAS2 produce trimeric and 
tetrameric 2’-5’-linked polyadenylates that are capable of strong RNaseL activation and the mutations 
disrupting oligomerization of the enzymes at least for OAS2 abolish the enzyme activity [190-193]. In 
contrast to OAS2, OAS1 was also reported to be active in monomeric state [173]. Monomeric OAS3 
synthesizes only dimeric pppA(2’-5’)pA that are not efficient RNaseL activators [193, 194]. 
Polyadenylates produced by OAS proteins are bound by autoinhibited monomeric RNaseL that leads to 
its homodimerization and activation (Figure 4) [195, 196]. Active RNaseL degrades viral and cellular 
ssRNAs including rRNA and preferentially cuts after UA and UU sequences [197-200]. The resulting 
fragments of cellular RNA and dsRNA fragment arising from cleavage of single-stranded parts of viral 
replication products are recognized by the cell as non-self RNAs and are reported to stimulate IFN 
response through RIG-I and MDA5 pathways [201, 202]. RNaseL antiviral functions also include 
induction of apoptosis of the infected cell further eliminating viral infection (Figure 4) [203, 204]. 
OAS proteins were reported to have RNaseL-independent functions. Enzymatically inactive family 
member OASL was shown to increase resistance to single-stranded RNA and DNA viruses via its C-
terminal ubiquitin-like domain and to suppress viral replication by enhancing RIG-I signaling by poly-
ubiquitin mimicking [205, 206]. Mouse OASL1, on the other side, inhibits translation of IFN-regulating 
transcription factor 7 (IRF7) and thus reduces type I IFN production resulting in increased viral 
persistence [207, 208]. OAS3 was shown to have RNaseL-independent antiviral function in response to 
Chikungunya virus [209]. 
The importance of OAS/RNaseL axis in antiviral defenses is supported by the evolvement of viral 
mechanisms inhibiting the pathway. For example, L protein from Theiler’s virus directly inhibits RNaseL 
and phosphodiesterases from murine coronavirus and group A rotavirus were reported to degrade 
polyadenylates to reduce RNaseL activation [210-212].  
3.5. cGAS-STING pathway 
DNA emerging from pathogens or damaged cells is also a potent DAMP recognized by the innate 
immune system [4]. Unlike pathogen-associated RNAs that can be distinguished by the various structural 
and chemical features from host RNAs, sensing of foreign DNA relies mostly on DNA 
compartmentalization [4]. The presence of DNA in cytosol is a danger-associated signal and misplaced 
self-DNA and DNAs emerging from viral or bacterial genomes are detected in cytosol by a range of 
PRRs. cGAS/STING axis displays a central pathway of cytosolic DNA sensing and is responsible for 
DNA recognition in the majority of cell types [213]. Other DNA-sensing PRRs like TLR9 and AIM2 can 
not fully rescue IFN induction in the absence of cGAS/STING [214, 215]. The cGAS/STING axis is 
responsible for detection of various DNA viruses, such as herpes simplex virus 1 (HSV-1), murine 
gamma-herpesvirus 68 (MHV68), Kaposi's sarcoma-associated herpesvirus (KSHV), vaccinia virus 
(VACV), hepatitis B virus (HBV), retrovirus HIV-1 through its replication intermediates, as well as 
bacterial and synthetic dsDNAs [213, 215-223]. Cellular DNA emerging in the cytosol is also an activator 
of the cGAS/STING pathway. For example, DNA exposure to UV irradiation or reactive oxygen species 
results in DNA oxidation and its recognition by cGAS/STING [224]. Mitochondrial nucleoids were 
recently reported to leak to the cytosol under mitochondrial stress conditions and induce cGAS/STING 
mediated type I IFN synthesis [225-227]. Chromatin fragments arising from missegregation of DNA  
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Figure 4 cGAS/OAS nucleic acid sensing pathways.  
Upon dsRNA binding OAS (PDB:4RWN) produces polyadenylates (pppApAn) that activate RNaseL (PDB:4OAU). 
RNaseL digests cellular and viral ssRNA abolishing translation and produces short dsRNA fragments recognized by 
RIG-I and MDA5. 
cGAS (PDB: 4KB6) is activated by cytosolic dsDNA and synthesizes 2’3’-cGAMP that activates the adaptor 
STING (PDB: 4KSY) residing on endoplasmic reticulum (ER). STING undergoes trafficking to Golgi complex in 
perinuclear region and recruits kinase TBK1 for IRF3, STAT6 and NF-κB transcription factors activation. 
Additionally, STING mediates NF-κB activation through IKK kinases. Active IRF3, NF-κB and STAT6 are 
translocated into the nucleus and facilitate expression of type I IFNs and proinflammatory cytokines and 
chemokines. 
 
during the mitosis are also detected by cGAS/STING [228, 229]. Interestingly, cGAS was also found to 
recognize chromatin fragments in senescent and cancer cells and to promote proinflammatory response 
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and paracrine senescence through production of various cytokines, chemokines, extracellular matrix 
proteins and growth factors, collectively referred to as the senescence-associated secretory phenotype 
(SASP) [230, 231]. 
Cyclic GMP-AMP synthase (cGAS) is a dsDNA sensor binding various DNA species sequence-
unspecifically [232]. It belongs to the family of nucleotidyltransferases and shares a similar fold with 
OAS proteins (Figure 4) [233-235]. The dsDNA ligand is bound with a positively charged helix on the 
opposite side of the active center similar to OAS and introduces structural changes in the active site of 
cGAS [233, 234, 236]. Though long dsDNA is reported to be the most potent cGAS activator, ssDNA and 
dsRNA can also be bound by cGAS, however, binding of these ligands does not lead to cGAS activation 
unless ssDNA has a secondary structure with double-stranded stem regions [232, 233, 235, 237]. Active 
cGAS generates a second messenger cyclic GMP-AMP (cGAMP) from ATP and GTP (Figure 4). Unlike 
bacterial cyclic dinucleotides, composed of 3’-5’-phosphodiester linkages, cGAS catalyzes formation of 
an uncanonical 2’-5’ linkage between 2’OH of GMP and 5’-phosphate of AMP [234, 238, 239]. In 
contrast to OAS that produces linear 2’-5’ polyadenylates in a one-step mechanism, cGAS synthesizes 
two phosphodiester linkages via two-step mechanism catalyzed by a single active site. During the first 
step GTP and ATP bind to acceptor and donor binding sites, respectively, and pppG(2’-5’)pA linear 
intermediate is formed. In order to perform the cyclization, the linear product has to rebind to cGAS in 
reverse order, so adenine part in positioned in acceptor and guanine part in donor binding sites, so the 
second 3’-5’ linkage can be synthesized [234, 240]. Resulting 2’3’-cGAMP can be transferred between 
the adjacent cells via gap junctions or by packaging into viral particles and induce IFN signaling not only 
in infected cells, but also in the neighboring cells [241-243].  
Second messenger cGAMP binds and activates downstream adaptor stimulator of interferon genes 
(STING) residing on endoplasmic reticulum (Figure 4) [215, 244, 245]. STING is a dimeric membrane 
protein with large C-terminal cytosolic domain and a flexible C-terminal tail responsible for signal 
transduction [244, 246, 247]. cGAMP binds between monomeric parts of STING and introduces an active 
closed STING conformation [248-250]. Upon cGAMP binding STING is translocated to the perinuclear 
region and recruits TANK-binding kinase 1 (TBK1) responsible for phosphorylation of the C-terminal 
domain of STING [143, 215, 251]. Phosphorylated STING builds a complex with TBK1 and interferon 
regulatory factor 3 (IRF3) resulting in IRF3 phosphorylation, dimerization and translocation into the 
nucleus, where is initiates expression of type I IFNs (Figure 4) [245, 247]. STING was also reported to 
recruit transcription factor STAT6 in a TBK-1-dependent manner leading to chemokine production [252]. 
Moreover, STING was proposed to induce NF-κB transcription factor activation through kinases TBK-1 
and IKK (Figure 4) [253]. Interestingly, cGAS and STING are both IFN-stimulated genes and their 
expression is strongly enhanced by type I IFNs creating a positive feedback loop [254, 255]. 
STING serves not only as downstream adaptor of cGAS, but also as direct sensor of bacterial CDNs. 
Though 2’3’-cGAMP was shown to be the most affine STING ligand, STING triggers type I IFN 
signaling in response to c-di-GMP and c-di-AMP produced by such bacteria, as L. monocytogenes, M. 
tuberculosis and C. trachomatis [256-260]. Surprisingly, the cGAS/STING pathway was also reported to 
be involved in antiviral defense against some RNA viruses, such as West Nile virus or vesicular stomatitis 
virus, presumably through cGAS activation with intrinsic DNAs or STING trafficking or interaction with 
RIG-I [215, 216, 244].  
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Structural basis of cGAS/STING sensing and its regulation will be described in more detail in the next 
chapters.  
3.6. Other DNA sensors 
The cells are equipped with DNases, such as TREX1, DNaseI and DNaseII residing in cytosol, 
extracellular space and lysosomes, respectively, which eliminate unwanted DNA accumulation. However, 
the malfunction or inactivation of these DNases by pathogens triggers a potent type I IFN response and is 
associated with autoimmune diseases [261-264]. Apart from cGAS, several other proteins were reported 
to be involved in type I IFN signaling upstream of STING, including DAI, DNA-dependent 
serine/threonine protein kinase complex (DNA-PK), MRE11, DEAD box protein 41 (DDX41), 
polyglutamine binding protein 1 (PQBP1), Sox2 and IFI16. Though cGAS seems to be the central 
cytosolic dsDNA sensor, these proteins may play an important role in IFN signaling in specific cases and 
cell types. 
One of the first proposed DNA sensors to be involved in IRF3-dependent type I IFN production was 
DNA-dependent activator of IFN-regulatory factors (DAI, also known as Z-DNA binding protein 1, 
ZBP1) [265]. Overexpression of DAI resulted in enhanced production of type I IFNs and its knock-down 
in the murine fibroblast L929 cell line strongly inhibited IFN response to HSV-1. Co-
immunoprecipitation assays showed association of DAI with TBK1 and IRF3, suggesting the mechanism 
of DAI-mediated IRF3 activation [265]. Moreover, DAI was shown to be necessary for type I IFN 
synthesis and inhibited human cytomegalovirus (HCMV) replication in human fibroblasts [266]. The later 
studies, however, did not confirm the role of DAI in type I IFN induction in mouse bone marrow–derived 
macrophages, mouse embryonic fibroblasts or in vivo [68, 267]. DAI was also shown to stimulate 
necrosis in fibroblasts during murine cytomegalovirus infection and thus to activate antiviral response 
[268]. 
DNA damage response proteins were also reported to participate in cytosolic DNA sensing. DNA-PK 
complex is a complex of catalytic subunit DNA-PKcs kinase with Ku70 and Ku80 and is known to be 
responsible for non-homologous end joining in DNA repair [269]. Remarkably, DNA-PKcs was shown to 
co-localize with cytosolic viral DNA and its knock-out impaired IRF3-dependent IFN response to dsDNA 
and modified virus Ankara (MVA) in mouse embryonic fibroblasts [270]. Another complex member 
Ku70 responsible for DNA-ends recognition was recently discovered to recognize cytosolic DNA and 
interacts with STING for IRF1 and IRF7-dependent synthesis of IFN-λ1 (a member of type III IFN) [271, 
272]. Other proteins normally involved in DNA-damage response - meiotic recombination 11 (MRE11) 
and RAD50 - were also described to participate in cytosolic DNA sensing. MRE11 and RAD50 together 
with Nijmegen breakage syndrome 1 (NBS1) form the MRN complex that is crucial for double-strand 
DNA breaks recognition and repair [273]. MRE11 knock-down or mutations associated with ataxia-
telangiectasia–like disorder dramatically decreased type I IFN production in response to transfected DNA 
but not Listeria monocytogenes or HSV-1 and its involvement in IFN expression is STING-dependent 
[274]. The importance of MRE11 for cytosolic DNA sensing is supported by the finding that LANA 
protein of Kaposi Sarcoma herpesvirus (KSHV) inhibits NF-κB signaling through MRE11 thus 
promoting lytic replication of KSHV [275]. RAD50 was reported to activate NF-κB and to facilitate IL-
1β production in response to cytosolic DNA via its direct interaction with caspase recruitment domain-
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containing protein 9 (CARD9) and deficiency of this pathway resulted in reduced production of IL-1β in 
response to vaccinia virus in vivo [276].        
DExD/H box helicase DDX41 was also revealed to induce type I IFN response to cytosolic DNA with 
involvement of STING, TBK1 and IRF3 [277, 278]. DDX41 was shown to bind to both DNA and STING 
and its knock-down abolished type I IFN production in response to transfected DNA, HSV-1 or Listeria 
monocytogenes infection in myeloid dendritic cells [278]. Another study shows the ability of DDX41 to 
directly bind bacterial second messengers cyclic di-GMP and cyclic di-AMP and induce type I IFN 
response [279]. E3 ubiquitin ligase TRIM21 was shown to target DDX41 for degradation resulting in 
decreased levels of IFN-β in response to intracellular DNA, further supporting the involvement of 
DDX41 in cytosolic DNA sensing [280]. However, several studies did not confirm the importance of 
DDX41 for DNA-induced type I IFN production [223, 281]. Other DExD/H box helicases were described 
to be involved in DNA signaling. DHX9 and DHX36 were reported to bind CpG DNA and participate in 
MyD88-dependent TNF-α and IFN-α signaling, as well as take part in NF-kB and IRF3 activation in 
response to dsRNA in MAVS-dependent manner in dendritic cells [282-284].  
Another protein - polyglutamine binding protein 1 (PQBP1) – was shown to act as cGAS co-factor in 
HIV-1 sensing [219]. According to the study, PQBP1 binds HIV transcript, directly interacts with cGAS 
and is necessary for cGAS activation by HIV-1 transcript upstream of STING in human monocyte-
derived dendritic cells and monocyte-like THP-1 cell line. Interestingly, such effects were not observed 
for DNA or RNA viruses, suggesting PQBP1 as a specific binder of retroviral DNA products. Moreover, 
mutations in PQBP1 were found to be associated with reduced immune response to HIV-1 infection in 
patients. [219].  
High-mobility-group box (HMGB)-containing proteins Sox2 and HMGB1 may also participate in 
cytosolic DNA recognition. Sox2 is a transcription factor playing an important role during development 
and tissue regeneration [285, 286]. In neutrophils Sox2 was discovered to be responsible for sequence-
specific recognition of bacterial genomes leading to expression of proinflammatory cytokines, but not 
IFNs [287]. Upon DNA binding Sox2 dimerizes and forms a complex with kinase TAK1 and its binding 
partner TAB2 leading to activation of transcription factors NF-κB and AP-1. Other hematopoietic cells 
were shown to activate cGAS-STING pathway upon DNA stimulation and do not express Sox2 [287]. 
HMGB1 is a nuclear architectural chromatin protein participating in chromatin maintenance, nucleosome 
sliding and transcription regulation [288-290]. Secreted HMGB1 was reported to be involved in 
inflammation acting as a cytokine interacting with TLRs and chemokine CXCL12 and to trigger cytokine 
production in monocytes [291-297]. However, according to recent studies HMGB1 and its homologs 
HMGB2 and HMGB3 play a crucial role in recognition of intracellular nucleic acids [298]. Depletion of 
HMGB1 resulted in reduced IFN production in response to intracellular DNA and poly(I:C), the lack of 
HMGB2 impaired response to intracellular DNA and the loss of all HMGBs lead to defects in AIM2-
dependent IL-1β production and reduced IFN response to both DNA and RNA viruses. HMGBs depletion 
also reduced TLR3, TLR7 and TLR9 signaling [298]. However, the exact nature of these effects remains 
to be discovered. 
IFI16 was also suggested to be a DNA sensor. IFI16 is a member of PYHIN family of proteins and shares 
similar domain organization with AIM2 [299]. IFI16 recognizes foreign DNA in the nucleus by scanning 
the long stretches of unprotected pathogenic DNA and assembling into oligomeric structures [300]. 
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Though IFI16 is a nuclear protein, it was discovered to co-precipitate with cytosolic DNA and co-localize 
with dsDNA during HSV-1 infection [68]. Moreover, IFI16 forms filaments upon DNA binding similar to 
those of AIM2 and was proposed to induce inflammasome formation upon Kaposi’s sarcoma herpesvirus 
or Epstein-Barr virus infection [67, 76, 80, 301]. The depletion of IFI16 or its mouse homolog p204 
resulted in impaired IFN response to HSV-1 and HIV-1 in STING-dependent manner [68, 237, 302]. 
IFI16 was also shown to directly interfere with viral replication [303]. IFI16 was linked to cGAS sensing 
and the direct interaction of the proteins and their co-localization on cytosolic DNA were shown [304]. 
Importance of IFI16 in DNA sensing is further supported by the presence of viral proteins targeting IFI16 
for degradation [305]. However, the latest studies revealed the role of IFI16 as cGAS/STING co-factor, 
rather than an independent DNA sensor. Two recent studies showed that both cGAS and IFI16 are 
essential for IFN response, since IFI16 directly interacts with STING and promotes its association with 
TBK1, whereas the direct influence of IFI16 on cGAS activity remains controversial [306, 307].    
4. Structural basis of cytosolic DNA recognition by cGAS-STING pathway 
4.1. cGAS structure and activation mechanism 
Since its discovery in 2013 many structures of cGAS from different species, in different activation states 
and with various substrates were published. cGAS belongs to nucleotidyltransferase family of proteins, 
which share a similar protein fold and catalyze phosphodiester bond formation between donor nucleoside 
monophosphate and acceptor hydroxyl group residing on protein, nucleic acid or small molecules [182, 
308-310]. Nucleotidyltransferases are involved in such processes, as replication and repair (DNA 
polymerases, DNA-ligases), transcription and RNA processing (RNA-polymerases, mRNA capping 
enzymes) and signal transduction (OAS, cGAS). Though the members of different nucleotidyltransferase 
classes share little similarity on the sequence level, they all share a common α/β-fold with conserved 
catalytic aspartates/glutamates responsible for divalent ions coordination and polarization of the acceptor 
hydroxyl group and hG[GS] pattern (h – hydrophobic amino acid) that helps by substrate binding [308, 
309]. The NTase core is composed of three-stranded β-sheet flanked by 4 α-helices with the catalytic 
triade of aspartates/glutamates positioned on the β-strands and can be accompanied by additional domains 
for different families of nucleotidyltransferases [308].        
cGAS is a 60 kDa protein with an unconserved unstructured N-terminus of 150 amino acids and highly 
conserved C-terminal catalytic male abnormal 21 (Mab21) domain that belongs to the NTase superfamily 
and shares sequence homology with catalytic domain of OAS1 [223, 310]. The Mab21 domain was first 
described for Caenorhabditis elegans protein Mab21 and is sufficient for both DNA binding and 
enzymatic activity in cGAS [223, 311]. The Mab21 domain of cGAS was a subject of extensive structural 
studies [233-236, 312-314]. In contrast, the exact function and structure of the N-terminal part of cGAS 
remains unclear. Several studies revealed that it participates in DNA binding and thus increases cGAS 
affinity towards DNA and gains its fold first upon DNA binding [223, 315].  
The catalytic domain of cGAS has an α/β-fold and harbors a bilobal structure with a catalytic cleft 
between two lobes connected by a long “spine” helix (Figure 5a). The N-terminal Lobe 1 represents an 
NTase fold with 8 β-sheets flanked by two helices. Lobe 1 contains the catalytic residues E225, D227 and 
D319 (numbering is given for human cGAS, correspond to E211, D213, D307 in mouse and E200, D202, 
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D294 in pig) on the side of the cleft that coordinate two catalytic Mg2+ ions and the nucleotides (Figure 
5b). GS-motif characteristic for NTAses is represented by G212/S213 (G198/S199 in mouse and 
G187/S188 in pig) and is located between the first and second β-strands in an “activation loop” (Figure 
5b). C-terminal Lobe 2 consists of α-helices and a Zn-thumb with a highly conserved histidine and 
cysteines H390, C396, C397 and C404 (H378, C384, C385 and C392 in mouse and H365, C371, C372 
and C379 in pig) coordinating the Zn2+ cation (Figure 5c). The molecular surface opposite to the active 
site between the “spine” and Zn- thumb is flat and positively charged and forms a “platform” for DNA 
binding (Figure 5c). Inactive cGAS is a monomeric protein with a rather unstructured nucleotide-binding 
activation loop. Apo-cGAS was co-crystallized with UTP and a variety of CDNs including reaction  
 
Figure 5 cGAS structure. 
(a) Apo-form of mouse cGAS Mab21 domain (PDB: 4K8V, orange) represents a bilobal structure (N-terminal 
Lobe 1 and C-terminal Lobe 2) connected with a “spine” helix.  
(b) DNA-bound mouse cGAS (PDB: 4K98, green). Activation loop (purple) rearrangement opens cGAS active 
site. Catalytic residues (blue) coordinate two Mg2+ cations (spheres) and linear reaction product (pppGpG). 
DNA binding is stabilized by R/H fingers (red). 
(c) DNA-binding by cGAS. DNA interacts with a positively charged “platform” and is stabilized by Zn-thumb 
(orange) with chelated Zn2+ cation (blue sphere). 
(d) Superposition of apo- (orange) and DNA-bound (green) cGAS forms. Conformational changes upon cGAS 
activation are indicated with arrows and include “spine” helix break, rearrangement of the activation loop 
(teal in apo-cGAS and purple in DNA-bound cGAS) and closure of the active site. Active cGAS 
coordinates Mg2+ (spheres) and linear intermediate (pppGpG) for the second reaction step. 
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product 2’3’-cGAMP, however, though some coordination of catalytic residues took place, the activation 
loop was not fully ordered and the substrate and product were not correctly positioned [233, 312, 313]. 
Surprisingly, cyclic di-UMP introduced changes in the activation loop of apo-cGAS corresponding to 
cGAS’s active state, whereas the catalytic pocket remained unchanged, suggesting that activation loop 
and active site conformations are two distinct events needed for cGAS activation [312]. Moreover, the B-
factors of the Lobe 1 containing catalytic residues were two times higher than those of C-terminal Lobe 2, 
indicating a high level of active site flexibility in apo-form of cGAS [314]. 
Dramatic changes in cGAS active site are induced by B-form DNA binding (Figure 5d). DNA is bound 
by the cGAS “platform” between “spine” α-helix and a “Zn-thumb”. Consistent with sequence-
independent DNA binding, cGAS contacts mostly the sugar-phosphate backbone of DNA. Positively 
charged residues of the “spine” helix and the “platform” interact with the minor groove of DNA via side- 
or main-chain contacts, whereas the “Zn-thumb” grips the DNA at the major groove resulting in cGAS 
specificity towards B-form DNA and not A-form RNA ligands. DNA binding is additionally stabilized by 
two arginine/histidine fingers R176/H217 (R161/H203 in mouse, R150/R192 in pig), positioned on the 
“spine” helix and “platform”, respectively, that are inserted into the minor groove of DNA (Figure 5d). 
Upon DNA binding the “spine” helix breaks in two parts inducing Lobe 1 closure and the opening of the 
entrance to catalytic pocket of cGAS. The catalytic residues undergo realignment and the “activation 
loop” with conserved GS motif is restructured allowing Mg2+ coordination and effective nucleotide 
binding (Figure 5d) [233, 
234, 314].  
Though apo-cGAS is a 
monomeric protein, a closer 
look at the structure of apo- 
and DNA-bound cGAS 
reveals the packing of cGAS 
into dimers (Figure 6) [233, 
234, 313, 314]. Small-angle 
X-ray scattering and 
analytical ultracentrifugation 
studies confirmed that DNA 
binding introduces 
cGAS2:DNA2 complex 
formation with 16-20 bp DNA 
[313, 314]. Two DNA 
molecules in such complex are 
“sandwiched” between two 
cGAS protomers and point to 
each other, so that the same binding mode will result in clashes between long DNA strands, if cGAS is 
bound to the middle of such long DNA. cGAS:DNA 2:2 complex is stabilized by protein-protein 
interactions between cGAS molecules and the secondary DNA-binding site that contributes to ~35-40% 
of the total surface area between cGAS and DNA. This secondary DNA-binding site (site “B”) interacts 
with the same DNA molecule that is bound by the main DNA-binding site (site “A” formed by “spine”-
helix, “platform” and Zn-thumb) of partner cGAS protomer (Figure 6). Site “B” forms two salt bridges to 
Figure 6 cGAS dimer. 
cGAS protomers (green and orange, PDB: 4LEZ) bound to two dsDNA molecules 
(grey). A single cGAS protomer binds two DNA molecules with DNA-binding 
sites A (includes “spine” helix) and B (shown with arrows). Annotated DNA-
binding residues of site A (cyan) and site B (red), as well as protein-protein 
contacts in dimer interface (blue) are represented as sticks. Zn2+ ions are depicted 
as blue spheres. 
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sugar-phosphate backbone of DNA (residues R236/K347 in human, R222/K335 in mouse and 
R211/K322 in pig) and an arginine finger (L354 in human, R342 in mouse and R329 in pig) is inserted 
into the minor groove but does not interact with the DNA backbone. Protein-protein contacts are mediated 
by electrostatic interactions between K394 and E398 (K382/E386 in mouse and K369/E373 in pig) 
residues of two cGAS protomers and are situated in the Zn-binding loop (Figure 6). Mutational studies in 
vitro and in the cells confirmed the importance of these contacts for cGAS dimer formation and its 
activity. Amino acid substitutions in protein-protein interaction loops or DNA-binding site “B” decreased 
DNA binding, impaired 2:2 complex formation and significantly reduced cGAS activity for both full 
length and Mab21-domain containing constructs indicating that cooperative binding of DNA by both 
DNA-binding sites and cGAS dimerization are necessary for cGAS activity [313, 314].  
The DNA-bound cGAS fold is very similar to the RNA-bound OAS1 state, likely representing a common 
activation mechanism for these evolutionary connected enzymes (Figure 4) [178, 179, 316]. RNA-binding 
induces the same break in the “spine” helix and active site rearrangement necessary for subsequent 
nucleotide and Mg2+ binding by OAS1. Unlike cGAS, OAS1 does not have a Zn-thumb and binds two 
minor grooves segments by its interactions with the sugar-phosphate backbone of RNA. Moreover, cGAS 
possesses a second DNA-binding site and forms 2:2 active complexes, whereas no high-order structures 
of OAS1:RNA were observed [178, 313, 314]. Taken together, cGAS and OAS1 use differences in 
nucleic acid topology and nucleic acid binding mode to distinguish between DNA and RNA ligands. 
Intriguingly, according to the published structures, both OAS1 and cGAS nucleic acid binding sites are 
much shorter than the reported RNA or DNA length needed for enzymes full activation [180, 281]. Thus, 
additional mechanisms might be needed to achieve full activation of cGAS and OAS1.     
4.2. Mechanism of the second messenger cGAMP synthesis by cGAS 
Bacteria are well known for using CDNs as signal molecules involved in such processes, as biofilm 
formation, antibiotic signaling, virulence and bacterial stress response [317]. However, bacterial 
diguanylate and diadenylate cyclases differ significantly from eukaryotic OAS and cGAS proteins. The 
most of bacterial CDN-synthases are obligate oligomers in which each of the monomers catalyzes 
formation of one phosphodiester linkage between ATPs or GTPs [318-320]. In contrast, cGAS generates 
a mixed-based cyclic dinucleotide G[2ʹ–5ʹ]pA[3ʹ–5ʹ]p (2’3’-cGAMP) – a novel second messenger 
consisting of one 3’-5’ and one unusual 2’-5’ linkage - with one active site [234, 239, 240]. The same 2’-
5’-linkage seems to be a hallmark of eukaryotic signaling shared by both cGAS and OAS proteins [149]. 
Interestingly, prokaryotic enzyme DncV from Vibrio cholerae was discovered to generate a mixed-based 
G[3ʹ–5ʹ]pA[3ʹ–5ʹ]p (3’3’-cGAMP) [321]. Despite a very low sequence homology with cGAS, DncV is a 
structural and functional homolog of cGAS revealing evolutional connection between prokaryotic and 
eukaryotic signaling systems [322].   
Upon DNA binding cGAS coordinates ATP and GTP in the catalytic site (Figure 7). During the first step 
of reaction donor- and acceptor-binding pockets are occupied by ATP and GTP, respectively, so that 
pppG2’-5’pA linear intermediate can be produced. Two nucleotides are sandwiched between T321 and 
Y436 (I309/Y421 in mouse and I296/Y411 in pig) hydrophobic residues and stacked in 90° rotated 
orientation [233]. Triphosphate from ATP is coordinated by two Mg2+ ions bound to catalytic triade E225, 
D227 and D319 (E211, D213, D307 in mouse and E200, D202, D294 in pig) and additionally stabilized 
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by hydrogen-bonds formed by residues S213 and S435 (S199/S420 in 
mouse and S188/S410 in pig). The adenine base is stacked with Y436 
(Y421 in mouse and Y411 in pig) and the ribose of ATP makes 
hydrogen-bonds with E383 (E371 in mouse and E358 in pig) 
providing additional coordination [233, 234]. GTP binding to acceptor 
pocket is stabilized by hydrogen bonding with S378, S380, T211 and 
R376 (S366/S368/T197/R364 in mouse and S353/S355/T186/R351 in 
pig) providing specificity towards guanine base (Figure 7). Nucleotide 
coordination results in close proximity of α-phosphate of donor ATP 
to the attacking 2’-OH of GTP, 2’-OH polarization by D319 (D307 
and D294 in pig) and linear product pppGpA formation (Figure 8a) 
[233]. Consistent with specific hydrogen-bonding to guanine base and 
only stacking interaction with adenine, cGAS can tolerate GTP as 
donor and produce cyclic di-GMP [234, 240]. 
The cyclization step requires a 180° flip of linear intermediate in 
cGAS catalytic pocket, so that guanine and adenine bases occupy 
donor- and acceptor-binding sites, respectively (Figure 8b). It was 
recently proposed to dissociate and rebind to cGAS competing for 
binding with ATP and GTP [312]. According to structural studies of 
cGAS in complex with pppG(2’-5’)pG or pG(2’-5’)pA, triphosphate 
of the linear product is coordinated by Mg2+ cations analogically to ATP binding mode during the first 
step of reaction (Figure 8c). Guanine and adenine bases reside in syn and anti glycosidic torsion 
orientations in pppG(2’-5’)pA, respectively, and guanosine ribose is flipped in donor site in comparison 
to ATP binding mode during the first reaction step [234]. Such orientation leads 
 
Figure 8 A mechanism of 2’3’-cGAMP synthesis by cGAS.  
(a) The first reaction step: after DNA binding ATP and GTP are sandwiched between residues Y421 and I309 
(teal) and triphosphate of ATP is positioned by Mg2+ ions coordinated by catalytic triad (blue) and 
hydrogen bonds (dashed lines) with S420 and S199 (purple). D307 polarizes 2’OH of GTP for a 
nucleophylic attack (black arrows) of α-phosphate of ATP. 
(b) The resulting pppG(2’-5’)pA linear intermediate has to flip over (black arrow) in cGAS catalytic pocket to 
enable the second cyclization step.  
(c) The second reaction step: 3’OH of adenosine attacks α-phosphate of pppG(2’-5’)pA (black arrows) 
resulting in cyclic product with mixed phosphordiester linkages 2’3’-cGAMP.  
(d) 2’3’-cGAMP leaves cGAS catalytic pocket. 
Residue numbering corresponds to mouse cGAS. 
 
Figure 7 Coordination of ATP 
and GTP in cGAS catalytic 
pocket.  
OH groups of ribose in ATP and 
GTP base are coordinated with 
hydrogen bonds (dashed lines) with 
E371 (green) and 
T197/S368/S366/R364 (cyan) 
residues, respectively. Numbering is 
given for mouse cGAS. 
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to polarization of 3’-OH from adenosine and 2’3’-cGAMP formation that is indeed observed in crystal 
structure (Figure 8c) [314]. Though the riboses and bases of cGAMP interact with cGAS, the close 
proximity of phosphodiester bond 3’-5’ pApG to catalytic negatively charged residue D227 (D213 in 
mouse and D202 in pig) destabilizes the binding and presumably promotes product dissociation (Figure 
8d) [314]. 
The catalytic mechanism of 2’-5’ polyadenylates synthesis by OAS1 is very similar to that of cGAS. 
Interestingly, OAS1 coordinates donor ATP with a number of hydrogen-bonds required for adenine 
specificity. Like in cGAS, OAS1 binds the donor nucleotide by unspecific hydrophobic interactions 
[179]. 
Such specificity towards acceptor adenine results in OAS adding any nucleotide to 2’-OH group of RpA 
[166]. However, unlike cGAS, OAS1 catalyzes only a one-step reaction producing linear polyadenylates 
probably by suppressing product binding in reverse order and thus preventing full cyclization. 
Striking similarity in structure and catalytic mechanism can be observed between cGAS and DncV from 
Vibrio cholerae producing 3’3’-cGAMP (Figure 9) [322-324]. DncV has the same organization of the 
catalytic core as cGAS and OAS proteins and unlike these proteins maintains an autoactivated state by 
bracing two lobes with α-helices surrounding the catalytic core (Figure 9a). Interestingly, despite the 
constitutive activation DncV possesses a positively charged “platform” with conserved residues opposite 
to the active site at the position of DNA binding by cGAS. DncV also lacks regulatory loops closing the 
active site and maintains an open entrance into the catalytic pocket. In contrast to cGAS, DncV binds 
GTP in the donor pocket and produces pppA(3’-5’)pG linear product during the first reaction step, 
however, syn and anti configurations within pppA(3’-5’)pG correspond to same orientations of bases 
within pppG(2’-5’)pA cGAS intermediate (Figure 9b, c). Strikingly, single nucleotides as well as linear 
intermediate in DncV is rotated ~40° away from the catalytic triad as compared to cGAS and this 
positioning is defined by the catalytic pocket residues of DncV and cGAS that would clash with 
alternative substrate or linear product binding mode (Figure 9b, c). In cGAS the long side chain of R376  
 
Figure 9 Comparison of cGAS and DncV structures.  
(a) Superposition of cGAS (PDB: 4K98) and DncV (PDB: 4TY0). Active site residues are depicted in blue and 
red for cGAS and DncV, respectively.  
(b-c) DncV (b) and cGAS (c) active sites with pppA(3’-5’)pG and pppG(2’-5’)pA linear intermediates, 
respectively. Active site residues (red and blue, respectively) coordinate Mg2+ ions (spheres) and a triphosphate. 
Corresponding residues responsible for substrate orientation and linkage specificity are depicted in teal, yellow 
and purple. Relative rotation of linear intermediates is indicated with black arrow. 
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residing on the opposite site of catalytic triad and short T211 (R364/T197 in mouse and R351/T186 in 
pig) push pppG(2’-5’)pA closer to catalytic residues. DncV has a short I258 and long Q113 side chains in 
corresponding positions pushing the linear product away from catalytic triad. Additional coordination of 
intermediate in enzyme-specific way emerges from base stacking with Y436 (Y421 in mouse and Y411 in 
pig) in cGAS, whereas DncV and other bacterial enzymes favor non-aromatic non-polar residues in this 
position (I303 in DncV) (Figure 9b, c). Exchanging of cGAS R376/T211 with DncV I238/Q113 resulted 
in cGAS synthesizing 3’3’-cGAMP, indicating the mechanism of phosphodiester bond specificity [322].   
4.3. STING structure and mechanism of activation by cyclic dinucleotides 
Stimulator of interferon genes (STING, also called MITA, ERIS, MPYS or TMEM173) is a central 
adaptor protein for cytosolic DNA-sensing pathway and a direct sensor of cyclic dinucleotides [215, 256, 
257]. Though it was also reported to interact with major histocompatibility complex class II molecules 
and participate in interferon response to cytosolic RNA, these findings remain controversial [244, 245, 
252, 257, 325]. STING is widely expressed in endothelial and epithelial cells, as well as in T cells, 
macrophages and dendritic cells and its overexpression leads to strong activation of IRF3 and NF-κB 
transcription factors and type I IFN production [244, 245]. 
STING is a 42 kDa protein and consists of 4 transmembrane helices anchored to the endoplasmic 
reticulum (ER) membrane (aa 1-154), a large globular C-terminal domain pointing towards the cytosol 
that binds CDNs (155-342) and a flexible C-terminal tail (CTT, aa 343-379) responsible for signal 
transduction and interaction with TBK1 kinase and transcription factor IRF3 (Figure 10a) [244, 247, 250, 
326]. STING recognizes a variety of cyclic dinucleotides and was shown to trigger type I IFN production 
in response to metazoan second messenger 2’3’-cGAMP, bacterial c-di-AMP, c-di-GMP and 3’3’-
cGAMP and synthetic 3’2’- and 2’2’-cGAMP [250]. Upon activation it re-localizes to the Golgi complex 
and assembles into punctate structures containing TBK1 in perinuclear region [215]. STING re-
localization and regulation is a function of its N-terminal transmembrane domain. Though no structural 
data about this region are available, deletions or mutations of the N-terminal domain result in impaired 
STING activity and trafficking [244, 327]. 
Though some structural similarities between STING and leucine-rich repeat kinase 2 can be observed, the 
overall STING structure is unique [248]. Some sequence similarities of STING could be found with L. 
monocytogenes diadenylate cyclase, however, there seems to be no homology between STING and 
bacterial CDN receptors [326]. Cytosolic CDN-binding domain structures and solution studies show that 
STING operates as a butterfly-shaped dimer (Figure 10b) [248-250, 328-333]. Each protomer has an α+β-
fold in which a curved five-strand β-sheet is surrounded by α-helices. The dimer is held together by 
hydrophobic interactions between α-helices at the bottom of the V-shaped structure. Some studies 
proposed STING dimerization upon CDN binding to be an activating mechanism, however, the nature of 
STING intermolecular interaction and a strong conservation of the interacting amino acids suggest that 
STING maintains dimeric conformation in both inactive and activated states. The C-terminal tail of 
STING is flexible and was not observed in crystal structures. A region surrounding the CDN-binding cleft 
– “lid” region - is also unstructured in apo-STING (Figure 10b). The goldenticket mutation I200N (I199N 
in mouse) that was reported to abolish STING activity is located in the β-sheet region and impairs STING 
folding and expression [257, 331].  
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The apo-form of human STING represents an open conformation in which the distance between the 
“wings” of butterfly-structure is ~60Å [329, 330]. CDN binding induces a closure of the V-shape and 
decrease in protomer distance to ~35Å. Upon 2’3’-cGAMP binding the “lid” region of STING (aa 224-
245) gains its fold and arranges into a two-strand β-sheet closing the CDN binding pocket increasing the 
interaction interface within the dimer (Figure 10b) [249, 250]. cGAMP interacts with STING via purine 
bases stacking with aromatic residues Y167 and Y240 and α-phosphates contacting R238 and R232 
(Figure 10c). The interaction is further stabilized by polar contacts between free 3’-OH of 2’3’-cGAMP 
with S162 and between guanine base and E260 and T263 side chains resulting in specific 2’3’-cGAMP 
recognition (Figure 10c) [250]. 2’3’-cGAMP specificity is also defined by its intrinsic free-ligand 
conformation. Unlike 3’2’- and 3’3’-cGAMP, 2’3’-cGAMP conformation has a “closed” geometry with a 
90° rotated guanine group stabilized by a hydrogen-bond between guanine base and adenosine phosphate  
 
Figure 10 STING structure. 
(a) Domain structure of human STING. STING consists of transmembrane domain (TM, orange), CDN-
binding domain (CBD, blue) and C-terminal tail (CTT). Numbers indicate position within the sequence. 
(b) Superposition of apo- (PDB: 4EMU, green) and 2’3’-cGAMP-bound human STING (PDB: 4KSY, blue). 
(c) Close-up view on CDN-binding pocket (PDB: 4KSY). 2’3’-cGAMP is coordinated by stacking with 
aromatic residues (yellow) and hydrogen bonds (dashed lines) between arginines of the “lid” (orange) and 
phosphates. Additionally, 3’-OH forms hydrogen bonds (dashed lines) with S162 (green), and guanine base 
– with E260 and T263 residues (purple). 
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group. Such conformation matches well with the STING-bound 2’3’-cGAMP mode and thus requires less 
entropy cost for binding to STING in comparison to other combinations of phosphodiester linkages [332].   
Interestingly, STING variants were discovered to have different affinities to CDNs [334]. R232H variant 
of human STING and R231A variant of mouse STING were shown to be activated by 2’3’-cGAMP, but 
not c-di-GMP [239]. By contrast, human STINGR232 and mouse STINGR231 respond to all CDNs with 
their affinities decreasing in the following order: 2’3’-cGAMP/3’3’-cGAMP/c-di-GMP/c-di-AMP. 
Though in general the CDN affinity towards STING correlates with STING stimulation potential, human 
STINGH232 responding only to 2’3’-cGAMP shows similar dissociation constants for 2’3’-cGAMP and 
3’3’-cGAMP revealing that differential activation might occur due to additional conformational changes 
[249, 250, 314]. Consistent to type I IFN production rates and in vitro binding assays, the structures of 
human STINGH232 with c-di-GMP represent an open conformation [248, 329, 331], whereas one of two 
STINGR232 structures with c-di-GMP shows a closed active conformation with ordered lid region [328].  
Unlike human STING, mouse protein resembles a closed conformation independently of CDN binding. 
However, the presence of c-di-AMP, c-di-GMP, 2’3’-cGAMP or small compounds 10‐carboxymethyl‐9‐
acridanone (CMA) and 5,6-dimethylxanthenone-4-acetic acid (DMXAA) induce the rearrangement of the 
“lid” region [249, 333, 335, 336]. Functional analysis revealed that mouse STING shows less preference 
for cGAS product 2’3’-cGAMP and is strongly activated by all CDNs, CMA and DMXAA [333, 337]. 
These results suggest that not the STING closure itself, but the proper folding of the “lid” is the major 
conformational change driving STING into its active state. The importance of the “lid” region of STING 
for CDN specificity and signaling is further supported by single mutation that increases stability of β-
sheets of the “lid” driving human STING towards DMXAA sensing [249]. 
According to the current model CDN binding induces reorganization of the C-terminal tail of STING that 
serves as a scaffold for TBK1 and IRF3 recruitment and activation [247, 331]. CTT directly interacts with 
TBK1 and is phosphorylated at residues S355, S358, S366 and L374 that facilitates IRF3 transcription 
factor binding [247]. A conserved phosphorylation pLxIS (p- the hydrophilic residue, x - any residue, S - 
the phosphorylation site) motif common for all adaptor proteins activating IRF3 – STING, MAVS and 
TRIF – was shown to bind C-terminal domain of IRF3 in extremely similar mode revealing a general 
mechanism of IRF3 activation [338]. Moreover, the same motif is responsible for phosphorylation and 
dimerization of IRF3 itself and is released from an autoinhibited state by adaptor protein binding [338, 
339]. Rotavirus protein NSP1 also possesses pLxIS motive on its C-terminus and is able to mimic the 
host adaptor proteins binding [338]. NSP1 targets IRF3 for ubiquitination and degradation thus abolishing 
IRF3 activation and IFN-β synthesis [340, 341].    
Molecular dynamics simulations and mutational analysis of STING recently shed light on CTT 
rearrangement upon CDN binding. In in silico simulations the lid of human STINGR232 remained in stable 
closed conformation only in 2’3’-cGAMP-bound model, whereas c-di-GMP ligand failed to maintain the 
structured lid region. CTT end was making a contact with the lid regions on both STING subunits in 
ligand-bound STING, but only in 2’3’-cGAMP bound STING CTT arranged into a short β-sheet [342]. 
Notably, this local secondary structure formation appeared in the region of CTT sensible for TBK1-
mediated phosphorylation and responsible for IRF3 binding [338]. Mutations impairing this β-sheet 
formation decreased IFN-β production. The importance of CTT interaction with the lid region of STING 
was also shown by exchanging the non-conservative lid residue K224 in human STING to methionine, 
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present in mouse protein in the same position. The resulting increase of lid hydrophobicity leads to more 
stable interaction of the CTT end with the lid region and higher IFN-β induction by human STING [342]. 
This observation also clarifies a surprisingly reduced activity of human STING in comparison to its 
mouse homolog and lower CDN specificity of mouse STING [239, 249, 333, 342].  
4.4. Evolutional origins of cGAS and STING 
Though IFN signaling is a feature of the innate immune system in vertebrata, homologs of cGAS and 
STING can be found in most metazoans and in unicellular choanoflagellate M.brevicollis – a member of a 
phylum evolutionally close to animals [343, 344]. Other kingdoms – fungi, plants and protists – do not 
have cGAS/STING homologs leaving these proteins to be a unique feature of multicellular animals. 
cGAS and STING ancestors can be found as early in metazoan evolution, as in cnidarians like 
Nematostella vectensis, but some phyla like nematodes, some insects and flat worm Schistosoma mansoni 
lost them during evolution (Figure 11). Interestingly, most analyzed animals either have both cGAS and 
STING homologs or have lost both proteins. Except for some species having two or three homologs of 
cGAS or STING, most of the metazoans possess only one copy of each gene. 
Bioinformatic and structural analysis of STING homologs revealed that CDN recognition is one of the 
most ancient characteristics of STING [343-345]. All STING homologs share a conserved dimerization 
and CDN-binding domains. The amino acid sequence analysis revealed a strong conservation of the 
residues responsible for CDN binding (ex. Y167 and R238) and lid closure (ex. R232) [343, 344]. STING 
proteins from different phyla are capable of CDN binding, except for STING homologs from the 
Drosophila family that do not interact with CDN (Figure 11). Surprisingly, STING from most vertebrates 
including non-mammalian species Danio rerio and Xenopus tropicalis shows preferential binding of 2’3’-
cGAMP compared to other CDNs [345]. This indicates that specific 2’3’-cGAMP recognition is not the 
most recent evolutional achievement and evolved in the beginning of evolution of vertebrates. Despite the 
poor similarity on the amino acid sequence level, STING proteins seem to share a common dimeric 
structure and CDN binding mechanism. The structure and CDN binding mode of the most ancient STING 
from Nematostella vectensis is nearly identical to that of the human protein. Crystal structure of N. 
vectensis (nv) STING shows a possibility for both “open” and “closed” conformation corresponding to 
previously reported human and mouse STING, respectively. Likely, the apo-STING is a flexible dimer 
and upon CDN binding adopts an active conformation similar from see anemone to humans. Indeed, 
though nvSTING apparently recognizes 3’3’-cGAMP in see anemone in its “open” conformation, its 
binding mode to 2’3’-cGAMP is nearly indistinguishable from that of human STING indicating that the 
nature of the second messenger and not the changes of the protein itself resulted in different STING 
conformations upon CDN binding. Though the major conformation and CDN binding residues are 
conserved in all metazoan species, subtle changes in the lid region moved the mode of CDN recognition 
from a simple base staking in N. vectensis to specific recognition of phosphodiester linkages in mammals 
[345].   
Though the CDN-binding domain seems to be highly conserved in structure and function within all 
metazoans, STING homologs share similarities in other domains as well. Most STING homologs were 
discovered to have three to four N-terminal transmembrane helices, except for three arthropod species 
[343]. In contrast to CDN-binding domain and N-terminal transmembrane part, C-terminal tail 
responsible for signal transduction in mammals is a rather recent evolutional feature and was found only  
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Figure 11 Distribution of cGAS and STING homologs in metazoans. 
Branch lengths in species tree are not scaled. STING (blue) and cGAS (green) homologs are depicted as ovals 
corresponding to the species and were defined by Wu X., et al, 2014 [343]. C-terminal tail (CTT) in STING 
homologs is depicted as blue line. CDN-binding function of STING is indicated with green circle and was defined 
by Kranzusch P.J. et al, 2015 [345]. cGAS homologs possessing Zn-thumb are indicated with orange circle. 
Adopted from Margolis S.R., et al, 2017 [346].   
    
in vertebrates, except for amphibians, that correlates with the evolvement of the IFN system (Figure 11) 
[247, 343]. The CTT is critical for TBK1 recruitment and activation in humans and zebrafish and even 
can trigger IFN production when attached to N. vectensis STING homolog [247, 338, 345, 347]. This 
illustrates how IFN signaling might have evolved from STING ancestors with only CDN binding 
function. However, the functions of the cGAS-STING system in invertebrates seem to be independent of 
the CTT and remain to be discovered.  
Like STING, cGAS homologs can be found throughout the most of the metazoan species and M. 
brevicollis (Figure 11) [343, 344]. However, the functionality of these proteins is difficult to predict, since 
many other NTases and Mab21-containing proteins, like Mab21L1 or Mab21L2 proteins involved in 
development, exist that despite a tremendous similarity to cGAS in sequence and structure do not bind 
DNA and produce CDN [348-350]. Moreover, cGAS shows a remarkable structural and functional 
similarity to OAS1 and bacterial DncV protein producing linear polyadenylates and 3’3’-cGAMP, 
respectively, making it even more difficult to search for functional analogs of cGAS [178, 322].  
Sequence analysis revealed a strong conservation of the key cGAS residues throughout the evolution 
[343]. Except for the catalytic triad present in all NTases including OAS1 and DncV, cGAS homologs in 
vertebrates and cephalochordates share conserved substrate/product binding residues (K362, R376 and 
S378 of human cGAS). The DNA-binding residue K407 on the main cGAS DNA-binding site and Y436 
participating in base stacking are highly conserved in all metazoans. Higher degree of conservation can be 
observed in vertebrates in the main DNA-binding helix, the dimer interface and the second DNA-binding 
site of cGAS that differs from other phyla. 
According to bioinformatic analysis of the domain organization cGAS homologs gained a Zn-thumb 
DNA-interacting insertion and therefore their DNA-binding function in vertebrata (Figure 11). Moreover, 
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vertebrate cGAS homologs share a long (~167 aa) N-terminal domain, except for chicken and turkey, 
whereas the N-terminal cGAS domain in other phyla is much shorter (7-70 aa). According to recent 
studies, the N-terminal domain of cGAS plays an important role in DNA binding along with a Zn-thumb. 
The gain of DNA-binding domains correlates with the evolvement of STING signaling C-terminal tail 
during evolution with an exception in amphibian (Figure 11). The Zn-thumb was observed in the cGAS 
homolog in Xenopus tropicalis that does not have a CTT on its STING homolog. Interestingly, evolution 
of the downstream components of cGAS-STING pathway matches the evolvement of CDN binding 
properties of STING rather than cGAS DNA-binding properties. Though IFN signaling and transcription 
factors IRF3 and 7 evolved only in vertebrates together with cGAS DNA-binding and STING C-terminal 
tail, kinases TBK1 and IKKε, as well as NF-κB transcription factor can be found in cnidarians, 
cephalochordates, mollusks and insects that may indicate a mechanism of CDN-induced NF-κB activation 
different from a well-studied cGAS-STING-IRF3 signaling [346].   
Though the most functional features of cGAS seem to have evolved in vertebrates, other metazoans 
including N. vectensis, as well as bacterium Vibrio cholerae seem to have structural and functional 
analogs of cGAS that may have other functions instead of DNA recognition [322, 345]. However, only in 
primates cGAS and OAS seem to have undergone similar rapid evolution in nucleic acid binding sites 
driven by positive selection [351, 352]. Though cGAS dominates DNA-sensing in vertebrates, other 
species likely utilize alternative pathways.      
4.5. Other Mab21-domain containing proteins 
Apart from the best studied male-abnormal 21 (Mab-21) family member cGAS (Mb21D1) 11 other Mab-
21 proteins were discovered in humans [310]. They include Mb21D2, three Mab21-like proteins 
Mb21L1, Mb21L2 and Mb21L3, mitochondrial dynamics proteins 49 and 51 (MiD49 and MiD51), 
transmembrane protein 102 (TMEM102, also common β chain associated protein, CBAP), inositol 1,4,5-
trisphosphate receptor-interacting protein (ITPRIP, also  DANGER), ITPRIP-like proteins 1 and 2 
(ITPRIPL1 and ITPRIPL2) and an uncharacterized protein C2orf54. The Mab-21 family proteins are 
poorly characterized, though some of their functions are linked to development and mitochondrial fission. 
TMEM102 (CBAP) was reported to have a pro-apoptotic function under granulocyte-macrophage-
colony-stimulating factor (GM-CSF) depletion. TMEM102 was shown to interact with GM-
CSF/interleukin-3 (IL-3)/IL-5 receptor in the absence of the ligand and to induce mitochondrial 
dysfunction and therefore apoptotic cell death [353]. TMEM102 was also shown to regulate chemokine-
promoted T-cell trafficking and T-cell adhesion, as well as to participate in T-cell receptor signaling and 
thus to modulate apoptosis of thymocytes during negative selection [354, 355]. Another member of the 
family ITPRIP – a membrane associated protein with partial Mab-21 domain – was reported to bind and 
co-localize with inositol 1,4,5-trisphosphate receptors (IP3R) in neuronal membranes. ITPRIP 
allosterically enhances Ca2+ inhibition of IP3R-mediated Ca2+ release and modulates Ca2+ dynamics [356]. 
ITPRIP was also shown to bind and inhibit death-associated protein kinase (DAPK). ITPRIP depletion 
resulted in increased sensitivity to cell death stimuli and brain damage after excitotoxicity revealing the 
function of ITPRIP to regulate neuron viability [357]. ITPRIP inhibition of DAPK also results in 
impairment of DAPK-p53 signaling axis leading to attenuation of anchorage-dependent apoptosis. High-
glucose conditions lead to high ITPRIP expression levels and thus to decreased efficiency of apoptosis 
-29- 
 
and radioresistance of non-small cell lung cancer cells [358]. C2orf54 was also described in the context of 
cancer among genes with down-regulated expression in esophageal squamous cell carcinoma [359].  
Mitochondrial dynamics proteins of 49 and 51 kDa (MiD49 and MiD51, respectively, or SMCR7L) were 
first described to cause altered mitochondrial distribution in random cellular localization screen [360]. 
Both proteins are anchored in the outer mitochondrial membrane and have a cytosolic Mab-21 domain 
(Figure 12). MiD49 and Mid51 were shown to form rings around mitochondria and recruit the fission 
mediator GTPase dynamin-related protein 1 (Drp1) to mitochondrial surface independently from other 
factors, such as mitochondrial fission protein 1 (Fis1) or mitochondrial fission factor (Mff) [361, 362]. 
However, MiD49 and MiD51 are involved into the cross-talk between Drp1 and Mff and suppress Mff-
dependent enhancement of GTPase activity of Drp1[363]. Knock-out of MiD proteins results in irregular 
distribution and fusion of mitochondria, whereas their overexpression sequesters Drp1 function and 
blocks mitochondrial fission [361, 364]. Tough these two proteins are redundant and have similar 
functions, MiD49 and MiD51 are differentially expressed in human tissues and during development and 
have different oligomerization states suggesting the possibility for distinct though similar functions of 
these proteins [365]. MiD51 forms mostly dimers by interaction between cytosolic domains, whereas 
MiD49 forms higher oligomers through interactions between its transmembrane domains and can even 
form heterodimers with MiD51 (Figure 12) [365, 366]. MiD proteins are involved in sensitivity to 
apoptotic stimuli and are controlled by E3 ubiquitin ligase MARCH5 targeting MiD49 for degradation 
and reducing cell sensitivity to stress-induced apoptosis [363, 367-369].   
A number of Mab-21 family members are involved in cell fate determination and development. The first 
described Mab-21 gene was found in Caenorhabditis elegans responsible for cell fate determination of 
several cells in C. elegans mail tail and rays formation that lead to family name male-abnormal 21 (Mab-
21) [370]. Mab-21 mutants had also pleotropic effects on movement, body shape and fecundity of C. 
elegans [311]. Further analysis revealed that Mab-21 acts downstream of transforming growth factor-β-
like (TGF-β-like) small (sma) pathway regulating nematode body length and ray formation [371]. 
Components of this pathway are homologs to Drosophila and vertebrate SMAD proteins participating in 
signal transduction from TGF-β receptor [372, 373]. Mab-21 is negatively regulated by TGF-β member 
cet-1, which is a ligand of the sma pathway, and may participate in chromatin remodeling via regulation 
of histone deacetylase activity [371, 374]. Vertebrate homologs of C. elegance Mab-21 gene - Mab21L1 
and Mab21L2 - were found to be involved in eye, preputial gland and ventral body wall development 
[375-379]. Mab21L1 and Mab21L2 have most probably evolved by ancestral Mab21 gene duplication 
prior to vertebrate divergence [380]. Both proteins have strongly intercepting expression pattern and are 
present in retina, midbrain, spinal cord, branchial arch and limb bud during development, though sub-
localization of Mab21L1 and Mab21L2 differ [376, 381-383]. Mab21L1 and Mab21L2 are also expressed 
in adult tissues such as cerebellum and eyes [376, 384]. Depletion of Mab21L1 or Mab21L2 was reported 
to arrest axial turning and resulted in severe defects in neural tube and other organs’ development in 
mouse embryos [350]. Mice lacking Mab21L1 revealed eye defects, and homozygous Mab21L2-knock-
out embryos were not viable, though eye and ventral body wall defects could be observed during 
development [378, 379]. Mutation in R51G in one copy of Mab21L2 is associated with ocular coloboma 
and cataracts caused by protein instability and dysfunction during development [385]. Another mutation 
in Mab21L2 R51C was reported in two patients revealing a range of eye malformations, abnormal 
shortness and joint formation and intellectual disability [386]. More mutations in Mab21L2 (e.g. R51H, 
E49K and R247Q) were reported to influence eye development by impairing ssRNA binding and 
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Mab21L2 stability [387]. The third member of Mab21-like proteins – Mab21L3 – was first found in 
Xenopus laevis to mediate dorsoventral patterning in embryos, and its knock-down inhibits dorsalization 
of gastrula-stage mesoderm and neurula-stage ectoderm [388]. Mab21L3 is also required for formation of 
multiciliate cells and ionocytes responsible for generating extracellular fluid flow and regulating ionic 
homeostasis, respectively, during development of embryonic epidermis. The study showed that Mab21L3 
acts downstream of Notch pathway that downregulates its expression in Xenopus and mouse embryos 
[389].   
All Mab-21 proteins consist of an N-terminal NTase core followed by PAP/OAS1 substrate binding 
domain. Sequence analysis reveals that among human proteins only cGAS, Mab21D2 and Mab21-like 
group members have some conservation in catalytic residues, though only cGAS and Mab21D2 have a 
full catalytic triad. C. elegans Mab-21 has similar pattern in catalytic site, though its third catalytic 
residue is substituted to glutamine. Thus, only several group members seem to have catalytic activity 
similar to cGAS.  
So far structures of human 
Mab21L1 and cytosolic 
domains of mouse MiD49 and 
human and mouse MiD51 were 
solved [348, 390-392]. All 
Mab-21 protein structures 
represent a bilobal fold with a 
mixed α/β topology very 
similar to cGAS (Figure 12). 
Mab21L1 structure is very 
similar to apo-state of cGAS 
with intact spine helix. MiD49 
and MiD51 structures, on the 
other side, have a brake in 
activation spine helix that 
refers to an active state of 
cGAS. Unlike cGAS, other 
Mab-21 proteins do not have a 
Zn-thumb and thus are not able 
to bind dsDNA. Interestingly, 
all crystallized Mab-21 proteins 
have positively charged patches 
on the opposite side of the catalytic pocket in the region corresponding to DNA-binding platform of 
cGAS [348, 390-392]. Since Mab21L1 and Mab21L2 were reported to bind ssRNA, this could be 
explained as a potential ssRNA binding site, however, the same positively charged platform could be 
found in bacterial homolog DncV that doesn’t bind nucleic acids and is constitutively active [322, 348, 
387]. Differences between the proteins can be observed in their oligomeric states. Though Mab21L1 
forms two stacked pentameric rings, it seems to be a monomer in solution [348]. In contrast, MiD51 was 
reported to form dimers in solution that are also observed in crystals [365, 390]. Unlike cGAS dimers that 
are held together by DNA-mediated interactions in spine helix and additional short helix between the 
Figure 12 Mab-21 proteins. 
MiD49 (PDB: 4WOY, yellow) and MiD51 dimer (PDB: 4OAG, green and 
orange) are anchored in mitochondrial membrane and recruit Drp1 (green 
oval) to induce mitochondrial fission. Mab21L1 (teal) is involved in 
embryonic development. Different nucleotide (red) binding modes are 
illustrated for CTP-bound Mab21L1 and ADP-bound MiD51.  
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lobes, mouse MiD51 monomers make a direct protein-protein interaction using N-terminal α-helical 
segment (Figure 12). However, such dimerization was not necessary for Drp1 binding and function of 
MiD51 in the cells [390]. Surprisingly, human homolog of MiD51 does not make analogical dimeric 
packing in the crystal [391]. Though MiD49 structure is highly similar to MiD51, MiD49 lacks 
conservation of residues involved in MiD51 dimerization and is present in monomeric form without its 
transmembrane domain [392]. Mab21L1 and MiD51, but not MiD49 were reported to bind nucleotides, 
though unlike cGAS none of these proteins coordinates Mg2+ ions in their NTase core [348, 390-392]. 
Instead the binding of the nucleotides – CTP, CDP, ATP and ADP for Mab21L1, and ADP and GDP for 
MiD51 – occurs by direct interaction of proteins’ side chains with the nucleotide base and phosphate 
groups [348, 390]. ADP binding by MiD51is facilitated by the residues corresponding to the catalytic 
triad of cGAS, but Mab21L1 seems to have a completely different nucleotide binding site close to its 
“spine” helix (Figure 12). Though the nucleotide binding was shown to stabilize the proteins in vitro, it 
does not introduce dramatic conformational changes in the structure and the functional importance of the 
nucleotide binding remains unclear.        
5. Regulation of cGAS-STING pathway 
The cGAS-STING pathway is a key platform not only for bacterial and viral infection detection, but also 
for recognition of cellular damage and tumor-derived DNA. Since the pathway plays the major role in 
cytosolic DNA recognition, many viral mechanisms counteracting type I IFN induction by cGAS-STING 
axis exist. Dysregulation of DNA sensing via cGAS-STING and its hyperactivation is associated with a 
number of autoimmune and inflammatory diseases. Recent discoveries described cGAS and STING as 
potential targets for cancer therapies. cGAS-STING pathway is regulated by a variety of posttranslational 
modifications, direct degradation of second messenger 2’3’-cGAMP and cellular co-factors and is tightly 
connected to other innate immune programs. cGAS-STING regulation mechanisms in health and disease 
will be addressed in detail in this chapter.  
5.1. Post-translational modifications regulating cGAS-STING DNA-sensing axis 
Except for regulation of cGAS activation by type and structure of the nucleic acid, cGAS is controlled by 
such post-translational modifications as phosphorylation, glutamylation, ubiquitination and SUMOylation 
affecting its DNA-binding, enzymatic activity and degradation rate (Figure 13). Akt-kinase that was 
identified in relation to cell proliferation and survival, as well as to metabolism, was reported to 
phosphorylate cGAS at S305 (corresponds to S291 in mouse protein) in cells and in vitro suppressing its 
enzymatic activity [393, 394]. Interestingly, cGAS has an Akt-kinase recognition motif 
[RK]x[RK]xx∗[ST] (x - any amino acid) that is highly conserved in vertebrates, suggesting an evolutional 
importance of this regulation pathway. Overexpression of wild type cGAS but not S305A mutant 
incapable of phosphorylation resulted in lower levels of type I IFN production in response to transfected 
DNA or HSV-1 infection in mouse L929 cGAS-KO cell line, though in in vitro system enzymatic activity 
was not altered by this point mutation [394]. Akt-kinase was also shown to be activated by type I IFN in 
mouse fibroblasts and its depletion resulted in a dramatic reduction of IFN-induced antiviral responses, 
since it regulates mTOR pathway responsible for translation of IFN-inducible mRNA [395]. Moreover, 
Akt is activated by TBK1 kinase which apparently initiates negative feedback loop of DNA-sensing 
[396]. Though two opposite functions of Akt-kinase were proposed, it may act on early stages of cGAS 
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activation inhibiting excessive type I IFN production and supporting antiviral response. Furthermore, 
enzymatic activity of cGAS is regulated by mono- and polyglutamylation by tyrosine ligase-like enzyme 
(TTLL) 4 and 6, respectively [397]. TTLL4 attaches one glutamate group to E314 (E302 in mice) of 
cGAS at the entrance to the catalytic pocket rendering it catalytically inactive, whereas TTLL6 
polyglutamylates cGAS at E286 (E272 in mice) and suppresses its DNA-binding ability. Glutamylation 
of cGAS was shown to be reversed by cytosolic carboxypeptidases (CCP) 5 and 6 that hydrolyze the 
glutamate chain on mono- and polyglutamylated cGAS, respectively. Thus, depletion of CCP5 or CCP6 
led to higher susceptibility to DNA viruses in vivo and lower IFN-β production in cells [397].   
Positive regulation of cGAS was recently found to be achieved by K27-linked polyubiquitination of 
cGAS presumably at K173 and K384. ER ubiquitin ligase RNF185 was discovered to interact with cGAS 
during HSV-1 infection and potentiate its catalytic activity [398]. cGAS is constitutively negatively 
regulated by K48-linked ubiquitination of K414 that targets cGAS to autophagic degradation [399]. 
However, viral infection triggering type I IFN production increases E3 ligase tripartite motif 14 
(TRIM14) expression which causes cGAS stabilization. TRIM14 was shown to recruit ubiquitin 
carboxyl-terminal hydrolase 14 (USP14) and induce cleavage of the ubiquitin chains on cGAS at K414. 
Thus TRIM14/USP14 blocks cGAS degradation and generates a positive feedback loop of cGAS 
signaling [399]. cGAS ubiquitination was recently shown to be counteracted by SUMOylation [400]. This 
process is driven by ubiquitin ligase TRIM38 that dynamically SUMOylates cGAS in uninfected cells 
and during the early phase of viral infection attaching one or two SUMO1 moieties to K217 residue of 
cGAS. A mutation of this residue abolished SUMOylation and dramatically decreased cGAS protein level 
and IFN response to HSV-1 infection. The same study showed that at the late phase of viral infection 
SUMOylation of cGAS was decreased by desumoylating enzyme Senp2, that together with TRIM38 
provides a mechanism for dynamic regulation of cGAS by post-translational modification [400]. Another 
SUMOylation event seems to occur at the late stages of infection. cGAS was found to undergo 
SUMOylation at residues K335, K372 and K382 of DNA-binding site which abolish DNA-binding and 
cGAS enzymatic activity. Sentrin/SUMO-specific protease 7 (SENP7) was found to counteract such 
SUMOylation and restore cGAS activity [401]. 
Downstream of cGAS adaptor STING is also strongly controlled by post-translational modifications 
(Figure 13). The necessity of STING phosphorylation by TBK1 for downstream signaling was described 
earlier [143]. This is further confirmed by the fact that protein phosphatase magnesium-dependent 1A 
(PPM1A) dampens the whole downstream phosphorylation cascades by removing S358 phosphorylation 
from STING [402]. Another kinase - UNC51-like kinase-1 (ULK1) – was also described to phosphorylate 
STING at the same position; however, it unexpectedly suppressed IRF3 activation by STING [403]. 
According to this study, 2’3’-cGAMP initiates a negative feedback loop triggering dissociation of ULK1 
from its repressor AMP activated protein kinase (AMPK) that results in STING phosphorylation and 
inactivation. These conflicting results may indicate that other modifications and other players may be 
responsible for such opposite effects on STING activation. 
STING is dynamically regulated by polyubiquitination that depending on the type of polyubiquitin and 
modified STING residues either activates STING or targets it to degradation. E3 ubiquitin ligases 
TRIM32 and TRIM56 were reported to ubiquitinate STING and facilitate its interaction with TBK1 [404, 
405]. TRIM56 introduces K63-linked polyubiquitin chains to K150 and TRIM32 additionally modifies 
residues K20, K224 and K236, positively regulating IFN-β expression. Overexpression of these ubiquitin 
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ligases enhanced IFN-β promotor activation, whereas knockdown of either protein abrogated IFN 
signaling through STING in presence of cytosolic dsDNA or poly(I:C). Similar to TRIM32 and TRIM56 
ER complex consisting of ubiquitin ligase  autocrine motility factor receptor (AMFR) and its adaptor 
insulin-induced gene 1 (INSIG1) introduces K27-linked polyubiquitin chains to K137, K150, K224 and 
K236 STING residues and facilitates TBK1 recruitment and type I IFN production [406]. Deficiency of 
AMFR resulted in dramatic decrease of IRF3-activated genes expression in response to cytosolic dsDNA, 
2’3’-cGAMP treatment or infection with HSV-1 or Listeria monocytogenes, and the lack of INSIG1 
resulted in higher susceptibility to HSV-1 infection in mice. In contrast, K48-linked polyubiquitination of 
STING at the same residue K150 by E3 ubiquitin ligase RING finger protein (RNF) 5 inhibits STING- 
mediated signaling [407]. Overexpression of RNF5 dramatically decreased activation of NF- κB and 
IRF3 transcription factors upon ssRNA Sendai virus (SeV) infection and reduced IFN-β promotor 
activation upon transfection with poly(I:C) or dsDNA. Fluorescent microscopy and fractionation assays 
revealed that RNF5 ubiquitinates STING at mitochondria, where it targets STING for proteasomal 
 
Figure 13 Regulation of cGAS/STING signaling pathway.  
cGAS and STING are regulated by posttranslational modifications: phosphorylation (yellow circle, P), 
ubiquitination (purple circle with indicated type of linkage between polyubiquitin chains), glutamylation (green 
circle, E), SUMOylation (light blue oval, SUMO), palmitoylation (blue waved line). Positive regulation of 
cGAS/STING signaling is indicated in black, negative – in red. Arrows indicate activation, blunt lines – inhibition. 
Components of the pathway are connected with black dashed lines. 
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degradation [407]. K11-linked polyubiquitination of STING at K150 by RNF26 was described to 
counteract RNF5-mediated STING ubiquitination and its degradation upon viral infection [408]. In 
agreement to this, RNF26 knockdown inhibited activation of NF-κB and IFN-β promoters by HSV-1 and 
SeV infection. However, the overexpression of RNF26 promoted IRF3 degradation and reduced SeV-
induced activation of the IFN-β promoter. Though no direct interaction between RNF26 and IRF3 or 
polyubiquitination of IRF3 was detected, RNF26 was suggested to mediate autophagic degradation of 
IRF3, since autophagy inhibitors or expression of catalytically inactive RNF26 mutant prevented IRF3 
degradation. Apparently, RNF26 stimulates type I IFN production by STING ubiquitination at the early 
stages of infection and prevents excessive IFN response at the late phase of viral infection by targeting 
IRF3 [408]. Additionally to differential functions of STING polyubiquitination, deubiquitination was 
found to regulate STING activation. For example, eukaryotic translation initiation factor 3, subunit 5 
(eIF3S5) was reported to be recruited to STING by inactive rhomboid protein 2 (iRhom2) and act as 
deubiquitinase to remove K48-linked polyubiquitin chains and thus to stabilize STING [409]. STING-
stabilizing effect was observed as well by its SUMOylation. TRIM38 reported to modify cGAS and 
counteract its degradation can also SUMOylate STING at K338 increasing STING stability and mediating 
IRF3 recruitment and activation. DeSUMOylation at this position is performed by SENP2 and is 
facilitated by ULK1-dependent phosphorylation, giving a possible explanation for the negative regulatory 
effect of ULK1 [400].   
STING function is also strongly regulated by its trafficking from ER to the perinuclear compartments as 
inhibition of such trafficking by brefeldin A abolishes STING phosphorylation and activation (Figure 13) 
[403]. iRhom2 apart for protecting STING from polyubiquitin-mediated degradation positively regulates 
type I IFN signaling by facilitating STING association with the translocon-associated protein TRAPβ and 
promoting STING trafficking [409]. STING was also shown to undergo palmitoylation at the in mammals 
conserved residues C88 and C91 taking place at the trans-Golgi network that was found to be necessary 
for type I FN production [410]. Palmitoylation inhibitor 2-BP abolished the expression of IFN-stimulated 
genes upon transfection of dsDNA or STING agonists. Furthermore, disruption of lipid rafts on Golgi 
inhibited STING-dependent phosphorylation of TBK1 and IRF3, suggesting that palmitoylation of 
STING facilitates STING clustering and thus affects TBK1 recruitment and IRF3 activation [410]. 
In addition to post-translational modification, cGAS and STING functions are controlled by microRNAs. 
MiR-576-3p expressed in response to STING and IRF3 activation was found to target STING, MAVS 
and TRAF3 reducing IFN response and generating a negative feedback mechanism for IFN signaling 
[411]. cGAS is downregulated in hypoxic tumors by miR-25/93 that target epigenetic factor maintaining 
cGAS basal expression level. Such cGAS repression results in immunological escape of tumor cells and 
tumor progression [412].              
5.2. cGAMP degradation and transport 
Besides STING activation and negative regulation of cGAS-STING pathway within the infected cells, 
2’3’-cGAMP has a number of functions outside the cell where it was produced. For example, cGAMP 
was found to be and adjuvant of immune effects and was shown to boost antibody production in mice 
immunized with a model protein antigen ovalbumin [213, 413]. Moreover, such co-immunization resulted 
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in CD8 T cells expansion and higher expression levels of IFNγ and IL-2 in response to the antigen [213]. 
cGAMP was also shown to prolong cellular and humoral immune responses induced by influenza 
vaccines by intradermal immunization [414].  
Additionally to its effects on T and B cell activation, cGAMP was discovered to be transferred through 
gap junctions in murine and human cells and participate in paracrine-like activation of the neighboring 
cells. Distinct connexin proteins forming gap junctions were shown to be redundant for cGAMP transfer 
and the depletion of one connexin member resulting in the impairment of STING activation in bystander 
cells was rescued by overexpression of other connexins [241]. Gap junctions were also reported to 
participate in tumor growth and chemoresistance. Brain metastatic cancer cells were described to form 
protocadherin 7 (PCDH7)-induced connexin 43 gap junctions with astrocytes and activate production of 
inflammatory cytokines and IFNs by transferring cGAMP. IFN-α and TNF expressed by astrocytes in 
turn activate STAT1 and NF-κB signaling in cancer cells leading for their expansion and survival during 
chemotherapy [415]. Since cGAS and STING are not always co-expressed in different cell types, the 
horizontal transfer of cGAMP allows not only to amplify inflammatory signals and escape viral 
mechanisms counteracting cell defense, but also to elicit IFN response in the cells lacking cGAS but 
competent for STING activation [416]. For example, T cells were found to be capable of cGAMP 
production but fail to activate IFN response [417]. In this case cGAMP transfer through direct cell contact 
is based on membrane fusion between HIV infected T cells expressing HIV envelope and primary 
macrophages. Such membrane fusion is triggered by interaction between the HIV-1 envelope on T cells 
with the CD4/co-receptor residing on primary macrophages resulting in STING-dependent type I IFN 
production in macrophages [418]. 
Another way of cGAMP transport between the cells includes its incorporation into the viral particles of 
herpesviruses, poxviruses and lentiviruses including HIV-1 [242, 243]. cGAMP-loaded viral particles 
were shown to trigger stronger cGAS-STING activation and IFN induction in newly infected cells [242]. 
Extracellular vesicles that are also involved in cellular mRNA and microRNA, as well as viral RNA 
transport between the cells, were also shown to contain cGAMP, however, their stimulation of uninfected 
cells was rather inefficient [243, 419, 420].        
Unique 2’-5’ phosphodiester linkage of 2’3’-cGAMP results not only in distinct thermodynamic 
properties and conformation leading to high-affinity binding to STING, but also provides a better stability 
towards degradation. There is a number of bacterial phosphodiesetases (PDs) known to degrade 3’-5’-
phosphodiester linkages, however, only few 2’-5’ PDs were discovered. For example, Vibrio cholerae 
cGAMP PDEs (V-cGAPs) selectively hydrolyze 3’3’-cGAMP to the linear pApG product but fail to 
hydrolyze metazoan 2’3’-cGAMP [421]. One 2’-5’-specific phosphodiesterase – 2’-PDE (also PDE12) - 
was discovered to disrupt 2’-5’ polyadenylates produced by OAS and its suppression resulted in reduction 
of vaccinia virus replication [422]. Another 2’-5’-PDE was discovered to specifically degrade 2’3’-
cGAMP in human cell lines and murine liver and spleen [423]. Ecto-nucleotide 
pyrophosphatase/phosphodiesterase (ENPP1) is a plasma membrane and ER lumen protein that 
coordinates Ca2+ and Zn2+ ions and effectively digests 2’3’-cGAMP to nucleoside-monophosphates, but 
not 3’3’-cGAMP or 3’3’-c-diGMP of bacterial origin (Figure 13) [423-425]. Other ENPP1 substrates 
include ATP and diadenosine tetraphosphate (AP4A), whereas UTP and cAMP were hydrolyzed with less 
efficiency [425]. Tissues of ENPP1-knockout mice failed to degrade 2’3’-cGAMP efficiently [423]. 
ENPP1 can also be secreted into extracellular space, and in agreement to that, bovine and human sera 
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were shown to possess 2’3’-cGAMP hydrolase activity. In the same study 2’3’-cGAMP analog with 
phosphothioate diester linkages were synthesized and shown to have higher resistance to ENPP1 
cleavage. Moreover, such 2’3’-cGAMP analogs were capable to inhibit 2’3’-cGAMP hydrolysis acting as 
a competitive inhibitor [423]. However, ENPP1 is a transmembrane protein, so it is not clear how it 
degrades 2’3’-cGAMP with a catalytic site located either in the extracellular space or inside the ER 
lumen. Interestingly, 2’3’-cGAMP levels were shown to be much higher in STING/Trex1-double 
knockout mice in comparison to a single Trex1-knockout suggesting that STING might facilitate 2’3’-
cGAMP clearance and eventually participate in 2’3’-cGAMP transport into ER lumen [426, 427].     
5.3. Cellular co-factors of cGAS-STING pathway 
Though the presence of cGAS, STING and effector proteins TBK1 and IRF3 are the key players of type I 
IFN response to the cytosolic DNA, other cellular co-factors were found to contribute to cGAS/STING 
pathway (Figure 14). Ribosomal protein S6 kinase 1 (S6K1) was shown to interact with STING and to 
promote IFN signaling upon adenovirus infection [428]. S6K1 is an effector serine-threonine kinase 
downstream of mTOR that is involved in regulating cell growth, apoptosis, as well as transcription and 
translation in response to various cell stresses. Depletion of S6K1 in bone marrow–derived myeloid 
dendritic cells (BMDCs) resulted in a decreased IRF3 phosphorylation in response to adenovirus, HSV-1 
or transfected DNA or cGAMP, but not to RNA virus VSV. S6K1 was shown to be required for the 
binding of IRF3 to the activated STING-TBK1 complex and to form a complex S6K1-STING-TBK1 in 
the presence of cytosolic DNA. Such tripartite complex was important for the early-phase expression of 
IRF3 target genes and induction of T cell responses in mice [428]. ZDHHC1 was found to be another co-
factor of virus-triggered immune response through the cGAS/STING axis [429]. Zn-finger aspartate-
histidine-histidine-cysteine (DHHC) domain-containing protein 1 (ZDHHC1) is an ER-associated protein 
and a member of the palmitoyl acytransferase family. ZDHHC1 knockdown abolished activation of IRF3 
and NF-κB in response to HSV-1, but not SeV infection in mouse embryonic fibroblasts and in mice led 
to higher susceptibility to HSV-1 infection. Fluorescent microscopy revealed that ZDHHC1 co-localizes 
with STING independently of infection. ZDHHC1 was also discovered to support cGAMP-induced 
activation of STINGH232 variant, otherwise incapable to stimulate IFN-β production. Surprisingly, though 
STING palmitoylation was shown to be necessary for STING activation, ZDHHC1 function in STING 
activation was described to be independent of its catalytic activity as palmitoyl transferase [429]. 
However, overexpression and transfection with high amounts of DNA might have resulted in too high 
level of IFN-β production and hidden any differences in ZDHHC1 mutants’ activities.            
Polyglutamine binding protein 1 (PQBP1) and NLRX1 were recently shown to regulate cGAS-STING 
pathway activation during HIV-1 infection (Figure 14). HIV-1 induces IFN innate immune response by 
cGAS-mediated recognition of HIV-1 reverse transcripts [220]. However, human dendritic cells (DCs) 
are resistant to HIV-1 infection because of SAM domain and HD domain containing protein 1 
(SAMHD1) that depletes cellular deoxynucleoside triphosphate pools. Co-infection of HIV-1 with 
lentiviral protein VpX targeting SAMHD1 for degradation results in susceptibility of DCs to HIV-1 and 
elevated levels of type I IFNs [430-432]. In such system PQBP1 was defined as a co-factor of HIV-1 
induced IFN signaling, since PQBP1 depletion resulted in reduced IFN response to HIV-1 and other 
retroviruses in monocyte-derived DCs and monocyte-like cell line THP-1 [219]. PQBP1 was discovered 
to associate with HIV-1 reverse-transcribed DNA product independently of cGAS and attracts cGAS to 
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HIV-1 DNA by direct interaction between proteins. PQBP1-deficient cells produced less cGAMP in 
response to HIV-1 infection showing that PQBP1 positively regulates cGAS activity in presence of 
retroviral products of reverse transcription. Interestingly, PQBP1 did not co-immunoprecipitate with 
cytosolic dsDNA from dsDNA viruses, making PQBP1 a unique sensor of retroviruses stimulating cGAS 
activation [219]. NLRX1, on the other side, was found to be a negative regulator of IFN signaling during 
HIV-1 or DNA virus infection [433]. NLRX1 is a member of NLRs usually associated with 
inflammasome formation. Unlike other NLRs, NLRX1 resides in mitochondria and induces ROS 
production and attenuates RIG-I/MAVS and TRAF/IKK signaling [434-437]. Additionally, NLRX1 
downregulates cGAS/STING pathway by disrupting STING interaction with TBK1 [433]. NLRX1 was 
shown to directly interact with STING and to decrease STING-TBK1 interaction in a dose-dependent 
manner. Consistent to this, NLRX1 deficiency enhances immune responses to HSV-1 and HIV-1 viruses, 
as well as dsDNA and CDNs. Intriguingly, NLRX1 was demonstrated to support nuclear import of HIV-1 
DNA promoting HIV-1 infection. However, STING-knockout cells showed the same HIV-1 infection rate 
independently of NLRX1 leading to conclusion that enhancement of HIV-1 infection by NLRX1 depends 
strongly on its function as STING inhibitor [433].   
IFN-γ-inducible protein 16 (IFI16), initially proposed as DNA-sensor upstream from STING, was also 
reported to participate in HIV-1 immune recognition (Figure 14). HIV infection in primary human 
macrophages induces IFN response in IFI16- and STING-dependent manner and hence does not result in 
productive infection [237]. Permissive CD4+ T cells, on the other hand, are defective in DNA-signaling 
machinery, and despite IFI16 binding cytosolic DNA and STING recruiting TBK1 and IRF3 no IFN-
induced genes are expressed leading to viral propagation [417]. Another role of IFI16 includes restriction 
of human papillomavirus and human cytomegalovirus replication by epigenetic modifications of viral 
promoters [438, 439]. Histone H2B was proposed to be a co-factor for IFI16-mediated recognition of 
HSV-1 and KSHV genomes in de novo infections leading to IFN production [440]. IFI16 was often 
linked to cGAS/STING pathway. IFI16 acetylation was discovered to drive IFI16 translocation into the 
cytosol where it engages STING for IFN-β production [237, 301]. On the other hand, nuclear localized 
cGAS was proposed to interact and stabilize the nuclear fraction of IFI16 [304]. Sensing of DNA from L. 
monocytogenes was shown to be dependent on cGAS and STING, as well as on IFI16 in human myeloid 
cells [222]. Recent data indicate that IFI16 positively regulates cGAS/STING axis by recruiting TBK1 to 
STING (Figure 14) [306, 307]. IFI16 knockout significantly reduced IFN response to transfected dsDNA 
and DNA viruses in human keratinocytes and macrophages. IFI16 forms a complex with TBK1 
independently of infection and in presence of cytosolic dsDNA or 2’3’-cGAMP recruits TBK1 to STING 
to promote STING phosphorylation and activation. Though IFI16 involvement in STING activation 
seems to be robust, its influence on cGAS activity remains controversial. Some data suggest that IFI16 
supports 2’3’-cGAMP production by cGAS and both domains of IFI16 are involved in this process [307]. 
However, another study failed to detect any decrease in cGAS-mediated 2’3’-cGAMP production in the 
absence of IFI16, though DNA-mediated interaction between IFI16 and cGAS was observed in co-
immunoprecipitation studies, leaving the question whether IFI16 is a cGAS co-factor open [306]. 
Among recently discovered factors regulating cGAS/STING pathway are small GTPase RAB2B and its 
effector protein Golgi-associated RAB2B interactor-like 5 (GARIL5) (Figure 14). Upon DNA stimulation  
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Figure 14 Cellular co-factors of cGAS/STING pathway. 
cGAS/STING co-factors are indicated as grey ovals with green text for positive and with red text for negative 
regulation of the pathway. Black arrows stand for activation, red lines with blunt ends – for inhibition. Components 
within the pathway are connected with black dashed lines. Abbreviations used: ubiquitin (Ub) and phosphate (P).  
 
RAB2B binds GTP and co-localizes with STING on the Golgi apparatus to recruit GARIL5. 
RAB2B/GARIL5 complex promotes IRF3 phosphorylation on STING and knockout of each protein leads 
to decreased IFN-β expression in presence of cytosolic dsDNA and cGAMP [441]. Another protein was 
found to link TBK1 and IKKβ into a positive feedback loop during cGAS/STING activation. Apart from 
IRF3, NF-κB is also activated by STING via an unknown mechanism. NF-κB is activated by the IKK 
complex consisting of kinases IKKα and IKKβ and regulatory subunit NF-κB essential modulator 
(NEMO). cGAS/STING activation was found to stimulate ubiquitin-ligases TRIM32 and TRIM56 to 
produce polyubiquitin chains that are bound by NEMO resulting in IKKβ activation. IKKβ was found to 
be essential for cytosolic DNA sensing and for TBK1, IRF3 and STING phosphorylation since its 
catalytically inactive mutant failed to restore phosphorylation upon STING activation. Interestingly, 
TBK1 was analogically required for NF-κB activation in response to cytosolic DNA, coupling IRF3 and 
NF-κB signaling during cGAS/STING activation (Figure 14) [442]. 
5.4. Cross-talk between cGAS/STING, autophagy, inflammasomes and apoptotic 
caspases 
cGAS/STING DNA-sensing pathway is tightly linked to other innate immune pathways in cells. 
Crosstalk between DNA and RNA-sensing was first demonstrated by the discovery of RNA-polymerase 
III-driven synthesis of dsRNA from AT-rich dsDNA fragments. Resulting dsRNA activates the RIG-I 
pathway in parallel to dsDNA priming cGAS/STING activation [443]. HIV-1 with ssRNA genome 
produces a number of intermediates that are recognized by cGAS/STING axis, whereas STING in 
involved in RIG-I signaling upon RNA virus infection by forming RIG-I/MAVS/STING complex [220, 
244, 245, 444]. Conversely, MAVS knockout in HeLa and HepG2 cells show reduced IFN response to 
cytosolic dsDNA [445]. 
Autophagy is an ancient mechanism counteracting infection and is induced upon bacterial infection under 
nutrient starvation [446]. Autophagy is integrated in nearly all innate immune pathways and is modulated 
by the majority of PAMPs and pathogen signaling pathways including cytosolic nucleic acid sensing 
pathways. For example, when MAVS signaling is triggered by viral invasion, autophagy protein 
ATG16L1 is recruited to the mitochondria by NLRX1, mediates mitophagy and eliminates the adaptor 
MAVS thus inhibiting cytosolic RNA sensing via RIG-I and MDA5 [447, 448]. Activation of DNA-
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sensing cGAS/STING pathway can also initiate autophagy (Figure 15). M. tuberculosis infection was 
shown to be targeted by the components of ubiquitin-mediated autophagy in response to cGAS/STING 
activation resulting in delivery of bacteria to autophagosomes for degradation [449]. Activation of STING 
by DNA viruses HSV-1 and HCMV was also reported to elicit autophagy [450, 451]. Some autophagy-
associated proteins like kinase ULK1 negatively regulating STING were described in the previous 
chapter. Moreover, upon dsDNA stimulation STING co-localizes with autophagy proteins microtubule-
associated protein 1 light chain 3 (LC3) and autophagy-related gene 9a (Atg9a) [251]. Depletion of 
ATG9a results in increased STING trafficking to perinuclear region and enhances IFN production. Thus, 
ATG9a limits an excessive STING activation (Figure 15) [251]. Another autophagy protein – Beclin-1 – 
was found to be involved in negative regulation of cGAS. Beclin-1 is essential for autophagy induction 
and autophagosome maturation by forming complexes with its positive (ATG14 and UV irradiation 
resistance-associated gene, UVRAG) or negative (Bcl-2 and Rubicon) modulators [452-455]. Upon 
dsDNA stimulation cGAS was shown to bind Beclin-1 thus releasing it from the complex with Rubicon 
leading to Beaclin-1 mediated phosphatidylinositol 3-kinase class III (PI3KC3) activation and induction 
of autophagy for degradation of pathogen cytosolic DNA. Beclin-1 additionally suppresses cGAS 
enzymatic activity resulting in negative regulation of IFN signaling [456]. Negative regulation of IFN 
production by autophagy can be further illustrated by the observation that its inhibition in intestinal tissue 
and tumors leads to enhanced type I IFN signaling [457-459]. Autophagic elimination of DNA is also 
essential for preventing pathological STING activation: the leakage of chromatin DNA usually degraded 
by DNAse2a or autophagy results in elevated IFN levels and autoimmunity [460]. 
Crosstalk between cGAS/STING pathway and inflammasome activation, as well as activation of 
inflammatory and apoptotic caspases, also plays a crucial role in fine-tuning of cellular responses to 
PAMPs and DAMPs (Figure 15). Several inflammasome components were described to negatively 
influence innate immune responses like NLRX1 interfering with RIG-I/MAVS and TRAF6/NF-κB 
pathways, NLRP12 repressing NF-κB signaling and tumorigenesis in colon in mice, NLRP6 inhibiting 
TLR-induced NF-κB response to Gram-positive and -negative bacteria or NLRC5 interacting with IKKα 
and IKKβ and blocking NF-κB-dependent responses [101, 436, 461-463]. Some NLRs were reported to 
inhibit cGAS/STING activation through different mechanisms. A negative regulation of cGAS/STING by 
NLR protein NLRX1 was already described above. Another inflammasome component - NLRC3 - was 
found to directly bind STING and similar to NLRX1 to impede STING interaction with TBK1 [464]. 
NLRC3 associates with both ER-bound STING and TBK1 reducing their direct interaction and impairs 
STING trafficking to the perinuclear region attenuating type I IFN production in response to cytosolic 
DNA, cGAMP and DNA viruses in vivo and in the cells [464]. In addition, NLRC3 was reported to 
interact with TLR signaling adaptor TRAF6 blocking its ubiquitination and activation of NF-κB upon 
LPS treatment [465]. NLRP4, on the other hand, counteracts type I IFN production by targeting TBK1 for 
degradation [466]. NLRP4 was found to reduce IFN response to cytosolic dsDNA or dsRNA recruiting 
DTX4 to activated TBK1 after viral infection that results in TBK1 K63-linked ubiquitination and 
degradation. Importantly, NLRP4-mediated suppression of IFN signaling is specific towards TBK1-IRF3 
type I IFN production and does not influence MyD88-IRF7 pathway triggered by CpG DNA [466]. 
Similarly to NLRP4, NLRP14 was discovered to target TBK1 for ubiquitination and degradation 
inhibiting RIG-I and cGAS RNA and DNA sensing pathways [467]. Another mechanism to inhibit IFN 
response was proposed for DNA-sensing AIM2 inflammasome. AIM2 activation was shown to counteract 
cGAS/STING pathway by promoting caspase-1-dependent cell death and AIM2 deficiency resulted in 
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elevated level of cGAMP production, STING activation and IFN-β synthesis in murine macrophages and 
dendritic cells [468]. In line with the assumption for AIM-2 inflammasome, a recent study suggested a 
general mechanism of cGAS/STING inhibition by canonical and non-canonical inflammasome activation. 
Caspase-1 or caspases 4, 5 and 11 activated upon DNA virus infection or by a non-canonical 
inflammasome formation, respectively, were found to cleave N-terminal domain of cGAS dramatically 
impairing its activity [469].  
Unlike the most NLRs, IFI16 seems to have dual functions in regulating cGAS/STING and 
inflammasome pathways (Figure 15). IFI16 ability to positively regulate cGAS/STING pathway and 
facilitate type I IFN production was described in the previous chapter. On the other hand, IFI16 having 
the same domain organization as inflammasome-related AIM2 DNA sensor was proposed to assemble 
into inflammasome in response to Kaposi’s sarcoma herpesvirus or Epstein-Barr virus infection and 
activate caspase-1 [67, 301]. IFI16 was also described to regulate inflammasome responses controlling 
Asc expression and to induce pyroptotic cell death in T cells and thus abolishing HIV replication [470, 
471].  
Interferon and inflammasomes cooperate during infection (Figure 15). Expression of inflammasome 
components and inflammatory caspases were found to be dependent on IFN-β [472-476]. The 
cGAS/STING pathway was reported to prime AIM2 inflammasome formation in human and mouse 
antigen-presenting cells in response to poxvirus [477]. STING was found to prime inflammasome 
formation upon infection with Chlamydia trachomatis which activated inflammasome cell death through 
its metabolic products [478]. On the other hand, IFN-β can induce IL-1R antagonist expression to 
attenuate IL-1 signaling and suppress IL-1β release from macrophages by inducing expression of anti-
inflammatory cytokine IL-10 or by stimulating synthesis of inducible nitric oxide synthase which 
increases concentration of endogenous NO that inhibits NLRP3 oligomerization [479-482]. The latest 
research revealed that cGAS/STING activation can not only prime inflammasome formation, but also 
trigger NLRP3 inflammasome activation (Figure 15). AIM2 was found to be dispensable for DNA-
induced inflammasome activation and IL-1β release in human myeloid cells. cGAS/STING activation 
was discovered to result in STING trafficking to lysosome and induction of lysosomal cell death. 
Activated STING was shown to trigger membrane permeabilization which caused K+ efflux and NLRP3 
activation [29]. According to another study 2’3’-cGAMP was found to prime and activate AIM2 and 
NLRP3 inflammasomes in mouse bone marrow–derived macrophages (BMDMs) and human primary 
macrophages and dendritic cells. Interestingly, 2’3’-cGAMP-induced inflammasomes were composed of 
both AIM2 and NLRP3 and led to STING-dependent IL-1β secretion, but not cell death [483]. Thus, 
cGAS/STING activation induces inflammasome formation differentially depending on organism and cell 
type. Taken together, inflammasome and cGAS/STING axis present a dynamic response to invading 
pathogens. Initial activation of IFN producing pathways leads to priming and activation of 
inflammasomes that in turn switch off IFN production and drive IL-1β and IL-18 secretion and pyroptotic 
cell death. 
Apart from inflammatory caspases, apoptotic caspases were found to control IFN response. Defective 
enzymatic activity of caspase 8 was found to cause elevated levels of IRF3 and TBK1 activation and 
chronic inflammatory skin disorder in mice (Figure 15) [484]. Caspase 8 was found to negatively regulate 
RIG-I and TLR activation by cleaving polyubiquitinated RIPK1 thus inhibiting type I IFN production 
[485, 486]. Apoptotic caspases 3, 7 and 9 activated by intrinsic apoptotic pathway were found to inhibit 
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Figure 15 A cross-talk between cGAS/STING, autophagy and inflammasome pathways. 
Components of cGAS/STING pathway (green) are interconnected with proteins involved in autophagy (purple), 
RIG-I signaling (orange) and inflammasome formation (blue). Components within one pathway are connected with 
dashed black arrows. Activation is indicated with black arrows, inhibition – with red lines with blunt ends.  
 
cGAS/STING activation and type I IFN production during apoptosis. Knockout or pharmacological 
inhibition of these caspases together with activation of apoptosis leads to Bak/Bax-mediated release of 
mitochondrial DNA, cGAS/STING activation and IFN synthesis. Knockout of apoptotic initiator caspase 
9 or double knockout of effector caspases 3/7 is sufficient for elevated type I IFN levels, and this effect is 
further increased by treatment with pro-apoptotic drug ABT-737 [226, 227]. Since some viruses express 
caspase inhibitor proteins to prevent apoptosis of the host cell, such mechanism of IFN response might 
have evolved as counteracting viral defenses. However, if active apoptotic caspases target mitochondrial 
DNA, cGAS/STING or downstream components of the pathway, remains to be uncovered.     
5.5. Viral inhibition of cytosolic DNA sensing 
During co-evolution bacteria and viruses evolved several mechanisms counteracting host defenses, some 
of them inhibiting cGAS and STING (Figure 16). Group B Streptococcus expresses ectonuclease CdnP 
which degrades extracellular c-di-AMP and limits STING activation. Though CdnP limits host IFN 
response, it does not digest 2’3’-cGAMP and fails to abolish bacterial DNA sensing via cGAS [487]. 
Phosphodiesterase CdnP from Mycobacterium tuberculosis, however, is capable of hydrolysis of not only 
bacterial derived c-di-AMP, but cGAS-generated 2’3’-cGAMP as well effectively inhibiting M. 
tuberculosis detection by both cGAS and STING [488]. Shigella flexneri utilizes IpaJ and virA proteins to 
inhibit STING transport from ER to Golgi and deletion of both proteins results in a robust IFN response 
to Shigella infection [489].  
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STING is also a target for viral defensive programs (Figure 16). vIRF1 from KSHV was discovered to 
bind STING and prevent its association with TBK1 [217]. Similarly, ICP27 protein from HSV-1 interacts 
with activated STING and TBK1 preventing phosphorylation of IRF3 [490]. Oncogenes E7 and E1A 
from the DNA tumor viruses human papillomavirus (HPV) and adenovirus (AdV), respectively, were 
described to bind STING and abolish its activity [491]. Surprisingly, according to another study 
adenovirus E1A did not suppress TBK1/IRF3 activation through cGAS/STING in the early stage of 
infection and replication of adenovirus was not affected by the lack of cGAS or STING [492]. Such 
results can be explained with E1A blocking antiviral gene expression downstream of IFN-β by inhibition 
STAT1 activation [493]. Polymerase of Hepatitis B virus (HBV) was found to associate with STING and 
prevent its K63-linked ubiquitination that is necessary for STING activation [494].  
The importance of STING for RNA viruses is supported by their STING-inhibiting strategies. HCV, 
usually recognized by RIG-I signaling pathway, encodes NS4B protein that inhibits STING either by 
intersecting its interaction with TBK1 or by disrupting STING-MAVS interactions [495, 496]. Dengue 
virus (DENV) encodes protease complex NS2B/3 that cleaves STING between its transmembrane helices 
inhibiting IFN response. Interestingly, NS2B/3 is not capable for murine STING degradation explaining 
the resistance of murine cells to DENV infection [497-499]. Human and porcine coronaviruses, as well as 
severe acute respiratory syndrome coronavirus (SARS-CoV) possess a membrane-anchored papaine-like 
protease (PLP) domain containing protein that co-localizes with STING, disrupts its interaction with 
TBK1 and repress K63-linked polyubiquitination of STING resulting in decreased IFN-β production 
[500-503]. However, whether or not these PLPs need their deubiquitinating activity remains debatable. 
cGAS activity is also directly targeted by some pathogens (Figure 16). KSHV tegument protein ORF52 
and its homologs in other gammaherpesviruses were discovered to bind both cGAS and DNA and to 
inhibit cGAS enzymatic activity [504]. Another protein from KSHV - latency-associated nuclear antigen 
(LANA) – was also reported to inactivate cGAS. N-terminally truncated cytosolic LANA was found to 
interact with cGAS and abolish 2’3’-cGAMP production promoting reactivation of KSHV from its latent 
state, otherwise suppressed by cGAS/STING IFN signaling [505]. LANA was also shown to recruit 
members of the MRN complex in the cytosol and to inhibit their function in cytosolic DNA sensing. Such 
inhibition results in decrease of NF-κB activation and KSHV progression into lytic replication cycle 
[275]. Furthermore, ORF64 tegument protein from murine gammaherpesvirus MHV68 was found to 
carry a deubiquitination activity which is necessary to antagonize cGAS/STING pathway and to facilitate 
MHV68 latent infection [506]. 
Another way to avoid immune recognition is to hide their genomes and replication products within a 
capsid. For example, reverse transcription of HIV-1 is covered from cytosol by viral capsid and only 
cDNA is later injected directly into nucleus thus avoiding activation of cGAS and STING. HIV-1 capsid 
regulates recruitment of the host factors cleavage and polyadenylation factor 6 (CPSF6) and the 
components of the nuclear pore complex cyclophilins (Nup358 and CypA) that participate in 
translocation of HIV reverse transcripts into the nucleus [507, 508]. However, depletion or impaired 
interaction of HIV capsid with these factors, or loss of other host factors like TREX1 and SAMHD results 
in detection of HIV by cGAS/STING pathway [430-432, 509, 510]. HIV capsid interacts with another 
host factor - prolyl-isomerase cyclophilin A (CypA) – that counteracts the masking of HIV cDNA and 
induces IFN response in dendritic cells. Mutations in capsid proteins causing an enhanced binding of 
CypA lead to a potent immune response to HIV-1 in human dendritic cells thus driving HIV-1 capsid  
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Figure 16 Inhibition of cGAS/STING pathway by pathogens. 
Components of the pathway are connected with black dashed lines. Bacterial and viral proteins are indicated by 
abbreviations with an organism name given in brackets. Inhibition is depicted with red lines with blunt ends, 
activation with black arrows. Polyubiquitination is marked with purple circle (text inside indicates a type of linkage 
between ubiquitin monomers). “P” stands for phosphorylation.    
 
evolution to escape interaction with CypA [511, 512]. 
Surprisingly, some viruses and bacteria profit from type I IFN production. In cancer-derived HEp-2 or 
HeLa cells STING activation was shown to be necessary for HSV-1 replication. HSV-1 proteins ICP0, 
ICP4 and protein kinase US3 stabilized STING in these cell lines and their deletion resulted in STING 
degradation and inhibited HSV-1 replication. Conversely, in human embryonic lung cells and HEK293T 
derived from normal tissues STING activation repressed HSV-1 replication, suggesting that HSV-1 
interaction with the host are dependent on the cell type [513]. Unexpectedly, mice deficient in IRF3 were 
discovered to be resistant to M. tuberculosis infection. Activation of cGAS/STING in macrophages by 
cytosolic DNA emerging from M. tuberculosis was found to promote long-term infection and explains 
type I IFN signature in tuberculosis [221]. Similarly, L. monocytogenes requires STING and IFN-β 
expression in response to its cytosolic DNA and c-di-AMP for downregulation of cell-mediated immunity 
and STING knockout mice exhibited enhanced immunity against infection [514]. Type I IFN is beneficial 
for systemic infection with L. monocytogenes since the IFN receptor is required for cell-to-cell spread of 
bacteria in macrophages and in mouse liver [515].       
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5.6. cGAS/STING pathway in self-DNA recognition and disease 
In addition to pathogen DNA and CDN recognition, cGAS/STING pathway also participates in type I 
IFN induction in response to self-DNA (Figure 17). Though cellular DNA is strictly compartmentalized 
and under normal circumstances is not present in cytosol, under certain conditions it can leak into the 
cytoplasmic compartment leading to cGAS/STING activation. Recent studies revealed that DNA 
emerging from mitochondrial nucleoids (mtDNA) is a potent activator of IFN response (Figure 17) [225]. 
Mitochondrial stress resulting from depletion of mtDNA-binding protein TFAM (transcription factor A, 
mitochondrial) or infection with herpesviruses HSV-1, HSV-2 or MHV-68 leads to hyperfused 
mitochondrial phenotype and, apparently, mitochondrial membrane rupture. As a result of such 
mitochondrial stress mtDNA leaks into the cytosol where it engages cGAS causing enhanced type I IFN 
response (Figure 17). Reduction of mtDNA copy number by dideoxycytidine (ddC) attenuated ISG 
expression [225]. Furthermore, inhibition of apoptosis was found to lead to mtDNA leakage into cytosol 
through Bax/Bak protein pores in mitochondrial membrane and to induce type I IFN production by 
activating cGAS/STING axis [226, 227]. Deficiency or pharmacological inhibition of apoptotic caspase-
9, apoptotic protease- activating factor 1 (Apaf-1) or caspases-3/7 alone or together with activation of 
intrinsic apoptotic pathway by targeting Bax/Bak inhibitors Bcl-2 and Bcl-xL in murine hematopoietic 
stem cells and mouse embryonic fibroblasts results in elevated IFN response (Figure 17). However, 
whereas importance of caspase catalytic activity for inhibiting cGAS signaling in apoptosis is clarified, 
the questions why activated caspase 9 in caspase-3/7 knockout cells is not sufficient for IFN inhibition 
and what is the exact mechanism of immunological silencing of apoptosis remain open. Additionally, 
mitochondrial damage and consequent mtDNA leakage was previously reported to induce NLRP3 
activation and IL-1β release that according to the recent research can be linked to cGAS/STING 
activation [29, 516, 517]. Elevated mtDNA levels in serum are a hallmark of diabetes and mtDNA was 
shown to induce NLRP3 activation and increased expression of IL-1β in diabetic mice [518, 519]. 
Mitochondrial polymorphisms and dysfunction were also linked to the autoimmune disease systemic 
lupus erythematosus (SLE) that has a characteristic IFN signature. However, whether cGAS/STING 
recognition of mtDNA is responsible for elevated type I IFN levels in SLE remains unclear [520-523]. 
Involvement of mtDNA in SLE pathogenesis is further supported by the presence of anti-mtDNA 
antibodies in blood of SLE patients [524]. Moreover, neutrophils from SLE patients were found to 
accumulate oxidized mtDNA that upon extrusion activates type I IFN expression by plasmacytoid 
dendritic cells [525]. 
Another source of self-DNA emerges from nucleus (Figure 17). Chromatin DNA was recently found to 
form cytosolic micronuclei and activate the cGAS/STING pathway [228, 229]. Mitotic progression 
despite the presence of double-stranded DNA breaks caused by ionizing radiation was shown to result in 
chromosomal missegregation and formation of micronuclei – chromatin fragments surrounded by their 
own nuclear membrane. Micronuclei membrane having defective lamina organization undergoes rupture 
resulting in accessibility of DNA fragments for cytosol. cGAS was shown to co-localize with such 
structures and to trigger type I IFN production. Excessive micronuclei formation was also observed in 
cells deficient of RNase H2 responsible for ribonucleotide excision repair and genome stability [228, 526, 
527]. Importantly, cGAS/STING-dependent elevated levels of IFN-stimulated genes and proinflammatory 
response were characteristic to mouse embryonic fibroblasts (MEFs) deficient in functional RNase H2 
[528, 529]. Moreover, malfunction of RNase H2 is associated with the autoinflammatory disorders 
Aicardi-Goutières syndrome (AGS) and SLE bridging micronuclei formation to cGAS activation and 
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autoinflammation [529-532]. Activation of cGAS/STING by micronuclei formation plays an important 
role in cancer therapy. Indeed, depletion of STING in irradiated melanoma cells results in larger tumor 
volumes and smaller survival rates in mice [229].  
Incomplete DNA damage repair caused by environmental stresses constantly results in generation of 
ssDNAs emerging from aberrant replication intermediates or endogenous retroelements that leak to the 
cytosol (Figure 17) [261, 533]. Normally these DNA fragments are cleaved by exonuclease TREX1 
anchored to the nuclear membrane and TREX1 deficiency results in DNA accumulation in cytosol and 
cGAS/STING activation followed by type I IFN production [426, 534, 535]. Chronic cytokine and IFN 
production is characteristic for autoinflammatory diseases and mutations in exonuclease TREX1 are 
associated with AGS, SLE, familial chilblain lupus and retinal vasculopathy with cerebral leukodystrophy 
[536-540]. Remarkably, oxidative stress and UV irradiation result in enhanced levels of oxidized self-
DNA that is resistant to TREX1-mediated degradation and therefore a very potent activator of 
cGAS/STING. DNA oxidation was found to be responsible for sun-induced skin lesion in SLE patients 
[224]. Another nuclease - DNase I – that is secreted into extracellular space to eliminate DNA fragments 
emerging from apoptotic and necrotic cells has also an important role in controlling autoimmunity [541, 
542]. DNase I activity was decreased in SLE patients and DNase I deficiency in mice led to higher levels 
of antibodies against DNA [263, 543]. SLE patients were found to have mutations in DNaseI, and a 
polymorphism of this gene was associated with SLE susceptibility, though it does not seem to influence 
DNase I activity [544-546]. Unlike DNase I, DNase II is an endonuclease degrading lysosomal DNA 
fragments in macrophages. DNase II deficiency results in type I IFN overexpression caused by 
cGAS/STING pathway activation and development of polyartritis and anemia in mice [264, 547-549]. 
Genetic studies identified mutations in sterile α motif and histidine-aspartic acid (HD) domain–containing 
protein 1 (SAMHD1), adenosine deaminase acting on RNA 1 (ADAR1) and dsRNA sensor MDA5 to be 
associated with AGS [532]. SAMHD1 was first described as an antiviral GTP-dependent deoxynucleotide 
triphosphohydrolase that reduces dNTP levels below the concentration sufficient for HIV-1 replication 
[550, 551]. SAMHD1 was reported to maintain genome stability and its depletion results in impaired 
proliferation, DNA damage and increased IFN levels [552]. Moreover, bone marrow-derived 
macrophages (BMDMs) lacking SAMHD1 showed spontaneous IFN response that was dependent on 
cGAS/STING activation providing one more link between cGAS/STING axis and AGS [553]. Other 
nucleic acid sensing pathways can also be involved in autoimmunity and AGS. ADAR1 catalyzing 
deamination of adenosine in dsRNA destabilizes RNA secondary structures and prevents recognition of 
endogenous dsRNA derived from 5’-untranslated regions, introns and rRNA by MDA5 [554-556]. Thus, 
mutations in both ADAR1 and MDA5 can be linked to increased type I IFN response through 
MDA5/MAVS pathway and autoimmunity [557]. 
Gain of function mutations in human STING were found to correlate with inflammatory diseases and 
hyperproduction of cytokines and IFNs. V147L, N154S, V155M, G166E, and R284M point mutations in 
STING located close to membrane-embedded part of the protein were described to result in its 
autoactivated state presumably due to uncontrolled dimerization of STING, its traffic from ER and 
enhanced ability to bind TBK1 [489, 558-561]. 
Interferons play a crucial role in cancer surveillance [562]. They exhibit cytotoxic effects on cancer cells 
directly and promote maturation of dendritic cells (DCs) linking innate and adaptive immunity [563, 564]. 
Spontaneous T-cell priming against tumors is dependent on STING and its deficiency results in 
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Figure 17 Main sources of DNA recognized by cGAS/STING pathway. 
Components of one pathway are connected with black dashed lines. Inhibition is shown as black lines with blunt 
ends. Induction of mitochondrial (mt) and nuclear stresses (orange stars) is shown with red arrows. Depletion or 
dysfunction of the proteins is depicted as red dashed line. DNA digestion is shown with scissors. 
 
higher tumor growth in mice and a decreased response to CD47-blocking antibody, counteracting CD47-
mediated inhibition of phagocytosis [565-567]. Dying tumor cells are phagocytized by DCs where their 
DNA is detected by cGAS leading to type I IFN production [568]. Type I IFNs, in turn, facilitate cross-
presentation and recruit effector T-cells to tumor microenvironment [566, 569]. Cleavage of genomic 
DNA in prostate cancer cells was found to lead to accumulation of cytosolic DNA and cGAS/STING 
activation promoting phagocytosis of tumor cells and T cell responses [570]. cGAS/STING activation 
plays important role in radio- and chemotherapy as well. DNA-damage induced by irradiation or 
chemotherapeutics like cisplatin and etoposide results in DNA leakage into cytosol and cGAS/STING-
mediated IFN production [228, 229, 566, 571]. Treatment with chitosan - cationic polysaccharide - was 
shown to cause increased ROS production and mtDNA leakage into cytosol in dendritic cells and trigger 
type I IFN production via cGAS/STING pathway resulting in antigen-specific T helper 1 (Th1) activation 
[572]. Importance of cGAS/STING pathway in anti-tumor immunity is further illustrated by cGAMP 
functions as immune adjuvant. Efficiency of immune checkpoint therapy targeting PD-1/PD-L1 
interaction that prevents tumor cells from T-cell mediated lysis was strongly improved by simultaneous 
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activation of STING pathway by cGAMP or its analogs [573-575]. Intratumoral injection of cGAMP or 
its analogs was shown to enhance antitumor immunity and to inhibit tumor growth in mouse models of 
colon, brain, skin, pancreatic, breast and B cell cancers revealing a new field of anti-cancer therapeutics 
[566, 575-580]. Interestingly, STING is not activated in animals with acute myeloid leukemia resulting in 
the absence of type I IFN response and poor survival rate, however, administration of STING agonist 
DMXAA induced expression of IFN-β and other inflammatory cytokines and resulted in leukemia-
specific T cell activation and higher survival rates [566, 581].    
Given its major role in DCs activation and T cells priming, cGAS/STING pathway is often suppressed in 
cancer cells. Colon adenocarcinoma and melanoma cells have impaired cGAS/STING signaling by 
hypermethylation of cGAS and STING promoter regions, decreased cGAS and STING protein expression 
and impaired STING trafficking to avoid immune surveillance [582, 583]. Furthermore, oncogenes from 
DNA tumor viruses like E1A from human papilloma virus are potent inhibitors blocking STING 
activation [491]. Several tumors were shown to accumulate extrachromosomal telomere repeats (ECTRs) 
that are used as a template for telomere length extension and can activate cGAS/STING pathway when 
introduced into human fibroblasts [584-587]. Such tumors, including osteosarcoma, neuroblastoma and 
adenocarcinoma, do not express STING presumably due to its epigenetic silencing in order to avoid 
immune surveillance [587].         
Surprisingly, in some cases cGAS/STING activation can contribute to carcinogenesis and tumor 
propagation. For example, treatment with the polyaromatic hydrocarbon 7,12-dimethylbenz[α]anthracene 
(DMBA) inducing leakage of nuclear DNA into cytosol promotes proinflammatory cytokines and skin 
carcinogenesis in STING-dependent manner [571, 588]. Chronic infection with Helicobacter pylori 
results in STING upregulation and IFN-β expression and correlates with gastric cancer development, 
since STING was found to be crucial in controlling viability, migration and invasion of gastric cancer 
cells [589]. STING-dependent type I IFN production in response to genotoxic agents was also associated 
with survival and growth of breast cancer resulting in its resistance to chemotherapy [590]. STING-
mediated DNA sensing leading to IFN-α/β production was found to activate indoleamine-2,3-dioxygenase 
(IDO) that limits T cell function and suppress Th1 responses [591, 592]. This mechanism was found to 
promote the growth of Lewis lung carcinoma, but not B16 melanoma suggesting that DNA sensing 
through cGAS/STING can promote growth of tumors with low antigenicity [593]. Moreover, a transfer of 
cGAMP via gap junctions between tumor cells and astrocytes was found to stimulate growth and 
chemoresistance of brain metastatic cells [415]. Taken together, these findings indicate that though 
STING activators may become a potent anti-tumor therapeutics, discriminating between STING-mediated 
anti-tumor effects and tumor-promoting inflammation is necessary for a good clinical outcome.      
 
 
 
-48- 
 
6. Objectives 
cGAS/STING pathway is a major mechanism for cytosolic DNA detection and is well characterized. A 
huge range of biochemical and structural studies on cGAS revealed its functions and detailed molecular 
mechanisms of DNA recognition and 2’3’-cGAMP synthesis. A strong conservation of the Mab-21 
domain of cGAS on sequence and structural levels throughout evolution and structural similarity to 
bacterial CDN-synthases is remarkable. Despite of this, the Zn-thumb element and the DNA-sensing 
function of cGAS homologs seems to be a rather novel feature that developed in vertebrates.  
The majority of data obtained about cGAS are based on the studies of its conserved Mab-21 domain-
containing part comprising main DNA binding and catalytic functions. Though the mode of DNA binding 
and a mechanism of 2’3’-cGAMP synthesis are well understood, several questions about cGAS Mab-21 
domain remain open. As such, according to the published structures it can accommodate 14-20 bp long 
dsDNA that introduces a “spine” helix break and active site rearrangement. According to this, the 20 bp 
DNA ligand should be in principle sufficient for cGAS activation since it spans the entire length of the 
catalytic domain, however, it fails to fully activate cGAS in vivo and can stimulate cGAS in vitro only in 
artificially high concentrations of all reaction components. A second question arises from the finding that 
cGAS has two DNA-binding sites and requires dimerization for its activity. In this case two DNA 
molecules held by two cGAS protomers are pointing to each other in such manner that prolonging these 
DNA fragments will result in steric clashes between DNA stands leading to an assumption that cGAS 
might preferentially bind DNA ends. This hypothesis is, however, contradicted by the fact that long DNA 
shows much higher potential for cGAS activation than the shorter fragments with higher number of DNA 
ends. The instability of such cGAS2:DNA2 complex with 20 bp DNA is another point that needs further 
clarification. Since such dimer was not found for OAS proteins and seems to be a unique feature of 
cGAS, it is puzzling why such peculiar and important for cGAS activity dimerization step is so sensitive 
and whether such instability was specifically selected during evolution. 
Since recent studies discovered an involvement of cGAS in the recognition of self-DNA emerging from 
mitochondria and nucleus, as well as in HIV-1 detection, the search for specific cGAS ligands and their 
structures seems to be a very important direction of research. Moreover, since several cross-talks between 
cGAS activation and other cellular pathways and proteins such as Mre11 and IFI16 were proposed, a 
finding of cGAS co-factors is of an utmost importance and might shed light on the mechanism of cGAS 
activation in vivo. 
The aim of this thesis was to investigate cGAS activation mechanism by long stimulating dsDNA ligands. 
For this purpose structural and biochemical in vitro studies, as well as cGAS stimulation in human cell 
lines were performed using DNA ligands of different lengths. In order to evaluate cGAS activity in a 
high-throughput manner a novel fluorescence-based cGAS activity assay was developed. A relevance of 
the obtained cGAS crystal structure with 39 bp stimulator DNA was validated using isothermal titration 
calorimetry (ITC) and right-angle light scattering. Moreover, cGAS mutagenesis studies in vitro and in 
cell lines were performed. Based on the crystal structure of cGAS active complex and the studies of 
cGAS enzymatic activity additional cGAS co-factors were proposed to facilitate cGAS function in vivo. 
To validate this hypothesis mutational analysis of these co-factors together with co-immunoprecipitation 
assays in human cell lines were performed. Further studies included three-dimensional structured 
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illumination and wide-field fluorescent microscopy to confirm co-localization of cGAS with its co-factors 
and DNA in cell lines.  
Additionally, biologically relevant cGAS nucleic acid ligands were studied. As such, reverse-transcribed 
ssDNA resulting from HIV-1 infection was analyzed. For this purpose stimulating effect of modified 
HIV-1 hairpins and synthetic DNA constructs on cGAS was investigated by cell line experiments and 
further validated with in vitro cGAS activity assays and co-immunoprecipitation studies. Moreover, 
another potential cGAS ligand - RNA:DNA hybrids – was evaluated by  stimulation of wild type and 
knock-out human cell lines. Cells were transfected with different synthetic constructs and cGAS activity 
was measured with luciferase reporter assays, IFN-β mRNA expression levels or ELISA. The results were 
confirmed in primary peripheral blood mononuclear cells and with in vitro cGAS activity assays.    
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Summary 
This publication provides the first crystal structure of cGAS in complex with immunostimulatory 39 bp 
DNA, as well as a mechanism for a cooperative DNA recognition by cGAS. cGAS is a central sensor of 
cytosolic DNA, which upon DNA binding produces a second messenger 2’3’-cGAMP. cGAMP triggers 
type I IFN response through activation of adaptor protein STING. Previously known structures explained 
a molecular mechanism of cGAS dimerization, activation and 2’3’-cGAMP synthesis, however, they 
contain only short 12-20 bp DNA fragments that fail to activate cGAS in vivo and stimulate 2’3’-cGAMP 
production in vitro only under non-physiologically high DNA and protein concentrations. In this study we 
offer a link between a well-established cGAS-dimerization and a necessity of long dsDNA strands for a 
full cGAS activation. According to our hypothesis, cGAS forms a DNA-protein ladder consisting of a 
row of cGAS dimers as “rungs” arranged on two long DNA “ladder sides”. Observed not only in crystal 
packing, but also in solution studies, such ladders introduce a cooperative DNA-binding of cGAS and 
explain its DNA length-dependent activation in in vitro and cell-based assays. We propose that the 
binding of the first cGAS dimer is rather unstable, however, if formed, it parallelizes two long DNA 
strands resulting in efficient binding of a subsequent cGAS dimer. cGAS dimers within such ladder are 
mutually stabilized, which explains a higher affinity and stronger cGAS activation by long DNA 
fragments. Moreover, previously published structures of DNA U-turns introduced by high-mobility group 
box (HMGB) proteins, such as mitochondrial transcription factor A (TFAM), HMGB-1 and bacterial 
nucleoid packaging HU proteins, share a remarkable similarity in DNA arrangement with discovered in 
this work cGAS-DNA ladders. Indeed, these DNA-bending proteins were shown to dramatically increase 
cGAS activity in vitro and competed with cGAS activation at high concentrations. Normally present in 
mitochondria and nucleus, TFAM and HMGB1 were found to relocalize to a cytosolic compartment 
under mitochondrial stress conditions or DNA transfection, respectively, giving a possibility for their 
engagement with cGAS in vivo. Furthermore, HMGB1 was shown to co-localize in cytosol with DNA 
and cGAS further supporting the hypothesis of its involvement in cGAS activation. Combined with 
cGAS-DNA protein ladder model these findings introduce a nucleation-oligomerization mechanism for 
cGAS activation similar to proposed for other innate immune sensors. Though nucleation of cGAS 
filament by the first cGAS dimer is rather inefficient, other co-factors like DNA-bending proteins might 
successfully prearrange DNA in nearly parallel manner and thus efficiently nucleate cGAS-DNA ladder 
-51- 
 
formation. This hypothesis explains instability of a single cGAS dimer that might have emerged to 
counteract an aberrant cGAS activation by short non-pathogenic DNA fragments and offers U-shaped 
structured DNA as a preferable cGAS ligand. In biological sense it provides a mechanism for specific 
recognition of partly dissociated mitochondrial and bacterial nucleoids, as well as nuclear DNA fragments 
and introduces HMGB proteins as a class of potent cellular cGAS co-factors.   
Author contribution 
The author of this thesis performed crystallographic and biochemical studies. She crystallized and 
collected diffraction data of cGAS in complex with 39 bp DNA. Together with Prof. Dr. K.-P. Hopfner 
she invented a novel fluorescence-based assay for cGAS activity measurement. The author of this thesis 
performed various in vitro cGAS activity assays for studying cGAS stimulation by DNA fragments of 
different lengths and cGAS co-factors. With help from C. Isakaj and O. Fettscher she cloned and purified 
cGAS point mutants and tested their activity in vitro. Assisted by D.J. Drexler she performed isothermal 
titration calorimetry (ITC) and determined stoichiometry of cGAS:DNA complexes and thermodynamic 
parameters of cGAS binding to various DNA constructs.  She also optimized size exclusion 
chromatography coupled to right-angle light scattering (SEC-RALS) and successfully used it for 
composition analysis of several cGAS:DNA complexes. She supervised an advanced research practical 
course in Biochemistry, where T. Schaller and her designed, cloned and purified HMGB1 point mutants 
and studied their DNA binding efficiency with electromobility shift assays (EMSA) and their cGAS-
activating capacity in different in vitro cGAS activity assays. Together with Prof. Dr. H. Leonhardt and 
Dr. C. Lässig she designed and interpreted localization studies of HMGB1 and cGAS with fluorescence 
microscopy. With contributions from all other co-authors she assisted Prof. Dr. K.-P. Hopfner in 
manuscript writing. 
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cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming 
protein–DNA ladders 
Liudmila Andreeva1,2, Björn Hiller1,2, Dirk Kostrewa1,2, Charlotte Lässig1,2, Carina C. de Oliveira Mann1,2†, David 
Jan Drexler1,2, Andreas Maiser3, Moritz Gaidt1,2, Heinrich Leonhardt3,4, Veit Hornung1,2,4 & Karl-Peter Hopfner1,2,4 
1Department Biochemistry, Ludwig-Maximilians-Universität München, 81377 Munich, Germany 
2Gene Center, Ludwig-Maximilians-Universität München, 81377 Munich, Germany. 
3Department Biology, Ludwig-Maximilians-Universität München, 82152 Planegg-Martinsried, Germany. 
4Center for Integrated Protein Science Munich, 81377 Munich, Germany. 
†Present address: Dana-Farber Cancer Institute, Harvard Medical School, MA 02115-5418 Boston, Massachusetts, 
USA. 
Cytosolic DNA arising from intracellular pathogens triggers a powerful innate immune 
response1,2. It is sensed by cyclic GMP–AMP synthase (cGAS) which elicits the production 
of type I interferons (IFN) by generating the second messenger 2′3-cyclic-GMP–AMP 
(cGAMP)3-5. Endogenous nuclear or mitochondrial DNA can also be sensed by cGAS under 
certain conditions, resulting in sterile inflammation. The cGAS dimer binds two DNA 
ligands shorter than 20 base pairs side-by-side6-9, but 20-base-pair DNA fails to activate 
cGAS in vivo and is a poor activator in vitro. Here we show that cGAS is activated in a 
strongly DNA length-dependent manner both in vitro and in human cells. We also show 
that cGAS dimers form ladder-like networks with DNA, leading to cooperative sensing of 
DNA length: assembly of the pioneering cGAS dimer between two DNA molecules is 
ineffective; but, once formed, it prearranges the flanking DNA to promote binding of 
subsequent cGAS dimers. Remarkably, bacterial and mitochondrial nucleoid proteins HU 
and mitochondrial transcription factor A (TFAM), as well as high-mobility group box 1 
protein (HMGB1), can strongly stimulate long DNA sensing by cGAS. U-turns and bends 
in DNA induced by these proteins pre-structure DNA to nucleate cGAS dimers. Our results 
suggest a nucleation-cooperativity-based mechanism for sensitive detection of 
mitochondrial DNA10 and pathogen genomes11, and identify HMGB/TFAM proteins as 
DNA-structuring host factors. They provide an explanation for the peculiar cGAS dimer 
structure and suggest that cGAS preferentially binds incomplete nucleoid-like structures or 
bent DNA. 
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cGAS detects a broad range of intracellular viral and bacterial pathogens11-16 but also 
senses mitochondrial (mt)DNA in the cytosol upon mitochondrial stress10. cGAS dimers bind 
two DNA ligands side-by-side, whereby each cGAS monomer directly recognizes fewer than 
20 base pairs (bp). In principle, 20 bp DNA should be sufficient to fully activate cGAS; 
however, it does not activate cGAS in human cells17. Longer DNA ligands were even proposed 
to lead to steric clashes unless cGAS binds near DNA ends8. Thus, the current model fails to 
explain the detection of immunostimulatory DNA. Keeping the overall amount of DNA constant, 
we stimulated a human monocyte cell line (BLaER1 cells) with DNA of different lengths and 
observed a striking concentration- and length-dependent activation of cGAS by measuring C-X-
C motif chemokine 10 (CXCL10) production as an appropriate surrogate parameter of cGAS 
activity18, as well as interferon- (IFN-) mRNA expression levels (Fig. 1a and Extended Data 
Fig. 1a-c). Long herring testis DNA robustly activated cGAS at all tested DNA amounts, while 
shorter cGAS ligands required increasing amounts of DNA. Consistent with previous studies, 
DNA of ~45 bp constituted a ‘length’ threshold, below which no activation was observed. 
Since other cellular factors could contribute to the length-sensitive detection, we analysed 
the intrinsic capability of mouse (m)cGAS and human (h)cGAS to sense DNA length in vitro, 
using a new fluorescent-based assay (Extended Data Fig. 2 and Methods). Both hcGAS and 
hcGAScd (catalytic domain) showed a remarkable DNA length-dependent activation, which 
appears to be independent of the cGAS N-terminal part (Fig. 1b). Like the ~45 bp threshold in 
vivo, robust activation at physiologically relevant cGAS concentrations in vitro required DNA 
>40 bp. Plasmid DNA was the most potent activator. Mouse mcGAScd exhibited a comparable 
length-dependent activation, with a gradual increase in activity until about 75 bp (Fig. 1c and 
Extended Data Fig. 1d). At higher DNA concentrations and short DNA lengths, mcGAS was 
activated in an almost stepwise fashion, with a first plateau between 30 and 45 bp and a second 
above 50 bp (Fig. 1c inset), perhaps reflecting stepwise binding along DNA. DNA <20 bp can 
also activate cGAS but requires 10–20 times higher cGAS and 50–250 times higher DNA 
amounts to induce activities similar to 50 bp DNA (Extended Data Fig. 1e, f). Finally, circular 
and linearized plasmid DNA activated cGAS equally well, ruling out the possibility that cGAS 
needs DNA ends (Extended Data Fig. 1g). 
To determine a mechanism for the DNA length sensing, we crystallized mcGAScd in 
complex with 39 bp DNA. The crystals diffracted anisotropically to 3.6–4.8 Å resolution and we 
determined the structure by molecular replacement. In the crystal, two cGAS dimers and two 
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DNA 39-mers form a cGAS4–DNA2 complex (Fig. 1d and Extended Data Fig. 3a). Each of the 
two cGAS dimers in our cGAS4–DNA2 complex is similar to the dimers seen in cGAS2–DNA2 
complexes determined with <20 bp DNA (Extended Data Fig. 3b, c), indicating that long DNA 
does not induce a substantially different structural state in cGAS than short DNA. The two cGAS 
dimers are arranged in a ‘head-to-head’ orientation along the DNA. DNA between the cGAS 
dimers is slightly curved (Fig. 1d), avoiding the proposed clashes and showing that cGAS does 
not need DNA ends (Extended Data Fig. 3c, d). 
The asymmetric unit contains one full cGAS4–DNA2 complex along with one half 
cGAS4–DNA2 complex situated on a twofold crystallographic symmetry axis (Extended Data 
Fig. 4a). Remarkably, these cGAS4–DNA2 complexes are further stacked into fibrils with 
alternating ‘head-to-head’- and ‘tail-to-tail’-oriented cGAS dimers (Fig. 1e), forming a DNA–
protein ladder with rungs (cGAS dimers) and two ladder sides (DNA). The DNA is continuous 
between ‘head-to-head’-oriented cGAS dimers and quasi-continuous (stacked 3 to 3 and 5 to 
5) between the ‘tail-to-tail’-oriented cGAS dimers. A ~5 bp (half helical turn) increased spacing 
of ‘tail-to-tail’-oriented cGAS dimers, however, would allow an energetically favourable 
continuous assembly of alternatingly oriented cGAS dimers between two long DNA elements 
(Extended Data Fig. 3e, f). 
Neighbouring cGAS dimers along the DNA barely interact in either ‘head-to-head’ or 
‘tail-to-tail’ orientations in the crystal lattice (Extended Data Fig. 4a). Consistently, mutational 
analysis in vitro and in vivo showed that while protein–DNA contacts are critical, protein–protein 
contacts between adjacent cGAS dimers in either orientation are not (Extended Data Fig. 4b-
d)8,9. Accordingly, the DNA–protein ladder does not require direct interactions between 
neighbouring cGAS dimers to be stable, because cGAS–DNA contacts and cGAS–cGAS dimer 
contacts between the DNA already generate a mesh-like structure. 
To see whether ladder-like structures exist in solution, we used isothermal titration 
calorimetry (ITC) and size-exclusion chromatography coupled to right-angle light scattering 
(SEC–RALS). ITC showed a DNA length-dependent increase in affinity and at the same time an 
increase in cGAS:DNA molar ratio (Fig. 2a and Extended Data Fig. 5). DNA of ~45 bp confered 
a threshold, resulting in higher affinity and at the same time binding of two cGAS molecules per 
DNA ligand. The affinity increase was driven by a decrease in binding enthalpy that also 
compensated a decreasing entropy (Fig. 2b and Extended Data Fig. 6a, b). The latter suggests the 
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formation of ordered structures on DNA >45 bp. Together with ITC, SEC–RALS showed that 
cGAS forms single homogeneous complexes with DNA of different length: a cGAS1–DNA1 
complex for 20-mer DNA, a cGAS4–DNA2 complex for 50-mer DNA, and cGAS6–DNA2 
complexes for 70/80-mer DNA (Fig. 2c-f and Extended Data Fig. 6c). Of note, cGAS2–DNA2 
complexes were instable in the presence of 20 bp DNA and only the cGAS1–DNA1 complex 
robustly formed with 20 bp DNA that poorly activates cGAS (Fig. 1a-c). Given that activation of 
cGAS requires additional dimerization8, this explains why 20 bp DNA is not a good cGAS 
activator. 
The DNA–protein ladders offer an intriguing mechanism for the DNA length-dependent 
activation of cGAS. Formation of a pioneering cGAS2–DNA2 complex is highly unfavourable, 
but once formed, it prearranges the two DNA molecules in its vicinity to promote formation of 
adjacent cGAS dimers with increased affinity (Fig. 3a). Multiple cGAS dimers in cGAS2n–DNA2 
(n  2) ladders stabilize each other by cooperatively holding together the two DNA ladder sides. 
An analytical equation for this ‘DNA–protein ladder’ model can be derived (see Supplementary 
Methods) and comprises a Vmax (maximal reaction velocity); three DNA constants K1, K2
2 and K3 
that describe interaction of monomeric cGAS with DNA (K1), interaction of cGAS dimers with 
two DNA ligands (K2
2), and the association/dissociation of cGAS–DNA and cGAS2–DNA2 
states (K3); and a parameter s that is a measure of cooperative binding sites of cGAS dimers 
along DNA (equivalent to a Hill coefficient). 
To test this model, we measured cGAS activity by varying both mcGAScd concentration 
and DNA length. We observed a dramatic length-dependent activation that was not due to an 
increase in Vmax, consistent with our model but was due to a DNA length-dependent increase in 
binding affinity, as seen with ITC (Fig. 3b). The data can be globally fitted with a simplified 
equation derived from the mathematical model (Supplementary Methods equation 3.6 and 
sections 4.1 and 4.2) and can be explained by a model in which Vmax and the DNA binding 
constants do not depend on the length of DNA, while s increases as a function of DNA length 
(Fig. 3c). Parameter s measures cooperativity between adjacent cGAS dimers owing to the DNA 
arranging activity19. The transitions of s around 40–50 bp and 2s  2.8 for plasmid DNA suggest 
that length sensing can be explained by cooperative binding of two or more adjacent cGAS 
dimers. Furthermore, titrating catalytically inactive mcGAScd(D307N) to low amounts of active 
mcGAScd markedly increased cGAS activity about 200-fold, providing direct evidence for 
cooperative sequestering of cGAS into oligomeric structures on DNA (Fig. 3d). Higher amounts 
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of the inactive mutant gradually competed mcGAScd away from DNA, as expected. These data 
can be fitted well (R2 = 0.96) with the ‘DNA–protein ladder’ equation (Supplementary Methods) 
and result in a cooperativity parameter 2s = 3.6, similar to that described in Fig. 3c. In summary, 
cGAS length sensing emerges from cooperative formation of cGAS2n–DNA2 (n  2) complexes. 
Cellular factors could enhance detection of DNA by cGAS if they suitably structure the 
DNA. We noticed that the HMGB proteins HMGB1/2 and mitochondrial nucleoid organizing 
protein TFAM could be well suited to nucleate cGAS dimers because they properly prearrange 
DNA by forming U-turns20,21 (Extended Data Fig. 7a, b) and because mtDNA activates cGAS10 
and HMGB1/2 facilitate cytosolic nucleic-acid sensing22. Bacterial HU proteins, for example 
from Listeria monocytogenes (lHU), also bend DNA to form bacterial nucleoids. Indeed, adding 
increasing amounts of mTFAM, mHMGB1, and lHU robustly activated mcGAScd in vitro up to 
~25-fold (Fig. 4a-c and Extended Data Fig. 7c). A similar activation was also seen for hTFAM 
and full-length hcGAS (Fig. 4d). cGAS activation required the DNA-bending ability of HMGB1, 
since mutations that decreased DNA-bending capacity without significantly affecting DNA 
binding23 reduced or nearly abolished cGAS activation (Extended Data Fig. 8a-d). TFAM 
activates cGAS both on circular and on linear plasmid DNA (Extended Data Fig. 8e), works 
without direct TFAM–cGAS interactions (Extended Data Fig. 8f), and even does not require 
proteins from the same species (Extended Data Fig. 8g, h). Thus, these proteins presumably 
activate cGAS not by protein–protein interactions but rather by prestructuring DNA to nucleate 
or stabilize cGAS dimers. At higher concentrations, TFAM and lHU sharply abolished cGAS 
activity, presumably because of cooperative formation of nucleoid-like structures24. HMGB1 
inhibited cGAS more gradually, probably because it does not cooperatively form compact 
nucleoids. Strong stimulation of cGAS activity by TFAM required DNA >100 bp (Extended 
Data Fig. 7d), suggesting that robust activation still involves cGAS2n–DNA2 complexes (n  2). 
TFAM normally resides in mitochondria; however, under mitochondrial stress 
conditions, induced by a combination of caspase and Bcl-2 inhibitors25,26, we saw increased 
TFAM presence in the cytosol (Extended Data Fig. 9a-d) where it can assist detection of leaked 
mtDNA. Consistently, cytosolic hcGAS and hTFAM co-immunoprecipitated (Extended Data 
Fig. 9e). Importantly, we found that upon DNA transfection of mouse embryonic fibroblasts 
(MEFs) endogenous HMGB1 co-localized with cytosolic DNA and cGAS in 85% of the 
observed cytosolic DNA loci (Fig. 4e and Extended Data Fig. 10). This is consistent with 
previous findings that HMGB1 is involved in cytosolic DNA sensing22 even though it normally 
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resides in the nucleus. However, HMGB1 shuttles between nucleus and cytoplasm27, enabling it 
to encounter cytosolic DNA where it could assist cGAS. 
In summary, we provide a molecular mechanism for the sensitive detection of long DNA 
by cGAS (Fig. 4f). cGAS1–DNA1 complexes appear to be inactive and cGAS2–DNA2 complexes 
unstable, requiring DNA of sufficient length to form stable cGAS2n–DNA2 ladders (n  2). 
Nucleic-acid-stress HMGB proteins and nucleoid-structuring proteins (TFAM, HU) can 
additionally nucleate and stabilize cGAS-ladders by prearranging DNA. Thus, cGAS 
preferentially senses structured DNA ligands and DNA with residual nucleoid proteins bound, 
rather than naked DNA. In terms of recognizing danger or pathogen-associated molecular 
patterns in the form of mtDNA and bacterial nucleoids, these findings make biological sense and 
provide a plausible rationale for the evolution of the peculiar cGAS dimer structure. 
TFAM/HMGB1/HU-enhanced stimulation of cGAS could be especially helpful for the initial 
detection of long cytosolic DNA with low amounts of cGAS present. In this context, it should be 
noted that short ~20-mer DNA can also strongly activate cGAS if it additionally contains G-rich 
ssDNA Y overhangs17. In principle, this flanking G-rich DNA could also stabilize cGAS dimers, 
but the precise mechanism, as well as that of other postulated host proteins28,29, remains to be 
uncovered. In any case, the nucleation- and cooperativity-based mechanism imposes a threshold-
like response that conceptually unifies DNA sensing by the cGAS–STING axis with other 
oligomerization-based nucleic-acid-sensing pathways30. 
Received 14 February; accepted 31 July 2017. 
Published online 13 September 2017. Nature 549, 394–398 (21 September 2017). 
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FIGURES 
 
Figure 1 cGAS shows DNA length-dependent activity and forms DNA–protein ladders. a, 
cGAS activation in trans-differentiated BLaER1 cells. Cells were stimulated with 20, 40, and 
60 ng DNA of different length (20–100 bp in 5 bp intervals) and herring testis DNA. First two 
bars each represent unstimulated cells and lipofectamine controls. Shown are mean values ± s.d., 
n = 3. b, In vitro activity of hcGAS, hcGAScd, and (c) mcGAScd in the presence of DNA of 
increasing length (20–100 bp in 5 bp intervals) or plasmid DNA (last bar). Mean values of initial 
cGAS reaction rates (∆F/∆t, relative fluorescence units (RFU) min-1), measured by the rate of 
fluorescent ATP analogue (fATP) incorporation into fluorescent cGAS product (fGAMP, see 
Extended Data Fig. 2) are plotted against DNA length ± s.d., n = 3–5. d, Crystal structure of 
cGAS in complex with 39 bp DNA. Two cGAS dimers (green and orange) assemble on DNA in 
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‘head-to-head’ orientation. Zinc-thumb dimerization elements and the nucleotidyl-transferase 
(NT) sites are indicated. e, Ladder-like cGAS assembly along a quasi-continuous DNA in the 
crystal lattice through alternating ‘head-to-head’ or ‘tail-to-tail’ orientations of cGAS dimers. 
 
 
Figure 2 cGAS and DNA assemble into cGAS2n–DNA2 complexes in solution. a, ITC of 
mcGAScd and DNA. Enthalpy (∆H) values are plotted against the molar ratio of DNA:mcGAScd. 
Obtained dissociation constant (Kd) values for 20, 40, 50, and 80 bp DNA are 
2.4 × 106 ± 1.89 × 106, 507 × 109 ± 128 × 109, 165 × 109 ± 166 × 109, and 
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73.3 × 109 ± 25.5 × 109 M, respectively. Molar ratios are 1.28 ± 0.125, 0.364 ± 0.01, 
0.371 ± 0.027, and 0.274 ± 0.006, respectively. b, Thermodynamic parameters obtained with 
ITC. c–f, SEC–RALS analysis of mcGAScd with 20 bp (c), 50 bp (d), 70 bp (e), and 80 bp (f) 
DNA; mAU, milli absorption units. Estimated molecular masses are indicated. Molecular masses 
12.2, 30.8, 43.1, and 49.3 kDa were used as reference for 20, 50, 70, and 80 bp DNA, 
respectively; mcGAScd was estimated with 43 kDa (see also Extended Data Fig. 6c). Some 
molecular mass deviation from reference values occurred because of limitations of measurement 
accuracy. 
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Figure 3 DNA–protein ladder model. a, Kinetic scheme for the DNA–protein ladder model. 
cGAS binds as monomer to DNA (dissociation constant K1). These cGAS1–DNA1 complexes 
can assemble into cGAS2–DNA2 structures with parallelized DNA (K3). Finally, two cGAS 
molecules can directly bind as dimer to the parallelized DNA ligands (K2
2). Overall, this scheme 
describes a cooperative, DNA length-dependent interaction of cGAS with DNA (see 
Supplementary Methods). b, Activity of mcGAScd on different DNA ligands as a function of 
protein concentration (symbols: circle, plasmid; downward arrowhead, 100 bp; diamond, 60 bp; 
square, 50 bp; rightward arrowhead, 40 bp; leftward arrowhead, 35 bp; upward arrowhead, 
30 bp; star, 20 bp). The overall concentration of base pairs in each reaction is kept constant. 
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Mean values of cGAS activity (see Fig. 1c legend) are plotted against mcGAScd 
concentrations ± s.d., n = 3. Superposed is a global least square minimization of the data with an 
equation describing the DNA–protein ladder model (R2 = 0.988) (see Supplementary Methods). 
c, Plot of the cooperativity parameter s obtained from b as a function of DNA length. d, Titration 
of catalytically inactive mcGAScd (D307N) into a sub-active solution of mcGAScd. Mean values 
of cGAS activity (see Fig. 1c legend) are plotted against mcGAScd (D307N) 
concentrations ± s.d., n = 3. Superposed is a least square minimization of the data with the 
DNA–protein ladder model (R2 = 0.96) (see Supplementary Methods). 
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Figure 4 DNA-bending proteins enhance cGAS activity by prearranging DNA into U-
shaped structures. a–d, cGAS activities (see Fig. 1c legend) in the presence of different DNA-
bending proteins. The last value corresponds to a control without DNA. Mean values of initial 
cGAS reaction rates (∆F/∆t) are plotted against increasing concentrations of DNA-bending 
proteins ± s.d., n = 3–6. a, mTFAM, (b) mHMGB1, and (c) lHU robustly enhance mcGAScd 
activity in a dose-dependent manner until they eventually compete cGAS away. d, hTFAM 
activates hcGAS. e, HMGB1 (red), cGAS (green), and cytosolic DNA (blue) co-localization. 
Wild-type (WT) or HMGB1-knockout (KO) MEFs were transfected with an enhanced green 
fluorescent protein (eGFP)–cGAS-expressing vector and stained for wide-field fluorescence 
microscopy (pDV) (compare with Extended Data Fig. 10). DNA was stained with 4,6-diamidino-
2-phenylindole (DAPI, blue). Fluorescent signal within enlarged images is enhanced until 
saturation of the nuclear signal to better visualize cytoplasmic structures. f, Model for DNA 
length- and structure-dependent cGAS activation. Activation of cGAS requires the formation of 
cGAS2–DNA2 dimers, which are very unstable. Multiple cGAS dimers along DNA  45 bp 
stabilize each other by cooperatively holding DNA together, leading to stable, active ladders 
(shaded panels). DNA-bending/U-turn-inducing proteins prearrange DNA, nucleating the 
formation of cGAS dimers and ladders (darker shaded panel). 
METHODS 
Constructs and cloning 
The plasmids encoding full-length (amino acids (aa) 1–522) and truncated (catalytic domain, 
‘cd’) Homo sapiens (h) (aa 155–522) and Mus musculus (m) (aa 141–507) cGAS for N-terminal 
His6–MBP (maltose-binding protein) fusion protein expression were described before
7. 
The sequence encoding mTFAM without a mitochondrial localization signal (aa 43–243) 
optimized for Escherichia coli expression was synthesized by Eurofins Genomics and cloned for 
N-terminal His6 fusion protein expression into modified pET28a vector (Novagen), where the 
thrombin cleavage site was exchanged with a tobacco etch virus (TEV) protease cleavage site. 
hTFAM (aa 43–246) sequence was obtained from total cDNA and inserted into pET28a 
for His6 fusion protein expression in E. coli. Full-length mHMGB1 (aa 1–215), as well as L. 
monocytogenes HU (lHU) (aa 1–121) sequences were purchased from Eurofins Genomics and 
cloned into pET28a for His6 fusion protein expression. Truncated mHMGB1 (aa 1–185) 
(mHMGB1dCTT) was cloned analogously. cGAS and mHMGB1dCTT point mutants were 
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generated by QuikChange site-directed mutagenesis with Pfu-Ultra polymerase (Agilent) 
followed by DpnI (Fermentas) digestion. For expression in human cells, Flag/haemagglutinin 
(HA)-tagged hcGAS (aa 1–522) and HA-tagged hTFAM (aa 43–246) were cloned into 
pcDNA5/FRT/TO (Invitrogen, Thermo Fisher Scientific). For localization studies hcGAS was 
cloned into pEGFP-C1vector (Clontech) for N-terminal eGFP-tagged cGAS expression.. All 
protein constructs abbreviations and descriptions are listed in Supplementary Table 1. 
Cell lines and reagents 
All DNA oligonucleotides were purchased from Metabion. The exact sequences of stimulatory 
DNAs are listed in Supplementary Table 2. Linearized plasmid DNA was obtained by digestion 
of pET28M–SUMO1–GFP vector (EMBL) with BamHI (NEB). A 200 bp PCR fragment was 
amplified from MBP sequence. Anti-hcGAS (catalytic domain) and a control antibody were 
produced by The Service Unit Monoclonal Antibodies (German Research Center for 
Environmental Health, Helmholtz Zentrum München). The following antibodies were purchased 
commercially: anti-HA–HRP (Cell Signaling, clone 6E2), mouse anti-hTFAM (Abnova), rabbit 
anti-hTOM20 (FL-145) (Santa Cruz Biotechnology), mouse anti-HMGB1 (Sigma, clone 2F6), 
goat anti-mouse Alexa Fluor 594 (Life Technologies), goat anti-rabbit Alexa Fluor 488 (Life 
Technologies), donkey anti-rabbit Alexa Fluor 594 (Life Technologies), and donkey anti-mouse 
Alexa594 and Alexa Fluor 488 (Life Technologies). The following cell lines were used: 
HEK293T (American Type Culture Collection, CRL-11268), HEK293T STING-KI31, primary 
human fibroblasts (provided by M. Cremer, T. Cremer’s group (Ludwig-Maximilians-University 
Munich, Biocentre Martinsried)), BLaER132 (provided by T. Graf’s group (Center for Genomic 
Regulation, Universidad Pompeu Fabra and Institució Catalana de Recerca i Estudis Avançats, 
Barcelona)), and BLaER1 cGAS-KO, HMGB1-KO and HMGB1-WT MEF (HMGBiotech, HM-
221). 
For generation of cGAS-deficient BLaER1 cells (BLaER1 cGAS-KO), a single-guide 
(sg)RNA targeting the sequence GAACTTTCCCGCCTTAGGCAGGG (protospacer adjacent 
motif is in bold type) of the human MB21D1 gene was cloned via ligation-independent cloning 
into pR-U6-gRNA to yield pR-U6-MB21D1 as previously described33. BlaER1 cells were 
electroporated with pR-U6-MB21D1 and pCMV-mCherry-T2A-Cas9 (ref. 31) expression 
plasmids using a GenePulser device (Biorad), and 2 days later FACS-sorted mCherry-positive 
cells were sub-cloned by limiting dilution. Monoclonal cell lines were rearranged and duplicated 
for genotyping. The genomic locus surrounding the sgRNA binding site was PCR amplified 
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(cGAS forward primer: 
ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTTTTGGCGCGGGCCCCAGTTG; 
cGAS reverse primer: 
TGACTGGAGTTCAGACGTGTGCTCTTCCGATCTAAGGCCATGCAGAGAGCTTCCGA) 
and subjected to deep sequencing using a MiSeq platform (Illumina) as previously described34. 
KO cell clones contained all-allelic frame shift mutations without any wild-type reads. The 
deficiency for cGAS was not validated at protein level. 
All bought cell lines were kept at low passages to maintain their identity. Non-
commercially available HEK293T STING-KI, BLaER1, and BLaER1 cGAS-KO cell lines were 
not authenticated. 
The female primary human fibroblast cell line was authenticated as follows. DNA was 
isolated separately from the samples. Genetic characteristics were determined by PCR-single-
locus-technology. Twenty-one independent PCR-systems (Amelogenin, D3S1358, D1S1656, 
D6S1043, D13S317, Penta E, D16S539, D18S51, D2S1338, CSF1PO, Penta D, TH01, vWA, 
D21S11, D7S820, D5S818, TPOX, D8S1179, D12S391, D19S433, and FGA) were investigated 
(PowerPlex 21 PCR Kit, Promega). In parallel, positive and negative controls were performed 
yielding correct results.  
No mycoplasma contamination of the used cells was detected in regular screenings. 
Cell culture 
Wild-type and cGAS KO BLaER1 cells were cultivated in RPMI medium containing heat-
inactivated 10% FCS, penicillin (100 U ml−1), streptomycin (100 µg ml−1) (Thermo Fisher 
Scientific), and 1 mM sodium pyruvate (Thermo Fisher Scientific). For trans-differentiation, 
5 × 104 cells were seeded per well of a flat bottomed 96-well plate and cultivated in the presence 
of -oestradiol (100 nM, Sigma-Aldrich), hr-IL-3 (10 ng ml−1), and M-CSF (10 ng ml−1) (both 
PeproTech) for 5 days before the experiment35. HEK293T, HEK293T STING-KI, and human 
fibroblasts were cultured in DMEM (Thermo Fisher Scientific or Sigma-Aldrich, respectively) 
supplemented with 10–20% heat-inactivated FBS (Thermo Fisher Scientific or Biochrom, 
respectively). All cells were incubated at 37 °C with 5% CO2. 
HMGB1-KO and WT MEFs were cultured in DMEM (Thermo Fisher Scientific) 
supplemented with 15% heat-inactivated FBS (Thermo Fisher Scientific), 2 mM L-glutamine 
(Sigma, G7513), 1% non-essential amino acids (Sigma, M7145), 0.1 mM -mercaptoethanol 
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(Sigma, M3148), and 0.1 mg ml−1 penicillin–streptomycin (Sigma, P4333) and incubated at 
37 °C with 5% CO2. 
Protein expression and purification 
All proteins were overexpressed in E. coli Rosetta (DE3) for 16–18h at 18 °C after induction 
with 0.2 mM IPTG. Cells were lysed by sonication in 50 mM Tris, 500 mM NaCl, 5 mM MgCl2, 
10 mM imidazole, 10% glycerol, pH 7.5, supplemented with 2 mM -mercaptoethanol and 
protease inhibitor cocktail (Sigma-Aldrich) and purified with Ni-NTA agarose resin (Qiagen). 
For truncated cGAS proteins and human full-length cGAS without MBP-tag, His6–MBP tag was 
removed with tobacco etch virus protease (1:50 mass ratio) during 16 h dialysis against 30 mM 
Tris, 100 mM NaCl, 2 mM DTT, pH 7.0. cGAS proteins were further purified by cation-
exchange chromatography (30 mM Tris, 100 mM/1 M NaCl, 2 mM DTT, pH 7.0) on HiTrap SP 
HP columns (GE Healthcare) followed by size exclusion chromatography (SEC) on HiLoad 
S200 16/60 column (GE Healthcare) equilibrated with 20 mM Tris, 100 mM NaCl, pH 7.5. Full-
length hcGAS with or without N-terminal His6–MBP tag (hcGAS) and mcGAS proteins was 
concentrated to 8–12 mg ml−1. Truncated hcGAS was concentrated to 4 mg ml−1. All proteins 
were flash-frozen in liquid nitrogen and stored at −80 °C mTfam and mHMGB1 variants were 
purified as described for full-length hcGAS with His6-MBP tag, except the cation-exchange 
chromatography step was omitted and after dialysis against 20 mM Tris, 300 mM NaCl, pH 7.5 
SEC on HiLoad S75 16/60 (GE Healthcare) column was performed. Proteins were concentrated 
to 10–13 mg ml−1. 
lHU was purified as described for full-length hcGAS with His6-MBP tag, except after 
dialysis affinity chromatography on a HiTrap Heparin HP (GE Healthcare) column was 
performed (20 mM Tris, 100 mM/1 M NaCl, 2 mM DTT, pH 7.5). HiLoad S75 16/60 (GE 
Healthcare) equilibrated with 20 mM Tris, 100 mM NaCl, pH 7.5 was used for SEC. Protein was 
concentrated to 7 mg ml−1. 
Crystallization of cGAS–DNA complex 
For crystallization, purified mcGAS (aa 141–507) 6 mg ml−1 was mixed with 39 bp DNA (39 bp-
s: AGATCTACTAGTGATCTATGACTGATCTGTACATGATCT; 39 bp-as: 
AGATCATGTACAGATCAGTCATAGATCACTAGTAGATCT) in a molar ratio of 1:0.6 
protein:DNA in a buffer containing 20 mM Tris pH 7.5, 300 mM NaCl and 20 mM MgCl2. 
Crystals were obtained by hanging-drop vapour diffusion in 0.1 M Tris pH 8, 0.2 M ammonium 
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citrate pH 7, 27.5% w/v PEG3350 after 1 month at 20 °C. The crystals were soaked in 25% 
glycerol diluted in reservoir solution, flash-frozen, and stored in liquid nitrogen. 
Data collection and refinement 
X-ray diffraction data were collected at the beamline PXI (X06SA) at the Swiss Light Source, 
Switzerland, using a Pilatus 6M detector. Data sets were processed with XDS and merged with 
XSCALE36. The STARANISO server37 was used to generate structure factor amplitudes and 
their s.d. with a local I/(I) cut-off of 1.9. The resulting data set showed varying high-resolution 
cut-offs between 4.8 Å and 3.6 Å and an effective resolution of 4.2 Å. The crystal structure was 
solved by molecular replacement with PHASER38,39 using six copies of a search model based on 
the published structure of mouse cGAScd in complex with 18 bp DNA8 (Protein Data Bank 
(PDB) accession number 4LEY). Iterative model building and refinement was done with the 
molecular graphics program MOLOC40 and the CCP4 suite refinement program REFMAC5 (ref. 
41). Owing to the rather low resolution, we could not identify the DNA sequence. Thus, sense 
and anti-sense strands, as well as the starting nucleotide, were chosen arbitrarily. At the 
symmetry contact between two neighbouring cGAS dimers, we saw continuous electron density 
for a 34 bp DNA passing through the crystallographic twofold axis. Since the DNA sequence 
was not palindromic, we modelled the DNA with two 17 bp long symmetry-halves. Except for 
removal of a steric clash with the bound DNA by choosing a different rotamer for Arg244, we 
did not attempt to re-model the cGAS protein. Data collection and refinement statistics are listed 
in Supplementary Table 3. 
Fluorescence-based cGAS activity assays 
In fluorescence-based cGAS activity assays, a fluorescent analogue of ATP (2-aminopurine 
riboside-5-O-triphosphate (Biolog) (fATP)) was used. DNA (6.5 ng µl−1) of different lengths 
(20–100 bp in 5 bp intervals, and pET28M–SUMO1–GFP vector (EMBL) (6.2 kbp, plasmid)) 
corresponding to roughly 0.5 µM 20 bp (approximate length of cGAS binding site) was 
premixed with 0.5 µM cGAS in 40 mM Tris pH 7.5 and 100 mM NaCl. Alternatively, 
2.6 ng µl−1 DNA (0.2 µM binding sites) and 1 µM cGAS, 13 ng µl−1 DNA (1 µM binding 
sites), and 0.2 µM cGAS or 2.6 ng µl−1 DNA (0.2 µM binding sites) and 0.2 µM cGAS were 
used. To compare cGAS mutants, the same 2.6 ng µl−1 DNA (0.2 µM binding sites) was mixed 
with 1 µM cGAS. The reaction was started by adding 5 mM MgCl2 with 500 µM GTP and 
50 µM fATP and performed at 32 °C. Fluorescence decrease was measured in 96-well black 
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non-binding PS plates (Greiner Bio-One) on Tecan infinite M1000 (ex = 305 nm, em = 363 nm, 
gain 100, settle time 10 ms, kinetic interval 2 min). In cGAS titration experiments, 2.6 ng µl−1 
DNA (0.2 µM binding sites) was mixed with increasing cGAS concentrations from 0.05 to 
20 µM. 
cGAS stimulation assays induced by DNA-bending protein were performed analogously. 
Briefly, 13 ng µl−1 DNA (1 µM binding sites) was premixed with DNA-bending proteins or 
cGAS inactive mutant in concentrations of 0–5 µM, after which 100 nM or 50 nM cGAS in 
40 mM Tris pH 7.5 and 100 mM NaCl was added. The reaction was started by adding 5 mM 
MgCl2 together with 500 µM GTP and 50 µM fATP and performed at 32 °C for mcGAS
cd or 
37 °C for hcGAS. Fluorescence measurement was made as described above. 
Data were analysed with OriginPro 8G (OriginLab). 
Radiolabelled cGAS activity assays 
Radiolabelled cGAS activity assays were performed analogously as previously described7. 
Briefly, 13 ng µl−1 DNA (1 µM binding sites) were mixed with 2 µM mcGAScd and the reaction 
started by adding 50 µM ATP, 500 µM GTP, 5 mM MgCl2 in 40 mM Tris pH 7.5, and 100 mM 
NaCl containing 1:800 [32P]ATP (3,000 Ci mmol−1, Hartman Analytic). Samples were 
incubated at 35 °C and the reactions were stopped by plotting on PEI-Cellulose F plates (Merck) 
and analysed by thin-layer chromatography with 1 M (NH4)2SO4/1.5 M KH2PO4 as running 
buffer. The radiolabelled products were visualized with a Typhoon FLA 9000 phosphor imaging 
system. For testing of fATP incorporation into cGAS enzymatic activity product, 1 µM 
mcGAScd was mixed with 13 ng µl−1 (1 µM binding sites) 55 bp, 500 µM fATP/ATP, 500 µM 
GTP, 5 mM MgCl2, and 1:160 [
32P]ATP or [32P]GTP (3,000 Ci mmol−1, Hartman Analytic) in 
the same condition. For testing TFAM-dependent increase in cGAS activity, 250 nM mcGAScd 
was mixed with 13 ng µl−1 (1 µM binding sites) plasmid in the same condition and 1:1,000 
instead of 1:160 [32P]ATP was added. The reaction was incubated at 32 °C and the 
radiolabelled products were separated and visualized as described previously. For testing cGAS 
activation by short DNAs, the previously described protocol was used8. Briefly, 10 µM or 5 µM 
cGAS was mixed with 650 ng µl−1 or 325 ng µl−1 DNA, respectively, in buffer containing 5 mM 
MgCl2, 2 mM ATP and GTP, and 1:400 [
32P]ATP. The reaction mixture was incubated at 
37 °C and the radiolabelled products were separated and visualized as described previously. 
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Anion-exchange chromatography of cGAS reaction products 
Ten micromolar mcGAScd or hcGAScd and 195 ng µl−1 (15 µM binding sites) plasmid DNA 
were incubated at 35 °C for 2 h in buffer containing 40 mM Tris pH 7.5, 100 mM NaCl, 10 mM 
MgCl2, 2 mM fATP, and 2 mM GTP. Reaction mixtures were centrifuged for 10 min at 16,100 
relative centrifugal force, and the supernatant was separated from cGAS by ultrafiltration 
(30 kDa, Amicon). Resulting flow through was diluted in 50 mM Tris pH 9.0 and loaded on a 
Mono Q 5/50 GL (GE Healthcare) for anion exchange chromatography (50 mM Tris, 0 M/1 M 
NaCl, pH 9.0). Control runs with fATP, GTP, 23- and 33-cGAMP were made analogously to 
validate the resulting peaks of cGAS reaction products. 
Electrophoretic mobility shift assay 
DNA (2.6 ng µl−1) of length 200 bp (0.2 µM binding sites) was incubated with 0–2.5 µM WT 
or mutant mHMGB1dCTT for 30 min on ice in the buffer containing 50 mM Tris pH 7.5 and 
100 mM NaCl. Samples were separated in 0.6% agarose gel prepared with Gel-Red (Biotium) in 
40 mM Tris pH 9.2 as running buffer. The gel images were obtained with Gel iX Imager (Intas). 
ITC 
The calorimetric titration of DNA (60–400 µM in the syringe) to mcGAScd (20 µM in the 
reaction cell) was performed with MicroCal PEAQ-ITC (Malvern) in buffer containing 30 mM 
HEPES, 100 mM NaCl, pH 7.5. The following parameters were used: 25 °C, 1 × 0.4 µl + 
13 × 3 µl injections,10 cal s−1 reference offset, 750 revolutions per minute syringe stirring 
speed, 60 s initial delay, 6 s injection duration, 150 s spacing between injections, high feedback. 
To study TFAM direct interaction with cGAS, 50 µM human full-length cGAS without MBP-tag 
in the reaction cell and 400–500 µM hTFAM in the syringe were used. ITC was performed with 
the same parameters as above at 25 °C, 35 °C, and 15 °C. Kd, molar ratio, Gibbs free energy, 
enthalpy, and entropy of the binding were calculated with MicroCal PEAQ-ITC analysis 
software (Malvern). 
SEC–RALS 
SEC of cGAS–DNA complexes was performed on a Superose 6 increase 10/300 column (GE 
Healthcare). mcGAScd (4 mg ml−1) was mixed with DNA in 1:0.6 molar ratio for 50 bp DNA or 
1:0.3 molar ratio for 70 and 80 bp DNA in binding buffer containing 20 mM Tris, 243 mM 
NaCl, pH 7.5. Alternatively, 6 mg ml−1 mcGAScd and 20 bp DNA in 1:1.1 molar ratio were used. 
One hundred microlitres of the mix were loaded to Superose 6 increase 10/300 column (GE 
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Healthcare) equilibrated with 20 mM Tris, 100 mM NaCl, pH 7.5 buffer and separate peaks were 
analysed with RALS using Viscotek 270 Dual Detector (Malvern) and Viscotek VE3580 
Refractive Index Detector (Malvern). Molecular masses of the complexes were calculated with 
OmniSEC 4.7.0 software (Malvern). 
ELISA 
Fifty thousand trans-differentiated BLaER1 cells were transfected with 20, 40, or 60 ng DNA of 
different lengths (20–100 bp in 5 bp intervals) and herring testis DNA using 0.5 l 
Lipofectamine 2000 Transfection Reagent (Thermo Fischer Scientific) in 50 l Opti-MEM 
Reduced Serum medium (Thermo Fischer Scientific). CXCL10 expression in the supernatants 
was quantified 8 h after transfection using ELISA (BD OptEIA, human IP-10 ELISA Set). Cells 
stimulated with transfection reagent only and unstimulated cells served as control. 
IFN- mRNA expression analysis 
Fifty thousand trans-differentiated WT and cGAS-KO BLaER1 cells were transfected with 40 ng 
DNA of different lengths (20, 40, 60, 80, 100 bp and herring testis DNA). Eight hours after 
stimulation, total RNA was isolated from 7.5 × 105 pooled cells using an RNeasy Mini Kit 
(Qiagen) following the vendor’s recommendations. Subsequently, RNA was digested with 
DNase I (Thermo Fisher Scientific) to remove residual DNA. Five hundred nanograms of RNA 
were reverse transcribed using poly (dT)18 oligonucleotides according to the manufacturer’s 
instructions (RevertAid cDNA Synthesis Kit). IFN- expression levels were analysed by 
quantitative PCR, using gene-specific primers (IFN- forward primer: 
CAGCATCTGCTGGTTGAAGA; reverse primer: CATTACCTGAAGGCCAAGGA), 
normalized to GAPDH expression measured analogously (GAPDH forward primer: 
GAGTCAACGGATTTGGTCGT; reverse primer: GACAAGCTTCCCGTTCTCAG) and the 
fold change was calculated on the basis of the unstimulated control. 
Luciferase reporter assays 
All immunostimulatory assays were performed in HEK293T STING-KI cells31. Five hundred 
thousand cells were seeded on 24-well plates and transfected with 100 ng p-125Luc42, 10 ng 
pGL4.74 (Promega), 50 ng Flag/HA–cGAS plasmids, and a total of 500 ng DNA per well (filled 
up with an empty vector pcDNA5) using Lipofectamine 2000 (Invitrogen, Thermo Fisher 
Scientific) as transfection reagent according to the vendor’s protocol. After 14 h, cells were lysed 
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in 200 µl passive lysis buffer (Promega). Immunoactivity experiments using a Dual-Glo 
luciferase assay system (Promega) were performed as previously described43. 
Co-immunopurification of cGAS and TFAM from HEK293T cells 
Ten million HEK293T cells were transfected with 10 µg Flag–HA–cGAS and 10 µg HA–TFAM 
expression vectors and harvested 24 h after transfection. Cell pellets were flash-frozen in liquid 
nitrogen and stored at −20 °C. For immunoprecipitation, cells were incubated in Nonidet P-40 
lysis buffer (50 mM HEPES, 150 mM KCl, 1 mM NaF, 0.5% NP-40, 2 mM DTT, 10 µM ZnCl2, 
protease inhibitor (Sigma Aldrich), pH 7.5) for 10 min on ice. Lysates were cleared by 
centrifugation for 30 min. Proteins were immunoprecipitated for 1.5 h with anti-hcGAS or a 
control antibody bound to magnetic protein G Dynabeads (Novex, Life Technologies). Beads 
were washed four times with Nonidet-P40 lysis buffer and subjected to SDS–polyacrylamide gel 
electrophoresis and immunoblotting. 
Fluorescence microscopy 
HEK293T cells and primary human fibroblasts were grown at 40–45% and 50–60% confluency, 
respectively, on coverslips in a six-well plate overnight and treated the next day with the 
inhibitors Q-VD-OPH (MP Biomedicals) and ABT-737 (Santa Cruz Biotechnology) at a final 
concentration of 10 µM for 0 h or 6 h. Cells were fixed with 3% paraformaldehyde and 0.1% 
glutaraldehyde in PBS for 12 min, reduced with 1 mg ml−1 NaBH4 for 7 min, permeabilized with 
0.25% (v/v) Triton X-100, and blocked with 3% (w/v) BSA in PBS for 3 h. 
MEF and MEF HMGB1-KO cells were grown at 40–50% confluency on coverslips in a 
six-well plate overnight and transfected with 2 µg pcDNA5/FRT/TO (Invitrogen, Thermo Fisher 
Scientific) or eGFP–cGAS expression vectors overnight. Cells were then fixed with 2% 
paraformaldehyde in PBS for 10 min at room temperature, permeabilized with 0.5% (v/v) Triton 
X-100, and blocked with 2% (w/v) BSA in PBST for 10 min. 
Immunostaining was performed for 1 h at room temperature with primary antibodies 
against TFAM (1:50), TOM20 (1:250), or HMGB1 (1:100). The primary antibodies were 
detected with the secondary anti-mouse or anti-rabbit goat or donkey antibodies (1:500) by 
incubation for 1 h. After immunostaining, samples were post-fixed in 4% paraformaldehyde for 
10 min, stained with 1 µg ml−1 (HEK293T and primary human fibroblasts) or 10 µg ml−1 DAPI 
(MEF) for 10 min, and mounted in VECTASHIELD (Vector Laboratories). Cells were washed 
three times with PBST after each step. 
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Three-dimensional structured illumination microscopy (3D SIM) was performed with a 
DeltaVision OMX V3 microscope (GE Healthcare), equipped with a ×100/1.40 numerical 
aperture PlanApo oil immersion objective (Olympus), Cascade II:512 EMCCD cameras 
(Photometrics), and lasers for 405 nm, 488 nm, and 594 nm. Image stacks were first 
reconstructed and corrected for colour shifts with softWoRx 6.0 Beta 19 (unreleased) software. 
After establishing composite tiff stacks with a custom-made macro in Fiji, the data were 
subsequently aligned again and maximum intensity projections were used. 
Wide-field fluorescent microscopy was performed with a personal DeltaVision (pDV) 
microscope (GE Healthcare) equipped with a ×60/1.42 oil-immersion objective PlanApo U 
(Olympus), Cool-Snap camera (12 bit, 1024 pixels × 1024 pixels, Photometrics) by acquiring 
one focal plane. Insight SSI LEDs (GE Healthcare) for 405 nm, 488 nm, 594 nm were used. 
Statistical analysis 
No statistical methods were used to predetermine sample size. The experiments were not 
randomized and investigators were not blinded to allocation during experiments or accessing the 
outcome. 
All experiments were conducted at least three times and the mean values and s.d. of 
technical or biological replicates (BLaER1 stimulation experiments) were calculated. Statistical 
significance, if applicable, was calculated on the basis of unpaired one-sided t-tests. 
For the data fitting in Fig. 3, the description is included in the figure legend and in 
Supplementary Methods. 
For quantification of TFAM signal in microscopy images presented in Extended Data 
Fig. 9c, maximum intensity projections were subsequently loaded as RGB into Volocity 
calculation software (Volocity 6.1.2 (Perkin Elmer)). Areas corresponding to mitochondria, 
nucleus, and cytosol were obtained, segmented, and measured in all channels by defining 
intensity threshold and minimum object size on each channel. Cytosolic TFAM signal was 
quantified according to number of counts and signal area, and additionally corrected and 
normalized to the cytosolic area in an image. For each calculation, three different cells and three 
segments per cell were used. 
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Figure preparation 
Figures showing protein structures and electron densities were prepared with PyMOL Molecular 
Graphic Systems44. Sequence alignment (Extended Data Fig. 8a) was prepared with Jalview45. 
All other figures were prepared with Microsoft Excel, OriginPro 8G (OriginLab), or 
Matlab_R2015a (The MathWorks). 
Data availability 
The coordinates and structure factors have been deposited in the PDB under accession number 
5N6I. All other data are available from the corresponding author upon reasonable request. 
Code availability 
Matlab code used in this study is available from the corresponding author upon reasonable 
request. 
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EXTENDED DATA FIGURES 
 
 
Extended Data Figure 1. cGAS activity increases with DNA length in vitro and in vivo. a, b, 
CXCL 10 cytokine production of WT (a) and cGAS KO (b) transdifferentiated BLaER1 cells. 
Cells were transfected with 20, 40, and 60 ng DNA of increasing length (20–100 bp in 5 bp 
intervals) and herring testis (HT) DNA, and CXCL 10 concentration in the supernatant was 
measured by ELISA. The first two bars of each series represent unstimulated cells and 
lipofectamine controls. Shown are mean values ± s.d., n = 3. c, Fold change of IFN- mRNA 
expression in WT and cGAS-KO BLaER1 cells transfected with 20–100 bp and herring testis 
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DNA. IFN- mRNA expression levels were normalized to GAPDH mRNA and the fold change 
was calculated on the basis of the unstimulated control. Shown are mean values ± s.d., n = 3. d, 
Radiolabelled cGAMP production of cGAS stimulated with DNA of different lengths (20, 35, 
55 bp, and plasmid). cGAS reactions in the presence of [32P]ATP were stopped at the indicated 
time points and radiolabelled compounds (shown with black arrows) were visualized. e, f, 
Radiolabelled cGAMP production by (left to right) hcGAScd, hcGAS, and mcGAScd stimulated 
with 14, 16, 18, 20, 50 bp and plasmid DNA. cGAS (e, 5 µM; f, 10 µM) was incubated with 
325 ng µl−1 (e) or 650 ng µl−1 (f) DNA of indicated length in the presence of ATP, GTP, and 
[32P]ATP at 37 °C. The reactions were stopped at the indicated time points and radiolabelled 
compounds (shown with black arrows) were visualized. g, mcGAScd activity measured by the 
rate of fATP incorporation into fGAMP (see Extended Data Fig. 2 for the assays) in the presence 
of linearized or circular plasmid DNA. Mean values of initial cGAS reaction rates (∆F/∆t) are 
plotted against DNA constructs ± s.d., n = 3. No significant difference between linearized and 
circular plasmid could be detected. 
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Extended Data Figure 2. Description of the fluorescence-based cGAS activity assay. a, 
Radiolabelled cGAS products obtained with different NTP combinations. Reactions were 
stopped at the indicated time points, and products separated by thin layer chromatography and 
visualized by radiography. b, The principle of the fluorescence-based cGAS activity assay. 
cGAS catalyses the conversion of fluorescent ATP analogue fATP (2-aminopurine riboside 
triphosphate, three orange stars) into less fluorescent fGAMP (fluorescent cGAS product, one 
orange star), resulting in a gradual decrease in fluorescence intensity during the reaction. c, 
General workflow for calculating the initial cGAS reaction rates. From initial fluorescence 
curves (left), the background fluorescence was subtracted and the resulting curve was inverted 
for better visualization (∆F). Initial rates were calculated as a slope of the linear intervals (red 
dashed lines) and defined as ∆F/∆t (relative fluorescence units per minute) (right). d, e, fGAMP 
mobility in anion-exchange chromatography on a MonoQ 5/50 GL column. d, Comparison of 
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fGAMP, produced by cGAS from fATP and GTP (red), 23-cGAMP (black), and 33-cGAMP 
(blue) mobilities. e, Comparison of fGAMP (red), fATP (black), and GTP (blue) mobilities. 
 
Extended Data Figure 3. Electron densities and comparison with cGAS in complex with 
18 bp DNA. a, 2Fo − Fc electron density of 39 bp DNA within the complex at a contour level of 
1. b, Close-up view of the cGAS active site (orange) superposed with a previously published 
structure of cGAS bound to 18 bp DNA (PDB accession number 4LEY, blue). Shown is the 
2Fo − Fc electron density of the active-site residues at a contour level of 1. c, Superposition of 
the cGAS complex with 39 bp DNA (green and grey) with 18 bp DNA-bound cGAS (PDB 
accession number 4LEY, blue). A slight rotation of superposed 18 bp-cGAS (blue) relative to 
39 bp-cGAS (grey) is shown with a black arrow. The superposition shows the difference 
between a hypothetical straight (red dashed line) DNA, leading the previously proposed DNA 
end preference of cGAS, and the curved DNA observed in our crystal structure. d, Binding mode 
of the DNA strands to cGAS within the previously published structure (PDB accession number 
4LEY). Two neighbouring crystallographic asymmetric units represent a ‘head-to-tail’ cGAS 
dimer orientation. Elongation of both strands (red dashed line) leads to a steric clash (orange 
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star). e, Schematic model of cGAS binding to continuous DNA in alternating ‘head-to-head’ and 
‘tail-to-tail’ arrangements. DNA curves over  bp (black arrows). f, Schematic model of cGAS 
binding to continuous DNA in a (not observed) ‘head-to-tail’ arrangement. DNA curves over 
/2 bp (black arrows), if the same density of cGAS per DNA is assumed. Thus DNA must be 
bent twice more often than in model e to sustain the parallel DNA arrangement and is 
energetically less favourable. 
 
Extended Data Figure 4. Asymmetric unit of the cGAS–39 bp complex and details of 
protein–protein and protein–DNA contacts. a, An overview of the asymmetric unit of 39 bp 
DNA-bound cGAS. Filled oval-like symbol represents a twofold crystallographic symmetry axis; 
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black dashed lines represent non-crystallographic twofold symmetry axes. The asymmetric unit 
contains one full and one half ‘head-to-head’-oriented cGAS4–DNA2 complex. Residues mutated 
to examine four areas (encircled 1-4) are shown as red sticks. b, Close-up view of mutated 
interfaces: 1, cGAS active site (yellow) with superimposed cGAMP (from PDB accession 
number 4LEZ, grey) and labelled active-site residues D213 and D307; 2–4, potential protein–
protein or DNA–protein interaction sites, respectively. Mutated residues are in red. c, d, 
Mutational analysis of the described regions of mcGAScd in vitro and hcGAS in vivo, 
respectively. D307N and D319N correspond to active-site mutations in mouse and human cGAS, 
respectively. c, cGAS activity measured by the rate of fATP incorporation into fGAMP (∆F/∆t, 
see Extended Data Fig. 2) and normalized to WT. Mean values represent percentage of WT 
activity ± s.d., n = 3. d, Percentage change of IFN- promoter-driven luciferase activity upon the 
expression of WT or mutant cGAS. IFN- response was measured as a proportion of firefly (FF) 
to Renilla (REN) luciferase activity in HEK293T STING-KI cells upon Flag/HA–hcGAS 
overexpression. All ratios were normalized to to WT. Mean values represent the percentage of 
WT activity ± s.d., n = 3. Mutants are named according to their position in hcGAS: D319N 
(active site), Q454R, S263K, R166E, K173E, K458E, K258E mutants refer to D307N, Q439R, 
S249K, K151E, R158E, R443E, and R244E in mcGAS. 
 
-84-
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology letter 
 DOI: 10.1038/nature23890. Author manuscript. 
Page 34 of 42 
 
Extended Data Figure 5. cGAS affinity to DNA increases with DNA length accompanied by 
increase in number of cGAS binding sites along the DNA. ITC measurements of mcGAScd 
binding to 20, 40, 45, 50, 70, and 80 bp DNA. For each DNA, the power differential (DP) is 
plotted against time and ∆H is plotted against the molar ratio of DNA:cGAS. Calculated binding 
parameters are given on each graph. 
 
 
 
-85-
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology letter 
 DOI: 10.1038/nature23890. Author manuscript. 
Page 35 of 42 
 
Extended Data Figure 6. cGAS forms higher-ordered structures on long DNA. a, Signature 
plots for each ITC measurement (Extended Data Fig. 5) showing ∆G (green), ∆H (blue), and 
−T∆S (red) for each binding reaction. b, ∆H and −T∆S components of Gibbs free energy 
measured with ITC for mcGAScd binding to 20–80 bp DNA are plotted against DNA 
length ± s.d. of the measured values from the fit. c, Molecular mass distribution within SEC 
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peaks (Fig. 2c-f) containing mcGAScd1–DNA1 (with 20 bp DNA), mcGAS
cd
4–DNA2 (with 50 bp 
DNA), and mcGAScd6–DNA2 (with 70 and 80 bp DNA) calculated with RALS. Refractive index 
(red) and estimated molecular mass (black) are plotted against retention volume. 
 
 
Extended Data Figure 7. TFAM enhances cGAS activity by prearranging DNA into U-
shape. a, DNA ladders (blue) and (b) DNA-bound TFAM structure (PDB 3TMM, red) arrange 
DNA in a remarkably similar fashion. The two similarly spaced DNA strands flanking cGAS 
ladders or the TFAM U-turn (black dotted lines) provide a possible explanation for the effect of 
TFAM on cGAS activity. c, Radiolabelled cGAMP production in the presence of increasing 
TFAM concentrations. cGAS reactions with ATP, GTP, and [32P]ATP were stopped at the 
indicated time points and the radiolabelled compounds (shown with black arrows) were 
visualized. d, Activation of mcGAScd by mTFAM and DNA of increasing length (20–200 bp or 
-87-
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology letter 
 DOI: 10.1038/nature23890. Author manuscript. 
Page 37 of 42 
plasmid DNA). Mean values of initial cGAS reaction rates (∆F/∆t, see Extended Data Fig. 2) are 
plotted against increasing concentrations of mTFAM ± s.d., n = 4–8. 
-88-
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology letter 
 DOI: 10.1038/nature23890. Author manuscript. 
Page 38 of 42 
 
-89-
Publisher: NPG; Journal: Nature: Nature; Article Type: Biology letter 
 DOI: 10.1038/nature23890. Author manuscript. 
Page 39 of 42 
Extended Data Figure 8. HMGB proteins activate cGAS through DNA bending. a, 
Sequence alignment of HMG boxes from different HMG proteins. Positions of intercalating 
residues, responsible for the DNA-bending activity (red), are shown with respect to their location 
within helices I, II, or III of HMGB1_boxA (green lines) and HMGB1_boxB (blue lines). b, 
Structures of box A in complex with DNA (PDB accession number 4QR9) and box B (PDB 
accession number 1HME) of rat HMGB1 with indicated intercalating residues (red). c, mcGAScd 
activity measured by the rate of fATP incorporation into fGAMP (see Extended Data Fig. 2) in 
the presence of increasing concentration of mHMGB1dCTT WT and intercalating residues 
mutants. Double mutations (F38A in box A, and F103A or I122A in box B) or triple mutants 
(F38A in box A, and both F103A and I122A in box B) were used. Mean values of initial cGAS 
reaction rates (∆F/∆t) are plotted against increasing concentrations of mHMGB1dCTT ± s.d., 
n = 7. d, Electrophoretic mobility shift assay of mHMGB1dCTT WT and point mutants with 
2.6 ng µl−1 (~200 nM binding sites) 200 bp DNA. Introduced mutations do not reduce DNA 
binding of mHMGB1 mutants under conditions used for cGAS activity assays (c). e, mcGAScd 
activity measured by the rate of fATP incorporation into fGAMP (see Extended Data Fig. 2) in 
the presence of mTFAM with circular or linearized plasmid. Mean values of initial cGAS 
reaction rates (∆F/∆t) are plotted against increasing concentrations of mTFAM ± s.d., n = 3. f, 
ITC of hcGAS with hTFAM at 35, 25, and 15 °C. Power differential (DP) is plotted against time 
of the experiment. hTFAM (~530 µM) was titrated to ~50 µM hcGAS. No binding is observed, 
indicating Kd > 100 µM. g, h, cGAS activity measured by the rate of fATP incorporation into 
fGAMP (see Extended Data Fig. 2) in the presence of increasing TFAM concentrations. Mean 
values of initial cGAS reaction rates (∆F/∆t) are plotted against increasing concentrations of 
TFAM ± s.d., n = 3 or 4. mcGAScd (g) and hcGAS (h) are activated by both human and mouse 
TFAM. 
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Extended Data Figure 9. TFAM relocalizes from mitochondria into cytosol during 
mitochondrial stress. a, b, TFAM (green) localization upon mitochondrial stress induction. 
Cells were incubated with caspase and Bcl-2 inhibitors for indicated time and stained for super-
resolution fluorescence microscopy (3D SIM). Mitochondria were visualized by TOM20 
(mitochondrial import receptor subunit, red) staining, cell nuclei by DAPI (blue). a, TFAM 
cytosolic localization under mitochondrial stress conditions in HEK293T cells. b, TFAM 
decondensation in mitochondria and its leakage into cytoplasm in human primary fibroblasts in 
response to mitochondrial stress. c, Example of statistical analysis in human primary fibroblasts 
(b). Cells were incubated with caspase and Bcl-2 inhibitors for 6 h and stained for super-
resolution fluorescence microscopy (3D SIM). Mitochondria were visualized by TOM20 
(mitochondrial import receptor subunit) staining, cell nuclei by DAPI. Areas stained for TFAM 
(green), TOM20 (red), and nucleus (blue) are defined with yellow line. Cytosolic TFAM spots 
are depicted on the top left view. d, Comparison of cytosolic TFAM signal in control cells (0 h) 
and under mitochondrial stress conditions (6 h) (b, c). Plotted are mean values of cytosolic 
TFAM signal calculated as area (top) or number of spots (bottom) ± s.d. Three cells of each type 
and three segments per cell were used (n = 9). Single asterisk indicates a statistically significant 
difference (P < 0.05, P = 0.0267), double asterisk indicates a statistically significant difference 
(P < 0.01, P = 0.0050), compared with control. The TFAM signal in the cytosol of control cells 
(0 h) represents background signal. e, Co-immunopurification of cGAS and TFAM. Cell lysates 
with overexpressed Flag/HA-cGAS and HA-TFAM were incubated with anti-hcGAS or with a 
control antibody (A/b) and the proteins in total lysates (TL) and elution fractions (IP) were 
visualized by immunoblotting (IB). 
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Extended Data Figure 10. HMGB1 but not eGFP co-localizes with cytosolic DNA. a, b, 
HMGB1 (red), eGFP (green), and DNA (blue) localization in WT or HMGB1-KO MEFs. DNA 
was stained by DAPI (blue). Images were obtained by wide-field fluorescence microscopy 
(pDV). Fluorescent signal within enlarged images is enhanced until saturation of the nuclear 
signal to better visualize cytoplasmic structures. a, Cells were transfected with eGFP expression 
construct. HMGB1 co-localizes with DAPI-staining in WT but not HMGB1-KO cells. eGFP 
does not co-localize with DNA or HMGB1. b, In non-transfected cells, HMGB1 and DAPI 
stainings are present only in the nucleus. The HMGB1 staining in the cytosol of non-transfected 
and HMGB1-KO cells represents background signals that become visible with the artificial 
signal amplification beyond saturation, as shown in the zoom-in images. 
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Summary 
In this publication reverse-transcribed HIV-1 negative-strand ssDNA is reported as the pathogen pattern 
recognized by major cytosolic DNA sensor cGAS and specific short dsDNA constructs with single-
stranded guanine-overhangs are defined as the minimal cGAS recognition motives. Apart from cytosolic 
DNA emerging from dsDNA viruses like HSV-1 cGAS senses a range of retroviruses including HIV-1, 
murine leukemia virus and simian immunodeficiency depending on their reverse transcription step and 
independently from their integration. However, the exact nature of retroviral cGAS ligands remained 
unknown. This work discovers stem-loop structures within negative-strand ssDNA transcribed from HIV-
1 genome during the first stages of infection to stimulate cGAS activity and type I IFN production in 
human macrophages. Strikingly, previously known to recognize dsDNA sequence-unspecifically, cGAS 
activation by HIV-1 or endogenous retroelement ssDNA was found to strongly depend on unpaired 
guanine bases flanking stem-loop regions. Mutations of these bases abolished IFN production in infected 
peripheral blood mononuclear cells. Based on this observation, synthetic short dsDNA constructs with G-
overhangs on both sides – Y-shaped DNAs (YSDs) - were designed and shown to potently activate cGAS 
in vitro and in human cells. Given that cGAS was previously shown to require at least 45 bp to recognize 
blunt-end dsDNA in cell lines, G-overhangs allow to overcome this dsDNA length limitation. This study 
shows that 20 bp dsDNA with flanking guanines is as potent cGAS activator, as plasmid or genomic 
DNA and that G-overhangs enhance cGAS-stimulating capacity of golden-standard 45 bp 
immunostimulatory DNA. Novel cGAS ligands discovered in this work were shown to activate cGAS 
independently of G-quadruplex formation and YSD aggregation and thus represent a new class of short 
highly-immunostimulatory motives recognized by cGAS in a sequence-dependent manner. 
Author contribution 
The author of this thesis participated in in vitro characterization of the cGAS complexes with various 
short guanine overhangs-containing dsDNA constructs – Y-shaped DNAs (YSDs). She assisted the 
authors of this publication with interpretation of the in vitro and cell-based assays and actively 
participated in discussion of possible mechanisms of cGAS specific activation by YSDs. 
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Abstract
Cytosolic DNA that emerges during infection with a retrovirus or DNA virus triggers antiviral 
type I interferon responses. So far, only double-stranded DNA (dsDNA) over 40 base pairs (bp) in 
length has been considered immunostimulatory. Here we found that unpaired DNA nucleotides 
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flanking short base-paired DNA stretches, as in stem-loop structures of single-stranded DNA 
(ssDNA) derived from human immunodeficiency virus type 1 (HIV-1), activated the type I 
interferon–inducing DNA sensor cGAS in a sequence-dependent manner. DNA structures 
containing unpaired guanosines flanking short (12- to 20-bp) dsDNA (Y-form DNA) were highly 
stimulatory and specifically enhanced the enzymatic activity of cGAS. Furthermore, we found that 
primary HIV-1 reverse transcripts represented the predominant viral cytosolic DNA species during 
early infection of macrophages and that these ssDNAs were highly immunostimulatory. 
Collectively, our study identifies unpaired guanosines in Y-form DNA as a highly active, minimal 
cGAS recognition motif that enables detection of HIV-1 ssDNA.
Sensing of nucleic acids is crucial to antiviral defense. Unlike pathogen-associated 
molecular patterns (PAMPs) of bacterial origin that are foreign to the host, nucleic acids are 
vital to both host and pathogen alike. Thus, receptors that are part of the innate immune 
system recognize foreign genetic material through its unusual localization or structural 
features or modifications.
In the endolysosome of some cells of the immune system, Toll-like receptor 9 (TLR9) 
‘preferentially’ detects DNA containing CpG dinucleotides1–3. In the cytosol, recognition of 
DNA triggers the secretion of both interferon-α (IFN-α) and IFN-β (collectively called 
‘IFN-α/β’ here) and proteolytically activated interleukin 1β (IL-1β). Sensing of DNA by the 
inflammasome-forming receptor AIM2 is considered essential for the activation of IL-1β4–6. 
In contrast, several cytosolic DNA receptors that induce IFN-α/β have been proposed7–15, 
although it is now broadly accepted that the IFN-α/β-inducing mitochondrial adaptor STING 
is downstream of this process16,17.
Two candidate receptors upstream of STING, IFI16 and cGAS (‘cyclic GMP-AMP 
(cGAMP) synthetase’), have been reported18,19. Involvement of IFI16 in the induction of 
IFN-α/β during infection with herpes simplex virus, human cytomegalovirus, human 
immunodeficiency virus (HIV) or Listeria monocytogenes has been reported20. However, no 
genetic proof confirming those findings has been provided so far. In contrast, cGAS-
deficient mice and cells demonstrate clear deficits in their immune response to cytosolic 
DNA. Moreover, direct interaction of DNA with cGAS promotes synthesis of the second 
messenger cGAMP, which activates STING19,21–29. Furthermore, cGAS is reported to be 
essential for the immunodetection of DNA viruses19,30,31 and retroviruses27,32,33.
Several studies have defined cytosolic DNA-recognition motifs11,34,35. Double-stranded 
DNA (dsDNA) with any sequence longer than 24 base pairs (bp) is known to induce IFN-
α/β in mouse cells, and a 45-bp dsDNA sequence (interferon-stimulatory DNA (ISD)) has 
been established as the ‘gold standard’ for the induction of IFN-α/β11. In human monocytes 
or the human monocytic cell line THP-1, length-dependent induction of IFN-α has a lower 
bound of 40–50 bp, with much less secretion of IFN-α in response to these short 
sequences7,18. Thus, it is assumed that recognition of DNA in the cytosol depends on duplex 
character and length but not sequence. However, it has been reported that lentivirus single-
stranded DNA (ssDNA) stem-loop structures comprising far fewer than 40 bp can also 
induce IFN-α/β, although induction of IFN-α/β has been observed to depend on base-paired 
stretches of DNA within the stem-loop structures36.
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In this study, we delineated the recognition of a 181-nucleotide early HIV type 1 (HIV-1) 
reverse transcript (‘strong-stop (−)-strand DNA’ (sstDNA)) by the immune system and 
found that an isolated stem-loop–structured sequence induced cGAS-dependent activation of 
the immune system. Such recognition of the stem-loop structure depended on the presence 
of 3′ and 5′ stem-flanking sequences containing unpaired guanosines. We also found that 
increasing the guanosine content enhanced the induction of IFN-α/β. The addition of 
unpaired guanosines to otherwise inactive, blunt, 20-nucleotide DNA duplexes rendered 
these immunoactive at a level comparable to that of plasmid or genomic dsDNA. Strikingly, 
additional unpaired guanosine flanks even enhanced the activity of the prototypic blunt, 45-
nucleotide ISD11. Furthermore, our data demonstrated the importance of these 
immunostimulatory Y-form DNA structures for the sensing of HIV-1 early reverse 
transcripts by the immune system in primary human macrophages as a model of infection 
with macrophage-tropic HIV-1. Collectively, our study documents a minimal 
immunostimulatory DNA motif that induces cGAS activity in a structure- and sequence-
dependent manner and thereby enables the recognition of partially mismatched stem-loop 
structures as found in ssDNA of HIV-1.
RESULTS
Detection of unpaired guanosines in HIV cDNA stem loops
HIV-1 is detected via the cGAS-STING pathway27,32,33. It has been reported that ssDNA is 
the predominant cytosolic DNA species during the first 4 h of HIV infection, while dsDNA 
is found later in the nuclear or perinuclear fractions37. Replication of HIV-1 is initiated by 
reverse transcription of the first ~181 nucleotides of the HIV-1 RNA genome, primed by 
lysyl-tRNA (tRNALys3), which generates sstDNA (Fig. 1a). A published study has reported 
the cytosolic recognition of sstDNA-derived sequences as being dependent on the presence 
of the base-paired stretches36. Although they are double stranded, these base-paired 
structures still seemed too short (<40 bp) to elicit IFN-α/β in human monocytes7 
(Supplementary Fig. 1a). Thus, we attempted to elucidate if features other than base 
pairing could enable activation of a cellular response. We modeled the complete HIV-1 
sstDNA complementary to bases 1–181 of the (+) strand using the mfold server (HIV-1 
strain HXB2; NCBI accession code, AF033819) and identified three stem-loop structures 
(SL1–SL3; Fig. 1a, top). Then, we transfected chloroquine-treated human peripheral blood 
mononuclear cells (PBMCs) with DNA corresponding to each stem-loop structure isolated. 
In this experimental setting, IFN-α/β is derived from monocytes, while TLR-dependent 
secretion of IFN-α (for example, activation of TLR9 by the CpG ODN 2216) is blocked by 
chloroquine7 (Supplementary Fig. 1b).
We found that among the stem-loop DNA structures, SL2 was immunostimulatory (Fig. 1b), 
despite containing only 21 bp in a stem sequence maximally 24–26 nucleotides in length. 
Notably, homologous sequences of another HIV-1 strain, as well as of a simian 
immunodeficiency virus strain, also demonstrated comparable immunostimulatory activity 
(‘immunoactivity’) (Supplementary Fig. 1c). Furthermore, the combination of SL2 and 
SL3 (116 nucleotides) had greater immunoactivity than SL2 alone (Fig. 1c), indicative of a 
synergistic immunostimulatory effect.
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To determine the origin of the immunoactivity, we systematically altered the structures of 
the stem-loop structure to modify melting temperature, mismatches and bulges, and unpaired 
stretches flanking the stem. While lowering the melting temperature of the stem via the 
introduction of A:T base pairs resulted in less secretion of IFN-α, increasing the melting 
temperature via the introduction of G:C base pairs resulted in a slight but insignificant 
increase in the secretion of IFN-α (Fig. 1d). The removal of mismatches enhanced the 
secretion of IFN-α (Fig. 1e), which excluded the possibility of mismatches as a recognition 
motif. However, the most prominent change resulted from the removal of the unpaired stem-
loop stretches, which abrogated the IFN-α signal and was not compensated by removal of 
the mismatches (Fig. 1f). This observation linked the adjacent, unpaired sequences to stem-
loop–associated immunoactivity. Next we assessed whether such recognition was sequence 
dependent. The removal of guanosines from the unpaired stretches of the hairpin rendered it 
inactive, while increasing the guanosine content increased its immunoactivity (Fig. 1g). 
Moreover, the immunoactivation induced by the combined stem-loop structures SL2 plus 
SL3 was also largely dependent on the presence of unpaired guanosines (Fig. 1h). Native 
PAGE and melting-curve analysis confirmed that mutations that removed guanosines did not 
substantially change folding or complex formation (Supplementary Fig. 1d). As observed 
for wild-type stems, the mismatch–bulge-deficient stem-loop structure induced far less 
secretion of IFN-α when guanosines within the loop and 3′ and 5′ flanking stretches were 
substituted (Fig. 1i). Notably, the combination of additional guanosines in the unpaired 
regions and a perfect duplex in the stem led to an IFN-α/β response comparable to that 
observed for standard stimuli such as genomic DNA (Fig. 1j). Furthermore, isolated primary 
human monocytes and monocyte-derived macrophages, which represent the main targets of 
macrophage-tropic HIV-1 infection, recognized short hairpin structures, and again, IFN-α-
induction depended on unpaired guanosines (Supplementary Fig. 1e,f. In conclusion, these 
data indicated that the unpaired regions of stem-loop structures within ssDNA substantially 
contributed to detection of the ssDNA and that guanosines were essential for this recognition 
mechanism.
Unpaired guanosines in Y-form DNA are a robust yet flexible PAMP
Next we investigated whether a closed loop of SL2 was essential for immunostimulation or 
if Y-form DNA junctions (the transition from dsDNA to ssDNA) were sufficient for 
immunoactivation. Opening the loop led to a slight yet insignificant reduction in the 
immunoactivity of the SL2 variants without mismatches (Fig. 2a), which showed that the 
unpaired stretches rather than the closed loop were necessary for recognition of the short 
stem-loop structures. Finally, simple, short DNA duplexes (20–21 bp) with various stem 
sequences (HIV derived, random non-palindromic, and palindromic) flanked by unpaired 
guanosine trimer (G3) ends exhibited the same IFN-α/β-inducing activity as did the 
guanosine-enriched SL2 hairpin or genomic DNA with removal of mismatches (Fig. 2b). 
That finding prompted us to further study the flexibility of this recognition motif, which we 
called ‘Gn-ended Y-form short DNA’ (Gn-YSD, where ‘n’ indicates the number of unpaired 
guanosines at each 3′, and 5′, end).
In line with those observations, substitution of the terminal G3 with adenosine (A3-YSD), 
thymidine (T3-YSD) or cytidine (C3-YSD) almost completely abrogated the induction of 
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IFN-α (Fig. 2c). Furthermore, the stimulatory effect of the G3 overhangs was neutralized by 
hybridization of G3-YSD with the fully complementary C3-YSD, but not by hybridization 
with the T3-YSD control, since the latter left free G3 ends available for recognition (Fig. 2c). 
Further experiments revealed that two G3 overhangs at opposite ends of the DNA duplex 
(regardless of whether it was at the 3′ end or 5′ end) were sufficient for robust induction of 
IFN-α (Fig. 2d). Nevertheless, the sequence requirements for recognition of the unpaired 
overhangs demonstrated considerable flexibility; one guanosine within one of five unpaired 
bases at each 5′ and 3′ end of a DNA duplex was sufficient to initiate an IFN-α/β response 
(Supplementary Fig. 2a). While a decrease in the length of the core duplexes of G3-YSD to 
12 bp elicited a diminished but still substantial IFN-α response, an increase in its length did 
not enhance IFN-α induction (Fig. 2e). Notably, G3 ends also further enhanced the already 
potent immunostimulatory activity of the prototypic blunt 45-nucleotide ISD11 by 
approximately fourfold (Supplementary Fig. 2b). Mismatches or bulges of up to 4 bp in the 
dsDNA core sequence of G3-YSD were tolerated, although this correlated with diminished 
immunoactivity (Fig. 2f).
We also observed specific recognition of G3-YSD in purified human monocytes as well as 
in monocyte-derived macrophages, even though both cell types responded weakly to ISD 
(Supplementary Fig. 2c,d). Finally, G end–dependent recognition of Y-form DNA was not 
restricted to human cells, as immortalized mouse macrophages also showed a similar 
response to YSD (Supplementary Fig. 2d), although these cells also responded to 30-
nucleotide blunt-ended dsDNA, as reported11. Together, these results demonstrated that 
unpaired guanosine extensions potently enhanced the immunoactivity of short DNA 
duplexes.
G-ended Y-form DNA is active as a monomeric duplex
To address whether variations in DNA stability and transfection efficiency might be 
responsible for the differences observed in the stimulatory activity of the short DNA 
duplexes38, we transfected THP-1 cells with 5′-labeled stimulatory DNA (G3-YSD; ISD) or 
non-stimulatory DNA (C3-YSD; blunt-ended 26-nucleotide DNA). At 4 h and 8 h after 
transfection, we assessed their presence in cytosolic lysates by denaturing polyacrylamide-
gel electrophoresis (PAGE) of equal lysate proportions and subsequent detection of label 
fluorescence. Here, G3-YSD exhibited fluorescence intensity in THP-1 cytosolic cell lysates 
similar to or somewhat less than that of the non-stimulatory C3-YSD or blunt-ended 26-
nucleotide DNA (Supplementary Fig. 3a). Furthermore, in vitro digestion of the same 
unlabeled DNA stimuli with recombinant DNase TREX1, DNase I or DNase II38 did not 
substantially reduce degradation (Supplementary Fig. 3b,c). Thus, we concluded that direct 
ligand-receptor interaction, not stability or translocation effects, was relevant for the 
induction of IFN-α/β by guanosine-ended Y-form DNA.
One characteristic feature of guanosine-rich DNA sequences is their ability to assemble into 
guanosine quadruplex (‘G quadruplex’) complexes (‘G tetrad’) (Fig. 3a). One possible 
explanation for the enhanced recognition of guanosine-ended YSD was the potential 
formation of long chains by such intermolecular G-quadruplex interactions. By native 
PAGE, high-molecular-weight bands were visible for G4-YSD or G5-YSD (Fig. 3c), which 
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indicated G quadruplex–mediated oligomerization (sequences and structures, Fig. 3b), while 
G2-YSD or G3-YSD migrated as a single, low-molecular-weight band (Fig. 3c). Since 
strong electric fields may interrupt weak interactions during electrophoresis, we investigated 
the molecular interactions in solution. Anti-parallel G quadruplexes are arranged chirally 
and are optically active at 295 nm (ref. 39). Their formation can be detected by circular 
dichroism spectroscopy, which measures the difference in the absorption of left-circularly 
polarized light and that of right-circularly polarized light (ellipticity) of the analyte at 30–70 
°C. G4-YSD and G5-YSD exhibited a substantial positive ellipticity at 295 nm that was lost 
at high temperatures (≥70 °C) (Fig. 3d), which indicated G-quadruplex formation at 
physiological temperatures. In contrast, G2-YSD or G3-YSD, like the negative controls A3-
YSD and a blunt-ended 30-nucleotide DNA, did not show considerable optical activity at 
295 nm (Fig. 3d), which indicated that G2-YSD and G3-YSD were present as monomeric 
duplexes. Notably, the quadruplex-forming YSDs did not induce larger amounts of IFN-α 
than the prototype G3-YSDs did (Fig. 3e). To exclude the intracellular formation of G 
quadruplexes, we made use of 26-nucleotide G2-YSD, which was as active as 20-nucleotide 
G3-YSD (Fig. 3e). Here, we replaced the terminal guanosines with 7-deaza-guanosine or 
inosine. Substitution of nitrogen N7 of the guanine by a C-H group (7-deaza-guanosine) and 
the missing amine group at carbon C3 of inosine disables formation of the hydrogen bonds 
essential for the G-quadruplex arrangement40. Substitution with 7-deaza-guanosine as well 
as substitution with inosine did not substantially alter the immunostimulatory activity (Fig. 
3f). We concluded that intermolecular G-quadruplex interactions were not involved in the 
recognition of G-ended YSD but that the monomeric duplex was detected and induced IFN-
α/β.
G-ended Y-form DNA activates cGAS via direct interaction
Of all human cell lines we tested, only the human monocytic cell line THP-1 was responsive 
to G3-YSD (data not shown), in line with what has been described for dsDNA with a 
random base composition41. The RNA helicase RIG-I has been linked to the detection of 
long AT-rich DNA7,8. To exclude the possibility of involvement of signaling via RIG-I and 
the signaling adaptor MAVS in the recognition of YSD in this cell line, we performed RNA-
mediated interference (RNAi) with small interfering (siRNA) targeting MAVS or STING. 
Knockdown of STING substantially repressed the induction of IFN-α/β by G3-YSD and 
plasmid DNA, but knockdown of MAVS did not; instead, knockdown of MAVS repressed 
the response to the RIG-I ligand 3P-dsRNA (triphosphorylated double-stranded RNA) but 
not to any of the DNA ligands (Fig. 4a and Supplementary Fig. 4a). These results 
demonstrated that G3-YSD indeed induced secretion of IFN-α/β via a STING-dependent 
pathway.
To identify the receptor responsible for the recognition of G3-YSD, we expressed Flag-
tagged candidate receptors in HEK293T human embryonic kidney cells and performed 
bead-coupled co-precipitation experiments with immobilized DNA ligands (Fig. 4b–d). 
IFI16, ZBP1, DDX41 and cGAS have been described as IFN-α/β-inducing cytosolic 
receptors for dsDNA in fibroblasts, monocytes, macrophages or conventional dendritic 
cells18,19,29,42,43. Among those candidates, IFI16 and cGAS bound to both G3-YSD and C3-
YSD, while ZBP1, DDX41 and the negative control RIG-I did not detectably precipitate 
Herzner et al. Page 6
Nat Immunol. Author manuscript; available in PMC 2015 December 03.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
-100-
together with YSD (Fig. 4c,d). Both IFI16 and cGAS bound to long (79-nucleotide) blunt-
ended DNA, whereas short (26-nucleotide) blunt-ended DNA did not precipitate these 
candidates (Fig. 4d). Only Ku80, a nonspecific DNA-binding control, did not show 
substantial ‘preference’ for any DNA structure or length (Fig. 4d). Of note, IFI16 showed a 
slight (threefold) ‘preference’ for the immunostimulatory YSD (G3-YSD over C3-YSD; Fig. 
4c,d and Supplementary Fig. 4b).
We performed RNAi experiments with siRNA in THP-1 cells to determine the contribution 
of IFI16 and cGAS to the secretion of IFN-α/β after stimulation with dsDNA. RNAi of 
cGAS almost completely abrogated the induction of IFN-α/β by dsDNA species, including 
G3-YSD (Fig. 4e and Supplementary Fig. 4c). In contrast, RNAi of IFI16 did not 
substantially suppress the induction of IFN-α/β by dsDNA (Supplementary Fig. 4d). 
Moreover, RNAi of MAVS again inhibited only RIG-I-dependent, 3P-dsRNA-induced 
secretion of IFN-α/β, not the G3-YSD-dependent response (Fig. 4e and Supplementary Fig. 
4c). These results demonstrated that G3-YSD-induced secretion of IFN-α/β depended on the 
cGAS-STING-axis.
To investigate whether guanosines were directly detected by cGAS, we performed in vitro–
activation assays of truncated recombinant cGAS (amino acids 155–522). In the presence of 
a ligand, cGAS catalyzes the conversion of ATP and GTP to the non-canonical cyclic 
dinucleotide cGAMP. We used untagged G3-YSD, C3-YSD and 26-nucleotide blunt DNA, 
as well as 45-nucleotide ISD as a positive control11: As expected, in the presence of ISD, 
ATP and GTP were converted to cGAMP, as visualized by the corresponding ultraviolet 
irradiation–absorption maxima in the HPLC chromatogram (Fig. 4f). While G3-YSD 
activated cGAS to the same extent as ISD did, C3-YSD and the blunt-ended 26-nucleotide 
DNA resulted in less conversion (Fig. 4f). Thus, we concluded that G-rich overhangs of 
short duplexes specifically and directly enhanced the activation of cGAS, which led to 
STING-dependent secretion of IFN-α/β.
The interferon response correlates with viral ssDNA content
During the life cycle of lentiviruses, reverse transcription of (−) ssDNA is followed by 
replication of second strand ((+)-strand) DNA, which leads to the generation of dsDNA37. A 
published study has shown detection of HIV-1 ssDNA predominantly in the cytosol, with 
dsDNA in the nuclear and perinuclear fraction37. Thus, we hypothesized that recognition of 
ssDNA by cGAS might be especially important during early infection. To investigate the 
kinetics of ssDNA formation, we developed a strand-specific quantitative PCR protocol to 
quantitatively detect (−)-strand DNA and (+)-strand DNA in infected cells (Supplementary 
Fig. 5a). To determine if dsDNA or ssDNA is crucial for cGAS stimulation, we generated 
replication-deficient HIV-1-derived lentiviral particles containing a mutant reverse 
transcriptase, RT(N265D) (Supplementary Fig. 5b), reported to be impaired in its use of 
DNA as template during replication44. Thus, we expected this mutant to produce little or no 
dsDNA, represented by the presence of (+)-strand DNA. We infected THP-1 cells for 4 h 
with these HIV-1 particles during inhibition of SAMHD1 (which controls reverse 
transcription) by the nonstructural protein Vpx, delivered by virus-like-particles, and 
analyzed cytosol-enriched fractions of these cells. To confirm that the induction of 
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interferon-stimulated genes by either wild-type particles or RT(N265D) particles was cGAS 
dependent, we infected wild-type THP-1 cells as well as cGAS-deficient THP-1 cells45. As 
reported37, in both wild-type and cGAS-deficient cells, we identified (−)-strand DNA as the 
predominant species in the cytosol (Fig. 5a). Compared with strand synthesis induced by 
wild-type RT particles, for the RT(N265D) particles, (+)strand synthesis was impaired but 
(−)-strand synthesis was not (Fig. 5a). Despite the diminished induction of (+)-strand 
synthesis by RT(N265D), induction of the interferon-stimulated gene IFIT2 by RT(N265D) 
particles was not diminished compared with its induction by wild-type particles but instead 
was slightly increased, in the responsive wild-type THP-1 cells (Fig. 5b). In addition, the 
induction of IFIT2 by both strains, as well as by the transfection of genomic DNA, but not 
by the transfection of 3P-dsRNA, was lost in cGAS-deficient cells (Fig. 5b,c), which 
demonstrated cGAS-mediated induction of an interferon-stimulated gene.
To verify that effect in primary cells, we also infected monocyte-derived macrophages, since 
these are particularly physiologically relevant for HIV infection. Again, we identified 
(−)ssDNA as the predominant DNA species in the cytosol-enriched fraction, with an even 
greater portion of (−)ssDNA than of (+)DNA (Fig. 5d); this confirmed both the presence and 
excess of ssDNA. While macrophages infected with RT(N265D) particles had slightly more 
(−)ssDNA than did cells infected with wild-type particles (Fig. 5d), the abundance of (+)-
strand DNA was reduced in the former cells, which led to a significantly lower ratio of (+) 
strand to (−) strand (Fig. 5e). Notably, the induction of both IFNB1 and IFIT2 was greater in 
cells infected with the mutant RT(N265D) particles than in cells infected with wild-type 
particles (Fig. 5f,g), which demonstrated a correlation with the presence of the (−) strand 
rather than the (+) strand for the induction of IFN-β and interferon-stimulated genes and 
linked ssDNA to the recognition of early HIV-1 infection. Together these data offered 
evidence that (−)-strand ssDNA was the predominant DNA species detected by cGAS, at 
least during early stages of HIV-1 infection, and that the impairment of (+)-strand synthesis 
did not hinder the activation of cGAS. Furthermore, these data emphasized the importance 
of the detection of ssDNA by cGAS in vivo.
Long ssDNA is highly immunostimulatory
Since the probability of forming cGAS-stimulating YSD structures increases with ssDNA 
length, we hypothesized that the induction of IFN-α/β might correlate with length of the 
HIV (−)ssDNA strand. Thus, we established a protocol to enrich very pure ssDNA from 
PCR products comprising the first 180 or 381 nucleotides of the (−) strand emerging during 
infection with HIV-1 strain HXB2. Here, we combined digestion of the (+) strand with 5′ 
phosphate–dependent λ-exonuclease with purification via biotin-mediated immobilization 
and digestion with a dsDNA-specific restriction enzyme (Supplementary Fig. 6a). Using 
this protocol, we produced very pure ssDNA (≥100-fold excess of (−) strand over (+) 
strand), with each product appearing as one prominent band by PAGE (Supplementary Fig. 
6b). Stimulation of monocyte-derived macrophages with these ssDNA species revealed a 
correlation between length and immunoactivity that culminated in the induction of IFN-α by 
the 381-nucleotide species that was comparable to that induced by G3-YSD and was even 
greater than that induced by human genomic DNA (Fig. 6a). This indicated that long 
ssDNAs emerging during HIV-1 infection could be as immunoactive as comparable dsDNA 
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sequences. In conclusion, these data supported the hypothesis that the detection of HIV-1 
depends on the recognition of ssDNA.
cGAS senses unpaired G in human retroelement sequences
We hypothesized that analogous to the detection of lentivirus, the recognition of ssDNA or 
YSD might be involved in the sensing of endogenous ssDNA derived from endogenous 
retroelements. These can accumulate and activate cGAS when the function of the cytosolic 
DNase TREX1 is impaired46,47, which leads to interferon-driven autoimmune diseases such 
as Aicardi-Goutieres syndrome. We assessed the immunstimulatory capacity of two long 
hairpin structures derived from endogenous retroelements (HERV-E and ERV3.1). Indeed, 
the structures with more unpaired guanosines (ERV3.1) elicited a mild IFN-α response in 
human PBMCs (Fig. 6b). This activity was abrogated upon mutation of guanosine in the 
unpaired stretches (Fig. 6b). Thus, our findings indicated that recognition of a G-YSD motif 
was also a possible mechanism for enabling the detection of single-stranded endogenous 
retroelements.
DISCUSSION
Length-dependent but not sequence-dependent recognition of cytosolic base-paired DNA 
has been reported7,11,19,29. By investigating the recognition of HIV-1 ssDNA stem-loop 
structures by the immune system, we have identified a hitherto-unknown cGAS recognition 
motif consisting of unpaired guanosines in Y-form DNA junctions (G-YSD). This motif 
rendered short (<20-bp), otherwise inert dsDNA highly immunostimulatory and was of 
particular importance in ligands compromised by limited duplex length, mismatches or 
bulges, such as the short stem-loop structures in single-stranded HIV-1 primary reverse 
transcripts. The predominance of cytosolic (−)-strand DNA and not (+)-strand DNA and its 
close correlation with the observed immunostimulation indicated that ssDNA might 
represent the main stimulus during early HIV-1 infection in macrophages, which are an 
important target of HIV.
Unpaired guanosines in YSD promoted high cGAMP-synthase activity of purified cGAS. 
Since we were able to exclude the possibility of effects of G-quadruplex self-assembly, 
stability or transfection, guanosines most probably activated cGAS itself. Although 
sequence-independent activation of cGAS by various DNA types (plasmids, PCR products 
and genomic DNA) would indicate internal binding of DNA duplexes, crystal-structure 
studies are less conclusive at present28,29. Here, two cGAS molecules formed a tight 2:2 
conformation with two DNA duplexes, which made internal binding to long DNA sterically 
unfavorable, since strand assembly would lead to duplex collision. Thus, binding of cGAS 
to DNA ends seems more plausible. Alternatively, a specific guanosine-cGAS (base-protein) 
interaction might be a plausible mechanism. Notably, although the in vitro cGAMP-
synthesis assay with cGAS truncated at the amino terminus generally correlated with 
activation in cell-based assays, the sequence-specific effect was much more pronounced in 
the cellular ‘read-out’. Therefore, we cannot exclude the possibility of a contribution by the 
cGAS amino terminus or a co-receptor (for example, PQBP1)48 to the recognition of G-
YSD.
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Lentiviral genomic (+)-strand RNA is rich in adenosine with a low proportion of cytidine, 
especially in unpaired regions49–51, corresponding to a low guanosine content in (−)ssDNA. 
Several mechanisms for selective pressure toward the elimination of cytidine in HIV-1 RNA 
have been proposed, including mutational bias of reverse transcriptase, avoidance of 
transcriptional silencing by methylation of CpG motifs, and detection by cytidine 
deaminases of the APOBEC family or TLR9 (ref. 50). Our results might also link the 
recognition of ssDNA by cGAS to this elimination process. Notably, cGAS is the main 
sensor of HIV-1 in myeloid cells, and a rapid and sustained IFN-α/β response in dendritic 
cells has been linked to an effective HIV-1-specific CD8+ T cell response52. Notably, the 
proportion of cytidine in the conserved, highly-structured HIV-1 long terminal repeats 
appears to be normal50. Here, RNA structure–dependent functions might limit mutagenesis 
and thereby preserve these cGAS recognition sites.
Apart from the detection of retroviruses, the YSD motif–dependent recognition of ssDNA 
by cGAS might be responsible for the elevated levels of IFN-α/β observed in Aicardi-
Goutieres syndrome and other auto-inflammatory disorders with impaired function of 
TREX1. TREX1 degrades endogenous cytosolic DNA derived mainly from single-stranded 
endogenous retroelements, including the long terminal repeat segments of endogenous 
retroviruses46. TREX1 deficiency thus leads to the accumulation of cytosolic DNA and the 
induction of a STING-cGAS–dependent IFN-α/β response47,53. We assessed two ssDNA 
stem-loop structures derived from endogenous retroviral long terminal repeats and found 
that one induced IFN-α/β via the detection of unpaired guanosines. Thus, endogenous 
ssDNA might also be sensed via the YSD-recognition motif.
In conclusion, cGAS can sense very short dsDNA sequences containing guanosines in Y-
form DNA (YSD recognition), and this PAMP enables the detection of ssDNA in the 
reverse transcripts of exogenous or endogenous retroviruses. Thus, we propose two distinct 
mechanisms for the cGAS-mediated recognition of DNA: While a base-paired stem of 12 bp 
or more is a necessary prerequisite, the additional presence of either a stem length of at least 
40 bp (ISD recognition) or guanosines in Y-form junctions (YSD recognition) is sufficient 
for the activation of cGAS. Nevertheless, it remains to be determined whether the 
recognition of ISD and YSD results in similar or distinct modes of cGAS activation.
ONLINE METHODS
Ethics statement
The studies of human PBMCs were approved by the local ethics committee 
(Ethikkommission der Medizinischen Fakultät Bonn) according to guidelines of the 
International Conference on Harmonisation of Technical Requirements for Registration of 
Pharmaceuticals for Human Use and Good Clinical Practice. Written informed consent was 
provided by voluntary blood donors.
Stimulatory nucleic acids
Synthetic DNA was obtained from Metabion, IDT, Invitrogen or EUROGENTEC 
(deazaguanosine-DNA). pDNA (pBluescript) was isolated from transformed Escherichia 
coli K12 with a PureLink HiPure Plasmid Filter Maxiprep Kit (Life Technologies). 
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Poly(dAdT) was obtained from Sigma-Aldrich. 3P-dsRNA (in vitro transcript 4 (IVT4)) was 
prepared as described9. DNA was hybridized in 25 mM Tris-HCl, pH 7.4 and 25 mM NaCl. 
DNA was heated to 72 °C for 5 min and was then cooled to 18 °C at a cooling rate of 1 °C/
min. DNA with a melting temperature of >70 °C was heated to 95 °C and then was cooled to 
18 °C at a cooling rate of 1 °C/min.
Cell culture and stimulation
Cell lines were cultured in RPMI-1640 medium (THP-1 cells) or DMEM (HEK293T cells 
(immortalized mouse macrophages54); Gibco), supplemented with 10% FCS and penicillin/
streptomycin (standard medium; Gibco). Human PBMCs were isolated from buffy coats 
derived from human blood from healthy, voluntary donors by Ficoll-Hypaque density-
gradient centrifugation (Biochrom). Monocytes were generated from PBMCs by magnetic 
cell sorting of CD14+ cells (Miltenyi Biotec). Human macrophages were differentiated in 
vitro from CD14+ monocytes in the presence of recombinant cytokine GM-CSF (50 U/ml) 
in standard RPMI-1640 medium. The generation of CD14hiCD80hiCD163− M1-polarized 
macrophages was confirmed by flow cytometry after 5 d (BD Biosciences).
For stimulation experiments, 4 × 105 PBMCs, 2 × 105 monocytes 1.5 × 105 macrophages or 
6 × 104 THP-1 cells per well were seeded into 96-well plates in standard RPMI-1640 
medium. For prevention of TLR9 activation, PBMCs were incubated in 2.5 μg/ml 
chloroqine 30 min before stimulation. Cells were stimulated for 20 h (PBMCs, monocytes or 
THP-1 cells) or 36 h (monocyte-derived macrophages). Nucleic acid stimuli were used at a 
final concentration of 0.8 μg/ml (PBMCs, monocytes or monocyte-derived macrophages) or 
1.3 μg/ml (THP-1 cells; immortalized mouse macrophages). RNA and DNA stimuli were 
used in complex with Lipofectamine 2000 (Invitrogen). Secretion of IFN-α was measured 
with ELISA kits supplied by eBioscience. Human IFN-α/β activity was quantified by 
incubation of the IFN-α/β-sensing reporter cell line HEK-Blue IFN-α/β (Invivogen) with 
supernatants of stimulated cells. Upregulation of Ifnb1 mRNA in immortalized mouse 
macrophages was detected by quantitative PCR 6 h after stimulation. The induction of 
IFNB1 or IFIT2 mRNA in infection experiments was measured 4 h after infection or 
transfection (described below in the subsection entitled “Infection of monocyte-derived 
macrophages and THP-1 cells”).
PAGE of nucleic acids
Samples were separated by electrophoresis through native polyacrylamide gels (15%) in 
KCl-supplemented TBE buffer (45 mM Tris-borate, pH 8.0, 1 mM EDTA and 20 mM KCl) 
at 12.5 V/cm and 4 °C. DNA was annealed in a buffer of 100 mM KCl, 10 mM Tris-HCl, 
pH 8.0, and 1 mM EDTA; 1 μg DNA was loaded per lane and, after electrophoresis, DNA 
was stained with methylene blue. For denaturing PAGE, nucleic acids or proteinase K–
digested lysate (described below in the subsection entitled “Detection of cytosolic 5′ 
IRD700–labeled DNA”) were denatured for 10 min at 65 °C (long ssDNA) or for 5 min at 
90 °C (short DNA duplexes) in an excess of formamide supplied with Orange G and then 
were ‘snap-cooled’ on ice. Samples were loaded onto a TBE-buffered 6% polyacrylamide 
gel (long ssDNA) or 15% polyacrylamide gel (short DNA duplexes) containing 48% (wt/
vol) urea and the gel was run at 12.5 V/cm and 18–20 °C. DNA was detected by infrared 
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fluorescence of the 5′-linked dye IRD-700 (described below) or by staining with GelRed or 
GelGreen (Biotium).
Circular dichroism spectroscopy
Circular-dichroism spectroscopy was recorded on a Jobin–Yvon Dichrograph model CD6 in 
a 1-cm quartz cell. For measurement of circular-dichroism, DNA was resolved in NaCl 
buffer (150 mM NaCl and 10 mM TRIS-HCl, pH 8) and was subsequently heated to 70 °C.
Detection of cytosolic 5′ IRD-700–labeled DNA
THP-1 cells seeded into 24-well plates (3 × 105 cells per well) were transfected with 1 μg 
hybridized DNA labeled at the 5′ end with IRD-700 (Metabion), followed by incubation for 
4 h or 8 h. The cells were washed with PBS and then were lysed for 5 min on ice with 40 μl 
NP40 buffer (25 mM Tris-HCl, pH 7.4, 1 mM MgCl2, 5 mM KCl, 0.5% NP-40 and 10 mM 
EDTA). Nuclei were precipitated by centrifugation at 300g (5 min at 4 °C), then 
supernatants were cleared by another centrifugation step at 5,000g (5 min at 4 °C). Lysates 
(5 μl each) were mixed with 5 μl proteinase K mix (1% (wt/vol) SDS, 20 mM EDTA, 60 
mM Tris-HCl, pH 6.8, and 0.2 mg/ml proteinase K), followed by digestion for 20 min at 50 
°C, then by heat inactivation for 10 min at 90 °C. Samples were separated by electrophoresis 
through denaturing gels, and IRD-700 fluorescence was detected with an Odyssey Imaging 
System (Li-COR). Loading controls were prepared as follows: hybridized DNA (2.5 ng) was 
mixed with 5 μl proteinase K mix and then was incubated, denatured with formamide and 
separated by electrophoresis as described above.
DNA interaction assays
FLAG-tagged proteins were expressed by transient transfection into HEK293T cells (seeded 
in six-well plates) via CaPO4 complexes. After 24 h, the cells were mechanically detached 
and then were resuspended in ice-cold PBS, precipitated and washed. Cells were lysed in 
DNA lysis buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl, 10% (vol/vol) 
glycerol, 0.3% (vol/vol) Triton X-100, 1× Phosphatase-Inhibitor-Cocktail and 1× complete 
protease inhibitor (Roche); 100 μl per six wells), then nuclei were precipitated for 30 min at 
20,000g and 4 °C. Hybridized DNA tagged with biotin at the 3′ end (5 μg ssDNA, or 10 μg 
dsDNA) was incubated for 30 min at 18–20 °C with 30 μl supernatant. Neutravidin beads 
(10 μl per reaction; Thermo Scientific) were washed twice with DNA lysis buffer and were 
loaded onto polyethylene filter columns (0.8 ml; Thermo Scientific). DNA-lysate mixes 
were added, followed by incubation for further 2 h. After that, the columns were opened at 
the bottom and the supernatant was collected in a 1.5 ml reaction tube. The beads were 
washed twice with DNA lysis buffer and once with DNA lysis buffer with a higher NaCl 
concentration (300 mM). Bound proteins were eluted for 30 min at 40 °C with Lämmli 
buffer (40 μl per reaction). A volume of 15 μl eluate or 3 μl cell lysate was assessed by 
standard immunoblot analysis with the monoclonal antibody ANTI-FLAG M2-Peroxidase 
(Sigma). The interaction assay analyzing the binding of the HIN domain of IFI16 to DNA in 
solution was performed as described55.
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cGAS in vitro activity assay
For in vitro reactions of cGAS in the presence of varying dsDNA stimuli, 2 μM recombinant 
human cGAS (truncated version: residues 155–522) was mixed with 88 ng/μl hybridized 
DNA, 0.1 mM ATP and 0.1 mM GTP in buffer A (100 mM NaCl, 40 mM Tris, pH 7.5, and 
10 mM MgCl2). After 90 min of incubation at 37 °C, the reaction mixture was analyzed by 
reverse-phase HPLC. Samples were prepared in 300 mM triethylammonium acetate, then 
were applied to a 4.1- × 250-mm PRP-1 column (Hamilton) and separated for 18 min at a 
flow rate of 1 ml/min in an isocratic gradient of 100 mM ammonium acetate.
RNAi
THP-1 cells were transfected by electroporation with siRNA at 72 h (Fig. 3a and 
Supplementary Fig. 2b) or 48 h (Fig. 3e) before stimulation. The siRNAs with 3′ dTdT 
modification (Biomers) targeted the following sequences: STING.1, 5′-
GGCAUCAAGGAUCGGGUUU-3′; STING.2, 5′-GGUCAUAUUACAUCGGAUA-3′; 
MAVS, 5′-UUAAAGGAGUUUAUCG AUGUA-3′; cGAS.2, 5′-
GGAAGAAAUUAACGACAUU-3′; cGAS.3, 5′-GAAGA AACAUGGCGGCUAU-3′; 
cGAS.4, 5′-AGAGAAAUGUUGCAGGAAA-3′; IFI16.2, 5′-
UCAGAAGACCACAAUCUAC-3′; IFI16.3, 5′-GGUGCUGAACGCA 
ACAGAAUCAUUU-3′; and controls, 5′-CAUAAGGCAAUGAAGAGAUAG-3 ′ 
(luciferase; Fig. 3a) or 5′-GCACCCCAAUAACGAGCUU-3′ (no target; Fig. 3e and 
Supplementary Fig. 2b). mRNA expression at the time point of stimulation was analyzed 
by quantitative PCR.
Quantitative PCR (RNA detection)
Cells were lysed in 350 μl RLT buffer (Qiagen), then 350 μl 70% ethanol was added and the 
mixture was loaded onto a Zymo-SpinTM IIIC column. The column was washed 
sequentially with 350 μl buffer RW1 (Qiagen) and 350 μl Zymo RNA Wash buffer (Zymo). 
The columns were dried by centrifugation and RNA was eluted with desalted RNase-free 
water. For the detection of mouse Ifnb1 mRNA, 1 h of on-column digestion (at 18–20 °C) 
with DNase I (Zymo) and an additional wash step (500 μl Zymo RNA Wash buffer) were 
included after the application of Zymo RNA Wash buffer. cDNA was synthesized with a 
RevertAid RT Kit according to the manufacturer’s protocol (Thermo Scientific), with 
random hexamers. Quantitative PCR was performed with EvaGreen QPCR-Mix II (ROX) 
(Biobudget) in an ABI7900HT cycler (primer sequences, Supplementary Table 2).
Lentiviral particles
Lentiviral particles containing wild-type reverse transcriptase or the mutant RT(N265D) 
reverse transcriptase were produced by cotransfection of HEK293T cells (by the calcium 
phosphate method) with expression plasmids encoding vesicular stomatitis virus 
glycoprotein (pVSV-G), HIV-1 transactivator of transcription (Tat) (pcTat), or regulator of 
the expression of virion proteins (Rev) protein of Rous sarcoma virus (pRev). HIV-1 group-
associated antigen and polymerase (Gag-Pol) sequence encoding wild-type reverse 
transcriptase (pMDL) or the mutant RT(N265D) reverse transcriptase (pMDL-N256D), and 
a lentiviral reporter construct expressing green fluorescent protein under the control of a 
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cytomegalovirus promoter (pHR-CMV-GFP W Sin18) at a ratio of 1.5:1:1:3.5:3.5. For all 
transfection, the culture medium was replaced after 6 h. The supernatants were harvested 48 
h after transfection, then were filtered (0.4 μm) and then purified by ultracentrifugation (90 
min at 175,000g) with a sucrose cushion (20% sucrose, 10 mM Tris, pH 7.5, 1 mM EDTA 
and 100 mM NaCl), separated into aliquots and frozen at −80 °C. Reporter viruses were 
‘titrated’ on HEK293T cells, and green fluorescent protein–positive cells were quantified at 
72 h after infection by flow cytometry. In addition, particles containing wild-type or 
RT(N265D) reverse transcriptase were also normalized for the amount of p24 capsid 
protein, measured by ELISA (Innogenetics). The mutation encoding the N265D reverse 
transcriptase mutant44 was introduced by cloning of a fusion PCR product into the AgeI and 
MfeI sites of the Gag-Pol gene of pMDL.
Infection of monocyte-derived macrophages and THP-1 cells
For infection, THP-1 cells (1 × 105 cells per well) or monocyte-derived macrophages (1.5 × 
105 cells per well) were seeded into 96-well plates. Cells were preincubated for 2 h with 
Vpx-delivering virus-like particles and then were infected with lentiviral particles containing 
wild-type reverse transcriptase at a multiplicity of infection of 1 (THP-1 cells) or 0.67 
(monocyte-derived macrophages; 1 × 105 infectious units per well). Infection with lentiviral 
particles generated with the N265D mutant reverse transcriptase was adjusted according to 
the concentration of p24 (details in figure legends and Results). At 4 h after infection, cells 
were washed twice with PBS and then were gently lysed for 5 min on ice in Nonidet-P40 
buffer (0.1 M NaCl, 10 mM Tris, pH 8, 2 mM EDTA, 1% β-mercaptoethanol and 0.5% 
Nonidet-P40). Nuclei were precipitated by centrifugation at 300g for 5 min at 4 °C, and the 
supernatant cleared by further centrifugation at 5,000g for 5 min at 4 °C. Supernatants were 
diluted in RLT buffer (Qiagen) and nucleic acids were isolated by a standard RNA-
purification protocol (described above in the subsection entitled “Quantitative PCR (RNA 
detection)”). This protocol did not markedly affect DNA yield compared with results 
obtained by other protocols (data not shown).
Strand-specific detection of HIV reverse transcripts
Specific detection of HIV (+) and (−) strands included two steps: first, introduction of a 
strand-specific linker by reaction with DNA polymerase I without exonuclease activity 
(Klenow exo ), and second, linker-specific quantitative PCR. For the strand-specific 
quantitative PCR (first step), linker-introducing primers (3 ′ Linker-LTR.1 for (+)-strand 
detection; 5′ Linker-LTR.2 for (−)-strand detection; Supplementary Table 2) were used for 
first-strand synthesis. Here, cytosolic nucleic acid extracts, mixed with the respective linker 
primer (4 μM), in 1× FastDigest Buffer (Thermo Scientific), were heated to 95 °C for 5 min, 
then were cooled to 37 °C. Next, dNTPs (final concentration, 0.1 mM each) and Klenow 
exo–(1 U/10 μl; Thermo Scientific) were added in 1× FastDigest Buffer for the initiation of 
first-strand synthesis. After incubation for 15 min at 37 °C, the reaction was stopped by 
incubation for 10 min at 95 °C.
For the second step, the reaction mix was diluted 1:2 in water and used for quantitative PCR 
as described for classic quantitative PCR, except that a two-step PCR-protocol was used (50 
s at 72 °C and 15 s at 95 °C for each cycle). Primers were 3′-Linker+5′LTR.3 for (+)-strand 
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detection and 5′Linker+3′LTR.4 for (−)-strand detection (Supplementary Table 2). In each 
experiment, serial dilution of a plasmid (Sigma SHC003) was used as a standard in the 
Klenow reaction and quantitative PCR. Copy numbers were normalized to the number of 
mitochondrial genome copies, determined by classic three-step quantitative PCR.
Preparation of ssDNA from PCR products
PCR products were amplified from gBlocks long synthetic DNA (IDT) by Dreamtaq 
polymerase (Thermo Scientific), with (−)-strand primers comprising a 5′ biotin tag, 5 
phosphothioate linkages at the 5′ end and a ApaI restriction site, followed by a sequence 
complementary to the HIV-1 RNA genomic sequence immediately 5′ of the original primer-
binding site (identical to the 3′ end of the genomic RNA). The (+)-strand primers had a 5′ 
phosphate and were derived from the (+)strand sequence 180 bp or 381 bp from the 3′ end 
of the RNA genome. Primer sequences are in Supplementary Table 2. PCR products were 
purified with an AnalytikJena PCRpure kit and were digested for 30 min with Lambda 
Exonuclease (Thermo Scientific), followed by heat inactivation for 10 min at 95 °C. DNA 
was diluted in PBS and then was coupled to NeutrAvidin beads overnight at 4 °C. Beads 
were spun down (3800g and 4 °C for 30 s), then were resuspended in 1× FastDigest buffer 
containing FastDigest ApaI, followed by incubation for 15 min at 37 °C. PBS was added in 
excess, and the beads were incubated again for 2 h at 4 °C. The beads were washed with 
PBS twice, then were resuspended in 1× FastDigest Buffer containing ApaI anti-sense DNA 
oligonucleotide and were incubated for 30 min at 18–20 °C. Then, FastDigest ApaI was 
added again and the beads were incubated for 30 min at 37 °C. The ssDNA was again 
purified with an AnalytikJena PCRpure kit. Single-strandedness was controlled by strand-
specific quantitative PCR (a ratio of (−) strand to (+) strand >100) and quality was assessed 
by denaturing gel electrophoresis (6%).
Statistical analysis
If not stated otherwise, statistical analysis was performed by repeated-measures two-sided, 
one-way ANOVA with data matched according to donor (PBMCs) or the same experiment 
(cell lines) with GraphPad Prism 6. If the P value calculated by ANOVA was considered 
significant (<0.05), individual comparisons were corrected for multiple comparisons by 
Tukey’s post-hoc test (if not stated otherwise).
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Figure 1. 
Immunostimulation by stem-loop-forming structures in HIV-1 sstDNA depends on unpaired 
guanosines flanking the stem. (a) mFOLD model of HIV-1 sstDNA, the primary lysyl-tRNA 
(tRNALys3)-primed reverse transcript of the 5′ untranslated region (R-U5). Gag-Pol and 
Env, regions encoding HIV-1 group-associated antigen (Gag), polymerase (Pol) and 
envelope (Env) proteins; U3-R, 3′ untranslated region and repeat. (b–j) Enzyme-linked 
immunosorbent assay (ELISA) of IFN-α in supernatants of chloroquine-treated human 
PBMCs 20 h after treatment with medium alone (Med) or transfection of genomic DNA 
(gDNA) or wild-type stem-loop structures SL1, SL2 or SL3 (b), or of wild-type SL2 (c–j) or 
a combination of SL2 and SL3 (SL2+3) (c), SL2 with introduced C:G base pairs (SL2 
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+G:C) or A:T base pairs (SL2 +A:T) (d), SL2 with mismatches and bulges removed from 
the stem (SL2 ds) (e), SL2 (SL2 blunt) or the SL2 mutant in e (SL2 ds blunt) with single-
stranded parts removed (f), SL2 with substitution of guanosines (SL2 ΔG) or conversion of 
various nucleotides (color loops) to guanosine (SL2+G) in the loop as well as the 3′ and 5′ 
ends (g), the combined SL2 plus SL3 in c with (SL2+3 ΔG) or without (SL2+3) substitution 
of unpaired guanosines (h), the SL2 mutant in e with (SL2 ds ΔG) or without (SL2 ds) 
substitution of unpaired guanosines (i), or SL2 with conversion of various nucleotides (color 
loops) to guanosine (SL2+G), removal of mismatches and bases (SL2 ds) or a combination 
of those changes (SL2 ds+G) (j). Below plots (b–j), mFOLD models of secondary structures 
(sequences, Supplementary Table 1): colors indicate mutations (key; ‘N’ is any base.); 
letters adjacent to stems indicate bases removed. NS, not significant (P > 0.05); *P ≤ 0.05; 
**P ≤ 0.01 and ***P ≤ 0.001 (one-way analysis of variance (ANOVA) followed by Fisher’s 
least-significant difference LSD test.). Data are pooled from two (b,d,e,g–j) or four (c,f) 
experiments with two biological replicates in each (mean and s.e.m. of n = 4 donors 
(b,d,e,g–j; same experiments) or n = 8 donors (c,f; same experiments)).
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Figure 2. 
Guanosine extensions render short DNA duplexes highly immunostimulatory. (a,b) ELISA 
of IFN-α in the supernatant of chloroquine-treated human PBMCs 20 h after treatment with 
medium alone or transfection of genomic DNA (as in Fig. 1) or the SL2 variant with 
mismatches and bulges removed from the stem (SL2 ds) and with a closed loop (first and 
third bars) or open loop (second and fourth bars) comprising the unmodified unpaired 
regions (first and second bars) or with conversion of various nucleotides to guanosine (as in 
Fig. 1j; third and fourth bars) (a) or with short duplexes comprising variants of single-
stranded regions (first bar as in the third bar in a; second bar as in the fourth bar in a; third 
bar with G3 at each end) as well as different stem elements (third, fourth and fifth bars), 
randomized stem sequence (R) or palindromic stem sequence (P) (b). (c) ELISA of IFN-α in 
chloroquine-treated human PBMCs as in a,b, transfected with palindromic G3-YSD, A3-
YSD, T3-YSD or C3-YSD, or with G3-YSD hybridized to C3-YSD or T3-YSD, the latter 
two at a twofold excess (‡); results are presented relative to those of cells transfected with 
G3-YSD, set as 100%. (d) ELISA of IFN-α in chloroquine-treated human PBMCs as in a,b, 
transfected with G3-YSD or YSD with various numbers and positions of unpaired G trimers 
flanking 20-nucleotide dsDNA (presented as in c). (e) ELISA of IFN-α in chloroquine-
treated human PBMCs as in a,b, transfected with G3-YSD of various duplex lengths (12–28 
bp) or with poly(dAdT) (AT); results are presented relative to those of cells transfected with 
G3-YSD with a 20-bp duplex, set as 100%. (f) ELISA of IFN-α in chloroquine-treated 
human PBMCs as in a,b, transfected with G3-YSD of various bulge-loop sizes in the base-
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paired region. Below plots, models of secondary structures (sequences, Supplementary 
Table 1); numbers adjacent to stems indicate stem length. ND, not detectable. NS, not 
significant (one-way-ANOVA followed by Fisher’s least-significant difference test). Data 
are pooled from two (a–c,e,f) or three (d) experiments with one or two biological replicates 
in each (mean and s.e.m. of n = 4 donors (a–c,f), n = 5 donors (d) or n = 3 donors (e)).
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Figure 3. 
Induction of IFN-α/β by Y-form DNA is independent of the G quadruplex. (a) G-quadruplex 
assembly: four guanosines form a planar structure, mediated by hydrogen bonds and 
stabilized by a central cation (gray). R, deoxyribose backbone. (b) Structures and sequences 
of YSD or short blunt DNA used in c–e. (c) Native PAGE of Gn-YSD variants (numbers 
above lanes correspond to models in b). (d) Circular-dichroism melting curve at 295 nm, 
with the ellipticity of YSD variants or blunt-end DNA (numbers in parentheses and 
diagrams at left match those in b) measured at 30–70 °C. (e) ELISA of IFN-α in 
supernatants of chloroquine-treated human PBMCs 20 h after transfection of Gn-YSD 
variants (numbers and diagrams below plots match those in b); results are presented relative 
to those of cells transfected with G3-YSD variant 3 (left) or variant 5 (right), set as 100%. (f) 
ELISA of IFN-α (bottom) as in e, after transfection of 26-nucleotide G2-YSD with stepwise 
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substitution of terminal guanosines (G) with deazaguanosine (Z; left) or inosine (i; right); 
top, chemical structure of 2′-deoxy-7-deazaguanosine and 2′-deoxy-inosine. Numbers 
adjacent to stems (b,d–f) indicate stem length (sequences of DNA structures, 
Supplementary Table 1). Data are representative of two experiments (c,d) or are pooled 
from two (e, f, right) or three (f, right) experiments with one or two biological replicates in 
each (e,f; mean and s.e.m. of n = 3 donors (e), n = 6 donors (f, left) or n = 4 donors (f, 
right)).
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Figure 4. 
G-YSD activates the cGAS-STING axis. (a) IFN-α/β activity in supernatants of THP-1 cells 
treated with control siRNA or siRNA targeting MAVS or STING (either of two target 
sequences (STING.1 or STING.2)) (key) and then, 72 h later, stimulated for 20 h with the 
RIG-I ligand 3P-dsRNA, plasmid DNA (pDNA), G3-YSD or C3-YSD; results are presented 
relative to those of THP-1 cells treated with control siRNA and stimulated with G3-YSD, set 
as 100%. (b) Secondary structures of biotinylated DNA duplexes used in interaction assays 
in c,d: G3-YSD or C3-YSD, or short, 26-nucleotide (26-mer) or long, 79-nucleotide (79-
mer) blunt dsDNA. (c) Immunoblot analysis of Flag-tagged receptor candidates (left 
margin) with lysate alone (0.1 volume of the lysate used in the precipitation assays; Input) at 
the beginning (0 h) of the assay (far left lane) or after precipitation (Ppt) with empty beads 
(middle left lane) or with G3-YSD or C3-YSD (above lanes; as in b). (d) Immunoblot 
analysis of Flag-tagged IFI16 or cGAS or of the nonspecific DNA-binding control Ku80 
with lysate alone (Input) at the beginning (0 h) or end (2.5 h) of the experiment, or after 
precipitation with empty beads, G3-YSD, C3-YSD (as in c), or with short (26-nucleotide) or 
long (79-nucleotide) blunt dsDNA (as in b) (above lanes). ‡, lysate and precipitate detection 
are from the same blot with one empty lane removed. (e) IFN-α/β in supernatants of THP-1 
cells treated with control siRNA or siRNA targeting cGAS (one of three target sequences 
Herzner et al. Page 25
Nat Immunol. Author manuscript; available in PMC 2015 December 03.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
-119-
(cGAS.2, cGAS.3 or cGAS.4)), MAVS or STING (horizontal axes) and then, 48 h later, 
stimulated for 20 h with G3-YSD (top) or plasmid DNA (bottom); results are presented 
relative to those of THP-1 cells treated with control siRNA, set as 100%. (f) HPLC detecting 
the conversion of ATP and GTP to cG2′5′AMP (cyclic [G(2′,5′)pA(3′,5′)p]) by cGAS in the 
presence of ISD, G3-YSD, C3-YSD or the 26-nucleotide blunt DNA (without biotin) in b, 
presented (in milli-absorption units (mAU)) as absorption at 254 nm (A254). Sequences of 
DNA structures, Supplementary Table 1. *P ≤ 0.01 and **P ≤ 0.001, presented only for 
results significantly different from control (two-way ANOVA followed by Bonferroni’s 
post-hoc test (a) or one-way ANOVA followed by Tukey’s post-hoc test (e)). Data are 
pooled from three (a,e, bottom) or four (e, top) independent experiments with biological 
replicates (mean and s.e.m.) or are representative of three experiments (c,d,f).
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Figure 5. 
The interferon response induced by HIV-1 infection correlates with the presence of (−)-
strand DNA but not with the presence of (+)-strand DNA. (a) Strand-specific quantitative 
detection of the HIV-1 (+) strand and (−) strand (key) in cytosol-enriched nucleic acid 
preparations of wild-type (WT) or cGAS-deficient (cGAS-KO) THP-1 cells 4 h after 
infection with HIV-1 particles containing wild-type (HIV: WT) or mutant (HIV: N265D) 
reverse transcriptase or without infection (HIV: −); results are presented as ssDNA copies 
per mitochondrial genome (mit gen). (b,c) IFIT2 mRNA in THP-1 cells 4 h after treatment 
as in a (b) or after transfection of genomic DNA or 3P-dsRNA or treatment with medium 
alone (Med) (c); results are presented as copies of IFIT2 mRNA per copy of control GAPDH 
mRNA (c), or that value relative to the results of wild-type THP-1 cells infected with wild-
type particles (b). (d) Strand-specific quantitative detection of the HIV-1 (+) and (−) strand 
(key) in cytosol-enriched nucleic acid preparations of monocyte-derived macrophages 4 h 
after no infection (Med) or infection with HIV-1 particles as in a (presented as in a). (e) 
Ratio of (+) strand to (−) strand in d. (f,g) IFNB1 mRNA (f) and IFIT2 mRNA (g) in 
monocyte-derived macrophages 4 h after stimulation with HIV-1 particles as in a or 
transfection of genomic DNA or 3P-dsRNA; results are presented as copies of IFNB1 
mRNA (f) or IFIT2 mRNA (g) per copy of control GAPDH mRNA. *P ≤ 0.01 (ratio-paired 
t-test). Data are from three (a,b) i or two (c) independent experiments (mean and s.e.m.) or 
are pooled from two experiments with two biological replicates in each (d–g; mean and 
s.e.m. of n = 4 donors).
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Figure 6. 
Long ssDNA comprising the 5′-terminal HIV-1 (−)-strand sequence is highly 
immunostimulatory, and the recognition of endogenous retroelement-derived ssDNA 
depends on unpaired guanosines. (a) ELISA of IFN-α in supernatants of monocyte-derived 
macrophages 36 h after treatment with medium alone (Med) or transfection of genomic 
DNA, G3-YSD or ssDNA species of various lengths (116 nucleotides (ss-116; this is SL2 
plus SL3 as in Fig. 1c), 180 nucleotides (ss-180) or 381 nucleotides (ss-381)); results are 
presented relative to those of cells transfected with G3-YSD, set as 100%. (b) IFN-α in 
supernatants of chloroquine-treated PBMCs 24 h after treatment with medium alone (Med) 
or transfection of wild-type (WT) or mutant (ΔG) HERV-E or ERV3.1 (right), and mFOLD-
derived models of the secondary structures of HERV-E or ERV3.1 (left); circles indicate 
mutation of guanosine (black, G to C; gray: G to A). *P ≤ 0.05 (one-way ANOVA followed 
by Tukey’s post-hoc test). Data are pooled from two experiments with one or two biological 
replicates in each (mean and s.e.m. of n = 3 donors (a) or n = 4 donors (b)).
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3. Cytosolic RNA:DNA hybrids activate the cGAS–STING axis 
Mankan, A. K., Schmidt, T., Chauhan, D., Goldeck, M., Höning, K., Gaidt, M., Kubarenko, A. V., 
Andreeva, L., Hopfner, K. P., & Hornung, V. 2014. Cytosolic RNA:DNA hybrids activate the cGAS–
STING axis. The EMBO Journal, 33(24): 2937-2946. 
DOI: http://dx.doi.org/10.15252/embj.201488726 
URL: http://emboj.embopress.org/content/33/24/2937.export 
 
Summary 
This publication for the first time describes and characterizes RNA:DNA hybrids as cGAS activators. 
cGAS was discovered as a central sensor for cytosolic DNA driving type I IFN production. Since 
autoinflammatory disorders like Aicardi–Goutières syndrome (AGS) or systemic lupus erythematosus 
(SLE) are characterized by elevated type I IFN production in the serum and are associated with mutations 
in nucleic acids metabolizing enzymes SAMHD1, TREX1, RNase H2 and ADAR1, an involvement of 
cytosolic nucleic acids sensors in their development was hypothesized. cGAS was shown to be 
responsible for IFN signature in TREX1-deficient mice recognizing endogenous DNA molecules. Though 
TREX1 deficiency was reported to result in accumulation of reverse transcription products emerging from 
retroelements, the exact nature of these DNA species remains unclear. In this work poly(rA):poly(dT) 
RNA:DNA hybrids were found to stimulate type I IFN response in mouse and human cells, as measured 
by IFN-β mRNA synthesis, cytokine IP-10 production and with luciferase-reporter assays. Knock-out 
studies in THP-1 cells revealed such IFN response to RNA:DNA hybrids to be strongly dependent on 
intact cGAS-STING pathway. In vitro studies confirmed a direct activation of cGAS by RNA:DNA 
hybrids of different lengths. Intriguingly, RNA:DNA hybrids were found to activate cGAS less efficiently 
in comparison to dsDNA of the same length both in vitro and in the cell-based assays. Though a 
modelling of cGAS complexes with dsDNA and RNA:DNA hybrids revealed a strong similarity of cGAS 
binding modes, RNA:DNA decreased efficiency in cGAS activation might arise from insufficient or 
unsteady conformational change introduced to cGAS, in contrast to dsDNA binding. However, given a 
self-enhancing positive feedback loop, even small amounts of cGAMP produced by cGAS upon binding 
of RNA:DNA hybrids might be sufficient to induce a powerful innate immune response. Thus, this works 
introduces RNA:DNA hybrids as potent cGAS activators and offers a link between cGAS activation and 
retroelement and retroviral replication intermediates, as well as autoinflammation. 
Author contribution 
The author of this thesis expressed and purified recombinant human cGAS Mab-21 construct in a large-
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Article
Cytosolic RNA:DNA hybrids activate the
cGAS–STING axis
Arun K Mankan1, Tobias Schmidt1,†, Dhruv Chauhan1,†, Marion Goldeck2, Klara Höning1, Moritz Gaidt1,
Andrew V Kubarenko1,‡, Liudmila Andreeva3, Karl-Peter Hopfner3 & Veit Hornung1,*
Abstract
Intracellular recognition of non-self and also self-nucleic acids can
result in the initiation of potent pro-inflammatory and antiviral
cytokine responses. Most recently, cGAS was shown to be critical
for the recognition of cytoplasmic dsDNA. Binding of dsDNA to
cGAS results in the synthesis of cGAMP(20–50), which then binds to
the endoplasmic reticulum resident protein STING. This initiates a
signaling cascade that triggers the induction of an antiviral
immune response. While most studies on intracellular nucleic acids
have focused on dsRNA or dsDNA, it has remained unexplored
whether cytosolic RNA:DNA hybrids are also sensed by the innate
immune system. Studying synthetic RNA:DNA hybrids, we indeed
observed a strong type I interferon response upon cytosolic deliv-
ery of this class of molecule. Studies in THP-1 knockout cells
revealed that the recognition of RNA:DNA hybrids is completely
attributable to the cGAS–STING pathway. Moreover, in vitro studies
showed that recombinant cGAS produced cGAMP upon RNA:DNA
hybrid recognition. Altogether, our results introduce RNA:DNA
hybrids as a novel class of intracellular PAMP molecules and
describe an alternative cGAS ligand next to dsDNA.
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Introduction
The innate immune system has evolved to defend the host against
invading pathogens. An important prerequisite for this task is the
specific and reliable detection of different microbial pathogens as
non-self. This is achieved by a conserved set of germ-line-encoded
pathogen recognition receptors (PRRs) that have evolved to detect
so-called pathogen-associated molecular patterns (PAMPs) as
foreign. PRRs include, amongst others, Toll-like receptors (TLRs),
Nod-like receptors (NLRs) and RIG-I-like receptors (RLRs)
(Medzhitov, 2007).
Detection of virus-derived nucleic acids plays a central role in the
initiation of antiviral immunity. Nucleic acid recognition by PRRs
results in the secretion of type I interferon (IFN) cytokines and
IFN-stimulated genes (ISGs), which function to impede viral replica-
tion. For example, 50-triphosphorylated RNA is detected by the cyto-
plasmic RNA helicase RIG-I, whereas long double-stranded RNA is
sensed by its related family member MDA5. Both RIG-I and MDA5
signal via their shared signaling adapter molecule MAVS, located at
the mitochondrion (Goubau et al, 2013). In certain cell types, RNA
can also be detected by TLR7 and TLR8, located in the endolysoso-
mal compartment. While these receptors display a certain prefer-
ence for non-self RNA, they are in principle also responsive to
endogenous RNA molecules. However, under normal circum-
stances, their localization in the endolysosomal compartment
shields them from endogenous RNA molecules, thereby precluding
erroneous activation by self-molecules. A similar scenario holds true
for TLR9, which is also located in the endolysosome, detecting DNA
of certain sequence composition (CpG motifs) (Barbalat et al, 2011).
More recently, a cytosolic nucleotidyltransferase named cGAS
(cyclic GMP-AMP synthase) was identified as the key sensor
required for DNA recognition in the cytoplasm (Sun et al, 2013; Wu
et al, 2013). Upon binding to dsDNA, cGAS catalyzes the formation
of the cyclic dinucleotide (CDN) molecule cGAMP using ATP and
GTP as substrates. Unlike previously known prokaryotic CDNs, the
cGAS-derived CDN contains an unusual 20–50 phosphodiester link-
age between GMP and AMP, with its second phosphodiester linkage
being 30–50: >Gp(20–50)Ap(30–50)>(cGAMP(20–50)) (Ablasser et al,
2013a; Diner et al, 2013; Gao et al, 2013b; Wu et al, 2013; Zhang
et al, 2013). Upon formation, cGAMP(20–50) binds to the endoplas-
mic reticulum resident protein STING, which results in the activa-
tion of the TBK1/IRF3 pathway and as such the production of type I
interferons. Interestingly, cGAMP(20–50) is not only bound to exert
its antiviral activity within the cell it has been produced in, but it
can also be passed on to bystander cells via gap junctions. This, in
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turn, can then initiate antiviral immune responses in cells that have
not been in contact with a virus yet (Ablasser et al, 2013c).
As mentioned above, certain PRRs not only recognize pathogenic
components but can also sense self-molecules, once mislocalized in
the respective PRR compartment (Ablasser et al, 2013b). For exam-
ple, defects in cytoplasmic nucleases can result in the accumulation
of endogenous nucleic acids in the cytosol and thereby lead to the
activation of innate sensing pathways. Aicardi–Goutières syndrome
(AGS) is a rare but generally fatal childhood inflammatory condition
with neurological dysfunction, that is associated with increased
production of type I interferons (Crow, 2011; Lee-Kirsch et al, 2014).
This disease predominantly results from loss-of-function mutations
in nucleic acid metabolizing enzymes such as SAMHD1, TREX1,
Ribonuclease H2 (RNASE H2A, RNASE H2B, RNASE H2C) or ADAR1
(Gall et al, 2012; Lee-Kirsch et al, 2014). TREX1 deficiency in mice
has been shown to result in the accumulation of endogenous DNA
molecules, which can serve as ligands for the cGAS–STING axis and
as such initiate antiviral immunity (Gall et al, 2012; Ablasser et al,
2014). However, the exact nature of these ligands is currently not
known. On the other hand, ablation of the Rnaseh2b gene in mice
results in the incorporation of ribonucleotides in the genomic DNA;
however, a mechanistic link to PRR-mediated proinflammatory gene
expression has not been established (Reijns et al, 2012).
Intrigued by the possibility of cytosolic RNA:DNA hybrids serv-
ing as PAMP molecules on their own, we set forth to investigate the
immunostimulatory capacity of this class of molecules in cells
competent for both dsRNA and dsDNA sensing pathways.
Results
Intracellular RNA:DNA hybrids induce antiviral gene expression
Using in vitro transcribed RNA molecules (e.g. T7 RNA polymerase)
as templates for reverse transcriptase, RNA:DNA hybrids of different
lengths can easily be produced enzymatically. However, reverse
transcriptase also possesses DNA-dependent DNA polymerase activ-
ity and as such can generate dsDNA from the newly synthesized
ssDNA (Hsieh et al, 1993). Therefore, to faithfully exclude dsDNA
contamination in assessing the immunostimulatory capacity of
DNA:RNA hybrids, we made use of enzymatically generated homo-
polymers of poly(rA) and poly(dT). Annealing of poly(rA) and poly
(dT) resulted in the formation of a poly(rA):poly(dT) RNA:DNA
hybrid with a predominant band of around 1,300 bp (Fig 1A). To
confirm that this product indeed represented a RNA:DNA hybrid,
we performed dot-blot assays wherein membrane-immobilized
nucleic acids were probed with a monoclonal antibody (S9.6)
specific for RNA:DNA hybrids (Boguslawski et al, 1986; Hu et al,
2006). We observed a specific detection of the hybrid by the anti-
body, correlating with the amount of nucleic acids immobilized
(Fig 1B). Digestion of the hybrid with RNase A which digests
dsRNA, DNase I which digests dsDNA or ssDNA and RNase H
which digests RNA part of RNA:DNA hybrids provided further
confirmation regarding the purity of the hybrid. Thus, while the
RNA:DNA hybrid was completely digested by RNase H and DNase I
enzymes, it was resistant, as expected, to RNase A activity (Fig 1C).
Control experiments confirmed the specificity of these enzymes
on dsDNA or dsRNA, respectively (A.K. Mankan, unpublished
observations). In order to assess the biological activity of RNA:DNA
hybrids, we then transfected the poly(rA):poly(dT) hybrids or
the single components poly(rA) or poly(dT) into murine bone
marrow-derived macrophages. Transfection of the hybrids resulted in
a robust induction of type I IFNs and pro-inflammatory genes (Ifna,
Ifnb, Il6 and Ip10) (Supplementary Fig S1A). Of note, a significant
activity of poly(dT), by itself, was also observed for some readouts
studied (see discussion below). To assess the relevance of hybrids
in the human system, we next transfected hybrids or the individual
polynucleotide components into peripheral blood mononuclear
cells. RT–PCR confirmed enhanced expression of IFNB gene in
PBMCs transfected with hybrids (Fig 1D). Synthetic poly(dA):poly
(dT), which was transfected as a dsDNA control, showed higher
activity with regard to IFNB induction. We also observed a signifi-
cant secretion of IP-10 in response to the RNA:DNA hybrids, while
only a minimal IP-10 induction was seen in cells transfected with
the single polynucleotides (Fig 1E). We next tested the activity of
RNA:DNA hybrids in differentiated human THP-1 cells. In line with
the PBMC data, RNA:DNA hybrids induced robust transcription of
IFNB in THP-1 cells, again with dsDNA being more active (Fig 1F).
In order to have a sensitive readout for antiviral gene expression,
we equipped THP-1 cells with Gaussia luciferase (GLuc) under the
promoter of IFIT1, a well-characterized ISG that is also directly tran-
scribed upon PRR stimulation (Supplementary Fig S2A). Studying
pIFIT1-GLuc THP-1 in response to these different stimuli paralleled
the data obtained by measuring IFNB (Fig 1G). However, as
observed in the previous set of experiments, the transactivation of
the IFIT1 promoter in response to RNA:DNA hybrid was never as
strong as upon dsDNA transfection, also when compared over a
broad range of different ligand concentrations (Fig 1H). Interest-
ingly, assessing the production of the antiviral chemokine IP-10 in
response to these stimuli revealed a similar plateau for both hybrids
as well as dsDNA at higher ligand concentrations, most likely due to
the fact that this chemokine is induced by both PRR-dependent as
well as type I IFN-dependent mechanisms (Supplementary Fig S1B).
Altogether, these data indicated that intracellular RNA:DNA hybrids
are indeed sensed by the innate immune system, leading to strong
antiviral immune responses.
RNA:DNA hybrid detection is independent of MAVS but requires
the cGAS–STING axis
We next focused on the identification of the intracellular receptor
that was essential for mediating the RNA:DNA hybrid-induced
innate immune response. As RNA:DNA hybrids contain a single
polyribonucleotide molecule, we first assessed the involvement of
the RLR system as sensors of RNA-DNA hybrids. MAVS constitutes
the critical signaling adapter downstream of both RIG-I and MDA-5
and as such, MAVS-deficient cells are devoid of both RIG-I and
MDA5 signaling. We made use of the CRISPR/Cas9 gene editing
system to knock out MAVS in THP-1 cells. As such, we targeted a
critical coding exon to disrupt the reading frame and therefore the
expression of MAVS (Supplementary Fig S2B). Transfection of
differentiated wild-type (WT) THP-1 cells with RNA:DNA hybrids
resulted in increased IFNB, and a similar response was also
observed in MAVS knockout cells (Fig 2A). As expected, MAVS-
deficient THP-1 cells failed to respond to 50-triphosphate RNA,
whereas dsDNA-mediated activation of THP-1 cells was not affected.
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To study the involvement of the cGAS–STING axis in RNA:DNA
hybrid recognition, we next generated THP-1 cells deficient in either
STING or cGAS (Supplementary Fig S2C and D). Interestingly, we
did not observe any induction of IFNB in response to transfection of
RNA:DNA hybrids in differentiated STING or cGAS KO THP-1 cells
(Fig 2B–D). As anticipated, dsDNA-mediated IFNB induction was
also completely abrogated in cGAS/STING KO cells, whereas
50-triphosphate RNA detection was still intact. Similar results were
also observed for IL-6 (Supplementary Fig S3). These data suggested
that, next to dsDNA, cGAS also serves as the receptor for cytosolic
RNA:DNA hybrids.
RNA:DNA hybrids bind with cGAS and produce cGAMP
To confirm the direct recognition of RNA:DNA hybrids by cGAS, we
took advantage of the fact that cGAS-mediated activation can be
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Figure 1. Synthetic annealed poly(rA):poly(dT) hybrid induces type I interferon response.
A Synthetic poly(rA) (lane 1) and poly(dT) (lane 2) oligos were annealed, and the samples were run on a 1% agarose gel. Arrows indicate the annealed poly(rA):poly(dT)
(lane 3) RNA:DNA hybrid.
B Different amounts of synthetic annealed poly(rA):poly(dT) hybrid was spotted on a nitrocellulose membrane and probed with anti-hybrid S9.6 antibody.
C Poly(rA):poly(dT) was either undigested (1) or digested with DNase I (2), RNase A (3) or RNase H (4), and the digested samples were analyzed on a 1% agarose gel.
D Human peripheral blood mononuclear cells (PBMCs) were transfected with or without poly(rA), poly(dT) or poly(rA):poly(dT) hybrid or poly(dA):poly(dT) dsDNA for 6 h.
RT–PCR was performed to check for the expression of IFNB. Figure shows values from two biological replicates. Data plot shows mean with SEM.
E Human PBMCs from two different donors were transfected with or without poly(rA), poly(dT) or poly(rA):poly(dT) for 16 h, and the amount of secreted IP-10 was
measured by ELISA. Each experiment was performed in duplicate. Data plot shows mean with SEM.
F Differentiated human monocyte THP-1 cells were transfected with or without poly(rA):poly(dT) hybrid, poly(dA):poly(dT) dsDNA and RT–PCR was performed to check for
the expression of IFNB. Each experiment was performed in duplicate. Data are representative of one of two independent experiments. Data plot shows mean with SEM.
G Differentiated human monocyte THP-1 cells with Gaussia luciferase knockin under IFIT1 promoter were transfected with or without poly(rA):poly(dT) hybrid, poly(dA):
poly(dT) dsDNA and luciferase assay was performed. Data shown are from two biological replicates. Data plot shows mean with SEM.
H Differentiated human monocyte THP-1 cells with Gaussia luciferase knockin under IFIT1 promoter were transfected with different amounts of poly(rA):poly(dT) hybrid
or poly(dA):poly(dT) dsDNA and luciferase assay was performed. Data shown are from two biological replicates. Data plot shows mean with SEM.
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studied in vitro. To this effect, we incubated the single polynucleo-
tides (poly(rA) and poly(dT)) or the synthetic RNA:DNA hybrids
(poly(rA):poly(dT)) with recombinant cGAS in the presence of ATP
and GTP. Moreover, we included synthetic dsRNA (poly(rA):poly
(rU)) and synthetic dsDNA (poly(dA):poly(dT)) as controls. The
samples were incubated for 45, 90 or 180 min. Analysis of the RNA:
DNA/cGAS sample via HPLC revealed a peak correlating with the
expected peak for cGAMP(20–50) (Fig 3A). However, no such prod-
uct was observed upon the incubation of cGAS with dsRNA or any
of the single polynucleotide preparations (Fig 3C and Supplemen-
tary Fig S4A). Compared to dsDNA, RNA:DNA hybrids induced less
cGAMP, also when studying cGAMP production over time (Supple-
mentary Fig S4B). Several groups have recently used shorter length
synthetic ssRNA and ssDNA to generate hybrids and to study the
immune cell activation by these shorter hybrids. To confirm
whether such short hybrids can also activate cGAS–cGAMP path-
way, we used 60-bp synthetic poly(rA) ssRNA and poly(dT) ssDNA
oligos and generated RNA:DNA hybrids by annealing them (Fig 4A).
To verify whether these shorter oligos were functionally active, we
transfected them into pIFIT1-GLuc THP-1 cells and observed a
robust secretion of luciferase only in response to hybrids and dsDNA
(Fig 4B). As above, incubation of these shorter hybrids with recom-
binant cGAS clearly resulted in the formation of cGAMP (Fig 4C).
To understand the structural basis for the interaction of cGAS
with RNA:DNA hybrids, we generated protein–nucleic acid interac-
tion models in silico. Modeling of the complexes of cGAS with either
RNA:DNA hybrid, dsDNA or dsRNA revealed that RNA:DNA hybrid
could bind in the cleft of cGAS (regardless of the orientation of RNA
and DNA strands) exactly in the same mode as dsDNA. At the same
time, the dsRNA helix could not be accommodated in this cleft
(Fig 5A–D). Structural alignment of dsDNA, RNA:DNA hybrid and
dsRNA helixes showed that dsDNA and RNA:DNA hybrid molecules
have a similar conformation of their double-stranded helix with
similar shapes of their minor and major groves. While there was an
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Figure 2. Poly(rA):poly(dT) RNA:DNA hybrids-induced type I interferon response is cGAS dependent.
A–C WT THP-1, MAVS KO THP-1, STING KO THP-1 and cGAS KO THP-1 cells were transfected with or without poly(rA):poly(dT) (hybrid), poly(dA):poly(dT) dsDNA or
pppRNA for 6 h. RT–PCR was performed to check for the expression of IFNB. Data shown are from experimental duplicates representative of two independent
experiments. Data plot shows mean with SEM.
D WT THP-1 cells or cGAS KO THP-1 cells were transfected with or without poly(rA):poly(dT) (hybrid), dsDNA or pppRNA for 16 h, and amount of IP-10 secreted was
detected by ELISA. Data shown are from experimental triplicate, representative of three independent experiments. Data plot shows mean with SEM.
Data information: ***P < 0.0001, one-way ANOVA, Tukey’s multiple comparison test.
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obvious overlap between the orientation of the bases of RNA:DNA
hybrids and dsDNA, the shape of a dsRNA helix differs from both
the dsDNA and hybrid helices with the dsRNA helix being wider
(Fig 5E and F). It is likely that this prevents its proper binding into
the cGAS cleft and as such the conformational switch of cGAS that
is required for its nucleotidyltransferase activity. As RNA:DNA
hybrids can bind to cGAS in both orientations of the RNA chain, its
binding to cGAS should lead to the same switch-like conformational
changes of the activation loop, which are induced by dsDNA bind-
ing (Zhang et al, 2014) (Supplementary Fig S5). Altogether, these
data proved that RNA:DNA hybrids can serve as ligands initiating
cGAS activity.
Discussion
The presence of foreign nucleic acids or aberrant formation or trans-
location of self-nucleic acids triggers an immune response that is
dependent on the interaction of these nucleic acids with different
cytoplasmic PRRs. While the receptors and the subsequent path-
ways activated by intracellular dsDNA and dsRNA have been clearly
ascertained, it was not established whether cytosolic RNA:DNA
hybrids can also initiate immune responses. Here, we report that
cytoplasmic RNA:DNA hybrids can indeed induce potent antiviral
immune responses. Furthermore, we can ascribe the immunostimu-
latory activity of this ligand to the direct activation of the recently
established dsDNA sensor cGAS.
To address the immunostimulatory activity RNA:DNA hybrids in
the first place, it was important to obtain hybrids devoid of dsDNA
contamination. A critical confounding factor present when generat-
ing RNA:DNA hybrids using reverse transcriptase is the synthesis of
dsDNA from the first strand cDNA (Hsieh et al, 1993). To check for
this possibility, we digested our in vitro transcribed hybrid samples
with RNase H; however, we still observed some residual activation
suggesting the presence of dsDNA. Consequently, we decided to use
enzymatically generated long polynucleotides that could be
annealed to form RNA:DNA hybrids. Of course, there is no biologi-
cal correlate for this artificial duplex molecule; however, we
consider it a sound model ligand, given the fact that ligand receptor
interactions of double-stranded nucleic acids usually occur indepen-
dent of their nucleobase composition, but are rather dependent on
their tertiary structure.
Our in vitro studies using recombinant cGAS in conjunction
with different nucleic acids show that the amount of cGAMP
produced in response to the hybrids is not within the same range
as observed with dsDNA. We hypothesize that this could be due to
suboptimal activation of cGAS resulting from an inefficient confor-
mational switch that is required for its enzyme activity. However,
in a situation in which multiple signals are integrated by the cell
(e.g. IP-10 production), low levels of cGAMP production might be
sufficient to reach activity levels that are comparable to dsDNA
stimulation. Interestingly, in some cases, we also observed an
enhanced IFN response to single-stranded poly(dT) molecule while
no such response was observed for poly(rA). However, at the same
time, our in vitro data clearly demonstrate that poly(dT) by itself
cannot activate cGAS. As such, we consider it likely that this
weak, but consistent cGAS activation by poly(dT) in vivo is due to
the intracellular formation of a cGAS stimulatory ligand (Supple-
mentary Fig S6). While this phenomenon might not directly
involve poly(dT) as a ligand, we speculate that poly(dT) can form
DNA:RNA hybrids with endogenous poly(rA) in the context of
mRNA tails.
Aberrant activation of the immune system in response to self-
nucleic acids forms the basis for several chronic inflammatory
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diseases. Aicardi–Goutières syndrome (AGS), for example, is a rare
but generally fatal condition associated with increased type I inter-
feron production in the serum of respective patients. This condition
can result from mutations in genes encoding for the nucleic acid
metabolizing enzymes SAMHD1, TREX1, Ribonuclease H2 (RNASE
H2A, RNASE H2B, RNASE H2C) or ADAR1 (La Piana et al, 2014;
Lee-Kirsch et al, 2014). Even though it is quite conceivable that
AGS-related mutations lead to the activation of cytosolic nucleic
acid sensing pathways, this has only been documented for TREX1
deficiency. Here, it has been shown in vivo that the fatal conse-
quences of TREX1 deficiency can be rescued by the deletion of
STING, and in vitro studies have revealed that this is fully attribut-
able to the activation of cGAS (Gall et al, 2012; Ablasser et al,
2014). However, the exact nature of the ligand that activates cGAS
in this context still remains unclear. Interestingly, TREX1 has been
shown to metabolize the reverse-transcribed DNA, and the absence
of TREX1 resulted in the accumulation of DNA from endogenous
retro elements (Stetson, 2012). On the other hand, the ribonuclease
H2 enzyme complex is involved in the removal of the Okazaki
fragments as well as aberrantly introduced ribonucleotides during
the replication of the genome (Reijns et al, 2012). As such, the
hypomorphic mutations in RNase H2 proteins, observed in AGS,
could result in less efficient removal of the RNA strand or the incor-
porated ribonucleotides, thereby culminating in the accumulation of
RNA:DNA hybrids. Unfortunately, the Rnaseh2b knockout mouse
model does not display the expected phenotype of type I IFN-driven
immune activation, which might be due to the fact that this condi-
tion does not lead to a cell-autonomous activation of nucleic acid
sensing PRRs. A secondary activation of immune cells in the context
of RNase H2 deficiency might, however, not be evident due to early
embryonic lethality of these mice (Hiller et al, 2012; Reijns et al,
2012). As such, it would be worth revisiting this model with regard
to identifying the culprit stimulatory ligand using conditionally
ablated Rnaseh2b.
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Figure 4. Recombinant cGAS protein synthesizes cGAMP(20–50) in the presence of 60-bp synthetic poly(rA):poly(dT) hybrids.
A 60-bp synthetic poly(rA) (lane 1) and 60-bp poly(dT) (lane 2) oligos were annealed, and the samples were run on a 1% agarose gel. Asterisk indicates annealed
poly(rA):poly(dT) RNA:DNA hybrid (lane 3).
B Differentiated human monocyte THP-1 cells with Gaussia luciferase knockin under IFIT1 promoter were transfected with or without 60-bp poly(rA), 60-bp poly(dT) or
60-bp poly(rA):poly(dT) (hybrid) and 60-bp poly(dA):poly(dT) (dsDNA) and luciferase assay was performed. Data shown are from two biological replicates. Data plot
shows mean with SEM.
C RP-HPLC chromatograms showing the presence of cGAMP(20–50) after incubation of recombinant cGAS protein for 180 min in the presence of ATP and GTP with:
(i) 60-bp poly(rA) (ssRNA), (ii) 60-bp poly(dT) (ssDNA), (iii) 60-bp poly(dA) (ssDNA), (iv) 60-bp poly(rA):poly(dT) (hybrid), or (v) 60-bp poly(dA):poly(dT) (dsDNA). Arrow
indicates the expected peak for cGAMP (20–50), the product of cGAS catalyzed reaction.
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Retroviruses could provide another source of intracellular RNA:
DNA hybrids, which are generated by reverse transcriptase in the
course of their replicative cycle (Telesnitsky & Goff, 1997). In this
context, it was recently shown that viral-derived RNA:DNA hybrids
accumulate in the cytoplasm and endosomal compartments of
retrovirus (MMLV)-infected fibroblasts (Rigby et al, 2014). In the
same study, the authors used synthetic 45- and 60-bp RNA:DNA
hybrid molecules as stimuli and observed that while the response to
the 45-bp hybrid molecule was completely TLR9 dependent, it was
only partially dependent in the case of 60-bp hybrids. As such, to
X-ray structure
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C
Docking model
cGAS + DNA:RNA hybrid
Docking model
cGAS + DNA:RNA hybrid
Docking model
A B
D
E
negative positive
negative positivenegative positive
negative positive
dsRNA: Yellow
dsDNA: Blue
Hybrid: Green
F
dsDNA
cGAS + dsRNA
Figure 5. Modeling of dsDNA, RNA:DNA hybrids and dsRNA interaction with cGAS.
A–D HADDOCK models of different double-stranded nucleic acids in the crystal structure of pig cGAS are shown (the cGAS structure is based on the cGAS:dsDNA PDB ID
4KB6). The DNA strand is shown in green, whereas the RNA strand is depicted in pink. (A) dsDNA bound to cGAS (PDB ID 4KB6). (B, C) Best docking results of an
RNA:DNA hybrid in two different orientations (PDB ID 4KB6 chain A) into cGAS are depicted. Hybrid molecules have been located in the cleft formed by the
Zn-thumb and Arg150 of cGAS. (D) The best docking solution of dsRNA into the dsDNA binding region of cGAS.
E, F Cartoon and surface representation of superposition of dsDNA (blue), DNA:RNA hybrid (green) and dsRNA (yellow) molecules based on published structures.
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account for the partial response still observed in the 60-bp hybrid-
stimulated cells, the authors alluded to the existence of other
cytoplasmic hybrid sensors. Given the restricted expression of TLR9
in the human system, we speculate that RNA:DNA hybrid detection
by cGAS could constitute the predominant sensing mechanism in
the human system. Indeed, the fact that retroviral infection has
been shown to trigger proinflammatory gene expression in cells
other than pDCs indicates the existence of additional cytoplasmic
receptors for retroviral infection (Luban, 2012). In this regard, under
permissive conditions, cGAS has been identified as the key intracel-
lular sensor essential for mounting an antiviral response in the
course of HIV infection in various cell types, including fibroblasts,
myeloid dendritic cells and macrophages (Gao et al, 2013a). Here, it
was demonstrated that inhibition of viral reverse transcriptase but
not of viral integrase resulted in significant inhibition of IFN-b
production. Unfortunately, this set of experiments cannot distin-
guish between the presence of RNA:DNA hybrids versus dsDNA
as there is currently no technical means to differentially influence
the formation of such nucleic acids during in vivo infections.
Consequently, further studies will be required to identify the cGAS-
stimulatory nucleic acid in the context of retroviral infection.
Interestingly, the presence of RNA:DNA hybrids has also been
described in the life cycle of a number of DNA viruses, including
herpesviridae (Prichard et al, 1998; Rennekamp & Lieberman, 2011)
and hepadnaviruses (Summers & Mason, 1982; Miller et al, 1984).
Moreover, mitochondrial nucleic acids, which have previously been
described as DAMP molecules (Oka et al, 2012), harbor stable RNA:
DNA hybrid structures that arise in the course of mtDNA replication
(Yasukawa et al, 2006). Again, additional studies will be needed to
decipher the possible contribution of RNA:DNA hybrids to the
immunostimulatory capacities of these infectious or sterile inflam-
matory conditions.
In conclusion, we demonstrate that the intracellular presence of
RNA:DNA hybrids elicits cGAS-dependent antiviral immune
responses. Future studies will be required to identify the biological
context of this sensing modality, yet as outlined above, we hypothe-
size that this mechanism could be of relevance in the context of
aberrant recognition of endogenous nucleic acids or viral infections.
Materials and Methods
Generation of RNA:DNA hybrids
Equal amounts of synthetic poly(dT) (Sigma #P6905) and poly(rA)
(Sigma # P9403) were mixed in 5× annealing buffer (50 mM Tris–
HCl pH 7,6, 250 mM NaCl, 5 mM EDTA), for example, 40 ll poly
(rA) (300 ng/ll) + 40 ll poly(dT) (300 ng/ll) in 20 ll 5× annealing
buffer. The samples were incubated in a PCR block starting at 95°C
with decreasing gradient of 1°C per 100 seconds until 20°C. 60-bp
poly(rA) was purchased from Biomers. 60-bp poly(dA) and 60-bp
poly(dT) were purchased from Integrated DNA Technologies.
Dot-blot for hybrids
Nitrocellulose membrane was marked and spotted with the RNA:
DNA hybrids or poly(dA:dT) (dsDNA) as a negative control. The
membrane was allowed to air dry for 2 h and then blocked in 0.5%
milk in PBST buffer. The membrane was then incubated with the
anti-hybrid S9.6 antibody overnight at 4°C, washed and probed with
anti-mouse secondary antibody.
Cell culture
Murine BMDMs were isolated and cultured as per standard proto-
cols. THP-1 cells were maintained in RPMI medium. The cells were
differentiated for 3 h with PMA (330 ng/ml), the medium was
removed, and the cells were washed with 1× PBS three times. The
cells were detached in PBS, and 7 × 104 cells were plated in 96-well
flat-bottomed plate. Isolation of PBMC from buffy coat was
performed using standard protocol.
Stimulation with RNA:DNA hybrids
7 × 104 cells were incubated overnight in flat-bottomed 96-well
plate. A transfection mix with Lipofectamine and 1 lg/ml of poly
(rA), poly(dT), poly(rA):poly(dT) was prepared as per standard
protocol. The cells were incubated with the nucleic acids overnight.
The supernatants were collected and subjected to further assays.
For RT–PCR, the cells were stimulated with the nucleic acids
for 6 h.
RNase H, RNase A and DNase I digestion
1 lg of hybrid was digested with 1 ll of the RNase H, RNase A or
DNase I (Fermentas) enzyme in a final reaction volume of 10 ll.
The sample was incubated at 37°C for 30 min. The enzyme was
heat-inactivated by incubating the samples at 65°C for 10 min, and
the efficiency of digestion was checked by running the samples in
0.8% agarose gel.
RNA analysis
RNA isolation was performed using the QIAcube system (Qiagen),
and equal amounts of RNA were used for cDNA synthesis. Real-time
PCR analysis with Eva Green PCR Master Mix (Biobudget) was
performed on Real-time PCR system (Roche). The expression of
target genes was normalized to HPRT or GAPDH expression and
plotted as arbitrary units on a linear scale. Primer sequences are
available on request.
ELISA
Cell culture supernatants were assayed for human IP-10 and
human IL-6 (BD Biosciences) according to the manufacturer’s
instructions.
STING, MAVS and cGAS KO THP-1 cells
THP-1 knockout cells were generated using the CRISPR/Cas9
system. A plasmid containing mCherry Cas9 and a U6 promoter-
driven gRNA against STING, MAVS or cGAS was electroporated
into THP-1 cells under following conditions: 5 lg plasmid were
mixed with 250 ll cell suspension (10 × 106/ml in OptiMEM) and
electroporated at 950 lF and 250 V. Cells were FACS sorted for
mCherry expression 24 h after electroporation. Positive cells were
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diluted under limiting conditions and plated in 96-well plates to
obtain single cell clones. The genotype of THP-1 clones was
analyzed by deep sequencing (Illumina, MiSeq) (Schmid-Burgk
et al, 2014).
Generation of pIFIT1-GLuc THP-1 reporter cell line
To study induction of interferon-stimulated genes at the natural
gene expression level using a reporter system, we generated a IFIT1
reporter cell line. Using the CRISPR/Cas9 system, the Gaussia lucif-
erase gene was knocked into the IFIT1 gene locus in THP-1 cells.
For this purpose, a reporter insert cassette, harboring flanking 50-bp
homology arms, a 2A peptide and the luciferase gene, was synthe-
sized by a two-step PCR. THP-1 cells were co-electroporated with a
CRISPR targeting the IFIT1 locus and the Gaussia luciferase insert
cassette. As the CRISPR construct contained a mCherry gene, elec-
troporated cells were sorted for mCherry expression by FACS 24 h
after electroporation. For isolation of reporter cell clones, cells were
seeded under limiting dilution conditions. Single cell clones were
tested for knockin of the luciferase gene by stimulation with
synthetic triphosphate RNA (pppRNA) and subsequent measure-
ment of luciferase induction. Positive reporter clones were validated
by sequencing of the insert locus.
In vitro assay for cGAS activity
For in vitro reactions of cGAS in the presence of varying nucleic
acids, 2 mM recombinant cGAS was mixed with 0.2 lg/ll poly(rA):
poly(dT), poly(dA):poly(dT), poly(rA):poly(rU) or the correspond-
ing single-stranded controls and 0.1 M ATP and 0.1 mM GTP in
buffer A (100 mM NaCl, 40 mM Tris pH 7.5, 10 mM MgCl2). After
45, 90 or 180 min of incubation at 37°C, the reaction mixture was
analyzed by RP-HPLC. Samples were prepared in 0.3 M triethyl-
ammonium acetate, applied to a Waters XBridge C18 column
(4.6 × 50 mm, 2.5 lm particle size) and separated in an isocratic
gradient of 100 mM ammonium acetate for 5 min at a flow rate of
1 ml/min. Chemically synthesized cGAMP(20–50) (Ablasser et al,
2013a) served as a positive control.
Modeling of cGAS dsDNA, DNA:RNA hybrid and dsRNA complexes
Complexes of cGAS with three short double-stranded nucleic acids
(NA) were modeled by docking of corresponding NA (dsDNA (PDB
ID 4KB6) (Civril et al, 2013) or (PDB ID 3V6T) (Deng et al, 2012),
DNA:RNA hybrid (PDB ID 4GG4) (Yin et al, 2012) and dsRNA (PDB
ID 3KS8) (Kimberlin et al, 2010) into the structure of pig cGAS (PDB
ID 4KB6 chain A) (Civril et al, 2013)). Docking was done on the
HADDOCK server (de Vries et al, 2010). HADDOCK permits position
restrained docking of NA into proteins. Sets of residues for docking
in cGAS and dsDNA that should interact with NA have been taken
from the original crystal structure of the cGAS–dsDNA complex
(PDB ID 4KB6) (Civril et al, 2013). Visualization of the results was
performed using PyMol.
Statistics
Statistical tests were performed using GraphPad Prism program. For
column statistics, one-way ANOVA with Bonferroni’s or Tukey’s
multiple comparison test was performed. P ≤ 0.05 was considered
significant.
Supplementary information for this article is available online:
http://emboj.embopress.org
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Supplementary Information 
Supplementary Figure 1: Synthetic annealed poly(rA):poly(dT) hybrid 
induces type I interferon response. 
a) Bone marrow derived macrophages (BMDM) were transfected with or
without poly(rA), poly(dT) or poly(rA):poly(dT) for 6 hrs. RT-PCR was 
performed to check for the expression of Ifn-α, Ifn-β, Il-6 and Ip-10. b) 
Differentiated Human monocyte THP-1 cells were transfected with different 
amounts of poly(rA):poly(dT) (hybrid) or poly(dA):poly(dT) dsDNA and IP-10 in 
supernatants was measured by ELISA. In all figures error bars represent 
SEM. 
Supplementary Figure 2: Scheme representing the coding region of 
IFIT1, MAVS, STING and cGAS targeted by the CRISPR/Cas9 system 
Depicted is a schematic representation of the genomic loci of human IFIT1, 
MAVS, STING and cGAS genes. Small black and large grey squares 
represent non-coding and coding exons, respectively. The red arrow 
highlights the location of the CRISPR target site. The sequences under the 
genomic loci are a magnification of the targeted region. The top sequences 
are the reference sequences, whereby the red letters highlight the 
protospacer (CRISPR binding site) and orange letters the PAM (protospacer 
adjacent motif). For MAVS, STING and cGAS the sequences below the 
reference sequence show the mutations that were detected by deep 
sequencing. 
Supplementary Figure 3: cGAS-dependent secretion of IL-6 
WT THP-1 cells or cGAS KO THP-1 cells were transfected with or without 
poly(rA):poly(dT) (hybrid), pDNA or pppRNA for 16hrs and amount of IL-6 
secreted was detected by ELISA.  
Supplementary Figure 4: Single stranded homopolymeric 
polynucleotides do not activate cGAS 
a) RP-HPLC chromatograms showing the synthesis of cGAMP(2´-5´) after
incubation of recombinant cGAS protein for 90 minutes in the presence of 
-134-
! 2!
ATP and GTP with different ligands (i) with poly(rA), (ii) with poly(dT), (iii) 
poly(dA) and (iv) poly(rU). b) Synthetic dsDNA, dsRNA and RNA:DNA hybrids 
were incubated for 45, 90 or 180 minutes with recombinant cGAS and the 
synthesis of 2’ 5’ cGAMP checked by RP-HPLC. In order to normalize for the 
total amount of sample loaded the % of AUC was calculated for each time 
point and each sample.  
Supplementary Figure 5: cGAS “activation loop” upon dsDNA and 
RNA:DNA hybrid binding 
Structure of cGAS bound to dsDNA (a) and RNA:DNA hybrid in two modes 
(b) and (c). The DNA strand is shown in green, whereas the RNA strand is 
depicted in light pink. The “activation loop” of cGAS is highlighted in blue.  
Supplementary F igure 6:  Induction of Type I IFNs by poly(dT) is 
cGAS dependent. WT THP-1 cells or cGAS KO THP-1 cells were transfected 
with or without poly(rA), poly(dT) and poly(rA):poly(dT) (hybrid) for 16hrs and 
amount of IP-10 secreted was detected by ELISA.  
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human MAVS genomic locus
TGGGTGGAGTACTTCATTGCGGCACTGAGGGGCTGTGAGCTAGTTGATCTCGCGGACGAAGTGGCCTCT  REF
TGGGTGGAGTACTTCATTGCGGCACTG--------TGAGCTAGTTGATCTCGCGGACGAAGTGGCCTCT  -Del
human STING genomic locus
Exon3
Exon3
ATGCCCCACTCCAGCCTGCATCCATCCATCCCGTGTCCCAGGGGTCACGGGGCCCAGAAGGCAGCCTTGG  REF
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4. A fluorescent cyclic dinucleotide and its use in methods of identifying 
substances having an ability to modulate the cGAS/STING pathway (Patent) 
Hopfner K.-P., Andreeva L., Drexler D.J. (Filed 24 July 2017) “A fluorescent cyclic dinucleotide and its 
use in methods of identifying substances having an ability to modulate the cGAS/STING pathway.” 
European Patent Application EP 17182689.4. 
 
Summary 
This work introduces a novel fluorescence-based high-throughput method for measuring cGAS activity 
and STING binding using a commercially available fluorescent ATP analogue 2-aminopurine-riboside-5'-
triphosphate. A growing knowledge of cGAS-STING pathway involvement in autoinflammatory diseases 
and cancer and successful trials on cGAMP as immune adjuvant for vaccination and anti-cancer therapy 
make cGAS-STING pathway a promising target for drug development. This makes a method 
development for easy and fast cGAS-STING activity assay an important direction of research. Previously 
reported methods for cGAS activity measurement, though having their advantages, are either low-
throughput and require expensive and not easily accessible equipment, or do not precisely discriminate 
specific 2’3’-cGAMP from other CDNs. Among others, cGAS activity assays based on radiolabeled ATP 
and GTP analogues or cGAMP quantitative measurements using anion-exchange chromatography, 
nuclear magnetic resonance spectroscopy (NMR) or mass spectrometry (MS) are either not safe, or time-
consuming and require several purification steps. Fluorescence-based assay based on fluorescence 
quenching of cyclic dinucleotide (CDN) 3’3’-cG(d2AP)MP – a fluorescent analogue of 3’3’-cGAMP – 
by its dimerization with other CDNs was proven to be a high-throughput non-toxic method for 3’3’-
cGAMP and c-di-GMP detection, but failed to recognize cGAS product 2’3’-cGAMP. Other high-
throughput methods utilizing a fluorescently labeled riboswitch or an antibody against 2’3’-cGAMP were 
either cross-reactive with 2’3’- and 3’3’-cGAMP isoforms, or did not allow a continuous measurement. A 
suitable assay for STING activity in vitro is an even harder to find, since STING is a receptor and not an 
enzyme. In this work we describe a novel assay for a reproducible time-resolved cGAS activity 
measurement and a method for STING binding studies using fluorescent CDN analogue fGAMP. This 
technique allows simultaneous measurements of cGAS and STING activity using a conventional 
fluorescence plate reader, is non-toxic and not limited by reaction conditions. Our assay is well-tailored 
for identifying cGAS and STING agonists and inhibitors in a high-throughput manner and is perfectly 
suitable for clinical applications. 
Author contribution 
The author of this thesis together with Prof. Dr. K.-P. Hopfner and D.J. Drexler invented a novel high-
throughput fluorescence-based method for studying cGAS activity and STING binding. She established 
and optimized its application for cGAS activity measurements with several cGAS constructs in a range of 
different conditions. She confirmed its reliability comparing the novel assay with the previously 
established radiolabeled cGAS activity measurement technique. She also evaluated limitations of the 
novel method and a possibility of its application to study cGAS activity-modulating factors. Moreover, 
together with D.J. Drexler she tested another application of this method for characterization of STING 
ligands’ affinity and proved its effectiveness for studying various STING-binding molecules.    
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Discussion 
1. Methods for cGAS activity measurement 
cGAS has a great importance in innate immune recognition of various viruses and intracellular bacteria, 
plays an emerging role in recognition of self-DNA and as involved in autoimmune diseases and cancer 
development. This makes a search for precise and high-throughput method for cGAS activity 
measurement of huge interest. The first discoveries of cGAS were made using incorporation of 
radioactively labeled ATP or GTP into the products of cGAS reaction and separation of these products by 
thin layer chromatography [235, 239, 240]. This method allows sensitive and direct measurement of 
cGAMP synthesis rate using small reaction volumes, however, its precision is limited by decreasing 
volume of the reaction between the time points, asynchronous termination of the reaction and variation in 
exposure time between experiments, making it difficult to compare cGAS activities obtained in different 
experiments. In different variations of this method reaction can be either stopped by direct plotting on the 
cellulose plate or by preceding ultrafiltration of the sample that might generate radioactive aerosols and 
additionally limits the precision of the assay by uncontrollable loss of the reaction material at the 
transferring step. Moreover, radioactivity assays are limited by the number of reactions that can be 
performed simultaneously and time-resolved kinetics performed using this method is rather time-
consuming.  
Another in vitro method developed to study cGAS activity was introduced by P. Li’s group and is based 
on anion exchange chromatography of cGAS reaction mixture on MonoQ column (GE Healthcare) [314]. 
In contrast to radiolabeled assays, in which the resolution and interpretation of side products of reaction 
are difficult to achieve, anion exchange chromatography allows a good separation of all the nucleotides 
and quantitative analysis of reaction products using UV absorption. Another advantage of the assay 
includes its application without additional labeling of the nucleotides and its nontoxicity. However, with 
this method the samples can not be measured simultaneously and variable loss of material by previous 
ultrafiltration and transfer to the column may occur. Similar to radiolabeled assays, anion exchange 
chromatography of cGAS products is a time-consuming method that is difficult to use for extensive 
screening. Moreover, the variation of reaction condition is limited by its influence on nucleotide binding 
to the column. Some reaction conditions can result in a weak interaction of reaction products with the 
column and an unsteady separation of the products thus limiting the method application for comparison of 
different cGAS reaction conditions. 
Two more methods of cGAS activity measurement without a need for labeling were suggested by J. Hall 
and colleagues [312, 594]. The first of them is based on fluorescence polarization of Cy5-labeled cGAMP 
in combination with an antibody [594]. Non-fluorescent cGAMP synthesized by cGAS was shown to 
compete for the antibody binding with its fluorescent analogue leading to a decrease in polarization 
signal. Though the antibody did not show a cross reactivity to ATP, GTP, c-di-AMP and c-di-GMP, the 
studies of its affinity to 2’3’- and 3’3’-cGAMP would be important. Given that the proposed antibody can 
be purchased commercially, this method is advantageous for a large-scale analysis of cGAS activity in 
vitro, but was not proved for measuring cGAMP concentrations in cell extracts. Moreover, it is not well-
suited for continuous time-resolved measurements of cGAS activity, because the reaction must be stopped 
before the addition of Cy5-labeled cGAMP and the antibody. However, the development of an anti-
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cGAMP antibody may be of interest for other applications like STING inhibition and used for medical 
research.    
The second method utilizes surface plasmon resonance at Biacore with serpentine flow connecting cells 
with immobilized cGAS-DNA complex and STING [312]. In this set-up injection of ATP and GTP 
resulted in production of cGAMP that could be detected by resonance in STING-containing cell. This 
method of an indirect measurement of cGAS activity was successfully used to determine KM values of the 
reaction, as well as to study substrate inhibition and the mechanism of cGAS catalysis, since it allows to 
overcome a competition for cGAS active site between the substrates and linear or side products of the 
reaction by applying a constant flow that counteracts the accumulation of the reaction intermediates and 
side products. However, though a high precision of this method allows to determine a range of kinetic 
parameters of the reaction, its flexibility in using different cGAS constructs and DNA ligands is limited, 
since each of the constructs must be separately coupled for the channel. Moreover, a coupling of cGAS-
DNA complex may influence complex arrangement and stability and interfere with cGAS dimerization 
and oligomerization. Furthermore, this method does not allow a direct measurement of cGAS activity and 
is limited by specific STING-mediated detection of cGAMP leaving analysis of other reaction products 
for complementary methods like NMR or MS. The latter techniques are also broadly used to study cGAS 
activity and have an advantage of quantitative and structural analysis of the reaction mixtures. For 
example, NMR and MS were used for the first discovery of cGAS product composition [238-240, 250]. 
Nevertheless, these specialized techniques require high sample purity and are commonly used after 
purification of the products by HPLC. This increases the number of steps and complexity of cGAMP 
measurement decreasing the precision of cGAMP quantitative measurement. Moreover, these techniques 
are time consuming and complex and are not always easily accessible. Unlike the in vitro methods for 
cGAS activity measurement described above, NMR and MS are broadly used to analyze cGAS activity in 
cells after purifying cGAMP from the cell lysates. 
Several fluorescence-based methods were suggested for a high-throughput cGAS activity measurement. 
Based on the structure of natural riboswitches and a finding that GEMM-I riboswitch from Geobacter 
recognizes 3’3’-cGAMP and can be fluorescently modified, M.C. Hammond’s group engineered a 
fluorescent biosensor capable of detecting 2’3’-cGAMP [595-598]. In this method binding of 2’3’-
cGAMP to a fluorescently labeled riboswitch results in its conformational change and increase of 
fluorescence thus allowing an easy large-scale monitoring of cGAMP production by fluorescent readouts 
in a fluorescence plate reader [597]. Moreover, it can be applied for measuring cGAMP levels in the cell 
extracts without need for luciferase reporter assays, which would introduce high amounts of plasmid 
DNA into the cell and thus trigger a potent cGAS activation interfering with a studied response. 
Disadvantages of such method are cross-reactivity of a biosensor with 3’3’-cGAMP and c-di-GMP, 
sensibility of the biosensor to DNA-intercalating agents inhibiting cGAS activity and its instability 
against RNase contaminations. 
An alternative fluorescent method of CDN detection was introduced by B.T. Roembke, et al. and is based 
on an elegant observation that in the presence of Mn2+ cations fluorescent analog of 3’3’-cGAMP - 3’3’-
cG(d2AP)MP – forms heterodimers with other non-fluorescent cyclic dinucleotides. Such dimerization 
was found to lead to quenching of fluorescence [599]. Fluorescence of 3’3’-cG(d2AP)MP emerges from 
incorporation of the fluorescent nucleic acid base analog 2-aminopurine instead of adenine in bacterial  
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Figure 18 A novel high-throughput fluorescent method for measuring cGAS activity. 
(a) The principle of the assay. cGAS incorporates highly fluorescent (three orange stars) ATP analogue 2- 
aminopurine-riboside-5'-triphosphate (fATP) into less fluorescent (one orange star) cGAMP analogue 
(fGAMP). Difference between fluorescent intensities corresponds to efficiency of cGAS reaction. 
(b) General workflow for calculating initial cGAS reaction rates. Initial curves represent a decrease of 
fluorescence upon cGAS reaction (on the left). Background fluorescence at each time point is subtracted 
from fluorescence at corresponding point of cGAS reaction and resulting curves are inverted to obtain 
positive values (in the middle). The slopes of linear intervals (red dashed lines) are calculated and 
correspond to cGAS initial reaction rates plotted as bars (on the right). 
Adopted from Andreeva L., et al., 2017 [600]. 
 
3’3’-cGAMP. This method is suitable for high-throughput measurements of CDN content of the sample 
using a simple fluorescence plate reader and is suitable for both CDN-synthase and phosphodiesterase 
time-resolved activity measurements. 3’3’-cG(d2AP)MP quenching emerging purely from dimerization 
with CDNs does not occur in presence of NTPs or linear dinucleotides resulting in method specificity 
towards CDNs. The limitations of this technique arise from the need for Mn2+ cations that might not be 
suitable for some enzymatic reactions and, most importantly, its incapability to detect c-di-AMP and 
cGAMP with mixed phosphodiester linkages rendering it inapplicable for cGAS activity measurement. 
A method presented in this thesis is inspired by the work of B.T. Roembke, et al. and, unlike described 
above, offers an easily accessible high-throughput fluorescent assay for a direct measurement of cGAS 
activity [600]. Briefly, we discovered that a fluorescent ATP analogue - 2-aminopurine-riboside-5'-
triphosphate (fATP) – can be incorporated by cGAS into a fluorescent product (fGAMP), which was 
accompanied by a quenching of 2-aminopurine base fluorescence within the molecule (Figure 18a). This 
allows both single-point and time-resolved monitoring of cGAS reaction without any additional 
components and sensors (Figure 18b). This method thus enables simultaneous and quick comparison of 
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different reaction compositions, cGAS constructs and DNA-ligands in a large-scale format and is suitable 
for a broad range of conditions. Furthermore, fATP used in this method is commercially available and no 
specialized instruments are needed to conduct an experiment, since it can be done in a fluorescent plate 
reader with tunable excitation and emission wave lengths. Though this method can be applicable for a 
broad range of CDN-synthases, the enzyme tolerance to fluorescent ATP analogue must be considered. 
For example, though we tested the assay with all available cGAS constructs to be functional, human 
cGAS seems to have a stronger preference for native nucleotides and shows less efficiency in 
incorporating fATP into fGAMP, as compared to mouse and porcine enzymes. In comparison to 
radiolabeled cGAS activity assays our method requires lager volumes and therefore is best suited for 
measuring rather high activities, whereas low incorporation rates of fATP would be enzyme-consuming. 
However, even in this case the replacement of radioactive material with fluorescent analogues might still 
be favored. One more limitation of the method includes the time frame of the reaction. Since an open 
plate is preferable for an optimal fluorescence measurement, long-lasting time-resolved kinetics should 
take into account evaporation rate of the sample. Given that the method described in this work is based on 
a direct measurement of cGAS activity, it can hardly be applicable for cell-based assays due to the 
abundance of natural ATP in the living cell, so a combination of the assays might be the best choice for 
studying cGAS both in vitro and in the cells. Following the described principle, further search of 
environment-sensitive and small fluorescent base analogues that can be metabolized by cGAS and other 
CDN-synthases like DncV or bacterial c-di-AMP synthases is of great interest. Fluorescent cGAS activity 
assays based on 2-aminopurine analogue might be advantageous for future studies of cGAS activators and 
inhibitors and of particular interest for clinical implications.     
2. A unique cGAS dimeric structure in context of long stimulatory DNA 
recognition 
Since the first cGAS structures with short DNA fragments from 14 to 18 bp were published, the question 
why such short DNA fragments fail to activate cGAS in vivo and in vitro remained open. Indeed, the 
length of the major cGAS DNA-binding site corresponds to around 18-20 bp DNA stretch and, at least in 
the crystal structures, such binding is fully capable to introduce a “spine” helix break, N-terminal lobe 
stabilization, movement of the activation loop and rearrangement and closure of the catalytic site – all the 
features of an active cGAS [233-236]. The subsequent discovery of cGAS dimerization introduced 
additional questions that could not be answered with the existing structures. cGAS was shown to form a 
unique dimer with two cGAS protomers held together by their interactions with each other and each of 
two DNA molecules [313, 314]. Intriguingly, such dimer is present in all known crystal structures of 
cGAS that together with mutational analyses supports the idea of its physiological relevance. However, 
such dimerization does not explain a contradiction between structural and biochemical data, since 
cGAS2:DNA2 complexes represent an active cGAS conformation with non-stimulatory DNA ligands. 
cGAS was reported to require DNA ligands > 40 bp for a full activation in vivo and is active with shorter 
DNA fragments only at unphysiologically high concentrations [68, 112, 232, 314].  Further confusion 
arises from the relative position of the DNA fragments within such a dimer [313, 314]. Indeed, elongation 
of the dsDNA strands in a cGAS dimer would result in a steric clash between DNA molecules (Figure 
19a). This means that such dimer formation would be reasonable, if cGAS preferentially recognized short 
DNA fragments in the cell to avoid dimerization on longer DNA species, which is contrast to the 
biochemical observations. Another plausible explanation of such cGAS dimer would include specific  
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Figure 19 Structures and crystal packing of cGAS in complex with 18 bp and 39 bp DNA. 
(a) Relative orientation of cGAS dimers within a complex of cGAS with 18 bp DNA (PDB: 4LEY). cGAS 
protomers within a dimer are represented in blue and light blue. Elongation of the DNA strands (red dashed 
lines) would lead to a steric clash of DNA molecules (orange star). 
(b) cGAS in complex with 39 bp stimulatory DNA (green and grey, PDB: 5N6I) superposed to a cGAS dimer 
with 18 bp (blue, PDB: 4LEY). cGAS dimer with 18 bp is slightly rotated relatively to a dimer in cGAS 
complex with 39 bp (black arrow). DNA bending within 39 bp cGAS complex allows to avoid steric clash 
otherwise introduced by DNA positioning by a cGAS dimer (red dashed lines). 
(c) cGAS-DNA fibril (ladder) emerging from crystal packing of cGAS in complex with 39 bp DNA (PDB: 
5N6I). cGAS dimers form a ladder by iterative binding orientation on two nearly parallel pseudo-
continuous DNA strands (grey and black). Each cGAS dimer is represented in one color. 
Adopted from Andreeva L., et al., 2017 [600].  
 
recognition of DNA ends by cGAS to avoid the clash. This hypothesis, however, does not explain the 
difference between long stimulatory and short inactive DNA constructs, since in both cases cGAS would 
form the same dimer stabilized by the same interactions. Moreover, plasmid DNA that was found to 
potently activate cGAS would also not fit into this hypothesis [223]. The mystery of a cGAS2:DNA2 
conformation includes the question about the stability of such a complex. Analytical ultracentrifugation, 
which was performed to show such a complex, required extremely high 80-150 µM cGAS concentrations 
and its dilution to still non-physiological 30 µM resulted in dissociation of the dimers [313, 314]. 
Intriguingly, in all crystal structures two DNA fragments from the neighboring cGAS dimers are stacked 
with each other in crystal packing mimicking a long ~40 bp DNA fragment (Figure 19a). Though the 
second DNA molecule bound to cGAS is pointing towards the other “pseudo-continuous” DNA strand 
and would induce the described collision in case of longer DNA segments, such binding of several cGAS 
along one stimulatory DNA might remotely refer to cGAS arrangement on DNA in vivo. 
A mechanism combining dimerization and activation of cGAS by DNA > 40 bp is introduced in the 
current thesis. According to our understanding, cGAS might form fibrils on long DNA by iterating cGAS 
dimer orientation in contrast to crystal packing of cGAS in complex with 18 bp DNA and shorter (Figure 
19c) [314, 600]. Our crystal structure shows how dimer formation occurs on long stimulatory DNA and 
how steric clash of DNA molecules is avoided without the need of DNA ends (Figure 19b). We also 
-148- 
 
propose a cooperative mechanism for DNA sensing by cGAS in which a single dimer formation is highly 
instable and gets mutually stabilized by other dimers within a cGAS-DNA ladder. This mechanism 
explains why dimerization itself on DNA around 20 bp, though present in crystal structures, is not 
sufficient for a full cGAS activation and why cGAS activity increases with DNA length at a constant 
concentration of cGAS DNA-binding sites [600, 601]. In line with previous studies, our cooperativity 
model shows that a 20 bp segment of DNA introduces all changes in cGAS necessary for its activation. 
cGAS, however, remains inactive within a single dimer simply because of its high dissociation rate. Such 
hypothesis of cooperative dimer stabilization provides the easiest explanation of cGAS dynamics. 
However, one can not exclude additional rearrangements in the active site of cGAS that could not be 
observed at low resolution. Nevertheless, since organization of the separate dimers in cGAS complex with 
stimulatory DNA is similar to the better resolved cGAS structures with shorter DNA fragments and since 
no protein-protein interactions between adjacent dimers that might influence cGAS active site were 
found, it seems unlikely that some unobserved due to low resolution dramatic changes in the catalytic 
pocket would occur and cause such a dramatic length-dependent increase in cGAS activity. 
The flexibility of the DNA in our structure allows several cGAS dimers to be formed on two parallel 
DNA strands [600]. Iterating “head-to-head” and “tail-to-tail” (N-termini and C-termini of cGAS facing 
each other, respectively) orientation of cGAS dimers seems to be thermodynamically preferred, since in 
this case the DNA has to be bent twice less frequently, compared to a single “head-to-tail” orientation 
(Figure 20). However, the relative orientation of a cGAS dimer within a fibril in solution and in the cell 
remains to be investigated. Another question includes the “macroscopic” organization of the proposed 
oligomers. Though ITC and SEC-RALS experiments confirm the fibril formation up to cGAS6:DNA2 
species in solution, net-like structures formed by several cGAS2n:DNA2 interconnected oligomers and not 
the compact fibrils with only two participating parallel DNA strands can not be excluded. In case of 
physiological cGAS ligands like HSV-1 genome or L. monocytogenes nucleoid (~ 152 kbp and ~2.9 
Mbp) DNA formation of one compact fibril is rather unlikely due to a high flexibility and amount of 
DNA. It is therefore possible that several interconnected or unconnected cGAS-DNA ladders with 
different spacing between the cGAS dimers might be formed. cGAS oligomerization, independent of the 
“macroscopic” organization of the ladder, is further supported by cGAS localization studies, since several 
groups reported cGAS to form aggregates in the cell upon DNA transfection [222, 223, 602]. Particular 
organization of cGAS ladder on physiological DNA ligands might be an intriguing subject for future  
 
Figure 20 Schematic representation of the possible binding modes of cGAS dimers on long DNA strands. 
Iterating “head-to-head” and “tail-to-tail” orientation of cGAS dimers (green and blue) on long DNA strands (a) 
would introduce less frequent bending to DNA compared to a repetitive “head-to-tail” positioning (b). Iterative (a) 
and repetitive (b) cGAS dimer orientation would induce one DNA curve within λ or λ/2 bp, respectively, as 
indicated with black arrows. 
Adopted from Andreeva L., et al., 2017 [600].   
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studies of cGAS oligomers. 
Cooperative mechanism of DNA sensing by cGAS also provides an explanation for low affinity of 
cGAS2:DNA2 complex formation. According to our data only oligomeric species bigger than 
cGAS4:DNA2 could be observed in solution in nearly physiological conditions and required DNA > 40 
bp, whereas cGAS complex with 20 bp DNA dissociated into cGAS1:DNA1 [600]. In agreement to 
previous studies, this supports the instability of cGAS dimer with 20 bp or shorter DNA [314, 600]. The 
nature of a cGAS1:DNA1 complex, however, is not clear. Though the “major” DNA-binding site (site 
“A”) of cGAS is usually understood to be a “spine” helix and the “platform”, the second DNA-binding 
site seems to be even more important. Mutational studies revealed that a single amino acid substitution in 
DNA-binding site “B”, in contrast to site “A”, can fully abolish DNA binding by cGAS [314]. This 
observation leads to the question, whether cGAS can form cGAS1:DNA1 complex at all or whether DNA-
binding occurs only within a cGAS dimer. However, since our data indicate the presence of cGAS1:DNA1 
in solution, the most probable explanation would be that the binding affinity of site “B” towards DNA is 
much higher in comparison to a “spine” helix and therefore its disruption results in a weak interaction 
with DNA. This could mean that cGAS interacts with the long DNA with site “B” first. Afterwards, when 
the condition is suitable for dimerization, cGAS would bind with the “spine” helix of site “A”, which 
would induce an active site rearrangement and cGAS activation. Such different affinity of the two DNA-
binding sites would explain a two-step mechanism of DNA binding by cGAS that, if true, would 
counteract an aberrant cGAS activation in the context of cGAS dimer. This hypothesis, however, is highly 
speculative, since a deletion of a “spine” helix analogously to a point mutation in site “B” was reported to 
completely abolish DNA binding by cGAS in co-immunoprecipitation experiments [223]. Further 
research is required to evaluate the affinities of both cGAS DNA-binding sites separately and to examine 
a time-resolved mechanism of cGAS interaction with DNA. 
As mentioned above, the cGAS dimer with short DNA is unstable and the first cGAS2:DNA2 species were 
observed at high cGAS and DNA concentrations that apparently shifted the equilibrium towards their 
formation. Remarkably, this correlates with cGAS activity, since 16-20 bp DNA was able to activate 
cGAS at non-physiologically high enzyme concentrations (10 µM), whereas decreasing cGAS 
concentrations twice or more resulted in a dramatic decrease of its stimulating capacity [234, 314, 600]. A 
requirement of cGAS dimerization and a unique structure of cGAS dimer accompanied by its high 
dissociation rate might have evolved during metazoan evolution in order to distinguish between pathogen- 
and damage-associated long DNA molecules and short dsDNA products resulting from nuclease cleavage 
or genome maintenance. Such length-sensitivity provides a sequence-independent mechanism of 
discriminating between danger-associated and harmless dsDNA products by cGAS needed to avoid the 
aberrant activation of the cGAS/STING pathway and autoinflammation.    
3. Function of N-terminal cGAS domain 
The majority of studies concentrated on the structure and function of the conserved Mab21 domain of 
cGAS comprising both DNA-binding and enzymatic activities, but no robust and mechanistic 
understanding of functions of the N-terminal part of cGAS was achieved so far [223, 233, 235]. Unlike 
Mab-21 domain, N-terminus of cGAS (aa 1-160 of human cGAS) is non-conserved and varies in length 
among cGAS homologs [315, 343]. The secondary structure suggests this cGAS part to be highly flexible 
[315]. However, some similarities in sequence can be observed among different mammalian cGAS N-
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termini that share similar length around 160 aa and are enriched in positively charged residues. In the first 
studies N-teminus of cGAS was hypothesized to stabilize the protein in vitro and participate in 
autoinhibition of cGAS analogously to other innate immune sensors like RIG-I and AIM2, though no 
robust confirmation of this functions was obtained so far [235].  
In agreement with abundance of positively charged residues in N-terminal part of cGAS it was reported to 
bind DNA independently of the catalytic domain. Co-immunoprecipitation studies revealed its association 
with 45 bp DNA with nearly the same efficiency, as Mab21 domain [223]. Further studies reported that 
the N-terminus increases cGAS affinity towards DNA. According to ITC measurements mouse cGAS 
catalytic domain binds 20 bp with ~ 20 µM affinity, whereas human full length protein exhibits ~300nM 
and ~ 90 nM affinity to 20 bp and immunostimulatory 45 bp DNA, respectively [235, 314]. 
Electromobility shift assays confirmed higher affinity of full length cGAS in comparison to Mab21 
domain towards 45 bp DNA for mouse cGAS [314]. A more systematic study revealed an increase in 
affinity for mouse and human cGAS towards all tested DNA species in a row: catalytic domain, N-
terminal part and full length construct, the last having the lowest Kd as determined in electromobility shift 
assays [315]. Dissociation constants of catalytic domain, N-terminus and full length cGAS to 16 bp DNA 
were estimated to be ~ 40 µM, 1.5 µM, 0.5 µM and 112 µM, 5 µM and 1 µM for human and mouse 
cGAS constructs, respectively, as calculated with microscale thermophoresis. The same study reported 
that the N-terminal domain of cGAS undergoes dramatic changes in its secondary structure upon DNA 
binding similarly to its catalytic domain [315].  
Though the N-terminal domain was quite early shown to participate in DNA binding and cGAS stability, 
the first studies did not observe any difference in enzymatic activity between full length and truncated 
cGAS constructs in vitro and in the cells [223, 235]. This, however, may be caused by high protein 
concentration in an in vitro system and an overexpression of cGAS constructs in the cells that might have 
driven cGAS to the maximal activity and thus decreased the sensitivity of the methods. The latter research 
using milder conditions showed that full length cGAS, having the best affinity to DNA, exhibits the 
highest enzymatic activity with 45 bp DNA in vitro and in human cells among cGAS constructs [315]. 
Moreover, a cleavage of cGAS by caspase-1 and other inflammatory caspases removing its N-terminal 
domain was shown to dramatically decrease cGAS-driven cGAMP production in the cells [469]. 
Intriguingly, this perfectly goes in line with the hypothesis proposed in this thesis that cGAS affinity 
towards DNA is a primary force increasing cGAS activity. Indeed, the increase of DNA length resulting 
in higher cGAS activity also directly correlates with affinity and stability of cGAS-DNA complexes in all 
DNA ranges including weak cGAS stimulators (12-20 bp) and immunoactive DNAs (20-1000 bp) both in 
vitro and in the cells (Figure 21) [68, 112, 232, 235, 314, 600]. 
 
Figure 21 Correlation between affinity of cGAS to DNA (black triangle) and cGAS (on the top) or DNA (on 
the bottom) constructs. 
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Since this work proposes the cGAS-Mab21 oligomerization to be a source of increased stability of the 
cGAS-DNA complex, the question arises, whether the same fibrils are formed in case of the full length 
cGAS. On the one hand, DNA-binding of the N-terminus might increase the minimal DNA length needed 
to occupy one cGAS monomer. Though the structural data about N-terminus are missing, it was found to 
bind 16 bp DNA with high affinity suggesting that together with the catalytic domain a DNA-binding site 
length would approach ~ 36 bp or more [315, 603]. This DNA length is quite close to transition in cGAS 
activity around 40-50 bp long DNAs, so one might assume a single full length cGAS dimer formation to 
be sufficient for a full cGAS activation [68, 112, 232, 600]. On the other hand, however, the DNA length-
dependency does not end at the initial point of 40-50 bp and further increase of DNA length results in 
continuous increase of cGAS activity. Though a composition of full length cGAS complex with 40-50 bp 
needs further research, these results suggest that also for a full length cGAS the oligomerization 
mechanism most likely remains relevant for stabilization of the dimers and cGAS activity.  
Another intriguing question includes the influence of N-terminal cGAS domain on dimerization and 
oligomerization and several possibilities might be expected. The N-terminus itself was reported to bind 
DNA as a 1:1 complex suggesting that it does not induce dimerization by itself, unlike the catalytic 
domain [315]. Moreover, the N-terminus of cGAS was also proposed rather to counteract dimerization of 
cGAS as tested by analytic ultracentrifugation [603]. However, the interpretation of the molecular 
weights in this study, as well as a reverse correlation between DNA length and cGAS activity is 
debatable. Moreover, the assumption that the N-terminal cGAS part deoligomerizes cGAS can be 
explained by a competition of cGAS domains for DNA binding resulting in disruption of cGAS dimers 
held together mostly by cGAS-DNA interactions and any other DNA binding protein would result in the 
same effect. Together with previously published mutational analysis of cGAS in cell lines and a 
stimulating effect of DNA-bending proteins on full length cGAS, discovered in this work, formation of 
dimers by the full length cGAS seems to be the best explanation of the existing data [314, 600]. However, 
the mechanism of such dimer formation remains enigmatic in regard of full length cGAS. One possibility  
 
Figure 22 Schematic representation of possible mechanisms of dimer stabilization by cGAS N-terminus. 
(a) The N-terminus might bind DNA and recruit the catalytic domain (cd) of cGAS to the DNA strands. 
(b) The N-termini might stabilize cGAS dimerization by crossed binding of the DNA strands opposite to the 
corresponding catalytic domain. 
(c) The N-termini might “hug” the cGAS dimer by protein-protein interactions and additionally interact with 
DNA. 
(d) The N-termini might bind both DNA strands simultaneously stabilizing a parallel arrangement of DNA 
strands. 
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would be that the N-terminal cGAS domain simply increases cGAS affinity to DNA and thus brings weak 
DNA-binding catalytic domains to its proximity facilitating DNA-binding and dimerization of Mab21 
domains (Figure 22a). Another possibility would be that the N-terminus of one cGAS protomer binds the 
neighboring parallel DNA strand resulting in additional dimer stabilization (Figure 22b). Since a co-
expression of the N-terminal cGAS fragment together with a catalytic core restored cGAS-Mab21 activity 
to that of a full length protein, following two functions of the cGAS N-terminus could also be imagined 
[603]. The N-terminus could interact directly with a neighboring cGAS protomer thus “hugging” a cGAS 
dimer and stabilizing cGAS active conformation (Figure 22c). To investigate this possibility protein-
protein interactions between cGAS catalytic core and N-terminus must be explored. Moreover, a single 
N-terminal domain could act as a hook binding two neighboring DNAs with its ends thus holding them 
together and pre-arranging DNA in a parallel manner (Figure 22d). All these possibilities, however, are 
highly speculative and further research is required to evaluate each of them. 
Intrinsic capability of full length cGAS to measure DNA length as observed for Mab21 domain and the 
formation of the aggregates as observed in electromobility shift assays with the cGAS full length 
construct rise the question, whether N-terminal cGAS domain specifically participates in further 
oligomerization of cGAS and fibrils formation [314]. Despite DNA-binding, the N-terminal domain of 
cGAS might participate in protein-protein interactions between adjacent cGAS dimers within a fibril or in 
a net formation by protein-protein or DNA-mediated interactions with other fibrils. Aggregation and 
oligomerization of the full length cGAS on different DNA constructs need further research, since 
electromobility shift assays, though showing increased aggregation for cGAS full length construct 
compared to Mab21 domain in the same condition, also show aggregate formation of a catalytic domain 
with DNA in some studies [233, 314]. Since a complex of the N-terminus with only a short 14 bp DNA 
was tested, its intrinsic capability of filament formation along DNA strand would be also of a particular 
interest [315]. Intriguingly, the N-terminus was found to possess a high sliding mobility along a DNA 
strand, which was reduced by the addition of a catalytic domain in full length cGAS construct  [315]. 
Together with the oligomerization mechanism proposed in this thesis it is tempting to speculate that 
cGAS might first bind DNA with its N-terminus and slide towards the previously formed cGAS-DNA 
ladder or fibril nucleation point where the DNA strands are already prearranged, so dimerization of the 
catalytic domain and cGAS activation may occur (Figure 23). Further structural and biochemical studies, 
however, are necessary to address all the points concerning oligomerization mechanism of the full length 
cGAS, as well as structure and function of its N-terminus in this process. 
 
Figure 23 A model for a ladder formation by full length cGAS. 
cGAS might first interact with the DNA with its N-terminus (hexagons) and slide towards the end of the formed 
ladder. The existing ladder parallelizes DNA strands in its proximity and therefore facilitates DNA binding and 
dimerization of the Mab21 catalytic domains (circles). Protomers within cGAS dimers are colored with different 
shades of blue. 
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4. cGAS co-factors and physiological ligands: genome products, mitochondrial 
DNA and bacterial nucleoids 
Following the first discovery of cGAS as a sensor of foreign DNA emerging from DNA-viruses and 
intracellular bacteria the complexity of its function evolved rapidly. The first break-through was made by 
the finding of mitochondrial DNA (mtDNA) leakage and its recognition by cGAS upon mitochondrial 
stress induction or viral infection [225]. Though the exact mechanism of mtDNA escape into the cytosol 
is unknown, TFAM depletion was found to result in accumulation of aberrant mtDNA and mitochondrial 
hyperfusive phenotype. Induction of the mitochondrial fission abrogated mtDNA leakage and IFN 
response. Mitochondrial stress was also shown to be induced by HSV-1 and (+)ssRNA Dengue virus 
explaining the involvement of cGAS/STING axis in recognition of RNA viruses [225, 604]. These 
findings indicate that even in the presence of viral DNA in the cytosol pathogen-induced self-DNA 
translocation may serve as the most potent cGAS activator. A crucial role of mtDNA in cGAS activation 
was further supported by the discovery of a cGAS-inhibiting role of apoptotic caspases [226, 227]. R.A. 
Flavell’s and D.C.S. Huang’s groups simultaneously published that inhibition of apoptotic caspases 
together with activation of apoptosis results in mtDNA escape from mitochondria and cGAS activation. 
According to the authors, dying cells release mtDNA into the cytosol in a Bax/Bak-dependent manner and 
trigger type I IFN response in the absence of apoptotic progression. However, the exact mechanism of 
mtDNA leakage into the cytosol remains unclear and needs further research. Mitochondrial hyperfusion 
may lead to a simple rupture of mitochondrial membrane followed by exposure of mitochondrial material 
into the cytosol. On the other side, involvement of Bax/Bak in mtDNA transition by apoptosis inhibition 
may indicate that mtDNA leaks through protein channels like Bax/Bak pores [226, 227]. The latter is, 
however, enigmatic given a small size of Bax/Bak channel – 5-6nm – that might not be sufficient for a 
transport of 16 nm in diameter supercoiled plasmid, but would suit for a single 2nm in diameter dsDNA 
fragment resulting from a preceding mtDNA cleavage [605-607]. Whether the nucleoid DNA interacts 
with the cytosolic compartment fully or partially by exposed loops, also remains to be uncovered. Based 
on the presence of mtDNA in cytosolic fractions free of mitochondrial contaminations, however, the 
leakage of the whole mitochondrial nucleoid into cytosol seems to be most likely [225]. 
Another source of self-DNA emerges from nucleus. Cytosolic chromatin fragments were shown to 
activate cGAS in cancer and senescent cells triggering IFN response [230, 231, 608]. Moreover, a 
mechanism explaining how nuclear instability and double-stranded DNA breaks (DSBs) induced by 
radio- and chemotherapies in cancer elicits IFN response was recently discovered [228, 229]. A.P. 
Jackson’s and R.A. Greenberg’s groups discovered that not DSBs themselves, but a mitotic progression 
following DNA damage results in formation of aberrant enveloped chromatin fragments – micronuclei – 
that stimulate cGAS activation and IFN signaling upon membrane rupture. Similar to mitochondrial 
stress, genome instability may be caused by such viruses as KSHV or Epstein-Barr virus, further 
supporting the role of self-DNA in cGAS activation [609-611]. Accumulation of aberrant mitochondrial 
nucleoids and chromosomes seems to fit into a general mechanism of cGAS activation by stress- or virus-
induced instability of genomic material and attracts a huge interest to further studies of cGAS activation 
by these DNA species. Moreover, the mechanism including membrane permeabilization followed by 
chromatin or mitochondrial nucleoid exposure is tempting to apply for cGAS sensing of intracellular 
bacteria, though precise mechanism of DNA leakage into cytosol in this case remains to be elucidated. 
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Based on these spectacular findings the question arises, if such a self-DNA-mediated cGAS activation 
evolved separately to cGAS recognition of dsDNA or if cGAS is specifically tailored for sensitive self-
DNA recognition. Or, formulated in another way, does self-DNA trigger a potent cGAS response only as 
an additional source of DNA, due to its length shown to be important for cGAS activation, or through 
special structures introduced by associated proteins? The work presented in this thesis offers a hypothesis 
explaining a particular role of self-DNA in cGAS activation. Since chromatin, mitochondrial and bacterial 
DNA are all structured by a range of DNA-binding proteins the function of these proteins as cGAS co-
factors was tempting to suggest. Among others, DNA-bending mitochondrial TFAM, nuclear HMGB1 
and bacterial nucleoid-packaging proteins HU attract special attention. HMGB1 was previously found to 
be involved in innate immune response as a cytokine activating TLR2, TLR4, TLR9 and receptor for 
advanced glycation end products (RAGE), as well as in IFN response to cytosolic DNA and poly(I:C) 
[295, 298, 612, 613]. Indeed, all mentioned proteins were found to strongly stimulate cGAS activity in 
vitro and mutations disabling DNA-bending properties were found to abolish this effect at least for 
HMGB1 [600]. According to the previously published structures U-turns introduced by these proteins can 
be perfectly aligned to a cGAS fibrils observed with 39 bp stimulatory DNA [600, 614]. Thus cGAS 
oligomerization on long DNA combined with DNA-bending cGAS co-factors stimulating its activity 
generate a novel view on nucleation-oligomerization mechanism of cGAS sensing [600]. In this 
hypothesis DNA-bending proteins pre-arrange long DNA in a way favorable for cGAS dimer binding and 
may serve as high-affinity starting points for cGAS fibril formation (Figure 24). In a physiological 
context this would mean that pre-structured TFAM/HMGB1/HU-bound long DNA species rather than 
naked DNA are preferable cGAS ligands. Such DNA structures may represent leaked into cytosol partly 
unfolded mitochondrial and bacterial nucleoids (Figure 24). However, further studies are needed to 
explore the physiological relevance of the proposed mechanism and the effect of these co-factors on 
cGAS activity in the cells and in vivo. For example, the activating effect of HU needs further clarification, 
since HU seems to introduce U-turns only in the context of specific distorted DNA [615]. Composition of 
HUα and HUβ E. coli proteins was found to influence their binding mode of bacterial plasmids switching 
between a single filament state and net-like DNA structures formed by bridging several DNA molecules 
into a network [616]. If not DNA-bending, formation of parallelized DNA strands by interacting HU 
proteins might explain the cGAS stimulation effect of these proteins. Structural studies on cGAS binding 
mode in context of HMGB-bound DNA are also of particular interest. Furthermore, a necessity of cGAS 
fibrils formation in the case of bent DNA must be further explored. Though nucleation-oligomerization 
mechanism of cGAS activation seems to be the most plausible explanation of the biochemical data 
obtained so far and was previously reported for other innate immune sensors like NAIP2/NLRC4 
inflammasome assembly [617], recognition of structured DNA and cGAS fibril formation might also 
occur separately in a biological context. Like for MDA5 dsRNA receptor [618], cGAS oligomerization 
might be a major mechanism for discriminating long pathogenic DNA molecules from short non-
stimulating digestion products independently from the DNA U-turns and DNA-bending proteins. The 
recognition of structured DNA by cGAS, on the other side, might function independently of cGAS 
oligomerization to specifically detect HMGB-bound self-DNA or bacterial nucleoids and require a single 
cGAS dimer stabilized by its proximity to a DNA-bending protein. However, the fact that TFAM 
stimulating activity on cGAS increases with DNA-length  up to 200 bp rather supports the hypothesis of 
nucleation followed by cGAS oligomerization [600]. Intriguingly, a rapid increase in the TFAM-
stimulating capacity around 200 bp coincides with a previously reported DNA-length, which is needed for 
an optimal TFAM dimerization  
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Figure 24 Nucleation-oligomerization mechanism of cGAS sensing. 
Leakage of mitochondrial (mt) and bacterial nucleoids, as well as chromatin fragments into cytosol results in their 
decondensation and partial dissociation of the associated proteins. Remaining DNA-bound TFAM, HU and HMGB1 
(green, violet and orange corners, respectively) prearrange the DNA in a nearly parallel way favorable for cGAS 
dimer binding (solid bold arrow) and thus efficiently nucleate cGAS filament formation. “Naked” DNA species like 
viral DNA are not structurally prearranged and thus potentiate cGAS filament formation slower (thin solid arrow). 
Consequent events are connected with black dashed arrows.  
 
[619]. This raises the question whether DNA U-turns or the loops introduced by TFAM dimerization and 
nucleoid packaging are the driving force for cGAS stimulation by TFAM. Given that TFAM dimer-
induced DNA compactization was reported to gradually increase with DNA length, the latter would result 
in further increase of TFAM capacity to stimulate cGAS on the DNA fragments above 200 bp, which is 
not the case [600, 619]. Moreover, since no further growth of TFAM-stimulated cGAS activity was 
observed above 200 bp threshold unlike TFAM-free system, cGAS oligomer growth from TFAM-nuclei 
might be either limited or unnecessary for the observed TFAM stimulation. Therefore such discrimination 
between DNA-structuring and cGAS oligomerization would be one of the important directions of the 
future studies.  
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Given that only a particular concentration of DNA-bending proteins resulted in stimulation of cGAS 
activity and above this concentration competed with cGAS for DNA binding and counteracted cGAS 
reaction, DNA compactization seems to play an important role in regulating cGAS activity. It would 
explain the immunosilence of mitosis despite the fact that cGAS co-localizes with chromatin after nuclear 
membrane disassembly and immunostimulatory activity of the micronuclei, on the other side [228, 229, 
608]. The need for a partly dissociation of chromatin or mtDNA structuring proteins for cGAS activation 
and its inactivity on fully condensed self-DNA would thus allow a “healthy”-self vs. “damaged”-self 
discrimination, as well as delayed cGAS response in the case of self-DNA leakage. The latter might be 
needed for activation of other interconnected pathways in order to fine-tune a final cellular response. The 
same principle could also be applied for bacterial nucleoids covered with HU DNA-binding proteins 
(Figure 24).         
The discovery of TFAM and HMGB1 in the context of self-DNA recognition by cGAS offers a broad 
field for searching for other potential cellular co-factors of cGAS. As such, nuclear proteins MRE11 and 
IFI16 previously shown to be involved in STING-dependent signaling represent promising potential 
candidates for assisting cGAS activation [274, 307]. Nuclear transcription factors that might reside on 
chromatin material within cGAS-stimulating micronuclei are another batch of potential cGAS DNA-
arranging co-factors. Moreover, chromatin and nucleosome structure itself may arrange DNA in a way 
favorable for cGAS dimerization and thus needs further characterization as cGAS activator. A recent 
study revealing the interferogenic potential of neutrophil extracellular traps (NETs) that consist of 
chromatin material bound to cytosolic and granular content attracts attention to these structures as cGAS 
activators [620]. Reactive oxygen species production by mitochondria that drive the exposure of NETs 
and mtDNA oxidation provide an additional link between chromatin and mitochondrial DNA recognition 
and is of particular interest as potential structured cGAS ligand due to its involvement in STING-
dependent IFN signaling and systemic lupus erythematosus [620]. 
Whether cGAS is capable to specifically attract the described and putative co-factors, is another 
intriguing question. Though no protein-protein interactions between human full length cGAS and TFAM 
could be detected, it can be different for other co-factors. Among others, the function of the N-terminal 
cGAS domain in cGAS oligomerization and its interaction with cellular co-factors is of particular interest. 
The involvement of described cGAS activators in recognition of initially naked transfected or viral DNA 
is another open question. Though TFAM normally localizes to mitochondria and leaks to the cytosol only 
under mitochondrial stress conditions, it might partly dissociate and bind viral DNA further increasing 
cGAS response to viral DNA [600]. Moreover, nuclear protein HMGB1 was found to co-localize with 
cGAS and transfected plasmid. The presence of cGAS does not seem to be necessary for HMGB1 
translocation from the nucleus. Indeed, DNA transfection itself was sufficient to induce HMGB1 
relocalization and resulted in its association with cytosolic DNA loci [600]. Based on the data presented 
in this thesis, no direct interaction of cGAS with its DNA-binding co-factors is necessary to assemble 
active co-factor-bound cGAS complexes. Instead, a dramatic increase of cytosolic DNA concentration 
during infection might lead to a shift in the equilibrium and attract HMGB1 and other co-factors into the 
cytosol. In this case a constant shuttling of the factors between their compartments and cytosol that was 
already proposed for HMGB1 would favor such association and accumulate low amounts of DNA-
binding cGAS co-factors on cytosolic DNA species thus increasing their potency as cGAS activators 
[621]. However, further studies on cGAS co-factors and their localization are needed to evaluate this 
hypothesis.   
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5. HIV genome and structured DNA as specific cGAS ligands 
The hypothesis that cGAS specifically recognizes structured self-DNA like mitochondrial nucleoids and 
chromatin fragments raises the question whether some host factors act in the same way in context of viral 
DNA. Since viral genomes often have secondary structured elements and are often covered with viral 
proteins, such structured DNA species also attract particular interest as potential strong cGAS activators, 
similar to that discovered for other innate immune sensors. For example, RIG-I specifically recognizes 
secondary structured elements within defective DenV viral genomes, which are produced when the viral 
polymerase slips from the template and copies back the short RNA strand [622]. Moreover, circular RNA 
species evolving during back-splicing from host mRNAs are also potent RIG-I activators and are 
proposed to be transmitted between the cells to amplify innate immune response [623, 624].   
Though cGAS is mostly known for sensing dsDNA viruses, recent discoveries introduced retroviruses as 
activators of the cGAS/STING axis [220, 509, 512]. In the series of knock-out and mutational studies the 
group of James Chen showed that cGAS is responsible for IFN induction in various human cell lines in 
response to murine leukemia virus (MLV), simian immunodeficiency virus (SIV) and HIV-1 [220]. 
Intriguingly, TREX1 knock-out decreased but not abolished this response. cGAS activation was shown to 
depend strongly on reverse transcription since its chemical inhibition or expression of SAMHD1 in 
human macrophages and dendritic cells abolished IFN production, which means that retroviral DNA 
species are responsible for immune response. An observation that HIV-1 elicits immune response 
independently of viral genome integration together with the finding that SAMHD1 activity leads to 
accumulation of HIV-1 reverse transcription intermediates activating STING and IRF3 attracted attention 
to these ssDNA species as potential cGAS activators [512, 625]. Indeed, ssDNA generated from HIV-1 
genome by reverse transcription was capable of inducing IFN response due to its secondary structure 
comprising dsDNA stems [237]. However, such dsDNA regions within HIV-1 ssDNA being ~20 bp long 
are below the minimal length needed for cGAS activation. Further studies, presented in this thesis, 
revealed that the presence of G-bases flanking a dsDNA hairpin are needed for HIV-1 ssDNA 
immunostimulatory capacity and designed synthetic short dsDNA sequences are capable of cGAS 
activation (Figure 25) [626]. In contrast to blunt dsDNA fragments that have to exceed ~ 45 bp to be 
efficient cGAS ligands, the dsDNA constructs with single or double G2-G3-overhangs on both sides – Y-
shaped DNA (YSD) - reduce this threshold up to 14 bp. Such YSDs represent a novel specific DNA 
structure of viral origin recognized by cGAS [626]. The mechanism of sensitive cGAS recognition of 
such DNA species, however, remains to be clarified. Since several hairpin regions are present within 
HIV-1 ssDNA, they might occur close to each other forming nearly parallel dsDNA strands that would 
stimulate cGAS dimer formation analogically to U-turn DNA species, which were described above 
(Figure 25a). Guanines at the end of dsDNA regions in this case might influence an overall fold of HIV-1 
ssDNA contributing to positioning of two dsDNA regions in close proximity favorable for cGAS 
activation. More enigmatic is a mechanism of cGAS activation by synthetic YSD constructs in which 
dsDNA regions are not connected within one molecule. Given that YSDs are potent cGAS activators not 
only in the cells, but also in in vitro system, their intrinsic capability of cGAS activation needs further 
research. Since cGAS active conformation corresponds to a dimer that is unstable in complex with 20 bp 
DNA, G-overhangs might contribute to cGAS dimer stabilization via guanine-protein interactions (Figure 
25c). Alternatively, given that guanines are prone of forming G-quadruplex structures by chelating a K+ 
cation, short YSDs might stick together through guanine interactions thus mimicking a long stimulatory 
DNA (Figure 25d). Though this hypothesis would go in line with cGAS oligomerization mechanism on 
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Figure 25 Nucleic acid species activating cGAS during HIV-1 infection and possible modes of their 
recognition.  
Reverse transcription of HIV-1 genome results in negative ssDNA with guanines flanking double-stranded stem 
regions recognized due to presumable specific parallel arrangement of dsDNA regions (a) or with help of PQBP1 
(b). G-overhangs of Y-shaped DNA (YSD) – an analogue of HIV-1 (-)ssDNA stem regions – might stabilize the 
cGAS dimer (c) or mimic long DNA by stacking of several short dsDNA fragments (d).  
 
long stimulatory DNA, it does not explain why a replacement of guanines with 7-deazaguanines or 
inosines that are incapable of G-quandruplex formation retain their high potential to activate cGAS in the 
cell system [600, 626]. Therefore further research is needed to clarify the mechanism of cGAS activation 
by YSDs and HIV-1 in general. 
Though the ssDNA structure itself is a prerequisite for cGAS activation by HIV-1, other cellular factors 
might also contribute to cGAS-mediated immune response to the virus in vivo. One might expect cellular 
co-factors to specifically bind HIV-1 ssDNA or G-overhangs and thus stimulate HIV-1 and YSD 
recognition by cGAS.  Remarkably, parallel to the discovery of cGAS as HIV-1 sensor, IFI16 was also 
shown to be involved in HIV-1 sensing [237]. Though the later studies found a role of IFI16 in mediating 
TBK1 recruitment by STING in the same cGAS/STING axis, its direct influence on cGAS remains 
unclear, thus offering a possibility of its involvement in recognition of structured HIV-1 ssDNA [306, 
307]. Though the role of IFI16 in HIV-1 DNA binding is highly speculative, another cellular co-factor 
was shown to specifically bind HIV-1 ssDNA and facilitate cGAS activation upon HIV-1 infection. 
Polyglutamine binding protein 1 (PQBP1) was found to be an essential co-factor for immune response to 
HIV-1 infection, as  discovered during RNAi screening of monocyte-derived dendritic cells (MDDCs) 
infected with HIV-1 (Figure 25b) [219]. PQBP1 was shown to interact directly with both HIV-1 ssDNA 
and cGAS, as shown in co-immunoprecipitation studies, and to be dispensable for viral and synthetic 
dsDNA sensing. The exact mechanism of PQBP1 cGAS stimulation upon HIV-1 infection, as well as 
importance of HIV-1 ssDNA secondary structure and guanines flanking HIV-1 hairpins for PQBP1 
binding represent one of the directions for future studies. Whether PQBP1 is able to recognize synthetic 
YSDs and trigger cGAS activation by these DNA species is another important question. Moreover, the 
discovery of PQBP1 further attracts attention to other putative co-factors stimulating cGAS activation in 
context of various DNA species.  
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The finding of cGAS activation by HIV-1 indicates a general mechanism of cellular response to 
retroviruses and raises the question whether retrotransposons might be another source of cellular DNA 
molecules triggering IFN response through cGAS. The majority of the retroelements in human genome 
are represented by long interspersed nuclear elements (LINEs, ~ 6kb in length) and short interspersed 
nuclear elements (SINEs, ~ 3kb in length) that are normally epigenetically silenced but upon transcription 
into RNA are reverse transcribed into cDNA and dsDNA and inserted into human genome [627, 628]. 
Though intermediates of retroelements are normally present in the nucleus and are not accessible to 
cytosolic sensors, their increased activation leads to accumulation of cytosolic nucleic acid species like 
dsRNA and dsDNA that were proposed to be recognized by RLRs and cGAS, respectively (Figure 26). 
Increased expression of retroelements was observed in human prostate cancer and metastatic colon tumor 
cells [629, 630]. Furthermore, tumor tissues are characterized by an increased level of demethylation of 
retroelement loci presumably leading to a loss of their epigenetic silencing in various cancers [631]. RNA 
intermediates of SINE replication were shown to activate TLR7 and contribute to SLE, whereas DNA 
methyltransferase inhibitors used as chemotherapeutics were shown to upregulate retroelements and 
induce MDA5 and TLR3 via their dsRNA intermediates [632-634]. Moreover, some viruses like MHV68  
 
Figure 26 Innate immune sensing of retroelements and sources of RNA:DNA hybrids. 
HIV-1 infection, as well as activation of retroelements by chemotherapeutics, viruses or cancer leads to enhanced 
transcription of retroviral ssRNA (red wave), which is reverse transcribed (RT) into ssDNA (black wave), 
RNA:DNA hybrids (black and red double wave) and dsDNA (black double wave) recognized by cGAS. Other 
sources of RNA:DNA hybrids include mitochondrial replication products and herpesviral genomes. dsRNA (red 
double wave) generated by annealing of sense- and antisense transcription of nuclear retroelements is detected by 
RIG-I, MDA5 and TLR3. Transition between nucleic acid species is shown with black solid arrows, detection – with 
dashed black arrows, inhibition – with red lines with blunt ends. 
 
-160- 
 
were described to induce SINE expression and therefore to activate MAVS-dependent NF-κB signaling 
[635]. Collectively, these findings indicate an important role of retroelements in innate immune response. 
Additionally to RNA species evolving from retroelements, their DNA-containing replication 
intermediates can also be linked to induction of IFN pathways. SAMHD1 inhibiting retroelement 
replication and exonuclease TREX1 that metabolizes reverse transcribed retroviral DNA control 
propagation of retroelements and their deficiency was associated with AGS and SLE autoimmune 
diseases making retroelements an important source of self-DNA and potential ligand for cGAS 
recognition [261, 636]. Apart from that deficiency of RNase H2 was linked to autoimmunity by inducing 
genome instability and formation of micronuclei that trigger cGAS activation [228, 526, 527]. Of note, 
activation of retroelements also results in chromosomal rearrangements and nuclear stress providing an 
additional link between their elevated expression and IFN response induced by cGAS activation [637, 
638]. RNase H2 dysfunction resulting in incorporation of ribonucleotides into genomic DNA, as well as 
RNA:DNA species that are produced as intermediates of retroelement replication point to RNA:DNA 
species as a specific immunogenic nucleic acid. Indeed, in vitro and in human cell lines RNA:DNA 
hybrids could activate cGAS though less efficiently than dsDNA [639]. RNA:DNA hybrids were also 
described to occur during herpesvirus infection and as part of mtDNA arising from mtDNA replication 
(Figure 26) [640-642]. However, the sources of RNA:DNA hybrids and an exact nature of retroviral 
DNA-containing species that stimulate cGAS remain to be discovered. Similar to recognition of HIV-1 
ssDNA, retroviral replication intermediates may possess specific secondary structures or could require 
other cellular co-factors for efficient cGAS activation. Despite a number of open questions it is tempting 
to broaden the research field of cGAS ligands from a single dsDNA to structured ssDNA and RNA:DNA 
hybrids. The involvement of cGAS in retrotransposon recognition, however, needs further research. 
Nevertheless, enhanced retroelement expression induced by type I IFN treatment [632], activation of 
retroelements upon viral infection and cancer, stress-induced mtDNA and chromatin exposure are 
tempting to be linked together into a general mechanism of cGAS activation initiated by viral infection 
and amplified using intracellular sources of DNA. Thus, a cross-talk between these mechanisms, as well 
as sources of cellular cGAS ligands and unique nucleic acid structures and co-factors are of a great 
interest for further studies.  
6. Oligomerization in innate immunity  
Signal transduction is usually understood as a chain of reactions or interactions serving as second 
messengers that lead to activation of enzymes and transcriptional or non-transcriptional effects. One of 
the well-studied examples includes β-adrenergic G-protein-coupled receptor (GPCR) which upon ligand 
binding undergoes conformational changes resulting in dissociation of G-proteins and activation of 
adenylyl cyclase that amplifies signals by producing several cAMP molecules and thus activates several 
molecules of protein kinase A that in turn phosphorylates cellular proteins [643]. Receptor tyrosine 
kinases (RTKs), on the other hand, possess a kinase activity that is stimulated upon ligand binding and 
directly initiate downstream kinase cascade [644]. Such pathways result in signal amplification through 
several rounds of second messenger production and a direct correlation between the induction strength, 
activated receptor lifetime and response. Unlike GPCRs and RTKs, innate immune receptors do not have 
enzymatic activity or are directly coupled to an enzyme. Instead, the majority of innate immune receptors 
initiate an assembly of huge signalosomes resulting in cooperative oligomerization of proteins after initial 
seed formation (Figure 27). Though GPCRs can also form oligomers on the cell surface, a monomeric  
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Figure 27 Schematic representation of innate immune signaling.  
Oligomerization of innate immune receptors upon ligand binding stabilizes such interaction and ensures specific 
ligand recognition. Receptor oligomerization further nucleates adaptor clustering and recruitment of multiple 
effector enzymes resulting in signal amplification and enzyme transactivation by the neighboring enzymes. Receptor 
and downstream clustering ensures noise reduction and a potent dose-threshold response upon specific, strong and 
persistent stimulus. 
 
receptor is fully capable of G protein activation and no propagation of its oligomeric state was observed 
in the downstream signaling events [645, 646]. Signal amplification in case of innate immune receptors 
emerges from subsequent oligomerization steps of receptor, adaptor and effector proteins resulting in 
recruitment of overstoichiometric numbers of signaling enzymes (Figure 27). Such a cooperativity leads 
to a sharp transition from non-active to activate states and dose-threshold response [647]. Since aberrant 
activation of innate immune programs might have deadly consequences, cooperative sensing ensures that 
the activating stimulus is strong enough to trigger the signaling. Time delay of such type of response 
provides additional mechanism to overcome transient and stochastic stimuli. Thus, cooperative signaling 
of innate immune receptors reduces noise signals and elicits immune response only upon strong and 
persistent activation. 
Toll-like receptor (TLR) signaling starts from TIR-TIR homotypic domain interaction between activated 
TLR and MyD88 adaptor protein [648]. Oligomeric clustering of MyD88 TIR-domains around TLR 
promotes an assembly of its N-terminal death domains (DD) and their interaction with IRAK family 
members resulting in formation of DD signaling scaffold also called the “MyDDosome” [649, 650]. 
According to a crystal structure the MyDDosome represents a left-handed helix characteristic for all DD-
fibrils with 6 MyD88 DDs followed by 4 IRAK4 and 4 IRAK2 kinases [649]. Increase of the local 
concentration of IRAK4 kinase domains results in its dimerization, autophosphorylation and enables 
IRAK4-mediated phosphorylation of IRAK1 or IRAK 2 [651, 652]. Intriguingly, formation of such 
oligomeric complex is extremely hierarchical and is determined by the shape and charge of interacting 
surfaces [649]. MyD88-DD is prone of oligomerization in higher protein concentrations whereas IRAK4-
DD is monomeric in solution and assembles into a helix only using pre-formed MyD88-DD platform. 
Moreover, IRAK2-DD does not form a stable complex with IRAK4 or MyD88 alone, meaning the 
sequential propagation of DD-helix from more stable MyD88-DD association to addition of IRAK4 and 
IRAK2 or IRAK1 DD-domains that together stabilize the MyDDosome [649]. Oligomerization scaffold 
further contributes to recruitment of TRAF6 to the membrane and its trimerization. Unlike helical DD-
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assembly, C-terminal TRAF6 domains forms trimers, whereas its N-terminal RING and ZF domains are 
dimeric [653-655]. This forms a 2-dimentional lattice that facilitates K63-linked polyubiquitination of 
IRAK1, NEMO and TRAF6 and downstream signaling [655, 656]. The TLR pathway represents a 
conjunction of three different types of oligomerization for signal amplification and proximity-driven 
activation of the participating enzymes and catalysis.     
Unlike TLR signaling, inflammasome assembly depends mostly on helical fibrils formed by different 
types of DDs including PYD and CARD domains. Nucleated by substoichiometric amount of AIM2 or 
NLRs oligomers bringing their CARD or PYD domains into close proximity, oligomerization 
hierarchically propagates through adaptor ASC PYD filament formation and further pro-caspase-1 
recruitment [87]. Strikingly, ASC PYD filaments have different helical symmetry from AIM2 PYD 
filaments [657]. Moreover, ASC PYD oligomers are able to nucleate oligomerization of death-effector 
domains (DEDs) of pro-caspase-8 indicating a high level of plasticity of this adaptor protein needed to 
accommodate different upstream and downstream proteins [658]. PYD domains of ASC create a cylinder-
like structure surrounded by a ring of flexibly attached CARD domains [87, 89]. The CARD domains in 
turn nucleate oligomerization of pro-caspase-1 into CARD-filaments thus stimulating its autoactivation. 
Unlike right-handed ASC-PYD helical filament, CARD domains of caspase-1 assemble into a left-handed 
helix similar to MyDDosome [659]. Remarkably, propagation of ASC-PYD filament was reported to be 
limited by CARD domains likely due to CARD aggregation [87]. A current model of inflammasome 
activation thus includes NLR-nucleated aggregation of a short ASC filament with a consequent assembly 
and growth of pro-caspase-1 fibrils resulting in a nucleated star-shaped ternary complex.  
Similar to inflammasomes, RLRs also utilize helical assemblies of CARD domains for signal 
transduction. RNA-bound RIG-I and MDA5 nucleate MAVS CARD filaments with their tetrameric 
CARDs resulting in aggregates of MAVS on mitochondria that recruit TBK1 and IRF3 directly or initiate 
NF-κB signaling through TRAF6 adaptor recruiting IKK and TAK1-kinase complexes. Intriguingly, 
MAVS has several features similar to cGAS signaling adaptor STING. Both STING and MAVS initiate 
the IFN production in overexpression system, require their membrane association for downstream 
cascades under physiological conditions and form punctate structures upon activation in perinuclear 
regions and mitochondria, respectively [141, 142, 215, 244]. Though oligomerization of MAVS and its 
localization in rod-shaped clusters on one side of mitochondria is well-studied, the nature of STING 
punctate structures remains enigmatic and needs further research [660]. STING oligomerization was 
observed in vitro for a full length protein, however, such aggregation might have emerged from stacking 
of the hydrophobic transmembrane domains [331]. Since STING itself does not possess any death 
domains and its cytosolic CDN-binding part is a stable dimer in solution, other factors or STING 
transmembrane region could influence its higher-order assemblies. Given direct binding of IRF3 by both 
STING and MAVS and a need of MAVS oligomerization for IRF3 activation [141, 661], the same 
mechanism is very tempting to propose for STING. For example, CTT clustering was proposed to 
increase the local concentrations of TBK1 and IRF3 and to enhance kinase activity and signal 
transduction similar to IRAK1 and IRAK4 proximity-driven activation in the MyDDosome [331, 649]. 
Downstream adaptor oligomerization in innate immune pathways is initiated by PRR clustering upon 
ligand binding. For example, dimerization of active TLRs or their conformational change upon ligand 
binding followed by clustering transmits oligomerization on MyDD88 and downstream adaptor 
assemblies [662-664]. Cytosolic PRRs do also aggregate for signal transduction. For example, 
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NAIP2/NLRC4 disc structures were shown to assemble hierarchically starting from ligand-bound NAIP2 
followed by subsequent binding of NLRC4 monomers resulting in CARD domains clustering for ASC 
nucleation [617]. Unlike TLRs and NLRC4/NAIP2 recognizing small PAMPs, nucleic acid recognizing 
PRRs often use DNA or RNA molecules as a scaffold for oligomerization. AIM2 was found to form long 
filaments around dsDNA through interactions between its DNA-binding HIN domains and further 
aggregation of PYD domains [79, 657]. Negative stain micrographs also clearly show IFI16 fibrils 
formed on DNA [80]. Unlike AIM2, IFI16 DNA-binding HIN-domains alone do not interact within a 
fibril and its oligomerization emerges purely from PYD-domains association [80]. Such clustering of 
PYD domains results in nucleation of ASC filament and inflammasome activation [87]. Oligomerization 
was also observed for MDA5 and RIG-I that form continuous and limited filaments, respectively, through 
interactions between their ATPase domains [136, 138]. The importance of such an oligomerization for 
CARD-domains association can be illustrated by the additional requirement of K63-linked polyubiquitin 
chains for signal transduction by RIG-I in case of short dsRNAs (< 60 bp) [130, 665]. Short dsRNA and 
ssRNA do not introduce RIG-I oligomerization and therefore released CARD domains need additional 
co-factor – K63-linked polyubiquitin chains – to stabilize their tetramerization. In case of longer dsRNA, 
however, several RIG-I molecules are clustered in close proximity thus resulting in increased local 
concentration of CARD domains and their tetramerization without need for stabilizing ubiquitin binding 
[138].  
Apart from driving downstream oligomerization events, such filament formation on nucleic acids plays an 
important role in discrimination between short non-stimulatory nucleic acids and long pathogen-derived 
or damage-associated species. For example, AIM2 was shown to recognize dsDNA fragments > 70 bp 
and binds 250-300 bp DNA fragments with highest affinity [79]. DNA-binding of AIM2 was found to 
sigmoidally increase with DNA length suggesting cooperativity [79]. In vivo studies showing cooperative 
increase of IL-1β production with DNA between 10 and 80 bp further confirm length-dependent 
activation of AIM2 inflammasome [76]. Similarly to AIM2 filaments, IFI16 was also found to 
cooperatively bind dsDNA with an optimal binding efficiency starting from 150 bp corresponding to 10 
IFI16 protomers in cluster [80]. Interestingly, IFI16 was proposed to act in a switch-like manner: no 
binding was observed with < 60 bp DNA, however, all IFI16 molecules were bound with 60 bp DNA 
corresponding to IFI16 tetramer assembling with high cooperativity [80]. The RNA-sensor MDA5 that is 
known to stimulate IFN response uses a similar oligomerization mechanism to measure DNA length. 
MDA5 is activated with dsRNA fragments exceeding 1 kbp and shows increasing activation with 
increasing dsDNA length between 1 kbp and 7 kbp [115]. MDA5 was shown to have a slow filament 
nucleation and a fast dissociation initiated by ATP hydrolysis (Figure 28a) [125, 135, 618]. Though ATP 
hydrolysis occurs throughout the whole filament, MDA5 is stabilized in the middle by neighboring 
protomers and the dissociation mostly occurs at the filament ends (Figure 28b) [618]. On the short 
dsRNA such destabilization would lead to a complete MDA5 dissociation and inefficient nucleation, thus 
limiting MDA5 fibril formation and signaling. On the long dsRNA, however, MDA5 forms long dynamic 
filaments with less fraction of unstably bound terminal MDA5 molecules and therefore slower 
dissociation and higher association rates, because no limiting de novo nucleation is needed (Figure 28b) 
[618]. Thus, different PRRs utilize the same oligomerization principle to specifically recognize pathogen-
derived nucleic acids and to avoid recognition of non-pathogenic nucleic acid species. 
Surprisingly, previously proposed to be monomeric or form dimers, cGAS also seems to adapt 
oligomerization mechanism for self- vs. non-self discrimination. In the study presented in this thesis 
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cGAS was found to oligomerize into fibrils on long DNA fragments [600]. Analogically to PRRs 
described above, we showed that such oligomerization enhances DNA-binding and thus the active 
conformation of cGAS. Similar to dynamic MDA5 assembly, the binding of the first cGAS dimer on 
DNA may represent a slow nucleation step that is followed by more rapid fibril elongation. Though some 
sensors like AIM2, RIG-I , NAIP2 and NLRC4 were reported to reside in autoinhibited state before 
ligand binding, others like MDA5, IFI16 and cGAS seem to use the same oligomerization mechanism to 
counteract spontaneous activation, since only formation of higher-order assemblies were shown to 
enhance the ligand binding and receptor activation [77, 80, 129, 133, 618, 666]. Instead of ATP 
hydrolysis stimulating MDA5 dissociation and driving its specificity to long (> 1kb) dsRNA fragments, 
cGAS may use weak dimeric interaction as a source of filament destabilization resulting in specific 
recognition of long pathogenic dsDNA species (Figure 28a). Based on MDA5 RNA-sensing model, we 
hypothesize that cGAS dimers may also partly disassemble within the fibril but not dissociate due to the 
stabilization by the neighboring cGAS dimers (Figure 28b) [600]. Given a number of similarities between 
cGAS and MDA5 oligomerization, a possibility of cGAS fibril editing is of great interest. MDA5 
oligomerization occurring from different seeds may result in oligomers proceeding in different directions. 
These MDA5 stretches were found to undergo disassembly in order to generate a unidirectional stable 
oligomer [618]. Since a cGAS filament might also be initiated from different starting points, it is  
 
Figure 28 Similarities between MDA5 and cGAS assemblies on short and long nucleic acid species. 
(a) Slow association and fast dissociation rates of MDA5 (green circles) and cGAS dimers (blue triangles) 
binding result in transient and unstable binding of short dsRNA and dsDNA fragments, respectively. 
(b) Longer nucleic acid species allow oligomerization of MDA5 on dsRNA and cGAS dimers on two parallel 
dsDNA strands. Monomers within the fibrils are mutually stabilized and dissociation mostly occurs on the 
ends of oligomers. MDA5 and cGAS oligomers nucleate fibril growth and result in effective association of 
further monomers or dimers. 
Thick and thin black arrows represent fast and slow processes, respectively. Dashed arrows represent a direction 
of events. 
Partly adopted from del Toro Duany Y., et al., 2015 [667].    
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intriguing to know, whether similar processes exist to remove gaps and inconsistencies within the cGAS 
ladders. 
Apart from stabilization of the active conformation common for nearly all PRRs, oligomerization may 
have additional effector functions. For example, RIG-I and MDA5 were found to remove viral proteins 
like influenza A NS1 from dsRNA and restrict viral replication [116]. Moreover, RIG-I was recently 
found to bind 5’ end of hepatitis B virus (HBV) and therefore to counteract viral polymerase recruitment 
and reverse transcription of HBV [105]. Similar to this, higher-order oligomers of PRRs might interfere 
with viral replication due to competition for nucleic acid binding. Whether such activities can be featured 
to cGAS and other PRRs, remains an open question and needs further research.  
Oligomerization mechanism is also applied for regulation of innate immune response. For example, 
cellular anti-apoptotic FLICE/Casp-8-like inhibitory proteins (cFLIP) containing tandem DED domains 
were shown to incorporate into caspase-8 filament formed upon Fas receptor activation and death-
inducing signaling complex (DISC) or inflammasome activation [668]. A short version of cFLIP – cFLIPS 
– was found to interfere with pro-caspase-8 clustering and to reduce local concentration of caspase-8 in 
the filament and therefore counteracting its dimerization and activation. A long form of cFLIP – cFLIPL – 
on the other side, additionally to DED possesses a caspase-like domain able to heterodimerize with 
caspase-8. Incorporation of cFLIPL in caspase-8 filament can therefore stimulate caspase-8 activation and 
promote cell death. However, since such heterodimers have lower activity in comparison to caspase-8 
dimers, cFLIPL inhibits caspase-8 activity in higher concentrations. Viral anti-apoptotic protein MC159 
from Molluscum contagiosum virus can also associate with caspase-8 filament, but, unlike cFLIPS, blocks 
the filament propagation and caspase-8 activation due to its defective interfaces that prevent further 
oligomerization [668]. The similar capping mechanism was shown for human inhibitor of CARD (INCA), 
which inhibits the inflammasome assembly. Having only a CARD domain with defective interfaces  
 
Figure 29 Schematic representation of possible mechanisms of cGAS inhibition based on interfering with 
cGAS oligomerization. 
Cellular or viral inhibitor proteins (green) might intercalate between two DNA strands in cGAS oligomer (on the 
left) increasing the distance and thus disrupting cGAS dimerization and activation. They might incorporate within 
cGAS filament (in the middle) increasing a spacing between cGAS dimers (blue triangles) leading to oligomer 
destabilization and dissociation of dimers. Inhibitory proteins might also compete for DNA binding with cGAS (on 
the right) thus preventing cGAS filament growth and disassembling existing oligomers.  
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INCA interacts with caspase-1 filament and blocks further filament growth [659]. Inhibition via 
oligomerization interfering was also found for mouse HIN-domain containing protein p202. P202 was 
shown to interact with HIN-domain of AIM2 within AIM2 oligomer and to separate AIM2 PYD domains 
preventing PYD clustering and inflammasome activation [669]. Though no p202 orthologs could be 
found in humans, a similar mechanism of inflammasome inactivation may be used by other human 
proteins. Since oligomerization destabilization is a common mechanism for inhibition of diverse cellular 
pathways, it is an important question whether cGAS can also be regulated in a similar way (Figure 29).  
As a single cGAS2:DNA2 complex is rather unstable, some cellular or viral cGAS inhibitors might exist 
that interfere with cGAS packing by intercalating between two DNA strands within cGAS filaments and 
thus increase the distance between DNA and disrupt cGAS dimers. Another option, analogous to other 
oligomers, would be an incorporation of inhibitory factors into cGAS filament and increasing spacing 
between neighboring cGAS dimers that would lead to a less efficient DNA positioning and thus to 
destabilization of cGAS dimers and cGAS inactivation. Moreover, a simple competition for DNA binding 
or an active translocation along DNA could be used to disassemble cGAS oligomers and inhibit cGAMP 
production and IFN response (Figure 29). However, these mechanisms are highly speculative and further 
research is needed to study cGAS inhibition and involvement of cGAS oligomerization in its regulation.  
Taken together, nucleation-oligomerization mechanism of cGAS activation goes in line with similar 
mechanisms proposed for various PRRs. Unlike other receptors using their aggregation to nucleate 
downstream adaptors that in turn stimulate proximity-driven enzyme activation, cGAS combines both 
pattern recognition and enzymatic function. For this reason its oligomerization is only required for 
stabilization of its active conformation. Another distinct feature of cGAS includes its higher-order 
assembly without protein-protein contacts. A unique cGAS dimeric structure seems to be sufficient for 
positioning of DNA strands in nearly parallel manner that is favorable for subsequent cGAS dimer 
binding and therefore mediates cGAS oligomerization through DNA arrangement rather than direct lateral 
cGAS contacts [600]. Despite the unique features described above, the oligomerization mechanism of 
cGAS further confirms importance of higher-order filaments in innate immune signaling and suggests a 
strong, specific and dose-threshold response to pathogen- or damage-associated cytosolic DNA.    
 
 
 
 
 
 
 
 
 
-167- 
 
References 
1. Du, B., et al., Targeting Toll-like receptors against cancer. Journal of Cancer Metastasis and 
Treatment; Vol 2, No 12 (2016), 2016. 
2. Hoffmann, J.A., et al., Phylogenetic Perspectives in Innate Immunity. Science, 1999. 284(5418): 
p. 1313-1318. 
3. Hartmann, G., Nucleic acid immunity. Adv. Immunol., 2017. 133: p. 121-169. 
4. Medzhitov, R. and C. Janeway, Jr., Innate immune recognition: mechanisms and pathways. 
Immunological Reviews, 2000. 173(1): p. 89-97. 
5. Long, E.O., Regulation of immune responses through inhibitory receptors. Annual Review of 
Immunology, 1999. 17(1): p. 875-904. 
6. Charles A. Janeway, J. and R. Medzhitov, Innate Immune Recognition. Annual Review of 
Immunology, 2002. 20(1): p. 197-216. 
7. Fearon, D.T. and R.M. Locksley, The Instructive Role of Innate Immunity in the Acquired 
Immune Response. Science, 1996. 272(5258): p. 50-54. 
8. Medzhitov , R. and C.J. Janeway Innate Immunity. New England Journal of Medicine, 2000. 
343(5): p. 338-344. 
9. Akira S., T.K., Kaisho T., Toll-like receptors: critical proteins linking innate and acquired 
immunity. Nat. Immunol., 2001. 2: p. 675-680. 
10. Medzhitov, R. and C.A. Janeway, Innate immunity: impact on the adaptive immune response. 
Current Opinion in Immunology, 1997. 9(1): p. 4-9. 
11. Charles A Janeway, J., Paul Travers, Mark Walport, and Mark J Shlomchik, Immunobiology: The 
Immune System in Health and Disease. 5th edition. 2001, New York: Garland Science. 
12. Ahn, J. and G. Barber, Self-DNA, STING-dependent signaling and the origins of 
autoinflammatory disease. Vol. 31. 2014. 
13. Sharma, S., et al., Triggering the Interferon Antiviral Response Through an IKK-Related 
Pathway. Science, 2003. 300(5622): p. 1148-1151. 
14. Sato, M., et al., Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in 
Response to Viruses for IFN-α/β Gene Induction. Immunity, 2000. 13(4): p. 539-548. 
15. Fitzgerald, K.A., et al., LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters 
TRAM and TRIF. The Journal of Experimental Medicine, 2003. 198(7): p. 1043-1055. 
16. Biron, C.A., Interferons α and β as Immune Regulators—A New Look. Immunity, 2001. 14(6): p. 
661-664. 
17. Darnell, J., I. Kerr, and G. Stark, Jak-STAT pathways and transcriptional activation in response 
to IFNs and other extracellular signaling proteins. Science, 1994. 264(5164): p. 1415-1421. 
18. Le Page, C., et al., Interferon activation and innate immunity. Reviews in immunogenetics, 2000. 
2(3): p. 374-386. 
-168- 
 
19. Goodman, A.G., et al., The Alpha/Beta Interferon Receptor Provides Protection against Influenza 
Virus Replication but Is Dispensable for Inflammatory Response Signaling. Journal of Virology, 2010. 
84(4): p. 2027-2037. 
20. Thornberry, N.A., et al., A novel heterodimeric cysteine protease is required for interleukin-
1[beta]processing in monocytes. Nature, 1992. 356(6372): p. 768-774. 
21. Ghayur, T., et al., Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ 
production. Vol. 386. 1997. 619-23. 
22. Brennan, M.A. and B.T. Cookson, Salmonella induces macrophage death by caspase-1-
dependent necrosis. Molecular Microbiology, 2000. 38(1): p. 31-40. 
23. Aliprantis, A.O., et al., Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like 
Receptor-2. Science, 1999. 285(5428): p. 736-739. 
24. Aliprantis, A.O., et al., The apoptotic signaling pathway activated by Toll‐like receptor‐2. The 
EMBO Journal, 2000. 19(13): p. 3325-3336. 
25. Sun, R., et al., Toll-like Receptor 3 (TLR3) Induces Apoptosis via Death Receptors and 
Mitochondria by Up-regulating the Transactivating p63 Isoform α (TAP63α). The Journal of Biological 
Chemistry, 2011. 286(18): p. 15918-15928. 
26. Zhang, Y. and J.B. Bliska, Role of Toll-Like Receptor Signaling in the Apoptotic Response of 
Macrophages to Yersinia Infection. Infection and Immunity, 2003. 71(3): p. 1513-1519. 
27. Ruckdeschel, K., et al., Signaling of Apoptosis through TLRs Critically Involves Toll/IL-1 
Receptor Domain-Containing Adapter Inducing IFN-β, but Not MyD88, in Bacteria-Infected Murine 
Macrophages. The Journal of Immunology, 2004. 173(5): p. 3320-3328. 
28. Upton, J.W., W.J. Kaiser, and E.S. Mocarski, DAI complexes with RIP3 to mediate virus-induced 
programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell host & microbe, 2012. 11(3): 
p. 290-297. 
29. Gaidt, M.M., et al., The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-
Cell Death Program Upstream of NLRP3. Cell, 2017. 171(5): p. 1110-1124.e18. 
30. Ikeda, K., et al., Serum lectin with known structure activates complement through the classical 
pathway. Journal of Biological Chemistry, 1987. 262(16): p. 7451-7454. 
31. Galiana-Arnoux, D., et al., Essential function in vivo for Dicer-2 in host defense against RNA 
viruses in drosophila. Nat Immunol, 2006. 7(6): p. 590-597. 
32. van Rij, R.P., et al., The RNA silencing endonuclease Argonaute 2 mediates specific antiviral 
immunity in Drosophila melanogaster. Genes & Development, 2006. 20(21): p. 2985-2995. 
33. Seo, Gil J., et al., Reciprocal Inhibition between Intracellular Antiviral Signaling and the RNAi 
Machinery in Mammalian Cells. Cell host & microbe, 2013. 14(4): p. 435-445. 
34. Schlee, M. and G. Hartmann, Discriminating self from non-self in nucleic acid sensing. Nat Rev 
Immunol, 2016. 16(9): p. 566-580. 
35. Anderson, K.V., L. Bokla, and C. Nüsslein-Volhard, Establishment of dorsal-ventral polarity in 
the drosophila embryo: The induction of polarity by the Toll gene product. Cell, 1985. 42(3): p. 791-798. 
-169- 
 
36. Lemaitre, B., et al., The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the 
potent antifungal response in Drosophila adults. Cell, 1996. 86(6): p. 973-983. 
37. Akira, S., S. Uematsu, and O. Takeuchi, Pathogen Recognition and Innate Immunity. Cell, 2006. 
124(4): p. 783-801. 
38. Alexopoulou, L., et al., Recognition of double-stranded RNA and activation of NF-[kappa]B by 
Toll-like receptor 3. Nature, 2001. 413(6857): p. 732-738. 
39. Diebold, S.S., et al., Innate Antiviral Responses by Means of TLR7-Mediated Recognition of 
Single-Stranded RNA. Science, 2004. 303(5663): p. 1529-1531. 
40. Heil, F., et al., Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 
8. Science, 2004. 303(5663): p. 1526-1529. 
41. Hemmi, H., et al., A Toll-like receptor recognizes bacterial DNA. Nature, 2000. 408(6813): p. 
740-745. 
42. Dinarello, C.A., Immunological and Inflammatory Functions of the Interleukin-1 Family. Annual 
Review of Immunology, 2009. 27(1): p. 519-550. 
43. Sims, J.E. and D.E. Smith, The IL-1 family: regulators of immunity. Nature Reviews 
Immunology, 2010. 10: p. 89. 
44. Yarovinsky, F., et al., TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like Protein. 
Science, 2005. 308(5728): p. 1626-1629. 
45. Mathur, R., et al., A mouse model of Salmonella typhi infection. Cell, 2012. 151(3): p. 590-602. 
46. Koblansky, A., Recognition of profilin by Toll-like receptor 12 is critical for host resistance to 
Toxoplasma gondii. Vol. 30. 2013. 119-130. 
47. Hidmark, A., A. von Saint Paul, and A.H. Dalpke, Cutting Edge: TLR13 Is a Receptor for 
Bacterial RNA. The Journal of Immunology, 2012. 189(6): p. 2717-2721. 
48. Matsushima, N., et al., Comparative sequence analysis of leucine-rich repeats (LRRs) within 
vertebrate toll-like receptors. Vol. 8. 2007. 124. 
49. Ozinsky, A., et al., The repertoire for pattern recognition of pathogens by the innate immune 
system is defined by cooperation between Toll-like receptors. Proceedings of the National Academy of 
Sciences, 2000. 97(25): p. 13766-13771. 
50. Takada, E., et al., C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization 
and signal transmission. Molecular Immunology, 2007. 44(15): p. 3633-3640. 
51. Zhang, H., et al., Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular 
targeting of TLRs and distinct mechanisms of TLR4 activation and signaling. FEBS Letters, 2002. 532(1): 
p. 171-176. 
52. Ivičak-Kocjan, K., et al., Determination of the physiological 2:2 TLR5:flagellin activation 
stoichiometry revealed by the activity of a fusion receptor. Vol. 435. 2013. 
53. Ohto, U., et al., Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. 
Nature, 2015. 520(7549): p. 702-705. 
-170- 
 
54. Wang, J., et al., The Functional Effects of Physical Interactions among Toll-like Receptors 7, 8, 
and 9. Journal of Biological Chemistry, 2006. 281(49): p. 37427-37434. 
55. G Motshwene, P., et al., An Oligomeric Signaling Platform Formed by the Toll-like Receptor 
Signal Transducers MyD88 and IRAK-4. Vol. 284. 2009. 25404-11. 
56. Kawasaki, T. and T. Kawai, Toll-Like Receptor Signaling Pathways. Frontiers in Immunology, 
2014. 5: p. 461. 
57. Honda, K., et al., Role of a transductional-transcriptional processor complex involving MyD88 
and IRF-7 in Toll-like receptor signaling. Proceedings of the National Academy of Sciences of the United 
States of America, 2004. 101(43): p. 15416-15421. 
58. Oshiumi, H., et al., TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-
mediated interferon-[beta] induction. Nat Immunol, 2003. 4(2): p. 161-167. 
59. Fitzgerald, K.A., et al., IKK[epsi] and TBK1 are essential components of the IRF3 signaling 
pathway. Nat Immunol, 2003. 4(5): p. 491-496. 
60. Cheng, Z., et al., Distinct single-cell signaling characteristics are conferred by the MyD88 and 
TRIF pathways during TLR4 activation. Science Signaling, 2015. 8(385): p. ra69-ra69. 
61. Harton, J.A., et al., Cutting Edge: CATERPILLER: A Large Family of Mammalian Genes 
Containing CARD, Pyrin, Nucleotide-Binding, and Leucine-Rich Repeat Domains. The Journal of 
Immunology, 2002. 169(8): p. 4088-4093. 
62. Kummer, J.A., et al., Inflammasome Components NALP 1 and 3 Show Distinct but Separate 
Expression Profiles in Human Tissues Suggesting a Site-specific Role in the Inflammatory Response. 
Journal of Histochemistry & Cytochemistry, 2007. 55(5): p. 443-452. 
63. Hamada, M., et al., The Complex NOD-Like Receptor Repertoire of the Coral Acropora digitifera 
Includes Novel Domain Combinations. Molecular Biology and Evolution, 2013. 30(1): p. 167-176. 
64. Initiative, T.A.G., Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. 
Nature, 2000. 408(6814): p. 796-815. 
65. Hornung, V., et al., AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating 
inflammasome with ASC. Nature, 2009. 458(7237): p. 514-518. 
66. Fernandes-Alnemri, T., et al., AIM2 activates the inflammasome and cell death in response to 
cytoplasmic DNA. Nature, 2009. 458(7237): p. 509-513. 
67. Kerur, N., et al., IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response 
to Kaposi sarcoma associated herpesvirus infection. Cell host & microbe, 2011. 9(5): p. 363-375. 
68. Unterholzner, L., et al., IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol, 
2010. 11(11): p. 997-1004. 
69. Miao, E.A., et al., Innate immune detection of the type III secretion apparatus through the 
NLRC4 inflammasome. Proceedings of the National Academy of Sciences, 2010. 107(7): p. 3076-3080. 
70. Gross, O., et al., Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host 
defence. Nature, 2009. 459(7245): p. 433-436. 
71. Mariathasan, S., et al., Cryopyrin activates the inflammasome in response to toxins and ATP. 
Nature, 2006. 440(7081): p. 228-232. 
-171- 
 
72. Craven, R.R., et al., Staphylococcus aureus α-Hemolysin Activates the NLRP3-Inflammasome in 
Human and Mouse Monocytic Cells. PLoS ONE, 2009. 4(10): p. e7446. 
73. Halle, A., et al., The NALP3 inflammasome is involved in the innate immune response to amyloid-
[beta]. Nat Immunol, 2008. 9(8): p. 857-865. 
74. Gasse, P., et al., Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury 
Inflammation and Fibrosis. American Journal of Respiratory and Critical Care Medicine, 2009. 179(10): 
p. 903-913. 
75. Zhou, R., et al., Thioredoxin-interacting protein links oxidative stress to inflammasome 
activation. Nat Immunol, 2010. 11(2): p. 136-140. 
76. Jin, T., et al., Structures of the HIN Domain:DNA Complexes Reveal Ligand Binding and 
Activation Mechanisms of the AIM2 Inflammasome and IFI16 Receptor. Immunity, 2012. 36(4): p. 561-
571. 
77. Hu, Z., et al., Crystal Structure of NLRC4 Reveals Its Autoinhibition Mechanism. Science, 2013. 
341(6142): p. 172-175. 
78. Poyet, J.-L., et al., Identification of Ipaf, a Human Caspase-1-activating Protein Related to Apaf-
1. Journal of Biological Chemistry, 2001. 276(30): p. 28309-28313. 
79. Morrone, S.R., et al., Assembly-driven activation of the AIM2 foreign-dsDNA sensor provides a 
polymerization template for downstream ASC. Nature Communications, 2015. 6: p. 7827. 
80. Morrone, S.R., et al., Cooperative assembly of IFI16 filaments on dsDNA provides insights into 
host defense strategy. Proceedings of the National Academy of Sciences, 2014. 111(1): p. E62-E71. 
81. Riedl, S.J., et al., Structure of the apoptotic protease-activating factor 1 bound to ADP. Nature, 
2005. 434(7035): p. 926-933. 
82. Qi, S., et al., Crystal Structure of the <em>Caenorhabditis elegans</em> Apoptosome Reveals 
an Octameric Assembly of CED-4. Cell, 2010. 141(3): p. 446-457. 
83. Faustin, B., et al., Reconstituted NALP1 Inflammasome Reveals Two-Step Mechanism of 
Caspase-1 Activation. Molecular Cell, 2007. 25(5): p. 713-724. 
84. Martinon, F., K. Burns, and J. Tschopp, The Inflammasome. Molecular Cell, 2002. 10(2): p. 417-
426. 
85. Broz, P., et al., Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense 
against <em>Salmonella</em>. The Journal of Experimental Medicine, 2010. 207(8): p. 1745-1755. 
86. Cai, X., et al., Prion-like Polymerization Underlies Signal Transduction in Antiviral Immune 
Defense and Inflammasome Activation. Cell, 2014. 156(6): p. 1207-1222. 
87. Lu, A., et al., Unified Polymerization Mechanism for the Assembly of ASC-Dependent 
Inflammasomes. Cell, 2014. 156(6): p. 1193-1206. 
88. Proell, M., et al., The CARD plays a critical role in ASC foci formation and inflammasome 
signaling. The Biochemical journal, 2013. 449(3): p. 613-621. 
89. Sborgi, L., et al., Structure and assembly of the mouse ASC inflammasome by combined NMR 
spectroscopy and cryo-electron microscopy. Proceedings of the National Academy of Sciences of the 
United States of America, 2015. 112(43): p. 13237-13242. 
-172- 
 
90. Mariathasan, S., et al., Differential activation of the inflammasome by caspase-1 adaptors ASC 
and Ipaf. Nature, 2004. 430(6996): p. 213-218. 
91. Ketelut-Carneiro, N., et al., IL-18 Triggered by the Nlrp3 Inflammasome Induces Host Innate 
Resistance in a Pulmonary Model of Fungal Infection. The Journal of Immunology, 2015. 194(9): p. 
4507-4517. 
92. Shi, J., et al., Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. 
Nature, 2015. 526(7575): p. 660-665. 
93. Liu, X., et al., Inflammasome-activated gasdermin D causes pyroptosis by forming membrane 
pores. Nature, 2016. 535(7610): p. 153-158. 
94. Man, S.M. and T.-D. Kanneganti, Converging roles of caspases in inflammasome activation, cell 
death and innate immunity. Nature reviews. Immunology, 2016. 16(1): p. 7-21. 
95. von Moltke, J., et al., Rapid induction of inflammatory lipid mediators by the inflammasome in 
vivo. Nature, 2012. 490(7418): p. 107-111. 
96. Sokolovska, A., et al., Activation of caspase-1 by the NLRP3 inflammasome regulates the 
NADPH oxidase NOX2 to control phagosome function. Nature immunology, 2013. 14(6): p. 543-553. 
97. Jabir, Majid S., et al., Caspase-1 Cleavage of the TLR Adaptor TRIF Inhibits Autophagy and β-
Interferon Production during Pseudomonas aeruginosa Infection. Cell host & microbe, 2014. 15(2): p. 
214-227. 
98. Shao, W., et al., The Caspase-1 Digestome Identifies the Glycolysis Pathway as a Target during 
Infection and Septic Shock. Journal of Biological Chemistry, 2007. 282(50): p. 36321-36329. 
99. Wilson, J.E., et al., Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis 
via DNA-PK and Akt. Nat Med, 2015. 21(8): p. 906-913. 
100. Bruchard, M., et al., The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. 
Nat Immunol, 2015. 16(8): p. 859-870. 
101. Anand, P.K., et al., NLRP6 negatively regulates innate immunity and host defence against 
bacterial pathogens. Nature, 2012. 488(7411): p. 389-393. 
102. Wang, P., et al., Nlrp6 regulates intestinal antiviral innate immunity. Science, 2015. 350(6262): 
p. 826-830. 
103. Liu, G., et al., Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and 
Interferon Induction. Journal of Virology, 2015. 89(11): p. 6067-6079. 
104. Choi, M.K., et al., A selective contribution of the RIG-I-like receptor pathway to type I interferon 
responses activated by cytosolic DNA. Proceedings of the National Academy of Sciences, 2009. 106(42): 
p. 17870-17875. 
105. Sato, S., et al., The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral 
Factor for Hepatitis B Virus. Immunity, 2015. 42(1): p. 123-132. 
106. Yoneyama, M., et al., Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, 
and LGP2 in Antiviral Innate Immunity. The Journal of Immunology, 2005. 175(5): p. 2851-2858. 
-173- 
 
107. Binder, M., et al., Molecular mechanism of signal perception and integration by the innate 
immune sensor retinoic acid-inducible gene-I (RIG-I). Journal of Biological Chemistry, 2011. 286(31): p. 
27278-27287. 
108. Hornung, V., et al., 5'-Triphosphate RNA is the ligand for RIG-I. Science, 2006. 
109. Goubau, D., et al., Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-
diphosphates. Nature, 2014. 514(7522): p. 372-375. 
110. Yoneyama, M., et al., The RNA helicase RIG-I has an essential function in double-stranded RNA-
induced innate antiviral responses. Nat Immunol, 2004. 5(7): p. 730-737. 
111. Weber, M., et al., Incoming RNA virus nucleocapsids containing a 5′-triphosphorylated genome 
activate RIG-I and antiviral signaling. Cell host & microbe, 2013. 13(3): p. 336-346. 
112. Ablasser, A., et al., RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA 
polymerase III-transcribed RNA intermediate. Nat Immunol, 2009. 10(10): p. 1065-1072. 
113. Gitlin, L., et al., Essential role of mda-5 in type I IFN responses to 
polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proceedings of the 
National Academy of Sciences, 2006. 103(22): p. 8459-8464. 
114. Runge, S., et al., In Vivo Ligands of MDA5 and RIG-I in Measles Virus-Infected Cells. PLOS 
Pathogens, 2014. 10(4): p. e1004081. 
115. Kato, H., et al., Length-dependent recognition of double-stranded ribonucleic acids by retinoic 
acid–inducible gene-I and melanoma differentiation–associated gene 5. The Journal of Experimental 
Medicine, 2008. 205(7): p. 1601-1610. 
116. Yao, H., et al., ATP-Dependent Effector-like Functions of RIG-I-like Receptors. Molecular Cell, 
2015. 58(3): p. 541-548. 
117. Li, X., et al., The RIG-I-like Receptor LGP2 Recognizes the Termini of Double-stranded RNA. 
Journal of Biological Chemistry, 2009. 284(20): p. 13881-13891. 
118. Pippig, D.A., et al., The regulatory domain of the RIG-I family ATPase LGP2 senses double-
stranded RNA. Nucleic Acids Research, 2009. 37(6): p. 2014-2025. 
119. Deddouche, S., et al., Identification of an LGP2-associated MDA5 agonist in picornavirus-
infected cells. eLife, 2014. 3: p. e01535. 
120. Bruns, Annie M., et al., The Innate Immune Sensor LGP2 Activates Antiviral Signaling by 
Regulating MDA5-RNA Interaction and Filament Assembly. Molecular Cell, 2014. 55(5): p. 771-781. 
121. Lu, C., et al., The Structural Basis of 5′ Triphosphate Double-stranded RNA Recognition by RIG-
I C-terminal Domain. Structure (London, England : 1993), 2010. 18(8): p. 1032-1043. 
122. Wang, Y., et al., Structural and functional insights into 5'-ppp RNA pattern recognition by the 
innate immune receptor RIG-I. Nat Struct Mol Biol, 2010. 17(7): p. 781-787. 
123. Uchikawa, E., et al., Structural Analysis of dsRNA Binding to Anti-viral Pattern Recognition 
Receptors LGP2 and MDA5. Molecular Cell, 2016. 62(4): p. 586-602. 
124. Li, X., et al., Structural basis of double-stranded RNA recognition by the RIG-I like receptor 
MDA5. Archives of Biochemistry and Biophysics, 2009. 488(1): p. 23-33. 
-174- 
 
125. Peisley, A., et al., Cooperative assembly and dynamic disassembly of MDA5 filaments for viral 
dsRNA recognition. Proceedings of the National Academy of Sciences, 2011. 108(52): p. 21010-21015. 
126. Louber, J., et al., Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and 
MDA5. BMC Biology, 2015. 13(1): p. 54. 
127. Lässig, C., et al., ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional 
recognition of self-RNA. eLife, 2015. 4: p. e10859. 
128. Jiang, F., et al., Structural basis of RNA recognition and activation by innate immune receptor 
RIG-I. Nature, 2011. 479(7373): p. 423-427. 
129. Kowalinski, E., et al., Structural basis for the activation of innate immune pattern-recognition 
receptor RIG-I by viral RNA. Cell, 2011. 147. 
130. Zeng, W., et al., Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored 
Polyubiquitin Chains in Innate Immunity. Cell, 2010. 141(2): p. 315-330. 
131. Gack, M.U., et al., TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated 
antiviral activity. Nature, 2007. 446(7138): p. 916-920. 
132. Peisley, A., et al., Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. 
Nature, 2014. 509(7498): p. 110-114. 
133. Saito, T., et al., Regulation of innate antiviral defenses through a shared repressor domain in 
RIG-I and LGP2. Proceedings of the National Academy of Sciences of the United States of America, 
2007. 104(2): p. 582-587. 
134. Yoneyama, M., et al., Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol., 2015. 
32C. 
135. Berke, I.C. and Y. Modis, MDA5 cooperatively forms dimers and ATP-sensitive filaments upon 
binding double-stranded RNA. The EMBO Journal, 2012. 31(7): p. 1714-1726. 
136. Wu, B., et al., Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal 
Activation by MDA5. Cell, 2012. 152(1): p. 276-289. 
137. Uchikawa, E., et al., Structural Analysis of dsRNA Binding to Anti-viral Pattern Recognition 
Receptors LGP2 and MDA5. Molecular Cell. 62(4): p. 586-602. 
138. Peisley, A., et al., RIG-I Forms Signaling-Competent Filaments in an ATP-Dependent, Ubiquitin-
Independent Manner. Molecular Cell, 2013. 51(5): p. 573-583. 
139. Seth, R.B., et al., Identification and Characterization of MAVS, a Mitochondrial Antiviral 
Signaling Protein that Activates NF-κB and IRF3. Cell, 2005. 122(5): p. 669-682. 
140. Wu, B., et al., Molecular Imprinting as a Signal-Activation Mechanism of the Viral RNA Sensor 
RIG-I. Molecular Cell, 2014. 55(4): p. 511-523. 
141. Hou, F., et al., MAVS forms functional prion-like aggregates to activate and propagate antiviral 
innate immune response. Cell., 2011. 146. 
142. Kawai, T., et al., IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon 
induction. Nat Immunol, 2005. 6(10): p. 981-988. 
-175- 
 
143. Liu, S., et al., Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF 
induces IRF3 activation. Science, 2015. 347(6227). 
144. Meylan, E., et al., Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by 
hepatitis C virus. Nature, 2005. 437(7062): p. 1167-1172. 
145. Saha, S.K., et al., Regulation of antiviral responses by a direct and specific interaction between 
TRAF3 and Cardif. The EMBO Journal, 2006. 25(14): p. 3257-3263. 
146. Guo, B. and G. Cheng, Modulation of the Interferon Antiviral Response by the TBK1/IKKi 
Adaptor Protein TANK. Journal of Biological Chemistry, 2007. 282(16): p. 11817-11826. 
147. Liu, S., et al., MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling 
cascades. eLife, 2013. 2: p. e00785. 
148. Hovanessian, A.G., R.E. Brown, and I.M. Kerr, Synthesis of low molecular weight inhibitor of 
protein synthesis with enzyme from interferon-treated cells. Nature, 1977. 268(5620): p. 537-540. 
149. Kerr, I.M. and R.E. Brown, pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with 
an enzyme fraction from interferon-treated cells. Proceedings of the National Academy of Sciences, 1978. 
75(1): p. 256-260. 
150. Clemens, M.J. and B.R.G. Williams, Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ 
p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell, 1978. 13(3): p. 565-
572. 
151. Williams, B.R.G. and I.M. Kerr, Inhibition of protein synthesis by 2[prime]-5[prime] linked 
adenine oligonucleotides in intact cells. Nature, 1978. 276(5683): p. 88-90. 
152. Baglioni, C., M.A. Minks, and P.A. Maroney, Interferon action may be mediated by activation of 
a nuclease by pppA2[prime]p5[prime]A2[prime]p5[prime]A. Nature, 1978. 273(5664): p. 684-687. 
153. Stark, G.R., et al., 2-5A synthetase: assay, distribution and variation with growth or hormone 
status. Nature, 1979. 278(5703): p. 471-473. 
154. Coccia, E.M., et al., A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells 
impairs EMCV but not VSV replication. Virology, 1990. 179(1): p. 228-233. 
155. Chebath, J., et al., Constitutive expression of (2[prime]-5[prime]) oligo A synthetase confers 
resistance to picornavirus infection. Nature, 1987. 330(6148): p. 587-588. 
156. Li, Y., et al., Activation of RNase L is dependent on OAS3 expression during infection with 
diverse human viruses. Proceedings of the National Academy of Sciences, 2016. 113(8): p. 2241-2246. 
157. Han, J.-Q. and D.J. Barton, Activation and evasion of the antiviral 2'-5' oligoadenylate 
synthetase/ribonuclease L pathway by hepatitis C virus mRNA. RNA, 2002. 8(4): p. 512-525. 
158. Schröder, H.C., et al., (2′-5′)Oligoadenylate and intracellular immunity against retrovirus 
infection. International Journal of Biochemistry, 1992. 24(1): p. 55-63. 
159. Cayley, P.J., et al., Distribution of the ppp(A2′p)nA-binding protein and interferon-related 
enzymes in animals, plants, and lower organisms. Biochemical and Biophysical Research 
Communications, 1982. 108(3): p. 1243-1250. 
-176- 
 
160. Torralba, S., J. Sojat, and R. Hartmann, 2’-5’ Oligoadenylate synthetase shares active site 
architecture with the archaeal CCA-adding enzyme. Cellular and Molecular Life Sciences, 2008. 65(16): 
p. 2613-2620. 
161. Wiens, M., et al., Origin of the interferon-inducible (2′-5′)oligoadenylate synthetases: cloning of 
the (2′-5′)oligoadenylate synthetase from the marine sponge Geodia cydonium 1. FEBS Letters, 1999. 
462(1-2): p. 12-18. 
162. Chebath, J., et al., Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified 
by immunoblotting in human cells. Journal of Biological Chemistry, 1987. 262(8): p. 3852-7. 
163. Hovanessian, A.G., et al., Identification of 69-kd and 100-kd forms of 2-5A synthetase in 
interferon-treated human cells by specific monoclonal antibodies. The EMBO Journal, 1987. 6(5): p. 
1273-1280. 
164. Rebouillat, D., I. Marié, and A.G. Hovanessian, Molecular cloning and characterization of two 
related and interferon-induced 56-kDa and 30-kDa proteins highly similar to 2′-5′ oligoadenylate 
synthetase. European Journal of Biochemistry, 1998. 257(2): p. 319-330. 
165. Hartmann, R., et al., p59OASL, a 2'-5' oligoadenylate synthetase like protein: a novel human 
gene related to the 2'-5' oligoadenylate synthetase family. Nucleic Acids Research, 1998. 26(18): p. 4121-
4128. 
166. Justesen, J., R. Hartmann, and N.O. Kjeldgaard, Gene structure and function of the 2′-5′-
oligoadenylate synthetase family. Cellular and Molecular Life Sciences CMLS, 2000. 57(11): p. 1593-
1612. 
167. Benech, P., et al., Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase of 
human cells based on cDNAs and gene sequences. The EMBO Journal, 1985. 4(9): p. 2249-2256. 
168. Marié, I. and A.G. Hovanessian, The 69-kDa 2-5A synthetase is composed of two homologous 
and adjacent functional domains. Journal of Biological Chemistry, 1992. 267(14): p. 9933-9939. 
169. Hovnanian, A., et al., The Human 2′,5′-Oligoadenylate Synthetase Locus Is Composed of Three 
Distinct Genes Clustered on Chromosome 12q24.2 Encoding the 100-, 69-, and 40-kDa Forms. 
Genomics, 1998. 52(3): p. 267-277. 
170. Marié, I., et al., Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A 
synthetase in human cells treated with interferon. Journal of Biological Chemistry, 1990. 265(30): p. 
18601-18607. 
171. Besse, S., et al., Ultrastructural Localization of Interferon-Inducible Double-Stranded RNA-
Activated Enzymes in Human Cells. Experimental Cell Research, 1998. 239(2): p. 379-392. 
172. Shiojiri, S., et al., Structure and Expression of a Cloned cDNA for Human (2'-5') Oligoadenylate 
Synthetase. The Journal of Biochemistry, 1986. 99(5): p. 1455-1464. 
173. Wathelet, M., et al., Full-length sequence and expression of the 42 kDa 2–5A synthetase induced 
by human interferon. FEBS Letters, 1986. 196(1): p. 113-120. 
174. Kristiansen, H., et al., Extracellular 2′-5′ Oligoadenylate Synthetase Stimulates RNase L-
Independent Antiviral Activity: a Novel Mechanism of Virus-Induced Innate Immunity. Journal of 
Virology, 2010. 84(22): p. 11898-11904. 
-177- 
 
175. Bordignon, J., et al., Expression profile of interferon stimulated genes in central nervous system 
of mice infected with dengue virus Type-1. Virology, 2008. 377(2): p. 319-329. 
176. Warke, R.V., et al., Dengue Virus Induces Novel Changes in Gene Expression of Human 
Umbilical Vein Endothelial Cells. Journal of Virology, 2003. 77(21): p. 11822-11832. 
177. Alagarasu, K., et al., Polymorphisms in the oligoadenylate synthetase gene cluster and its 
association with clinical outcomes of dengue virus infection. Infection, Genetics and Evolution, 2013. 
14(Supplement C): p. 390-395. 
178. Donovan, J., M. Dufner, and A. Korennykh, Structural basis for cytosolic double-stranded RNA 
surveillance by human oligoadenylate synthetase 1. Proceedings of the National Academy of Sciences, 
2013. 110(5): p. 1652-1657. 
179. Lohöfener, J., et al., The Activation Mechanism of 2′-5′-Oligoadenylate Synthetase Gives New 
Insights Into OAS/cGAS Triggers of Innate Immunity. Structure, 2015. 23(5): p. 851-862. 
180. Desai, S.Y. and G.C. Sen, Effects of Varying Lengths of Double-Stranded RNA on Binding and 
Activation of 2′-5′-Oligoadenylate Synthetase. Journal of Interferon & Cytokine Research, 1997. 17(9): p. 
531-536. 
181. Maitra, R.K., et al., HIV-1 TAR RNA Has an Intrinsic Ability to Activate Interferon-Inducible 
Enzymes. Virology, 1994. 204(2): p. 823-827. 
182. Steitz, T., et al., A unified polymerase mechanism for nonhomologous DNA and RNA 
polymerases. Science, 1994. 266(5193): p. 2022-2025. 
183. Steitz, T.A., DNA Polymerases: Structural Diversity and Common Mechanisms. Journal of 
Biological Chemistry, 1999. 274(25): p. 17395-17398. 
184. Balbo, P.B. and A. Bohm, Mechanism of Poly(A) Polymerase: Structure of the Enzyme-MgATP-
RNA Ternary Complex and Kinetic Analysis. Structure, 2007. 15(9): p. 1117-1131. 
185. Marié, I., et al., 69-kDa and 100-kDa Isoforms of Interferon-Induced (2′-5′)Oligoadenylate 
Synthetase Exhibit Differential Catalytic Parameters. European Journal of Biochemistry, 1997. 248(2): p. 
558-566. 
186. Ball, A., Induction, purification, and properties of 2′5′ oligoadenylate synthetase. Vol. 350. 1980. 
486-96. 
187. Cayley, P.J. and I.M. Kerr, Synthesis, Characterisation and Biological Significance of (2′-
5′)Oiigoadenylate Derivatives of NAD+, ADP-Ribose and Adenosine(5′)Tetraphosph0(5′)Adenosine. 
European Journal of Biochemistry, 1982. 122(3): p. 601-608. 
188. Justesen, J., et al., The interferon-induced enzyme 2-5A synthetase adenylates tRNA. Vol. 67. 
1985. 651-5. 
189. Ghosh, A., et al., Enzymatic Activity of 2'-5'-Oligoadenylate Synthetase Is Impaired by Specific 
Mutations that Affect Oligomerization of the Protein. Vol. 272. 1998. 33220-6. 
190. Sarkar, S.N., S. Pal, and G.C. Sen, Crisscross Enzymatic Reaction between the Two Molecules in 
the Active Dimeric P69 Form of the 2′-5′ Oligodenylate Synthetase. Journal of Biological Chemistry, 
2002. 277(47): p. 44760-44764. 
-178- 
 
191. Justesen, J., D. Ferbus, and M.N. Thang, Elongation mechanism and substrate specificity of 2',5'-
oligoadenylate synthetase. Proceedings of the National Academy of Sciences of the United States of 
America, 1980. 77(8): p. 4618-4622. 
192. Dougherty, J.P., et al., Interferon, double-stranded RNA, and RNA degradation. Isolation of 
homogeneous pppA(2'p5'A)n-1 synthetase from Ehrlich ascites tumor cells. Journal of Biological 
Chemistry, 1980. 255(9): p. 3813-6. 
193. Dong, B., et al., Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. 
Journal of Biological Chemistry, 1994. 269(19): p. 14153-14158. 
194. Rebouillat, D., et al., The 100-kDa 2′,5′-Oligoadenylate Synthetase Catalyzing Preferentially the 
Synthesis of Dimeric pppA2′p5′A Molecules Is Composed of Three Homologous Domains. Journal of 
Biological Chemistry, 1999. 274(3): p. 1557-1565. 
195. Dong, B. and R.H. Silverman, A Bipartite Model of 2-5A-dependent RNase L. Journal of 
Biological Chemistry, 1997. 272(35): p. 22236-22242. 
196. Dong, B. and R.H. Silverman, 2-5A-dependent RNase Molecules Dimerize during Activation by 
2-5A. Journal of Biological Chemistry, 1995. 270(8): p. 4133-4137. 
197. Silverman, R.H., et al., rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated 
encephalomyocarditis virus-infected cells. Journal of Virology, 1983. 46(3): p. 1051-1055. 
198. Li, X.-L., J.A. Blackford, and B.A. Hassel, RNase L Mediates the Antiviral Effect of Interferon 
through a Selective Reduction in Viral RNA during Encephalomyocarditis Virus Infection. Journal of 
Virology, 1998. 72(4): p. 2752-2759. 
199. Floyd-Smith, G., E. Slattery, and P. Lengyel, Interferon action: RNA cleavage pattern of a (2'-
5')oligoadenylate--dependent endonuclease. Science, 1981. 212(4498): p. 1030-1032. 
200. Wreschner, D., et al., Interferon action: Sequence specificity of the ppp(A2'p)(n)A-dependent 
ribonuclease. Vol. 289. 1981. 414-7. 
201. Malathi, K., et al., Small self-RNA generated by RNase L amplifies antiviral innate immunity. 
Nature, 2007. 448(7155): p. 816-819. 
202. Nilsen, T.W. and C. Baglioni, Mechanism for discrimination between viral and host mRNA in 
interferon-treated cells. Proceedings of the National Academy of Sciences of the United States of 
America, 1979. 76(6): p. 2600-2604. 
203. Castelli, J.C., et al., A Study of the Interferon Antiviral Mechanism: Apoptosis Activation by the 
2–5A System. The Journal of Experimental Medicine, 1997. 186(6): p. 967-972. 
204. Castelli, J.C., et al., The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosis. Cell 
Death Differ, 1998. 5(4): p. 313-20. 
205. Marques, J., et al., The p59 oligoadenylate synthetase-like protein possesses antiviral activity that 
requires the C-terminal ubiquitin-like domain. Journal of General Virology, 2008. 89(11): p. 2767-2772. 
206. Zhu, J., et al., Antiviral Activity of Human OASL Protein Is Mediated by Enhancing Signaling of 
the RIG-I RNA Sensor. Immunity, 2014. 40(6): p. 936-948. 
207. Lee, M.S., et al., OASL1 inhibits translation of the type I interferon–regulating transcription 
factor IRF7. 2013. 14: p. 346. 
-179- 
 
208. Lee, M.S., et al., Negative Regulation of Type I IFN Expression by OASL1 Permits Chronic Viral 
Infection and CD8+ T-Cell Exhaustion. PLOS Pathogens, 2013. 9(7): p. e1003478. 
209. Bréhin, A.-C., et al., The large form of human 2′,5′-Oligoadenylate Synthetase (OAS3) exerts 
antiviral effect against Chikungunya virus. Virology, 2009. 384(1): p. 216-222. 
210. Sorgeloos, F., et al., Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through 
Direct Inhibition of RNase L. PLOS Pathogens, 2013. 9(6): p. e1003474. 
211. Zhao, L., et al., Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine 
Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology. Cell host & microbe, 
2012. 11(6): p. 607-616. 
212. Zhang, R., et al., Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize 
antiviral innate immunity. Proceedings of the National Academy of Sciences of the United States of 
America, 2013. 110(32): p. 13114-13119. 
213. Li, X.-D., et al., Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune 
Adjuvant Effects. Science (New York, N.Y.), 2013. 341(6152): p. 10.1126/science.1244040. 
214. Gray, E. and D.B. Stetson, The AIM2-like receptors are dispensable for activation of the 
interferon stimulatory DNA (ISD) pathway. The Journal of Immunology, 2016. 196(1 Supplement): p. 
203.10-203.10. 
215. Ishikawa, H., Z. Ma, and G.N. Barber, STING regulates intracellular DNA-mediated, type I 
interferon-dependent innate immunity. Nature, 2009. 461(7265): p. 788-792. 
216. Schoggins, J.W., et al., Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in 
innate immunity. Nature, 2014. 505(7485): p. 691-695. 
217. Ma, Z., et al., Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses. 
Proceedings of the National Academy of Sciences, 2015. 112(31): p. E4306-E4315. 
218. Shravanthi, G.V., et al., HBV Induce Cytosolic DNA Sensor cGAS but Suppress IRF3 to Prevent 
Generation of Antiviral Defense Mechanism in Infected Cell. Journal of Clinical and Experimental 
Hepatology, 2015. 5(Supplement 2): p. S4. 
219. Yoh, Sunnie M., et al., PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to 
HIV-1. Cell, 2015. 161(6): p. 1293-1305. 
220. Gao, D., et al., Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other 
Retroviruses. Science, 2013. 341(6148): p. 903-906. 
221. Manzanillo, Paolo S., et al., Mycobacterium Tuberculosis Activates the DNA-Dependent 
Cytosolic Surveillance Pathway within Macrophages. Cell host & microbe, 2012. 11(5): p. 469-480. 
222. Hansen, K., et al., Listeria monocytogenes induces IFNβ expression through an IFI16-, cGAS- 
and STING-dependent pathway. The EMBO Journal, 2014. 33(15): p. 1654-1666. 
223. Sun, L., et al., Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I 
Interferon Pathway. Science, 2013. 339(6121): p. 786-791. 
224. Gehrke, N., et al., Oxidative Damage of DNA Confers Resistance to Cytosolic Nuclease TREX1 
Degradation and Potentiates STING-Dependent Immune Sensing. Immunity, 2013. 39(3): p. 482-495. 
-180- 
 
225. West, A.P., et al., Mitochondrial DNA stress primes the antiviral innate immune response. 
Nature, 2015. 520(7548): p. 553-557. 
226. Rongvaux, A., et al., Apoptotic Caspases Prevent the Induction of Type I Interferons by 
Mitochondrial DNA. Cell, 2014. 159(7): p. 1563-1577. 
227. White, Michael J., et al., Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I 
IFN Production. Cell, 2014. 159(7): p. 1549-1562. 
228. Mackenzie, K.J., et al., cGAS surveillance of micronuclei links genome instability to innate 
immunity. Nature, 2017. 548(7668): p. 461-465. 
229. Harding, S.M., et al., Mitotic progression following DNA damage enables pattern recognition 
within micronuclei. Nature, 2017. 548(7668): p. 466-470. 
230. Glück, S., et al., Innate immune sensing of cytosolic chromatin fragments through cGAS 
promotes senescence. Nature Cell Biology, 2017. 19: p. 1061. 
231. Dou, Z., et al., Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature, 
2017. 550: p. 402. 
232. Stetson, D.B. and R. Medzhitov, Recognition of Cytosolic DNA Activates an IRF3-Dependent 
Innate Immune Response. Immunity, 2006. 24(1): p. 93-103. 
233. Civril, F., et al., Structural mechanism of cytosolic DNA sensing by cGAS. Nature, 2013. 
498(7454): p. 332-337. 
234. Gao, P., et al., Cyclic [G(2′,5′)pA(3′,5′)p] Is the Metazoan Second Messenger Produced by DNA-
Activated Cyclic GMP-AMP Synthase. Cell, 2013. 153(5): p. 1094-1107. 
235. Kranzusch, Philip J., et al., Structure of Human cGAS Reveals a Conserved Family of Second-
Messenger Enzymes in Innate Immunity. Cell Reports, 2013. 3(5): p. 1362-1368. 
236. Kato, K., et al., Structural and Functional Analyses of DNA-Sensing and Immune Activation by 
Human cGAS. PLoS ONE, 2013. 8(10): p. e76983. 
237. Jakobsen, M.R., et al., IFI16 senses DNA forms of the lentiviral replication cycle and controls 
HIV-1 replication. Proceedings of the National Academy of Sciences, 2013. 110(48): p. E4571-E4580. 
238. Wu, J., et al., Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune 
Signaling by Cytosolic DNA. Science, 2013. 339(6121): p. 826-830. 
239. Diner, Elie J., et al., The Innate Immune DNA Sensor cGAS Produces a Noncanonical Cyclic 
Dinucleotide that Activates Human STING. Cell Reports, 2013. 3(5): p. 1355-1361. 
240. Ablasser, A., et al., cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that 
activates STING. Nature, 2013. 498(7454): p. 380-384. 
241. Ablasser, A., et al., Cell intrinsic immunity spreads to bystander cells via the intercellular 
transfer of cGAMP. Nature, 2013. 503(7477): p. 530-534. 
242. Bridgeman, A., et al., Viruses transfer the antiviral second messenger cGAMP between cells. 
Science, 2015. 349(6253): p. 1228-1232. 
243. Gentili, M., et al., Transmission of innate immune signaling by packaging of cGAMP in viral 
particles. Science, 2015. 349(6253): p. 1232-1236. 
-181- 
 
244. Ishikawa, H. and G.N. Barber, STING is an endoplasmic reticulum adaptor that facilitates innate 
immune signalling. Nature, 2008. 455(7213): p. 674-678. 
245. Zhong, B., et al., The Adaptor Protein MITA Links Virus-Sensing Receptors to IRF3 
Transcription Factor Activation. Immunity, 2008. 29(4): p. 538-550. 
246. Sun, W., et al., ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune 
signaling through dimerization. Proceedings of the National Academy of Sciences, 2009. 106(21): p. 
8653-8658. 
247. Tanaka, Y. and Z.J. Chen, STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA 
Signaling Pathway. Science Signaling, 2012. 5(214): p. ra20-ra20. 
248. Ouyang, S., et al., Structural Analysis of the STING Adaptor Protein Reveals a Hydrophobic 
Dimer Interface and Mode of Cyclic di-GMP Binding. Immunity, 2012. 36(6): p. 1073-1086. 
249. Gao, P., et al., Structure-Function Analysis of STING Activation by c[G(2′,5′)pA(3′,5′)p] and 
Targeting by Antiviral DMXAA. Cell, 2013. 154(4): p. 748-762. 
250. Zhang, X., et al., Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An 
Endogenous High-Affinity Ligand for STING. Molecular Cell, 2013. 51(2): p. 226-235. 
251. Saitoh, T., et al., Atg9a controls dsDNA-driven dynamic translocation of STING and the innate 
immune response. Proceedings of the National Academy of Sciences of the United States of America, 
2009. 106(49): p. 20842-20846. 
252. Chen, H., et al., Activation of STAT6 by STING Is Critical for Antiviral Innate Immunity. Cell, 
2011. 147(2): p. 436-446. 
253. Abe, T. and G.N. Barber, Cytosolic-DNA-Mediated, STING-Dependent Proinflammatory Gene 
Induction Necessitates Canonical NF-κB Activation through TBK1. Journal of Virology, 2014. 88(10): p. 
5328-5341. 
254. Ma, F., et al., Positive Feedback Regulation of Type I IFN Production by the IFN-Inducible DNA 
Sensor cGAS. The Journal of Immunology, 2015. 194(4): p. 1545-1554. 
255. Ma, F., et al., Positive feedback regulation of type I interferon by the interferon-stimulated gene 
STING. EMBO Reports, 2015. 16(2): p. 202-212. 
256. Jin, L., et al., MPYS is required for IRF3 activation and type I IFN production in the response of 
cultured phagocytes to bacterial second messengers c-di-AMP and c-di-GMP(). Journal of immunology 
(Baltimore, Md. : 1950), 2011. 187(5): p. 2595-2601. 
257. Sauer, J.-D., et al., The N-Ethyl-N-Nitrosourea-Induced Goldenticket Mouse Mutant Reveals an 
Essential Function of Sting in the In Vivo Interferon Response to Listeria monocytogenes and Cyclic 
Dinucleotides. Infection and Immunity, 2011. 79(2): p. 688-694. 
258. Woodward, J.J., A.T. Iavarone, and D.A. Portnoy, c-di-AMP secreted by intracellular Listeria 
monocytogenes activates a host type I interferon response. Science, 2010. 328(5986): p. 1703-1705. 
259. Dey, B., et al., A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and 
mediates innate resistance to tuberculosis. 2015. 21: p. 401. 
260. Barker, J.R., et al., STING-Dependent Recognition of Cyclic di-AMP Mediates Type I Interferon 
Responses during Chlamydia trachomatis Infection. mBio, 2013. 4(3): p. e00018-13. 
-182- 
 
261. Stetson, D.B., et al., Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity. Cell, 2008. 134(4): 
p. 587-598. 
262. Kawane, K., et al., Chronic polyarthritis caused by mammalian DNA that escapes from 
degradation in macrophages. Nature, 2006. 443(7114): p. 998-1002. 
263. Napirei, M., et al., Features of systemic lupus erythematosus in Dnase1-deficient mice. Nature 
Genetics, 2000. 25: p. 177. 
264. Yoshida, H., et al., Lethal anemia caused by interferon-β produced in mouse embryos carrying 
undigested DNA. Nature immunology, 2004. 6: p. 49. 
265. Takaoka, A., et al., DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate 
immune response. Nature, 2007. 448(7152): p. 501-505. 
266. DeFilippis, V.R., et al., Human Cytomegalovirus Induces the Interferon Response via the DNA 
Sensor ZBP1. Journal of Virology, 2010. 84(1): p. 585-598. 
267. Ishii, K.J., et al., TANK-binding kinase-1 delineates innate and adaptive immune responses to 
DNA vaccines. Nature, 2008. 451(7179): p. 725-729. 
268. Upton, Jason W., William J. Kaiser, and Edward S. Mocarski, DAI/ZBP1/DLM-1 Complexes with 
RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA. 
Cell host & microbe, 2012. 11(3): p. 290-297. 
269. Lieber, M.R., et al., Mechanism and regulation of human non-homologous DNA end-joining. Nat 
Rev Mol Cell Biol, 2003. 4(9): p. 712-720. 
270. Ferguson, B.J., et al., DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. eLife, 
2012. 1: p. e00047. 
271. Zhang, X., et al., Cutting Edge: Ku70 Is a Novel Cytosolic DNA Sensor That Induces Type III 
Rather Than Type I IFN. The Journal of Immunology, 2011. 186(8): p. 4541-4545. 
272. Sui, H., et al., STING is an essential mediator of the Ku70-mediated production of IFN-λ1 in 
response to exogenous DNA. Science Signaling, 2017. 10(488). 
273. Stracker, T.H. and J.H.J. Petrini, The MRE11 complex: starting from the ends. Nat Rev Mol Cell 
Biol, 2011. 12(2): p. 90-103. 
274. Kondo, T., et al., DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and 
induces type I interferon by regulating STING trafficking. Proceedings of the National Academy of 
Sciences, 2013. 110(8): p. 2969-2974. 
275. Mariggiò, G., et al., Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen 
(LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate 
immune signaling pathway and viral latency. PLOS Pathogens, 2017. 13(4): p. e1006335. 
276. Roth, S., et al., Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1[beta] production. 
Nat Immunol, 2014. 15(6): p. 538-545. 
277. Stein, S.C. and E. Falck-Pedersen, Sensing Adenovirus Infection: Activation of Interferon 
Regulatory Factor 3 in RAW 264.7 Cells. Journal of Virology, 2012. 86(8): p. 4527-4537. 
278. Zhang, Z., et al., The helicase DDX41 senses intracellular DNA mediated by the adaptor STING 
in dendritic cells. Nat Immunol, 2011. 12(10): p. 959-965. 
-183- 
 
279. Parvatiyar, K., et al., DDX41 recognizes bacterial secondary messengers cyclic di-GMP and 
cyclic di-AMP to activate a type I interferon immune response. Nature immunology, 2012. 13(12): p. 
1155-1161. 
280. Zhang, Z., et al., The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune 
response to intracellular double-stranded DNA. Nat Immunol, 2013. 14(2): p. 172-178. 
281. Abe, T., et al., STING Recognition of Cytoplasmic DNA Instigates Cellular Defense. Molecular 
Cell, 2013. 50(1): p. 5-15. 
282. Kim, T., et al., Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A 
helicases sense microbial DNA in human plasmacytoid dendritic cells. Proceedings of the National 
Academy of Sciences, 2010. 107(34): p. 15181-15186. 
283. Zhang, Z., et al., DHX9 Pairs with IPS-1 To Sense Double-Stranded RNA in Myeloid Dendritic 
Cells. The Journal of Immunology, 2011. 187(9): p. 4501-4508. 
284. Zhang, Z., et al., DDX1, DDX21, and DHX36 Helicases Form a Complex with the Adaptor 
Molecule TRIF to Sense dsRNA in Dendritic Cells. Immunity, 2011. 34(6): p. 866-878. 
285. Sarkar, A. and K. Hochedlinger, The Sox Family of Transcription Factors: Versatile Regulators 
of Stem and Progenitor Cell Fate. Cell Stem Cell, 2013. 12(1): p. 15-30. 
286. Arnold, K., et al., Sox2+ Adult Stem and Progenitor Cells Are Important for Tissue Regeneration 
and Survival of Mice. Cell Stem Cell, 2011. 9(4): p. 317-329. 
287. Xia, P., et al., Sox2 functions as a sequence-specific DNA sensor in neutrophils to initiate innate 
immunity against microbial infection. Nat Immunol, 2015. 16(4): p. 366-375. 
288. Bonaldi, T., et al., The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome 
sliding. The EMBO Journal, 2002. 21(24): p. 6865-6873. 
289. Ura, K., K. Nightingale, and A.P. Wolffe, Differential association of HMG1 and linker histones 
B4 and H1 with dinucleosomal DNA: structural transitions and transcriptional repression. The EMBO 
Journal, 1996. 15(18): p. 4959-4969. 
290. Calogero, S., et al., The lack of chromosomal protein Hmg1 does not disrupt cell growth but 
causes lethal hypoglycaemia in newborn mice. Nat Genet, 1999. 22(3): p. 276-280. 
291. Harris, H.E., U. Andersson, and D.S. Pisetsky, HMGB1: A multifunctional alarmin driving 
autoimmune and inflammatory disease. 2012. 8: p. 195. 
292. Scaffidi, P., T. Misteli, and M.E. Bianchi, Release of chromatin protein HMGB1 by necrotic cells 
triggers inflammation. Nature, 2002. 418(6894): p. 191-195. 
293. Hreggvidsdóttir, H.S., et al., High Mobility Group Box Protein 1 (HMGB1)-Partner Molecule 
Complexes Enhance Cytokine Production by Signaling Through the Partner Molecule Receptor. 
Molecular Medicine, 2012. 18(1): p. 224-230. 
294. Campana, L., et al., Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-
dependent migration of macrophages and dendritic cells. Journal of Leukocyte Biology, 2009. 86(3): p. 
609-615. 
295. Park, J.S., et al., High mobility group box 1 protein interacts with multiple Toll-like receptors. 
American Journal of Physiology - Cell Physiology, 2006. 290(3): p. C917-C924. 
-184- 
 
296. Yun, J., et al., The HMGB1–CXCL12 Complex Promotes Inflammatory Cell Infiltration in 
Uveitogenic T Cell-Induced Chronic Experimental Autoimmune Uveitis. Frontiers in Immunology, 2017. 
8: p. 142. 
297. Andersson, U., et al., High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory 
Cytokine Synthesis in Human Monocytes. The Journal of Experimental Medicine, 2000. 192(4): p. 565-
570. 
298. Yanai, H., et al., HMGB proteins function as universal sentinels for nucleic-acid-mediated innate 
immune responses. Nature, 2009. 462(7269): p. 99-103. 
299. Schattgen, S.A. and K.A. Fitzgerald, The PYHIN protein family as mediators of host defenses. 
Immunological Reviews, 2011. 243(1): p. 109-118. 
300. Stratmann, S.A., et al., The innate immune sensor IFI16 recognizes foreign DNA in the nucleus 
by scanning along the duplex. eLife, 2015. 4: p. e11721. 
301. Ansari, M.A., et al., Herpesvirus Genome Recognition Induced Acetylation of Nuclear IFI16 Is 
Essential for Its Cytoplasmic Translocation, Inflammasome and IFN-β Responses. PLOS Pathogens, 
2015. 11(7): p. e1005019. 
302. Conrady, C.D., et al., Resistance to HSV-1 infection in the epithelium resides with the novel 
innate sensor, IFI-16. Mucosal Immunol, 2012. 5(2): p. 173-183. 
303. Diner, B.A., et al., Viral DNA Sensors IFI16 and Cyclic GMP-AMP Synthase Possess Distinct 
Functions in Regulating Viral Gene Expression, Immune Defenses, and Apoptotic Responses during 
Herpesvirus Infection. mBio, 2016. 7(6). 
304. Orzalli, M.H., et al., cGAS-mediated stabilization of IFI16 promotes innate signaling during 
herpes simplex virus infection. Proceedings of the National Academy of Sciences, 2015. 112(14): p. 
E1773-E1781. 
305. Orzalli, M.H., N.A. DeLuca, and D.M. Knipe, Nuclear IFI16 induction of IRF-3 signaling during 
herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proceedings of the National 
Academy of Sciences, 2012. 109(44): p. E3008–E3017. 
306. Almine, J.F., et al., IFI16 and cGAS cooperate in the activation of STING during DNA sensing in 
human keratinocytes. 2017. 8: p. 14392. 
307. Jønsson, K.L., et al., IFI16 is required for DNA sensing in human macrophages by promoting 
production and function of cGAMP. 2017. 8: p. 14391. 
308. Aravind, L. and E.V. Koonin, DNA polymerase beta-like nucleotidyltransferase superfamily: 
identification of three new families, classification and evolutionary history. Nucleic Acids Research, 
1999. 27(7): p. 1609-1618. 
309. Holm, L. and C. Sander, DNA polymerase β belongs to an ancient nucleotidyltransferase 
superfamily. Trends in Biochemical Sciences, 1995. 20(9): p. 345-347. 
310. Kuchta, K., et al., Comprehensive classification of nucleotidyltransferase fold proteins: 
identification of novel families and their representatives in human. Nucleic Acids Research, 2009. 37(22): 
p. 7701-7714. 
-185- 
 
311. Chow, K.L., D.H. Hall, and S.W. Emmons, The mab-21 gene of Caenorhabditis elegans encodes 
a novel protein required for choice of alternate cell fates. Development, 1995. 121(11): p. 3615-3626. 
312. Hall, J., et al., The catalytic mechanism of cyclic GMP-AMP synthase (cGAS) and implications 
for innate immunity and inhibition. Protein Science, 2017: p. n/a-n/a. 
313. Zhang, X., et al., The Cytosolic DNA Sensor cGAS Forms an Oligomeric Complex with DNA and 
Undergoes Switch-like Conformational Changes in the Activation Loop. Cell Reports, 2014. 6(3): p. 421-
430. 
314. Li, X., et al., Cyclic GMP-AMP Synthase Is Activated by Double-Stranded DNA-Induced 
Oligomerization. Immunity, 2013. 39(6): p. 1019-1031. 
315. Tao, J., et al., Nonspecific DNA Binding of cGAS N Terminus Promotes cGAS Activation. The 
Journal of Immunology, 2017. 198(9): p. 3627-3636. 
316. Hartmann, R., et al., Crystal Structure of the 2′-Specific and Double-Stranded RNA-Activated 
Interferon-Induced Antiviral Protein 2′-5′-Oligoadenylate Synthetase. Molecular Cell, 2003. 12(5): p. 
1173-1185. 
317. Danilchanka, O. and John J. Mekalanos, Cyclic Dinucleotides and the Innate Immune Response. 
Cell, 2013. 154(5): p. 962-970. 
318. Chan, C., et al., Structural basis of activity and allosteric control of diguanylate cyclase. 
Proceedings of the National Academy of Sciences of the United States of America, 2004. 101(49): p. 
17084-17089. 
319. De, N., et al., Phosphorylation-Independent Regulation of the Diguanylate Cyclase WspR. PLOS 
Biology, 2008. 6(3): p. e67. 
320. Witte, G., et al., Structural Biochemistry of a Bacterial Checkpoint Protein Reveals Diadenylate 
Cyclase Activity Regulated by DNA Recombination Intermediates. Molecular Cell, 2008. 30(2): p. 167-
178. 
321. Davies, Bryan W., et al., Coordinated Regulation of Accessory Genetic Elements Produces Cyclic 
Di-Nucleotides for V. cholerae Virulence. Cell, 2012. 149(2): p. 358-370. 
322. Kranzusch, Philip J., et al., Structure-Guided Reprogramming of Human cGAS Dinucleotide 
Linkage Specificity. Cell, 2014. 158(5): p. 1011-1021. 
323. Zhu, D., et al., Structural Biochemistry of a Vibrio cholerae Dinucleotide Cyclase Reveals 
Cyclase Activity Regulation by Folates. Molecular Cell, 2014. 55(6): p. 931-937. 
324. Kato, K., et al., Structural Basis for the Catalytic Mechanism of DncV, Bacterial Homolog of 
Cyclic GMP-AMP Synthase. Structure, 2015. 23(5): p. 843-850. 
325. Jin, L., et al., MPYS, a Novel Membrane Tetraspanner, Is Associated with Major 
Histocompatibility Complex Class II and Mediates Transduction of Apoptotic Signals. Molecular and 
Cellular Biology, 2008. 28(16): p. 5014-5026. 
326. Burdette, D.L., et al., STING is a direct innate immune sensor of cyclic di-GMP. Nature, 2011. 
478(7370): p. 515-518. 
327. Surpris, G., et al., Novel Tmem173 allele reveals importance of STING N-terminus in trafficking 
and type I IFN production. Journal of immunology (Baltimore, Md. : 1950), 2016. 196(2): p. 547-552. 
-186- 
 
328. Huang, Y.-H., et al., The structural basis for the sensing and binding of cyclic di-GMP by STING. 
Nature Structural &Amp; Molecular Biology, 2012. 19: p. 728. 
329. Shu, C., et al., Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic 
dinucleotide recognition by the immune system. Nature Structural &Amp; Molecular Biology, 2012. 19: 
p. 722. 
330. Shang, G., et al., Crystal structures of STING protein reveal basis for recognition of cyclic di-
GMP. Nature Structural &Amp; Molecular Biology, 2012. 19: p. 725. 
331. Yin, Q., et al., Cyclic di-GMP Sensing via the Innate Immune Signaling Protein STING. 
Molecular Cell, 2012. 46(6): p. 735-745. 
332. Shi, H., et al., Molecular basis for the specific recognition of the metazoan cyclic GMP-AMP by 
the innate immune adaptor protein STING. Proceedings of the National Academy of Sciences, 2015. 
112(29): p. 8947-8952. 
333. Cavlar, T., et al., Species‐specific detection of the antiviral small‐molecule compound CMA by 
STING. The EMBO Journal, 2013. 32(10): p. 1440-1450. 
334. Yi, G., et al., Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune 
Response to Cyclic Dinucleotides. PLoS ONE, 2013. 8(10): p. e77846. 
335. Chin, K.-H., et al., Novel c-di-GMP recognition modes of the mouse innate immune adaptor 
protein STING. Acta Crystallographica Section D, 2013. 69(3): p. 352-366. 
336. Chin, K.H., et al., Structural Insights into the Distinct Binding Mode of Cyclic Di-AMP with 
SaCpaA_RCK. Biochemistry, 2015. 54(31): p. 4936-51. 
337. Conlon, J., et al., Mouse, but not Human STING, Binds and Signals in Response to the Vascular 
Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid. The Journal of Immunology, 2013. 190(10): p. 
5216-5225. 
338. Zhao, B., et al., Structural basis for concerted recruitment and activation of IRF-3 by innate 
immune adaptor proteins. Proceedings of the National Academy of Sciences, 2016. 113(24): p. E3403-
E3412. 
339. Qin, B.Y., et al., Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-
induced phosphoactivation. Nature Structural Biology, 2003. 10: p. 913. 
340. Arnold, M.M., M. Barro, and J.T. Patton, Rotavirus NSP1 Mediates Degradation of Interferon 
Regulatory Factors through Targeting of the Dimerization Domain. Journal of Virology, 2013. 87(17): p. 
9813-9821. 
341. Barro, M. and J.T. Patton, Rotavirus nonstructural protein 1 subverts innate immune response by 
inducing degradation of IFN regulatory factor 3. Proceedings of the National Academy of Sciences of the 
United States of America, 2005. 102(11): p. 4114-4119. 
342. Tsuchiya, Y., et al., Ligand-induced Ordering of the C-terminal Tail Primes STING for 
Phosphorylation by TBK1. EBioMedicine, 2016. 9: p. 87-96. 
343. Wu, X., et al., Molecular evolutionary and structural analysis of the cytosolic DNA sensor cGAS 
and STING. Nucleic Acids Research, 2014. 42(13): p. 8243-8257. 
-187- 
 
344. Schaap, P., Cyclic di-nucleotide signaling enters the eukaryote domain. IUBMB Life, 2013. 
65(11): p. 897-903. 
345. Kranzusch, Philip J., et al., Ancient Origin of cGAS-STING Reveals Mechanism of Universal 2′,3′ 
cGAMP Signaling. Molecular Cell, 2015. 59(6): p. 891-903. 
346. Margolis, S.R., S.C. Wilson, and R.E. Vance, Evolutionary Origins of cGAS-STING Signaling. 
Trends in Immunology, 2017. 38(10): p. 733-743. 
347. Ge, R., et al., Conservation of the STING-Mediated Cytosolic DNA Sensing Pathway in 
Zebrafish. Journal of Virology, 2015. 89(15): p. 7696-7706. 
348. de Oliveira Mann, C.C., et al., Structural and biochemical characterization of the cell fate 
determining nucleotidyltransferase fold protein MAB21L1. Scientific Reports, 2016. 6: p. 27498. 
349. Huang, Z.X., et al., The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye 
Development. Current Molecular Medicine, 2016. 16(7): p. 660-667. 
350. Wong, R.L.Y. and K.L. Chow, Depletion of Mab21l1 and Mab21l2 messages in mouse embryo 
arrests axial turning, and impairs notochord and neural tube differentiation. Teratology, 2002. 65(2): p. 
70-77. 
351. Mozzi, A., et al., OASes and STING: Adaptive Evolution in Concert. Genome Biology and 
Evolution, 2015. 7(4): p. 1016-1032. 
352. Hancks, D.C., et al., Overlapping Patterns of Rapid Evolution in the Nucleic Acid Sensors cGAS 
and OAS1 Suggest a Common Mechanism of Pathogen Antagonism and Escape. PLOS Genetics, 2015. 
11(5): p. e1005203. 
353. Kao, C.J., et al., CBAP interacts with the un-liganded common β-subunit of the GM-CSF/IL-3/IL-
5 receptor and induces apoptosis via mitochondrial dysfunction. Oncogene, 2007. 27: p. 1397. 
354. Chiang, Y.-J., et al., CBAP Functions as a Novel Component in Chemokine-Induced ZAP70-
Mediated T-Cell Adhesion and Migration. PLoS ONE, 2013. 8(4): p. e61761. 
355. Ho, K.C., et al., CBAP promotes thymocyte negative selection by facilitating T-cell receptor 
proximal signaling. Cell Death & Disease, 2014. 5(11): p. e1518. 
356. van Rossum, D.B., et al., DANGER, a Novel Regulatory Protein of Inositol 1,4,5-Trisphosphate-
Receptor Activity. Journal of Biological Chemistry, 2006. 281(48): p. 37111-37116. 
357. Kang, B.N., et al., Death-Associated Protein Kinase-Mediated Cell Death Modulated by 
Interaction with DANGER. The Journal of Neuroscience, 2010. 30(1): p. 93-98. 
358. Kwon, T., et al., DANGER is involved in high glucose-induced radioresistance through inhibiting 
DAPK-mediated anoikis in non-small cell lung cancer. Oncotarget, 2016. 7(6): p. 7193-7206. 
359. Karagoz, K., et al., Proteomic and Metabolic Signatures of Esophageal Squamous Cell 
Carcinoma. Curr Cancer Drug Targets, 2016. 2: p. 2. 
360. Simpson, J.C., et al., Systematic subcellular localization of novel proteins identified by large-
scale cDNA sequencing. EMBO Reports, 2000. 1(3): p. 287-292. 
361. Palmer, C.S., et al., MiD49 and MiD51, new components of the mitochondrial fission machinery. 
EMBO Reports, 2011. 12(6): p. 565-573. 
-188- 
 
362. Losón, O.C., et al., Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial 
fission. Molecular Biology of the Cell, 2013. 24(5): p. 659-667. 
363. Osellame, L.D., et al., Cooperative and independent roles of the Drp1 adaptors Mff, MiD49 and 
MiD51 in mitochondrial fission. Journal of Cell Science, 2016. 129(11): p. 2170-2181. 
364. Palmer, C.S., et al., Adaptor Proteins MiD49 and MiD51 Can Act Independently of Mff and Fis1 
in Drp1 Recruitment and Are Specific for Mitochondrial Fission. Journal of Biological Chemistry, 2013. 
288(38): p. 27584-27593. 
365. Liu, T., et al., The mitochondrial elongation factors MIEF1 and MIEF2 exert partially distinct 
functions in mitochondrial dynamics. Experimental Cell Research, 2013. 319(18): p. 2893-2904. 
366. Zhao, J., et al., Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes 
mitochondrial fusion rather than fission. The EMBO Journal, 2011. 30(14): p. 2762-2778. 
367. Otera, H., et al., Drp1-dependent mitochondrial fission via MiD49/51 is essential for apoptotic 
cristae remodeling. The Journal of Cell Biology, 2016. 212(5): p. 531-544. 
368. Xu, S., et al., Mitochondrial E3 ubiquitin ligase MARCH5 controls mitochondrial fission and cell 
sensitivity to stress-induced apoptosis through regulation of MiD49 protein. Molecular Biology of the 
Cell, 2016. 27(2): p. 349-359. 
369. Cherok, E., et al., Novel regulatory roles of Mff and Drp1 in E3 ubiquitin ligase MARCH5–
dependent degradation of MiD49 and Mcl1 and control of mitochondrial dynamics. Molecular Biology of 
the Cell, 2017. 28(3): p. 396-410. 
370. Baird, S.E., et al., Pattern formation in the nematode epidermis: determination of the 
arrangement of peripheral sense organs in the C. elegans male tail. Development, 1991. 113(2): p. 515-
526. 
371. Morita, K., K.L. Chow, and N. Ueno, Regulation of body length and male tail ray pattern 
formation of Caenorhabditis elegans by a member of TGF-beta family. Development, 1999. 126(6): p. 
1337-1347. 
372. Savage, C., et al., Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved 
family of transforming growth factor beta pathway components. Proceedings of the National Academy of 
Sciences of the United States of America, 1996. 93(2): p. 790-794. 
373. Heldin, C.-H., K. Miyazono, and P. ten Dijke, TGF-β signalling from cell membrane to nucleus 
through SMAD proteins. Nature, 1997. 390: p. 465. 
374. Choy, S.W., et al., C. elegans SIN-3 and its associated HDAC corepressor complex act as 
mediators of male sensory ray development. Biochemical and Biophysical Research Communications, 
2007. 358(3): p. 802-807. 
375. Lau, G.T.C., et al., Embryonic XMab21l2 Expression Is Required for Gastrulation and 
Subsequent Neural Development. Biochemical and Biophysical Research Communications, 2001. 280(5): 
p. 1378-1384. 
376. Mariani, M., et al., Two Murine and Human Homologs of Mab-21, a Cell Fate Determination 
Gene Involved in Caenorhabditis Elegans Neural Development. Human Molecular Genetics, 1999. 8(13): 
p. 2397-2406. 
-189- 
 
377. Wong, R.L.Y., H.T. Wong, and K. Chow, Genomic cloning and chromosomal localization of the 
mouse Mab21I2 locus. Vol. 86. 1999. 21-4. 
378. Yamada, R., et al., Cell-autonomous involvement of <em>Mab21l1</em> is essential for lens 
placode development. Development, 2003. 130(9): p. 1759-1770. 
379. Yamada, R., et al., Requirement for Mab21l2 during development of murine retina and ventral 
body wall. Developmental Biology, 2004. 274(2): p. 295-307. 
380. Wong, Y.-M. and K.L. Chow, Expression of zebrafish mab21 genes marks the differentiating eye, 
midbrain and neural tube. Mechanisms of Development, 2002. 113(2): p. 149-152. 
381. Mariani, M., et al., Mab21, the mouse homolog of a C. elegans cell-fate specification gene, 
participates in cerebellar, midbrain and eye development. Mech Dev, 1998. 79(1-2): p. 131-5. 
382. Wong, R.L.Y., K.K.L. Chan, and K.L. Chow, Developmental expression of Mab21l2 during 
mouse embryogenesis. Mechanisms of Development, 1999. 87(1–2): p. 185-188. 
383. Cederlund, M.L., et al., Mab21l2 transgenics reveal novel expression patterns of mab21l1 and 
mab21l2, and conserved promoter regulation without sequence conservation. Developmental Dynamics, 
2011. 240(4): p. 745-754. 
384. Margolis, R.L., et al., cDNA Cloning of a Human Homologue of the Caenorhabditis Elegans Cell 
Fate-Determining Gene Mab -21: Expression, Chromosomal Localization and Analysis of a Highly 
Polymorphic (CAG) n Trinucleotide Repeat. Human Molecular Genetics, 1996. 5(5): p. 607-616. 
385. Deml, B., et al., Mutations in MAB21L2 Result in Ocular Coloboma, Microcornea and Cataracts. 
PLOS Genetics, 2015. 11(2): p. e1005002. 
386. Horn, D., et al., A Novel Oculo-Skeletal syndrome with intellectual disability caused by a 
particular MAB21L2 mutation. European Journal of Medical Genetics, 2015. 58(8): p. 387-391. 
387. Rainger, J., et al., Monoallelic and Biallelic Mutations in MAB21L2 Cause a Spectrum of Major 
Eye Malformations. The American Journal of Human Genetics, 2014. 94(6): p. 915-923. 
388. Sridharan, J., et al., Xmab21l3 mediates dorsoventral patterning in Xenopus laevis. Mechanisms 
of Development, 2012. 129(5-8): p. 136-146. 
389. Takahashi, C., et al., Mab21-l3 regulates cell fate specification of multiciliate cells and ionocytes. 
Nature Communications, 2015. 6: p. 6017. 
390. Losón, Oliver C., et al., The Mitochondrial Fission Receptor MiD51 Requires ADP as a 
Cofactor. Structure, 2014. 22(3): p. 367-377. 
391. Richter, V., et al., Structural and functional analysis of MiD51, a dynamin receptor required for 
mitochondrial fission. The Journal of Cell Biology, 2014. 204(4): p. 477-486. 
392. Losón, O.C., et al., Crystal structure and functional analysis of MiD49, a receptor for the 
mitochondrial fission protein Drp1. Protein Science, 2015. 24(3): p. 386-394. 
393. Manning, B.D. and L.C. Cantley, AKT/PKB Signaling: Navigating Downstream. Cell, 2007. 
129(7): p. 1261-1274. 
394. Seo, Gil J., et al., Akt Kinase-Mediated Checkpoint of cGAS DNA Sensing Pathway. Cell Reports, 
2015. 13(2): p. 440-449. 
-190- 
 
395. Kaur, S., et al., Role of the Akt pathway in mRNA translation of interferon-stimulated genes. 
Proceedings of the National Academy of Sciences, 2008. 105(12): p. 4808-4813. 
396. Ou, Y.-H., et al., TBK1 Directly Engages Akt/PKB Survival Signaling to Support Oncogenic 
Transformation. Molecular Cell, 2011. 41(4): p. 458-470. 
397. Xia, P., et al., Glutamylation of the DNA sensor cGAS regulates its binding and synthase activity 
in antiviral immunity. Nature immunology, 2016. 17: p. 369. 
398. Wang, Q., et al., The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune 
response. PLOS Pathogens, 2017. 13(3): p. e1006264. 
399. Chen, M., et al., TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor 
p62 to Promote Innate Immune Responses. Molecular Cell, 2016. 64(1): p. 105-119. 
400. Hu, M.-M., et al., Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor 
STING to Regulate the Kinetics of Response to DNA Virus. Immunity, 2016. 45(3): p. 555-569. 
401. Cui, Y., et al., SENP7 Potentiates cGAS Activation by Relieving SUMO-Mediated Inhibition of 
Cytosolic DNA Sensing. PLOS Pathogens, 2017. 13(1): p. e1006156. 
402. Li, Z., et al., PPM1A Regulates Antiviral Signaling by Antagonizing TBK1-Mediated STING 
Phosphorylation and Aggregation. PLOS Pathogens, 2015. 11(3): p. e1004783. 
403. Konno, H., K. Konno, and Glen N. Barber, Cyclic Dinucleotides Trigger ULK1 (ATG1) 
Phosphorylation of STING to Prevent Sustained Innate Immune Signaling. Cell, 2013. 155(3): p. 688-
698. 
404. Tsuchida, T., et al., The Ubiquitin Ligase TRIM56 Regulates Innate Immune Responses to 
Intracellular Double-Stranded DNA. Immunity, 2010. 33(5): p. 765-776. 
405. Zhang, J., et al., TRIM32 Protein Modulates Type I Interferon Induction and Cellular Antiviral 
Response by Targeting MITA/STING Protein for K63-linked Ubiquitination. Journal of Biological 
Chemistry, 2012. 287(34): p. 28646-28655. 
406. Wang, Q., et al., The E3 Ubiquitin Ligase AMFR and INSIG1 Bridge the Activation of TBK1 
Kinase by Modifying the Adaptor STING. Immunity, 2014. 41(6): p. 919-933. 
407. Zhong, B., et al., The Ubiquitin Ligase RNF5 Regulates Antiviral Responses by Mediating 
Degradation of the Adaptor Protein MITA. Immunity, 2009. 30(3): p. 397-407. 
408. Qin, Y., et al., RNF26 Temporally Regulates Virus-Triggered Type I Interferon Induction by Two 
Distinct Mechanisms. PLOS Pathogens, 2014. 10(9): p. e1004358. 
409. Luo, W.-W., et al., iRhom2 is essential for innate immunity to DNA viruses by mediating 
trafficking and stability of the adaptor STING. Nature immunology, 2016. 17: p. 1057. 
410. Mukai, K., et al., Activation of STING requires palmitoylation at the Golgi. Nature 
Communications, 2016. 7: p. 11932. 
411. Yarbrough, M.L., et al., Primate-specific miR-576-3p sets host defense signalling threshold. 
Nature Communications, 2014. 5: p. 4963. 
412. Wu, M.-Z., et al., miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS. 
Nature Cell Biology, 2017. 19: p. 1286. 
-191- 
 
413. Škrnjug, I., C.A. Guzmán, and C. Ruecker, Cyclic GMP-AMP Displays Mucosal Adjuvant 
Activity in Mice. PLoS ONE, 2014. 9(10): p. e110150. 
414. Wang, J., P. Li, and M.X. Wu, Natural STING Agonist as an “Ideal” Adjuvant for Cutaneous 
Vaccination. Journal of Investigative Dermatology, 2016. 136(11): p. 2183-2191. 
415. Chen, Q., et al., Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP 
transfer. Nature, 2016. 533: p. 493. 
416. Mankan, A.K., et al., Cyclic Dinucleotides in the Scope of the Mammalian Immune System, in 
Non-canonical Cyclic Nucleotides, R. Seifert, Editor. 2017, Springer International Publishing: Cham. p. 
269-289. 
417. Berg, R.K., et al., T Cells Detect Intracellular DNA but Fail to Induce Type I IFN Responses: 
Implications for Restriction of HIV Replication. PLoS ONE, 2014. 9(1): p. e84513. 
418. Xu, S., et al., cGAS-Mediated Innate Immunity Spreads Intercellularly through HIV-1 Env-
Induced Membrane Fusion Sites. Cell host & microbe, 2016. 20(4): p. 443-457. 
419. Valadi, H., et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of 
genetic exchange between cells. Nature Cell Biology, 2007. 9: p. 654. 
420. Dreux, M., et al., Short-Range Exosomal Transfer of Viral RNA from Infected Cells to 
Plasmacytoid Dendritic Cells Triggers Innate Immunity. Cell host & microbe, 2012. 12(4): p. 558-570. 
421. Gao, J., et al., Identification and characterization of phosphodiesterases that specifically degrade 
3′3′-cyclic GMP-AMP. Cell Research, 2015. 25: p. 539. 
422. Kubota, K., et al., Identification of 2′-Phosphodiesterase, Which Plays a Role in the 2-5A System 
Regulated by Interferon. Journal of Biological Chemistry, 2004. 279(36): p. 37832-37841. 
423. Li, L., et al., Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs. 
Nature Chemical Biology, 2014. 10: p. 1043. 
424. Kato, K., et al., Crystal structure of Enpp1, an extracellular glycoprotein involved in bone 
mineralization and insulin signaling. Proceedings of the National Academy of Sciences of the United 
States of America, 2012. 109(42): p. 16876-16881. 
425. Namasivayam, V., S.-Y. Lee, and C.E. Müller, The promiscuous ectonucleotidase NPP1: 
molecular insights into substrate binding and hydrolysis. Biochimica et Biophysica Acta (BBA) - General 
Subjects, 2017. 1861(3): p. 603-614. 
426. Gao, D., et al., Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune 
diseases. Proceedings of the National Academy of Sciences of the United States of America, 2015. 
112(42): p. E5699-E5705. 
427. Tao, J., X. Zhou, and Z. Jiang, cGAS-cGAMP-STING: The three musketeers of cytosolic DNA 
sensing and signaling. IUBMB Life, 2016. 68(11): p. 858-870. 
428. Wang, F., et al., S6K-STING interaction regulates cytosolic DNA–mediated activation of the 
transcription factor IRF3. Nature immunology, 2016. 17: p. 514. 
429. Zhou, Q., et al., The ER-Associated Protein ZDHHC1 Is a Positive Regulator of DNA Virus-
Triggered, MITA/STING-Dependent Innate Immune Signaling. Cell host & microbe, 2014. 16(4): p. 450-
461. 
-192- 
 
430. Lahouassa, H., et al., SAMHD1 restricts the replication of human immunodeficiency virus type 1 
by depleting the intracellular pool of deoxynucleoside triphosphates. Nature immunology, 2012. 13: p. 
223. 
431. Goldstone, D.C., et al., HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate 
triphosphohydrolase. Nature, 2011. 480: p. 379. 
432. Berger, A., et al., SAMHD1-Deficient CD14+ Cells from Individuals with Aicardi-Goutières 
Syndrome Are Highly Susceptible to HIV-1 Infection. PLOS Pathogens, 2011. 7(12): p. e1002425. 
433. Guo, H., et al., NLRX1 Sequesters STING to Negatively Regulate the Interferon Response, 
Thereby Facilitating the Replication of HIV-1 and DNA Viruses. Cell host & microbe, 2016. 19(4): p. 
515-528. 
434. Abdul-Sater, A.A., et al., Enhancement of Reactive Oxygen Species Production and Chlamydial 
Infection by the Mitochondrial Nod-like Family Member NLRX1. The Journal of Biological Chemistry, 
2010. 285(53): p. 41637-41645. 
435. Tattoli, I., et al., NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK 
pathways by inducing reactive oxygen species production. EMBO Reports, 2008. 9(3): p. 293-300. 
436. Allen, Irving C., et al., NLRX1 Protein Attenuates Inflammatory Responses to Infection by 
Interfering with the RIG-I-MAVS and TRAF6-NF-κB Signaling Pathways. Immunity, 2011. 34(6): p. 854-
865. 
437. Xia, X., et al., NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 
and IKK. Immunity, 2011. 34(6): p. 843-853. 
438. Lo Cigno, I., et al., The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human 
Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters. Journal of 
Virology, 2015. 89(15): p. 7506-7520. 
439. Gariano, G.R., et al., The Intracellular DNA Sensor IFI16 Gene Acts as Restriction Factor for 
Human Cytomegalovirus Replication. PLOS Pathogens, 2012. 8(1): p. e1002498. 
440. Iqbal, J., et al., Histone H2B-IFI16 Recognition of Nuclear Herpesviral Genome Induces 
Cytoplasmic Interferon-β Responses. PLOS Pathogens, 2016. 12(10): p. e1005967. 
441. Takahama, M., et al., The RAB2B-GARIL5 Complex Promotes Cytosolic DNA-Induced Innate 
Immune Responses. Cell Reports, 2017. 20(12): p. 2944-2954. 
442. Fang, R., et al., NEMO–IKKβ Are Essential for IRF3 and NF-κB Activation in the cGAS–STING 
Pathway. The Journal of Immunology, 2017. 199(9): p. 3222-3233. 
443. Chiu, Y.-H., J.B. MacMillan, and Z.J. Chen, RNA Polymerase III Detects Cytosolic DNA and 
Induces Type I Interferons through the RIG-I Pathway. Cell, 2009. 138(3): p. 576-591. 
444. Nazmi, A., et al., STING Mediates Neuronal Innate Immune Response Following Japanese 
Encephalitis Virus Infection. Scientific Reports, 2012. 2: p. 347. 
445. Suzuki, T., et al., Cell Type-Specific Subcellular Localization of Phospho-TBK1 in Response to 
Cytoplasmic Viral DNA. PLoS ONE, 2013. 8(12): p. e83639. 
446. Tattoli, I., et al., Amino Acid Starvation Induced by Invasive Bacterial Pathogens Triggers an 
Innate Host Defense Program. Cell host & microbe, 2012. 11(6): p. 563-575. 
-193- 
 
447. Xia, M., et al., Mitophagy Enhances Oncolytic Measles Virus Replication by Mitigating 
DDX58/RIG-I-Like Receptor Signaling. Journal of Virology, 2014. 88(9): p. 5152-5164. 
448. Lei, Y., et al., The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates 
Type I Interferon and Autophagy. Immunity, 2012. 36(6): p. 933-946. 
449. Watson, R.O., P.S. Manzanillo, and J.S. Cox, Extracellular M. tuberculosis DNA Targets 
Bacteria for Autophagy by Activating the Host DNA-Sensing Pathway. Cell, 2012. 150(4): p. 803-815. 
450. McFarlane, S., et al., Early Induction of Autophagy in Human Fibroblasts after Infection with 
Human Cytomegalovirus or Herpes Simplex Virus 1. Journal of Virology, 2011. 85(9): p. 4212-4221. 
451. Rasmussen, S.B., et al., Activation of autophagy by alpha-herpesviruses in myeloid cells is 
mediated by cytoplasmic viral DNA through a mechanism dependent on STING. Journal of immunology 
(Baltimore, Md. : 1950), 2011. 187(10): p. 5268-5276. 
452. Liang, C., et al., Autophagic and tumour suppressor activity of a novel Beclin1-binding protein 
UVRAG. Nature Cell Biology, 2006. 8: p. 688. 
453. Matsunaga, K., et al., Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate 
autophagy at different stages. Nature Cell Biology, 2009. 11: p. 385. 
454. Zhong, Y., et al., Distinct regulation of autophagic activity by Atg14L and Rubicon associated 
with Beclin 1–phosphatidylinositol-3-kinase complex. Nature Cell Biology, 2009. 11: p. 468. 
455. Pattingre, S., et al., Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy. Cell, 
2005. 122(6): p. 927-939. 
456. Liang, Q., et al., Crosstalk between the cGAS DNA Sensor and Beclin-1 Autophagy Protein 
Shapes Innate Antimicrobial Immune Responses. Cell host & microbe, 2014. 15(2): p. 228-238. 
457. Mathew, R., et al., Functional Role of Autophagy-Mediated Proteome Remodeling in Cell 
Survival Signaling and Innate Immunity. Molecular Cell, 2014. 55(6): p. 916-930. 
458. Grimm, W.A., et al., The Thr300Ala variant in ATG16L1 is associated with improved survival in 
human colorectal cancer and enhanced production of type I interferon. Gut, 2016. 65(3): p. 456-464. 
459. Marchiando, Amanda M., et al., A Deficiency in the Autophagy Gene Atg16L1 Enhances 
Resistance to Enteric Bacterial Infection. Cell host & microbe, 2013. 14(2): p. 216-224. 
460. Lan, Yuk Y., et al., Dnase2a Deficiency Uncovers Lysosomal Clearance of Damaged Nuclear 
DNA via Autophagy. Cell Reports, 2014. 9(1): p. 180-192. 
461. Allen, Irving C., et al., NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the 
Negative Regulation of Noncanonical NF-κB Signaling. Immunity, 2012. 36(5): p. 742-754. 
462. Zaki, M.H., et al., The NOD-Like Receptor NLRP12 Attenuates Colon Inflammation and 
Tumorigenesis. Cancer Cell, 2011. 20(5): p. 649-660. 
463. Cui, J., et al., NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways. 
Cell, 2010. 141(3): p. 483-496. 
464. Zhang, L., et al., NLRC3, a Member of the NLR Family of Proteins, Is a Negative Regulator of 
Innate Immune Signaling Induced by the DNA Sensor STING. Immunity, 2014. 40(3): p. 329-341. 
-194- 
 
465. Schneider, M., et al., The innate immune sensor NLRC3 attenuates Toll-like receptor signaling 
via modification of the signaling adaptor TRAF6 and transcription factor NF-κB. Nature immunology, 
2012. 13(9): p. 823-831. 
466. Cui, J., et al., NLRP4 negatively regulates type I interferon signaling by targeting the kinase 
TBK1 for degradation via the ubiquitin ligase DTX4. Nature immunology, 2012. 13(4): p. 387-395. 
467. Abe, T., et al., Germ-Cell-Specific Inflammasome Component NLRP14 Negatively Regulates 
Cytosolic Nucleic Acid Sensing to Promote Fertilization. Immunity, 2017. 46(4): p. 621-634. 
468. Corrales, L., et al., Antagonism of the STING pathway via activation of the AIM2 inflammasome 
by intracellular DNA. Journal of immunology (Baltimore, Md. : 1950), 2016. 196(7): p. 3191-3198. 
469. Wang, Y., et al., Inflammasome Activation Triggers Caspase-1-Mediated Cleavage of cGAS to 
Regulate Responses to DNA Virus Infection. Immunity, 2017. 46(3): p. 393-404. 
470. Monroe, K.M., et al., IFI16 DNA Sensor Is Required for Death of Lymphoid CD4 T Cells 
Abortively Infected with HIV. Science, 2014. 343(6169): p. 428-432. 
471. Ghosh, S., et al., The PYHIN Protein p205 Regulates the Inflammasome by Controlling Asc 
Expression. The Journal of Immunology, 2017. 199(9): p. 3249-3260. 
472. Rathinam, Vijay A.K., et al., TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome 
Activation by Gram-Negative Bacteria. Cell, 2012. 150(3): p. 606-619. 
473. Broz, P., et al., Caspase-11 increases susceptibility to Salmonella infection in the absence of 
caspase-1. Nature, 2012. 490: p. 288. 
474. Cole, L.E., et al., Macrophage Proinflammatory Response to <em>Francisella tularensis</em> 
Live Vaccine Strain Requires Coordination of Multiple Signaling Pathways. The Journal of Immunology, 
2008. 180(10): p. 6885-6891. 
475. Henry, T., et al., Type I interferon signaling is required for activation of the inflammasome 
during <em>Francisella</em> infection. The Journal of Experimental Medicine, 2007. 204(5): p. 987-
994. 
476. Bauernfeind, F.G., et al., Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine 
Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression. The Journal of 
Immunology, 2009. 183(2): p. 787-791. 
477. Liu, F., et al., Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via 
the cGAS/IFI16–STING–Type I IFN Pathway and AIM2 Sensor. The Journal of Immunology, 2017. 
199(9): p. 3293-3305. 
478. Webster, S.J., et al., Detection of a microbial metabolite by STING regulates inflammasome 
activation in response to Chlamydia trachomatis infection. PLOS Pathogens, 2017. 13(6): p. e1006383. 
479. Molnarfi, N., et al., The Production of IL-1 Receptor Antagonist in IFN-β-Stimulated Human 
Monocytes Depends on the Activation of Phosphatidylinositol 3-Kinase but Not of STAT1. The Journal of 
Immunology, 2005. 174(5): p. 2974-2980. 
480. Guarda, G., et al., Type I Interferon Inhibits Interleukin-1 Production and Inflammasome 
Activation. Immunity, 2011. 34(2): p. 213-223. 
-195- 
 
481. Hernandez-Cuellar, E., et al., Cutting Edge: Nitric Oxide Inhibits the NLRP3 Inflammasome. The 
Journal of Immunology, 2012. 189(11): p. 5113-5117. 
482. Mishra, B.B., et al., Nitric oxide controls the immunopathology of tuberculosis by inhibiting 
NLRP3 inflammasome–dependent processing of IL-1β. Nature immunology, 2012. 14: p. 52. 
483. Swanson, K.V., et al., A noncanonical function of cGAMP in inflammasome priming and 
activation. The Journal of Experimental Medicine, 2017. 
484. Kovalenko, A., et al., Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory 
skin disease. The Journal of Experimental Medicine, 2009. 206(10): p. 2161-2177. 
485. Cuda, C.M., et al., Caspase-8 Acts as a Molecular Rheostat to Limit RIPK1- and MyD88-
Mediated Dendritic Cell Activation(). Journal of immunology (Baltimore, Md. : 1950), 2014. 192(12): p. 
5548-5560. 
486. Rajput, A., et al., RIG-I RNA Helicase Activation of IRF3 Transcription Factor Is Negatively 
Regulated by Caspase-8-Mediated Cleavage of the RIP1 Protein. Immunity, 2011. 34(3): p. 340-351. 
487. Andrade, W.A., et al., Group B Streptococcus degrades cyclic-di-AMP to modulate STING-
dependent type I interferon production. Cell host & microbe, 2016. 20(1): p. 49-59. 
488. Dey, R.J., et al., Inhibition of innate immune cytosolic surveillance by an M. tuberculosis 
phosphodiesterase. Nature Chemical Biology, 2016. 13: p. 210. 
489. Dobbs, N., et al., STING activation by translocation from the ER is associated with infection and 
autoinflammatory disease. Cell host & microbe, 2015. 18(2): p. 157-168. 
490. Christensen, M.H., et al., HSV‐1 ICP27 targets the TBK1‐activated STING signalsome to inhibit 
virus‐induced type I IFN expression. The EMBO Journal, 2016. 35(13): p. 1385-1399. 
491. Lau, L., et al., DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway. 
Science, 2015. 350(6260): p. 568-571. 
492. Lam, E. and E. Falck-Pedersen, Unabated Adenovirus Replication following Activation of the 
cGAS/STING-Dependent Antiviral Response in Human Cells. Journal of Virology, 2014. 88(24): p. 
14426-14439. 
493. Look, D.C., et al., Direct Suppression of Stat1 Function during Adenoviral Infection. Immunity, 
1998. 9(6): p. 871-880. 
494. Liu, Y., et al., Hepatitis B Virus Polymerase Disrupts K63-Linked Ubiquitination of STING To 
Block Innate Cytosolic DNA-Sensing Pathways. Journal of Virology, 2015. 89(4): p. 2287-2300. 
495. Ding, Q., et al., Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host 
innate immunity. Journal of Hepatology, 2013. 59(1): p. 52-58. 
496. Nitta, S., et al., Hepatitis C virus NS4B protein targets STING and abrogates RIG-I–mediated 
type I interferon-dependent innate immunity. Hepatology, 2013. 57(1): p. 46-58. 
497. Rodriguez-Madoz, J.R., et al., Inhibition of the Type I Interferon Response in Human Dendritic 
Cells by Dengue Virus Infection Requires a Catalytically Active NS2B3 Complex. Journal of Virology, 
2010. 84(19): p. 9760-9774. 
498. Aguirre, S., et al., DENV Inhibits Type I IFN Production in Infected Cells by Cleaving Human 
STING. PLOS Pathogens, 2012. 8(10): p. e1002934. 
-196- 
 
499. Yu, C.-Y., et al., Dengue Virus Targets the Adaptor Protein MITA to Subvert Host Innate 
Immunity. PLOS Pathogens, 2012. 8(6): p. e1002780. 
500. Sun, L., et al., Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune 
Response through Disruption of STING-Mediated Signaling. PLoS ONE, 2012. 7(2): p. e30802. 
501. Clementz, M.A., et al., Deubiquitinating and Interferon Antagonism Activities of Coronavirus 
Papain-Like Proteases. Journal of Virology, 2010. 84(9): p. 4619-4629. 
502. Xing, Y., et al., The papain-like protease of porcine epidemic diarrhea virus negatively regulates 
type I interferon pathway by acting as a viral deubiquitinase. The Journal of General Virology, 2013. 
94(Pt 7): p. 1554-1567. 
503. Chen, X., et al., SARS coronavirus papain-like protease inhibits the type I interferon signaling 
pathway through interaction with the STING-TRAF3-TBK1 complex. Protein & Cell, 2014. 5(5): p. 369-
381. 
504. Wu, J.-j., et al., Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein. Cell host & 
microbe, 2015. 18(3): p. 333-344. 
505. Zhang, G., et al., Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and 
antagonize the innate immune DNA sensor cGAS. Proceedings of the National Academy of Sciences of 
the United States of America, 2016. 113(8): p. E1034-E1043. 
506. Sun, C., et al., Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates 
establishment of latent infection(). Journal of immunology (Baltimore, Md. : 1950), 2015. 194(4): p. 
1819-1831. 
507. Lee, K., et al., Flexible Use of Nuclear Import Pathways by HIV-1. Cell host & microbe, 2010. 
7(3): p. 221-233. 
508. Schaller, T., et al., HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, 
Integration Targeting and Replication Efficiency. PLOS Pathogens, 2011. 7(12): p. e1002439. 
509. Rasaiyaah, J., et al., HIV-1 evades innate immune recognition through specific cofactor 
recruitment. Nature, 2013. 503: p. 402. 
510. Yan, N., et al., The cytosolic exonuclease TREX1 inhibits the innate immune response to HIV-1. 
Nature immunology, 2010. 11(11): p. 1005-1013. 
511. Manel, N., et al., A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. 
Nature, 2010. 467: p. 214. 
512. Lahaye, X., et al., The Capsids of HIV-1 and HIV-2 Determine Immune Detection of the Viral 
cDNA by the Innate Sensor cGAS in Dendritic Cells. Immunity, 2013. 39(6): p. 1132-1142. 
513. Kalamvoki, M. and B. Roizman, HSV-1 degrades, stabilizes, requires, or is stung by STING 
depending on ICP0, the US3 protein kinase, and cell derivation. Proceedings of the National Academy of 
Sciences, 2014. 111(5): p. E611-E617. 
514. Archer, K.A., J. Durack, and D.A. Portnoy, STING-Dependent Type I IFN Production Inhibits 
Cell-Mediated Immunity to Listeria monocytogenes. PLOS Pathogens, 2014. 10(1): p. e1003861. 
515. Osborne, S.E., et al., Type I interferon promotes cell-to-cell spread of Listeria monocytogenes. 
Cellular Microbiology, 2017. 19(3): p. e12660-n/a. 
-197- 
 
516. Shimada, K., et al., Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during 
Apoptosis. Immunity, 2012. 36(3): p. 401-414. 
517. Nakahira, K., et al., Autophagy proteins regulate innate immune response by inhibiting NALP3 
inflammasome-mediated mitochondrial DNA release. Nature immunology, 2011. 12(3): p. 222-230. 
518. Carlos, D., et al., Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to 
Type 1 Diabetes in Murine Model. Frontiers in Immunology, 2017. 8: p. 164. 
519. Liu, J., et al., Circulating Cell Free Mitochondrial DNA is a Biomarker in the Development of 
Coronary Heart Disease in the Patients with Type 2 Diabetes. Clin Lab, 2015. 61(7): p. 661-7. 
520. Jönsen, A., et al., Mitochondrial DNA polymorphisms are associated with susceptibility and 
phenotype of systemic lupus erythematosus. Lupus, 2009. 18(4): p. 309-312. 
521. Perl, A., R. Hanczko, and E. Doherty, Assessment of Mitochondrial Dysfunction in Lymphocytes 
of Patients with Systemic Lupus Erythematosus, in Autoimmunity: Methods and Protocols, A. Perl, 
Editor. 2012, Humana Press: Totowa, NJ. p. 61-89. 
522. Dall'Era, M., et al., Type I interferon correlates with serological and clinical manifestations of 
SLE. Annals of the Rheumatic Diseases, 2005. 64(12): p. 1692-1697. 
523. Bauer, J.W., et al., Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers 
for Active Human Systemic Lupus Erythematosus. PLoS Medicine, 2006. 3(12): p. e491. 
524. Wang, H., et al., Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in 
Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Arthritis & Rheumatology, 
2015. 67(12): p. 3190-3200. 
525. Caielli, S., et al., Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon 
production in human lupus. The Journal of Experimental Medicine, 2016. 213(5): p. 697-713. 
526. Reijns, Martin A.M., et al., Enzymatic Removal of Ribonucleotides from DNA Is Essential for 
Mammalian Genome Integrity and Development. Cell, 2012. 149(5): p. 1008-1022. 
527. Bartsch, K., et al., Absence of RNase H2 triggers generation of immunogenic micronuclei 
removed by autophagy. Human Molecular Genetics, 2017. 26(20): p. 3960-3972. 
528. Mackenzie, K.J., et al., Ribonuclease H2 mutations induce a cGAS/STING‐dependent innate 
immune response. The EMBO Journal, 2016. 35(8): p. 831-844. 
529. Pokatayev, V., et al., RNase H2 catalytic core Aicardi-Goutières syndrome–related mutant 
invokes cGAS–STING innate immune-sensing pathway in mice. The Journal of Experimental Medicine, 
2016. 213(3): p. 329-336. 
530. Crow, Y.J., et al., Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-
Goutières syndrome and mimic congenital viral brain infection. Nature Genetics, 2006. 38: p. 910. 
531. Günther, C., et al., Defective removal of ribonucleotides from DNA promotes systemic 
autoimmunity. The Journal of Clinical Investigation, 2015. 125(1): p. 413-424. 
532. Crow, Y.J., et al., Characterization of Human Disease Phenotypes Associated with Mutations in 
TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. American journal of 
medical genetics. Part A, 2015. 0(2): p. 296-312. 
-198- 
 
533. Yang, Y.-G., T. Lindahl, and D.E. Barnes, Trex1 Exonuclease Degrades ssDNA to Prevent 
Chronic Checkpoint Activation and Autoimmune Disease. Cell, 2007. 131(5): p. 873-886. 
534. Ablasser, A., et al., TREX1 Deficiency Triggers Cell-Autonomous Immunity in a cGAS-Dependent 
Manner. The Journal of Immunology, 2014. 192(12): p. 5993-5997. 
535. Gray, E.E., et al., cGAS is required for lethal autoimmune disease in the Trex1-deficient mouse 
model of Aicardi-Goutieres Syndrome(). Journal of immunology (Baltimore, Md. : 1950), 2015. 195(5): 
p. 1939-1943. 
536. Crow, Y.J., et al., Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause 
Aicardi-Goutières syndrome at the AGS1 locus. Nature Genetics, 2006. 38: p. 917. 
537. Richards, A., et al., C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause 
autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nature Genetics, 2007. 39: p. 
1068. 
538. Rice, G., et al., Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and 
Dominant Aicardi-Goutières Syndrome. American Journal of Human Genetics, 2007. 80(4): p. 811-815. 
539. Lee-Kirsch, M.A., et al., Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are 
associated with systemic lupus erythematosus. Nature Genetics, 2007. 39: p. 1065. 
540. Lindahl, T., et al., Biochemical properties of mammalian TREX1 and its association with DNA 
replication and inherited inflammatory disease. Biochemical Society Transactions, 2009. 37(3): p. 535-
538. 
541. Mannherz, H.G., et al., A New Function for an Old Enzyme: The Role of DNase I in Apoptosis, in 
Pathways for Cytolysis, G.M. Griffiths and J. Tschopp, Editors. 1995, Springer Berlin Heidelberg: Berlin, 
Heidelberg. p. 161-174. 
542. Napirei, M., S. Wulf, and H.G. Mannherz, Chromatin breakdown during necrosis by serum 
Dnase1 and the plasminogen system. Arthritis & Rheumatism, 2004. 50(6): p. 1873-1883. 
543. Skiljevic, D., et al., Serum DNase I activity in systemic lupus erythematosus: correlation with 
immunoserological markers, the disease activity and organ involvement, in Clinical Chemistry and 
Laboratory Medicine2013. p. 1083. 
544. Yasutomo, K., et al., Mutation of DNASE1 in people with systemic lupus erythematosus. Nature 
Genetics, 2001. 28: p. 313. 
545. Bodaño, A., et al., Study of DNASE I gene polymorphisms in systemic lupus erythematosus 
susceptibility. Annals of the Rheumatic Diseases, 2007. 66(4): p. 560-561. 
546. Bodaño, A., et al., Association of a non-synonymous single-nucleotide polymorphism of DNASEI 
with SLE susceptibility. Rheumatology, 2006. 45(7): p. 819-823. 
547. Kawane, K., et al., Requirement of DNase II for Definitive Erythropoiesis in the Mouse Fetal 
Liver. Science, 2001. 292(5521): p. 1546-1549. 
548. Krieser, R.J., et al., Deoxyribonuclease IIα is required during the phagocytic phase of apoptosis 
and its loss causes perinatal lethality. Cell Death And Differentiation, 2002. 9: p. 956. 
549. Ahn, J., et al., STING manifests self DNA-dependent inflammatory disease. Proceedings of the 
National Academy of Sciences of the United States of America, 2012. 109(47): p. 19386-19391. 
-199- 
 
550. Laguette, N., et al., SAMHD1 is the dendritic– and myeloid–cell–specific HIV–1 restriction factor 
counteracted by Vpx. Nature, 2011. 474(7353): p. 654-657. 
551. Hrecka, K., et al., Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the 
SAMHD1 protein. Nature, 2011. 474(7353): p. 658-661. 
552. Kretschmer, S., et al., SAMHD1 prevents autoimmunity by maintaining genome stability. Annals 
of the Rheumatic Diseases, 2015. 74(3): p. e17-e17. 
553. Maelfait, J., et al., Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive 
Immune Responses to HIV-1. Cell Reports, 2016. 16(6): p. 1492-1501. 
554. George, C.X., L. John, and C.E. Samuel, An RNA Editor, Adenosine Deaminase Acting on 
Double-Stranded RNA (ADAR1). Journal of Interferon & Cytokine Research, 2014. 34(6): p. 437-446. 
555. Neeman, Y., et al., RNA editing level in the mouse is determined by the genomic repeat 
repertoire. RNA, 2006. 12(10): p. 1802-1809. 
556. Liddicoat, B.J., et al., RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as 
nonself. Science, 2015. 349(6252): p. 1115-1120. 
557. Pestal, K., et al., Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid 
Sensor MDA5-Driven Autoimmunity and Multi-organ Development. Immunity, 2015. 43(5): p. 933-944. 
558. Jeremiah, N., et al., Inherited STING-activating mutation underlies a familial inflammatory 
syndrome with lupus-like manifestations. The Journal of Clinical Investigation, 2014. 124(12): p. 5516-
5520. 
559. Liu , Y., et al., Activated STING in a Vascular and Pulmonary Syndrome. New England Journal 
of Medicine, 2014. 371(6): p. 507-518. 
560. Tang, E.D. and C.-Y. Wang, Single Amino Acid Change in STING Leads to Constitutive Active 
Signaling. PLoS ONE, 2015. 10(3): p. e0120090. 
561. König, N., et al., Familial chilblain lupus due to a gain-of-function mutation in STING. Annals of 
the Rheumatic Diseases, 2017. 76(2): p. 468-472. 
562. Dunn, G.P., et al., A critical function for type I interferons in cancer immunoediting. Nature 
immunology, 2005. 6: p. 722. 
563. Woo, S.-R., L. Corrales, and T.F. Gajewski, The STING pathway and the T cell-inflamed tumor 
microenvironment. Trends in Immunology, 2015. 36(4): p. 250-256. 
564. Yang, X., et al., Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and 
Adaptive Immune Responses. Cancer Cell, 2014. 25(1): p. 37-48. 
565. Woo, S.-R., et al., STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune 
Recognition of Immunogenic Tumors. Immunity, 2014. 41(5): p. 830-842. 
566. Deng, L., et al., STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I 
Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity, 2014. 41(5): p. 843-852. 
567. Liu, X., et al., CD47 blockade triggers T cell–mediated destruction of immunogenic tumors. 
Nature Medicine, 2015. 21: p. 1209. 
-200- 
 
568. Klarquist, J., et al., STING-mediated DNA sensing promotes antitumor and autoimmune 
responses to dying cells. Journal of immunology (Baltimore, Md. : 1950), 2014. 193(12): p. 6124-6134. 
569. Diamond, M.S., et al., Type I interferon is selectively required by dendritic cells for immune 
rejection of tumors. The Journal of Experimental Medicine, 2011. 208(10): p. 1989-2003. 
570. Ho, Samantha S.W., et al., The DNA Structure-Specific Endonuclease MUS81 Mediates DNA 
Sensor STING-Dependent Host Rejection of Prostate Cancer Cells. Immunity, 2016. 44(5): p. 1177-1189. 
571. Ahn, J., et al., Inflammation-driven carcinogenesis is mediated through STING. Nature 
Communications, 2014. 5: p. 5166. 
572. Carroll, E.C., et al., The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor 
cGAS-STING-Dependent Induction of Type I Interferons. Immunity, 2016. 44(3): p. 597-608. 
573. Wang, H., et al., cGAS is essential for the antitumor effect of immune checkpoint blockade. 
Proceedings of the National Academy of Sciences of the United States of America, 2017. 114(7): p. 1637-
1642. 
574. Alsaab, H.O., et al., PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer 
Immunotherapy: Mechanism, Combinations, and Clinical Outcome. Frontiers in Pharmacology, 2017. 8: 
p. 561. 
575. Fu, J., et al., STING agonist formulated cancer vaccines can cure established tumors resistant to 
PD-1 blockade. Science translational medicine, 2015. 7(283): p. 283ra52-283ra52. 
576. Corrales, L., et al., Direct Activation of STING in the Tumor Microenvironment Leads to Potent 
and Systemic Tumor Regression and Immunity. Cell Reports, 2015. 11(7): p. 1018-1030. 
577. Li, T., et al., Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 
Mediated Innate Immune Response. Scientific Reports, 2016. 6: p. 19049. 
578. Demaria, O., et al., STING activation of tumor endothelial cells initiates spontaneous and 
therapeutic antitumor immunity. Proceedings of the National Academy of Sciences of the United States of 
America, 2015. 112(50): p. 15408-15413. 
579. Ohkuri, T., et al., STING contributes to anti-glioma immunity via triggering type-I IFN signals in 
the tumor microenvironment. Cancer immunology research, 2014. 2(12): p. 1199-1208. 
580. Tang, C.-H.A., et al., Agonist-mediated activation of STING induces apoptosis in malignant B 
cells. Cancer research, 2016. 76(8): p. 2137-2152. 
581. Curran, E., et al., STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid 
Leukemia. Cell Reports, 2016. 15(11): p. 2357-2366. 
582. Xia, T., et al., Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA 
Damage Responses and Correlates With Tumorigenesis. Cell Reports, 2016. 14(2): p. 282-297. 
583. Xia, T., H. Konno, and G.N. Barber, Recurrent Loss of STING Signaling in Melanoma Correlates 
with Susceptibility to Viral Oncolysis. Cancer research, 2016. 76(22): p. 6747-6759. 
584. Dilley, R.L. and R.A. Greenberg, ALTernative Telomere Maintenance and Cancer. Trends in 
Cancer, 2015. 1(2): p. 145-156. 
585. Henson, J.D., et al., DNA C-circles are specific and quantifiable markers of alternative-
lengthening-of-telomeres activity. Nature Biotechnology, 2009. 27: p. 1181. 
-201- 
 
586. Bryan, T.M., et al., Evidence for an alternative mechanism for maintaining telomere length in 
human tumors and tumor-derived cell lines. Nature Medicine, 1997. 3: p. 1271. 
587. Chen, Y.-A., et al., Extrachromosomal telomere repeat DNA is linked to ALT development via 
cGAS-STING DNA sensing pathway. Nature Structural &Amp; Molecular Biology, 2017. 
588. Swann, J.B., et al., Demonstration of inflammation-induced cancer and cancer immunoediting 
during primary tumorigenesis. Proceedings of the National Academy of Sciences of the United States of 
America, 2008. 105(2): p. 652-656. 
589. Song, S., et al., Decreased expression of STING predicts poor prognosis in patients with gastric 
cancer. Scientific Reports, 2017. 7: p. 39858. 
590. Gaston, J., et al., Intracellular STING inactivation sensitizes breast cancer cells to genotoxic 
agents. Oncotarget, 2016. 7(47): p. 77205-77224. 
591. Huang, L., et al., DNA sensing via the Stimulator of Interferon Genes (STING) adaptor in myeloid 
dendritic cells induces potent tolerogenic responses(). Journal of immunology (Baltimore, Md. : 1950), 
2013. 191(7): p. 3509-3513. 
592. Munn, D.H. and A.L. Mellor, IDO in the Tumor Microenvironment: Inflammation, Counter-
Regulation, and Tolerance. Trends in Immunology, 2016. 37(3): p. 193-207. 
593. Lemos, H., et al., STING promotes the growth of tumors characterized by low antigenicity via 
IDO activation. Cancer research, 2016. 76(8): p. 2076-2081. 
594. Hall, J., et al., Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel 
fluorescence polarization assay. PLoS ONE, 2017. 12(9): p. e0184843. 
595. Kellenberger, C.A. and M.C. Hammond, Chapter Eight - In Vitro Analysis of Riboswitch–
Spinach Aptamer Fusions as Metabolite-Sensing Fluorescent Biosensors, in Methods in Enzymology, 
D.H. Burke-Aguero, Editor. 2015, Academic Press. p. 147-172. 
596. Kellenberger, C.A., et al., RNA-Based Fluorescent Biosensors for Live Cell Imaging of Second 
Messengers Cyclic di-GMP and Cyclic AMP-GMP. Journal of the American Chemical Society, 2013. 
135(13): p. 4906-4909. 
597. Bose, D., et al., An RNA-Based Fluorescent Biosensor for High-Throughput Analysis of the 
cGAS-cGAMP-STING Pathway. Cell Chemical Biology, 2016. 23(12): p. 1539-1549. 
598. Ren, A., et al., Structural Basis for Molecular Discrimination by a 3′,3′-cGAMP Sensing 
Riboswitch. Cell Reports, 2015. 11(1): p. 1-12. 
599. Roembke, B.T., et al., A cyclic dinucleotide containing 2-aminopurine is a general fluorescent 
sensor for c-di-GMP and 3[prime or minute],3[prime or minute]-cGAMP. Molecular BioSystems, 2014. 
10(6): p. 1568-1575. 
600. Andreeva, L., et al., cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming 
protein–DNA ladders. Nature, 2017. 549(7672): p. 394-398. 
601. Luecke, S., et al., cGAS is activated by DNA in a length-dependent manner. EMBO Reports, 
2017. 18(10): p. 1707-1715. 
-202- 
 
602. Zhang, Y., et al., The DNA sensor, cyclic GMP-AMP synthase (cGAS) is essential for induction of 
IFN beta during Chlamydia trachomatis infection(). Journal of immunology (Baltimore, Md. : 1950), 
2014. 193(5): p. 2394-2404. 
603. Lee, A., et al., The N terminus of cGAS de-oligomerizes the cGAS:DNA complex and lifts the 
DNA size restriction of core-cGAS activity. FEBS Letters, 2017. 591(6): p. 954-961. 
604. Sun, B., et al., Dengue virus activates cGAS through the release of mitochondrial DNA. Scientific 
Reports, 2017. 7(1): p. 3594. 
605. Dejean, L.M., et al., Oligomeric Bax Is a Component of the Putative Cytochrome c Release 
Channel MAC, Mitochondrial Apoptosis-induced Channel. Molecular Biology of the Cell, 2005. 16(5): p. 
2424-2432. 
606. Martinez-Caballero, S., et al., Assembly of the Mitochondrial Apoptosis-induced Channel, MAC. 
Journal of Biological Chemistry, 2009. 284(18): p. 12235-12245. 
607. Torbet, J. and E. DiCapua, Supercoiled DNA is interwound in liquid crystalline solutions. The 
EMBO Journal, 1989. 8(13): p. 4351-4356. 
608. Yang, H., et al., cGAS is essential for cellular senescence. Proceedings of the National Academy 
of Sciences, 2017. 114(23): p. E4612-E4620. 
609. Shumilov, A., et al., Epstein–Barr virus particles induce centrosome amplification and 
chromosomal instability. Nature Communications, 2017. 8: p. 14257. 
610. Si, H. and E.S. Robertson, Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-
Associated Nuclear Antigen Induces Chromosomal Instability through Inhibition of p53 Function. Journal 
of Virology, 2006. 80(2): p. 697-709. 
611. Gruhne, B., et al., The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via 
induction of reactive oxygen species. Proceedings of the National Academy of Sciences, 2009. 106(7): p. 
2313-2318. 
612. Ivanov, S., et al., A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-
DNA. Blood, 2007. 110(6): p. 1970-1981. 
613. Dumitriu, I.E., et al., Requirement of HMGB1 and RAGE for the maturation of human 
plasmacytoid dendritic cells. European Journal of Immunology, 2005. 35(7): p. 2184-2190. 
614. Ngo, H.B., J.T. Kaiser, and D.C. Chan, The mitochondrial transcription and packaging factor 
Tfam imposes a U-turn on mitochondrial DNA. Nature Structural &Amp; Molecular Biology, 2011. 18: p. 
1290. 
615. Swinger, K.K., et al., Flexible DNA bending in HU–DNA cocrystal structures. The EMBO 
Journal, 2003. 22(14): p. 3749-3760. 
616. Hammel, M., et al., HU multimerization shift controls nucleoid compaction. Science Advances, 
2016. 2(7): p. e1600650. 
617. Zhang, L., et al., Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals 
nucleated polymerization. Science (New York, N.Y.), 2015. 350(6259): p. 404-409. 
618. Peisley, A., et al., Kinetic mechanism for viral dsRNA length discrimination by MDA5 filaments. 
Proc Natl Acad Sci U S A., 2012. 109. 
-203- 
 
619. Ngo, H.B., et al., Distinct structural features of TFAM drive mitochondrial DNA packaging 
versus transcriptional activation. Nature Communications, 2014. 5: p. 3077-3077. 
620. Lood, C., et al., Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are 
interferogenic and contribute to lupus-like disease. Nature Medicine, 2016. 22: p. 146. 
621. Bonaldi, T., et al., Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it 
towards secretion. The EMBO Journal, 2003. 22(20): p. 5551-5560. 
622. Xu, J., et al., Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by 
RIG-I. mBio, 2015. 6(5). 
623. Chen, Y.G., et al., Sensing Self and Foreign Circular RNAs by Intron Identity. Molecular Cell, 
2017. 67(2): p. 228-238.e5. 
624. Lasda, E. and R. Parker, Circular RNAs Co-Precipitate with Extracellular Vesicles: A Possible 
Mechanism for circRNA Clearance. PLoS ONE, 2016. 11(2): p. e0148407. 
625. Sze, A., et al., Host Restriction Factor SAMHD1 Limits Human T Cell Leukemia Virus Type 1 
Infection of Monocytes via STING-Mediated Apoptosis. Cell host & microbe, 2013. 14(4): p. 422-434. 
626. Herzner, A.-M., et al., Sequence-specific activation of the DNA sensor cGAS by Y-form DNA 
structures as found in primary HIV-1 cDNA. Nature immunology, 2015. 16: p. 1025. 
627. Dewannieux, M. and T. Heidmann, Endogenous retroviruses: acquisition, amplification and 
taming of genome invaders. Current Opinion in Virology, 2013. 3(6): p. 646-656. 
628. Molaro, A. and H.S. Malik, Hide and seek: how chromatin-based pathways silence retroelements 
in the mammalian germline. Current opinion in genetics & development, 2016. 37: p. 51-58. 
629. Goering, W., T. Ribarska, and W.A. Schulz, Selective changes of retroelement expression in 
human prostate cancer. Carcinogenesis, 2011. 32(10): p. 1484-1492. 
630. Kudo-Saito, C., et al., Induction of immunoregulatory CD271+ cells by metastatic tumor cells 
that express human endogenous retrovirus H. Cancer Res, 2014. 74(5): p. 1361-70. 
631. Szpakowski, S., et al., Loss of epigenetic silencing in tumors preferentially affects primate-
specific retroelements. Gene, 2009. 448(2): p. 151-167. 
632. Hung, T., et al., The Ro60 autoantigen binds endogenous retroelements and regulates 
inflammatory gene expression. Science, 2015. 350(6259): p. 455-459. 
633. Chiappinelli, Katherine B., et al., Inhibiting DNA Methylation Causes an Interferon Response in 
Cancer via dsRNA Including Endogenous Retroviruses. Cell, 2016. 164(5): p. 1073. 
634. Roulois, D., et al., DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral 
Mimicry by Endogenous Transcripts. Cell, 2015. 162(5): p. 961-973. 
635. Karijolich, J., E. Abernathy, and B.A. Glaunsinger, Infection-Induced Retrotransposon-Derived 
Noncoding RNAs Enhance Herpesviral Gene Expression via the NF-κB Pathway. PLOS Pathogens, 2015. 
11(11): p. e1005260. 
636. Zhao, K., et al., Modulation of LINE-1 and Alu/SVA Retrotransposition by Aicardi-Goutières 
Syndrome-Related SAMHD1. Cell Reports, 2013. 4(6): p. 1108-1115. 
-204- 
 
637. Gasior, S.L., et al., The Human LINE-1 Retrotransposon Creates DNA Double-strand Breaks. 
Journal of molecular biology, 2006. 357(5): p. 1383-1393. 
638. Maxwell, P.H., W.C. Burhans, and M.J. Curcio, Retrotransposition is associated with genome 
instability during chronological aging. Proceedings of the National Academy of Sciences, 2011. 108(51): 
p. 20376-20381. 
639. Mankan, A.K., et al., Cytosolic RNA:DNA hybrids activate the cGAS–STING axis. The EMBO 
Journal, 2014. 33(24): p. 2937-2946. 
640. Rennekamp, A.J. and P.M. Lieberman, Initiation of Epstein-Barr Virus Lytic Replication 
Requires Transcription and the Formation of a Stable RNA-DNA Hybrid Molecule at OriLyt. Journal of 
Virology, 2011. 85(6): p. 2837-2850. 
641. Prichard, M.N., et al., Identification of Persistent RNA-DNA Hybrid Structures within the Origin 
of Replication of Human Cytomegalovirus. Journal of Virology, 1998. 72(9): p. 6997-7004. 
642. Yasukawa, T., et al., Replication of vertebrate mitochondrial DNA entails transient 
ribonucleotide incorporation throughout the lagging strand. The EMBO Journal, 2006. 25(22): p. 5358-
5371. 
643. Granier, S. and B. Kobilka, A new era of GPCR structural and chemical biology. Nature 
Chemical Biology, 2012. 8: p. 670. 
644. Endres, N.F., et al., Regulation of the catalytic activity of the EGF receptor. Current Opinion in 
Structural Biology, 2011. 21(6): p. 777-784. 
645. Salahpour, A., S. Angers, and M. Bouvier, Functional Significance of Oligomerization of G-
protein-coupled Receptors. Trends in Endocrinology & Metabolism, 2000. 11(5): p. 163-168. 
646. Chabre, M. and M. le Maire, Monomeric G-Protein-Coupled Receptor as a Functional Unit. 
Biochemistry, 2005. 44(27): p. 9395-9403. 
647. Wu, H., Higher-Order Assemblies in a New Paradigm of Signal Transduction. Cell, 2013. 
153(2): p. 287-292. 
648. Medzhitov, R., et al., MyD88 Is an Adaptor Protein in the hToll/IL-1 Receptor Family Signaling 
Pathways. Molecular Cell, 1998. 2(2): p. 253-258. 
649. Lin, S.-C., Y.-C. Lo, and H. Wu, Helical assembly in the MyD88–IRAK4–IRAK2 complex in 
TLR/IL-1R signalling. Nature, 2010. 465: p. 885. 
650. Ve, T., et al., Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent 
TLR4 signaling. Nature Structural &Amp; Molecular Biology, 2017. 24: p. 743. 
651. Ferrao, R., et al., IRAK4 Dimerization and trans-Autophosphorylation Are Induced by 
Myddosome Assembly. Molecular Cell, 2014. 55(6): p. 891-903. 
652. Wang, L., et al., Crystal structure of human IRAK1. Proceedings of the National Academy of 
Sciences, 2017. 114(51): p. 13507-13512. 
653. Park, Y.C., et al., Structural basis for self-association and receptor recognition of human TRAF2. 
Nature, 1999. 398: p. 533. 
654. Ye, H., et al., Distinct molecular mechanism for initiating TRAF6 signalling. Nature, 2002. 418: 
p. 443. 
-205- 
 
655. Yin, Q., et al., E2 interaction and dimerization in the crystal structure of TRAF6. Nature 
Structural &Amp; Molecular Biology, 2009. 16: p. 658. 
656. Ferrao, R., et al., Structural Insights into the Assembly of Large Oligomeric Signalosomes in the 
Toll-Like Receptor–Interleukin-1 Receptor Superfamily. Science Signaling, 2012. 5(226): p. re3-re3. 
657. Lu, A., et al., Plasticity in PYD assembly revealed by cryo-EM structure of the PYD filament of 
AIM2. Cell Discovery, 2015. 1: p. 15013. 
658. Vajjhala, P.R., et al., The Inflammasome Adaptor ASC Induces Procaspase-8 Death Effector 
Domain Filaments. Journal of Biological Chemistry, 2015. 290(49): p. 29217-29230. 
659. Lu, A., et al., Molecular basis of caspase-1 polymerization and its inhibition by a new capping 
mechanism. Nature Structural &Amp; Molecular Biology, 2016. 23: p. 416. 
660. Xu, H., et al., Structural basis for the prion-like MAVS filaments in antiviral innate immunity. 
eLife, 2014. 3: p. e01489. 
661. Baril, M., et al., MAVS Dimer Is a Crucial Signaling Component of Innate Immunity and the 
Target of Hepatitis C Virus NS3/4A Protease. Journal of Virology, 2009. 83(3): p. 1299-1311. 
662. Tsukamoto, H., et al., Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 
dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-
associated CD14-expressing cells. International Immunology, 2010. 22(4): p. 271-280. 
663. Latz, E., et al., Ligand-induced conformational changes allosterically activate Toll-like receptor 
9. Nature immunology, 2007. 8: p. 772. 
664. Motshwene, P.G., et al., An Oligomeric Signaling Platform Formed by the Toll-like Receptor 
Signal Transducers MyD88 and IRAK-4. Journal of Biological Chemistry, 2009. 284(37): p. 25404-
25411. 
665. Jiang, X., et al., Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 
activates antiviral innate immune response. Immunity., 2012. 36. 
666. Jin, T., et al., Structure of the Absent in Melanoma 2 (AIM2) Pyrin Domain Provides Insights into 
the Mechanisms of AIM2 Autoinhibition and Inflammasome Assembly. The Journal of Biological 
Chemistry, 2013. 288(19): p. 13225-13235. 
667. del Toro Duany, Y., B. Wu, and S. Hur, MDA5—filament, dynamics and disease. Current 
Opinion in Virology, 2015. 12: p. 20-25. 
668. Fu, T.-M., et al., Cryo-EM Structure of Caspase-8 Tandem DED Filament Reveals Assembly and 
Regulation Mechanisms of the Death-Inducing Signaling Complex. Molecular Cell, 2016. 64(2): p. 236-
250. 
669. Yin, Q., et al., Molecular Mechanism for p202-Mediated Specific Inhibition of AIM2 
Inflammasome Activation. Cell Reports, 2013. 4(2): p. 327-339. 
 
 
 
 
-206- 
 
Acknowledgements 
First of all I would like to thank my supervisor and mentor Prof. Dr. Karl-Peter Hopfner for a chance to 
work on such challenging and exciting projects, his vision and ideas that made this work possible. I 
deeply appreciate his sincere involvement and trust that helped me during my whole PhD and the joy of 
discovery that we shared together. Under his supervision I learned a lot as a specialist and a person and 
his support always encouraged me to face challenges without hesitation and to develop my own view and 
ideas. 
I also want to express my sincere gratitude to Prof. Dr. Veit Hornung and Prof. Dr. Heinrich Leonhardt 
for their interest in my work, timely support and intellectual input, which were absolutely crucial for a 
successful accomplishment of my PhD project. I enjoyed and learned a lot from our discussions! 
My deep appreciation is also addressed to Prof. Dr. Martin Schlee and Anna Herzner, who first 
introduced me to an exciting world of structured DNA species. Thank you for your great ideas and 
motivating enthusiasm! 
Furthermore, I thank my colleagues Björn Hiller and Andreas Maiser for their optimism, productiveness 
and enormous time that they spent for the cell-based and microscopy experiments, despite their busyness 
with their own projects. 
I highly appreciate the tremendous help from Dirk Kostrewa and want to thank him not only for building 
the cGAS structure from difficult diffraction data under the time pressure, but also for his patience and 
kindness in answering my questions and correcting my mistakes. 
I would also like to thank my talented and motivated colleagues Charlotte Lässig, Carina Mann and David 
Drexler, who put so much effort, time and engagement to help me with my research. Thank you for 
staying optimistic and interested through the stressful times and especially for your patience and your 
kind understanding of my emotional involvement! 
My special thanks are also addressed to Agata Butryn who offered her help in need, supported me in the 
first structure evaluation and speeded up my PhD. Thank you for your professionalism and sympathy! 
Additionally, I want to thank Siret Somarokov and Gabriele Stöhr for their interest and creativity. I also 
highly appreciate the input from Gregor Witte and Katja Lammens that helped me with crystallization 
trials, as well as the support from Claudia Isakaj and Olga Fetscher in urgent and time-consuming 
experiments. I thank very much Moritz Gaidt and Stefan Bauernfried for their amazing cell lines, which 
were absolutely indispensable for my work.  
Moreover, my deepest gratitude is addressed to Tobias Deimling who took care of me at the beginning of 
my PhD, taught me all the basics in the lab, supported my curiosity and answered my countless questions. 
I also sincerely thank Martina Müller for her kind support in the lab and during the synchrotron trips. 
I also express my admiration and thankfulness to the whole Hopfner lab members for their help in the lab, 
fruitful scientific discussions, as well as for emotional support and involvement. 
I would also like to thank my dearest friends and family that are always with me, despite the long 
distances between us. Your love, trust and faith are keeping me alive and are the biggest treasure I was 
blessed to have. 
